{"label": 0, "source_ent": {"research_entity_id": "MSH:D008972", "canonical_name": "Molindone", "aliases": ["moban", "monohydrochloride, molindone", "4h-indol-4-one, 3-ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-", "endo brand of molindone hydrochloride", "molindone", "hydrochloride, molindone", "molindone hydrochloride", "molindone monohydrochloride"], "definition": "An indole derivative effective in schizophrenia and other psychoses and possibly useful in the treatment of the aggressive type of undersocialized conduct disorder. Molindone has much lower affinity for D2 receptors than most antipsychotic agents and has a relatively low affinity for D1 receptors. It has only low to moderate affinity for cholinergic and alpha-adrenergic receptors. Some electrophysiologic data from animals indicate that molindone has certain characteristics that resemble those of CLOZAPINE. (From AMA Drug Evaluations Annual, 1994, p283)", "other_contexts": ["Since 24 h pretreatment with molindone , unlike 30 min pretreatment with clomipramine , failed to antagonize fenfluramine and p - chloramphetamine - induced behavioural syndromes , it suggests that molindone and/or its metabolites most probably do not exert 5-HT neuronal uptake blocking activity and the potentiation of 5-HTP - induced behavioural syndrome is due to a metabolite 's MAO - A inhibitory activity .", "By means of a high performance liquid chromatographic technique , serum molindone levels were measured in 14 psychotic patients receiving a wide range of doses of this drug .", "Both drugs ( 1.0 mg / kg ) blocked responses to an alpha agonist ( methoxamine ) , but chlorpromazine was significantly more potent than molindone .", "Effects of molindone and fluphenazine on the brain concentration of some phenolic and catecholic amines in the mouse and the rat .", "24 h pretreatment with molindone enhanced the behavioural effects of L - dopa and 5-HTP , precursors of biogenic amines ( catecholamines and 5-HT respectively ) preferentially deaminated by MAO - A , confirming that a metabolite of molindone inhibits MAO - A. 24 h pretreatment with molindone enhanced the behavioural effects of tryptamine and antagonized reserpine - induced ptosis , and in molindone - pretreated rats L - tryptophan induced behavioural effects , probably because of the MAO - A inhibitory activity exerted by a metabolite of molindone .", "Finally , we contacted the manufacturer of molindone and the authors of any relevant trials .", "Treatment with molindone was generally well tolerated , with no clinically meaningful changes in laboratory or physical examination findings .", "Chlorpromazine and molindone were tested for their abilities to impair conditioned avoidance behavior of rats .", "Serum molindone and prolactin levels might help assess resistance to molindone treatment .", "For measures of global assessment , available data do not justify any conclusions on the comparative efficacy of molindone and placebo .", "Chlorpromazine was effective within the dose range of 0.3 to 7.0 mg / kg ( ID50approximately 2.0 mg / kg ) ; molindone was effective within the range of 0.3 to 5.0 mg / kg ( ID50 approximately 0.6 mg / kg ) .", "Psychopharmacological investigation of the monoamine oxidase inhibitory activity of molindone , a dihydroindolone neuroleptic .", "When molindone ( 1 - 10 mg / kg ) was administered concomitantly with guanethidine , there was no loss of blood pressure control .", "4 With high doses of molindone ( 100 mg / kg ) the effects on both tyramines and on dopamine metabolism were reversed .", "The antipsychotic drug molindone is considered to be atypical in its mode of action and to have mild side effects .", "Molindone in low intravenous doses ( 0.4 - 0.8 mg / kg ) was found to reverse d - amphetamine and apomorphine induced depression of DA neurons and to block apomorphine induced depression of these cells .", "METHODS This open - label , parallel - group , dose - ranging , multicenter trial randomized children , aged 6 - 12 years , with ADHD and persistent , serious conduct problems to receive oral molindone thrice daily for 9 - 12 weeks in four treatment groups : Group 1 - 10 mg ( 5 mg if weight < 30 kg ) , group 2 - 20 mg ( 10 mg if < 30 kg ) , group 3 - 30 mg ( 15 mg if < 30 kg ) , and group 4 - 40 mg ( 20 mg if < 30 kg ) .", "The pharmacokinetic measures of area under the curve and maximum concentration show that intramuscular molindone is 1.49 to 1.67 times more bioavailable than oral molindone .", "As shown previously with chronic amphetamine pretreatment , molindone also failed to enhance the stereotyped response produced by apomorphine .", "These results can be interpreted as molindone acting as a partial agonist .", "Chronic molindone treatment : Relative inability to elicit dopamine receptor supersensitivity in rats Chronic treatment of rats with the antipsychotic drug molindone ( 2.5 mg / kg ) did not elicit behavioral supersensitivity to apomorphine ( AP ) ( 0.25 mg / kg ) or increased striatal 3H - spiroperidol binding , whereas treatment with haloperidol ( 0.5–1.0 mg / kg ) produced manifestations of dopaminergic supersensitivity in both paradigms .", "5 The concentrations of hypothalamic p- and m - octopamine were increased by the higher doses of molindone ( 20 to 100 mg / kg ) employed while lower doses produced no significant effects .", "Molindone was also found to increase dopamine synthesis and dihydroxyphenylactic acid levels in the striatum and olfacotry tubercles .", "6 These results suggest that molindone acts as a blocker or a partial agonist of dopamine receptor sites and fit well with the proposal of a reciprocal relation between dopamine and tyramine .", "These results with molindone in an animal model of tardive dyskinesia suggest that this drug may have a lower potential for eliciting this disorder in humans .", "CONCLUSIONS Molindone at doses of 5 - 20 mg / day ( children weighing < 30 kg ) and 20 - 40 mg ( ≥ 30 kg ) was well tolerated , and preliminary efficacy results suggest that molindone produces dose - related behavioral improvements over 9 - 12 weeks .", "A comparison of the abilities of chlorpromazine and molindone to interact adversely with guanethidine .", "Possible mechanisms of action of molindone are discussed based on these findings .", "Chronic treatment with a high dose of molindone ( 20 mg / kg ) elicited a small , but significant increase in behavioral sensitivity to AP ( 57% ) which was , however , significantly less than that produced by 1 mg / kg haloperidol ( 126% , P<0.01 ) .", "The doses of molindone that blocked the apomorphine - induced reduction in the concentration of DOPAC in the striatum correlated with the doses that enhanced amphetamine - induced stereotypy .", "However , unlike most antipsychotic drugs previously tested , molindone failed to increase the baseline firing rate of DA cells and blocked haloperidol induced increases in DA neuron activity .", "Molindone may be an effective antipsychotic but its adverse effect profile does not differ significantly from that of typical antipsychotics ( apart from the event of weight loss ) .", "1 The concentrations of p- and m - tyramine , dopamine , 3,4-dihydroxyphenylacetic acid and homo - vanillic acid were measured in the mouse or rat striatum following the subcutaneous injection of molindone or fluphenazine .", "The authors suggest that molindone may have a range of serum levels consistent with therapeutic benefit .", "Molindone levels as high as 350 ng/mL were obtained and were not associated with any toxic effects.", "Researchers have suggested that molindone should be classified as an atypical antipsychotic .", "Molindone for schizophrenia and severe mental illness .", "The time to maximum concentration occurred significantly earlier ( P = 0.05 ) with intramuscular molindone ( 0.6 hours ) than with oral molindone ( 1.1 hours ) .", "This study was designed to assess the bioequivalence of intramuscular molindone hydrochloride and marketed oral molindone .", "However , in contrast to the effects of chronic administration of amphetamine , molindone both increased the striatal concentration of dihydroxyphenylacetic acid ( DOPAC ) and blocked the ability of small doses of apomorphine to decrease this dopamine ( DA ) metabolite .", "In all of these respects molindone behaves identically to most classical neuroleptics .", "This finding indicates that once a patient 's acute psychotic episode has been stabilized with intramuscular molindone , therapy can continue without interruption by substituting 1.5 mg of oral molindone for every 1 mg of intramuscular molindone .", "SELECTION CRITERIA We included all randomised controlled trials that compared molindone to other treatments for schizophrenia and schizophrenia - like psychoses .", "A phase 2a randomized , parallel group , dose - ranging study of molindone in children with attention - deficit / hyperactivity disorder and persistent , serious conduct problems .", "In order to determine whether molindone enhanced amphetamine - induced stereotypy by the same mechanism as chronic administration of amphetamine or drugs that inhibit central noradrenergic transmission , the effect of these drugs on the stereotyped behavior produced by beta - phenethylamine ( PEA ) was compared .", "OBJECTIVES To determine the effects of molindone compared with placebo , typical and other atypical antipsychotic drugs for schizophrenia and related psychoses .", "Further , since 2 h pretreatment with molindone failed to enhance the behavioural effects of L - dopa , it suggests that at 2 h the degree of MAO - A inhibition induced by molindone and/or the metabolite is not sufficient to counteract the neuroleptic activity of the parent compound .", "In this regard molindone most closely resembles thioridazine and clozapine .", "Molindone is no more or less likely than typical drugs to cause movement disorders , but it does cause significantly more weight loss ( 2RCTs n=60 RR 2.78 , CI 1.10 to 6.99 , NNH 5 CI 2 to 77 ) .", "The effect of molindone on the activity of dopaminergic ( DA ) neurons in the rat midbrain and on DA metabolism in the striatum and olfactory tubercles was studied using extracellular single unit recording and biochemical techniques respectively .", "On the last day each molindone formulation was given , plasma samples were collected at baseline and at 0.5 , 1 , 2 , 4 , 6 , 8 , and 12 hours after administration .", "Behaviorally relevant doses of chlorpromazine and molindone were then tested for their effects on blood pressure and on adrenergic mechanisms .", "Enhanced stereotyped response to amphetamine after pretreatment with small doses of molindone .", "In addition , chlorpromazine produced a dose - dependent ( 1.0 - 10.0 mg / kg ) inhibition of 3H - l - norepinephrine uptake into heart , but molindone at the same doses produced no inhibition of uptake .", "In contrast , neither molindone nor chronic pretreatment with amphetamine altered beta - phenethylamine - induced stereotypy .", "Since the decrease in DOPAC in the striatum produced by apomorphine is thought to be mediated through the stimulation of striatal DA autoreceptors , these results suggest that molindone enhances amphetamine - induced stereotypy by selectively inhibiting DA autoreceptors .", "Additional double - blind , placebo - controlled trials are needed to further investigate molindone in this pediatric population .", "As 2 h pretreatment with molindone induced catalepsy and antagonized apomorphine - induced climbing behaviour in mice and stereotypy in rats , while 24 h pretreatment failed to induce catalepsy and to antagonize apomorphine - induced behaviour , it appears that , at 24 h , the tissue levels of molindone are inadequate to block postsynaptic striatal and mesolimbic DA receptors and that , though a metabolite of molindone is biologically active so far as inhibition of MAO - A is concerned , the metabolites are devoid of neuroleptic activity .", "Effects of molindone on central dopaminergic neuronal activity and metabolism : similarity to other neuroleptics .", "Pretreatment of rats with small doses of the antipsychotic drug , molindone , enhanced the stereotyped behavioral response to amphetamine .", "A significant ( P<0.001 ) correlation of receptor binding acitivty and stereotypy score was obtained for haloperidol- , but not molindone - treated rats .", "Apparent tolerance to elevation of striatal and frontal cortical 3,4-dihydroxyphenylacetic acid ( DOPAC ) levels was obtained with chronic molindone treatment ( 5 or 20 mg / kg ) .", "Relation of serum molindone levels to serum prolactin levels and antipsychotic response .", "None of the molindone doses used ( 2.5–50 mg / kg ) increased striatal dopamine receptor binding .", "The primary outcome measure was to evaluate safety and tolerability of molindone in children with ADHD and serious conduct problems .", "It is concluded that molindone is an important drug , because it is an antipsychotic agent that does not interact adversely with guanethidine .", "3 The administration of low doses of molindone ( 1 to 10 mg / kg ) produced a reduction in striatal p - tyramine , an increase in m - tyramine and an increase in dopamine turnover .", "Ten schizophrenic patients ( mean age , 30.2 years ) received oral molindone in single daily doses of 100 or 150 mg for four to eight days followed by intramuscular molindone in single daily doses of 50 or 75 mg for four days ."], "par_relations": ["Indoles", "Antipsychotic Agents", "Molindone", "Molindone"], "chd_relations": ["Molindone", "Molindone"], "syn_relations": ["Molindone", "Molindone", "Molindone", "Molindone"], "sib_relations": ["Adrenochrome", "Alcian Blue", "Carbazoles", "Carbolines", "Cytochalasins", "Gliotoxin", "Hydroxytryptophol", "Ibogaine", "Indapamide", "Indican", "Indigo Carmine", "Indocyanine Green", "Indoleacetic Acids", "Indomethacin", "Indoramin", "Iprindole", "Isatin", "Methisazone", "Oxyphenisatin Acetate", "Skatole", "Sporidesmins", "Tryptamines", "Perindopril", "Delavirdine", "Indole Alkaloids", "Indolequinones", "Vilazodone Hydrochloride"]}, "target_ent": {"research_entity_id": "RXNORM:237025", "canonical_name": "Halometasone Monohydrate", "aliases": ["halometasone monohydrate"], "definition": "", "other_contexts": [], "par_relations": ["halometasone"], "chd_relations": [], "syn_relations": [], "sib_relations": []}}
{"label": 1, "source_ent": {"research_entity_id": "MSH:C538334", "canonical_name": "Nakajo syndrome", "aliases": ["nakajo syndrome", "nodular erythema with digital changes", "nodular erythema digital changes"], "definition": "", "other_contexts": ["CANDLE is an integrated device control system using Google Maps designed to meet these requirements .", "CANDLE : A Tool for Efficient Analysis of CAN Control Systems Construction and analysis of formal system models is increasingly accepted as a valuable technique in the rigorous development of real - time control systems .", "Finally , the incremental algorithm of attribute reduction in concept lattice for ALDD is presented .", "Urinary Microbiota Associated with Preterm Birth : Results from the Conditions Affecting Neurocognitive Development and Learning in Early Childhood ( CANDLE ) Study Preterm birth ( PTB ) is the leading cause of infant morbidity and mortality .", "By this simple core configuration and fuel setting , rather than using a complicated method , we can obtain the desired middle and large CANDLE fast cores with reasonable core geometry and thermal hydraulic parameters that perform safely and economically ; as is to be expected from CANDLE .", "CANDLE is a high - level language and development environment for CAN control systems .", "Autoinflammatory diseases , including CAPS , TRAPS , HIDS , FMF , Blau , and CANDLE , have unique dermatologic presentations that can be a clue to diagnosis .", "Using CANDLE , a user can control physically distributed devices through a web browser .", "To assist in understanding the CANDLE reactor 's attributes , analysis and discussion of the calculation results achieved are provided .", "CANDLE syndrome : chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature — a rare case with a novel mutation We described herein a patient with chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature ( CANDLE ) syndrome and a novel mutation in PSMB8 gene .", "An Incremental Attribute Reduction Approach with Concept Lattice for ALDD As an effective tool for knowledge discovery, concept lattice has been successfully applied to various fields.", "The existing work on attribute reduction has not focused on aquatic lives disease diagnosis (ALDD).", "In this paper , the middle and large CANDLE reactors are investigated with U - Pu and combined ThU - UPu fuel cycles , aiming to utilize the abundant thorium resources and optimize the radial power distribution .", "Blau , CANDLE . Autoinflammatory diseases , including CAPS , TRAPS , HIDS , FMF , Blau , and CANDLE , have unique dermatologic presentations that can be a clue to diagnosis . Although these", "This paper is my own interpretation of the challenges faced in the CANDLE project , and does not necessarily reflect the views of the whole CANDLE consortium .", "This paper describes an improved incremental approach of attribute reduction in concept lattice for ALDD.", "Preliminary response to Janus kinase inhibition with baricitinib in chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperatures ( CANDLE ) Preliminary response to Janus kinase inhibition with baricitinib in chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperatures ( CANDLE )", "Insights from Mendelian Interferonopathies : Comparison of CANDLE , SAVI with AGS , Monogenic Lupus Autoinflammatory disorders are sterile inflammatory conditions characterized by episodes of early - onset fever and disease - specific patterns of organ inflammation .", "In this review , we compare the clinical presentations and pathogenesis of two IFN - mediated autoinflammatory diseases , CANDLE and SAVI , with Aicardi Goutières syndrome ( AGS ) and monogenic forms of SLE ( monoSLE ) caused by loss - of - function mutations in complement 1 ( C1q ) or the DNA nucleases , DNASE1 and DNASE1L3 .", "This paper describes the core of an OPEN / CAESAR - compliant compiler for CANDLE which provides an interface to a reachability analyser and established tools such as CADP and OPEN / KRONOS .", "For many developing countries with a large population and high energy demands , such as China and India , middle ( 1000 MWth ) and large ( 2000 MWth ) CANDLE fast reactors are obviously more suitable than small reactors [ 2 ] .", "Thus , CANDLE is quite useful for distributed device control systems such as security , healthcare , and global monitoring systems .", "While IFN amplification is caused by predominantly innate immune cell dysfunction in SAVI , CANDLE , and AGS , autoantibodies to modified RNA and DNA antigens interact with tissues and immune cells including neutrophils and contribute to IFN upregulation in some SLE patients including monoSLE , thus justifying a grouping of “ autoinflammatory ” and “ autoimmune ” interferonopathies .", "clinical presentations and pathogenesis of two IFN - mediated autoinflammatory diseases , CANDLE and SAVI , with Aicardi Goutières syndrome ( AGS ) and monogenic forms of SLE ( monoSLE ) caused", "Integrated Device Control System using Google Maps This paper proposes an integrated device control system called Control Architecture for Networked Devices in Location Environments ( CANDLE ) , which controls devices with Google Maps .", ". While IFN amplification is caused by predominantly innate immune cell dysfunction in SAVI , CANDLE , and AGS , autoantibodies to modified RNA and DNA antigens interact with tissues and immune cells", "Autoinflammatory diseases in dermatology : CAPS , TRAPS , HIDS , FMF , Blau , CANDLE ."], "par_relations": ["Erythema Nodosum", "Fingers"], "chd_relations": [], "syn_relations": [], "sib_relations": ["abnormalities"]}, "target_ent": {"research_entity_id": "OMIM:177046", "canonical_name": "PROTEASOME SUBUNIT, BETA-TYPE, 8", "aliases": ["proteasome-related gene 7", "ring10", "psmb8", "proteasome subunit beta-5i", "proteasome subunit, beta-type, 8", "autoinflammation, lipodystrophy, and dermatosis syndrome", "large multifunctional protease 7", "lmp7"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["PROTEASOME SUBUNIT, BETA-TYPE, 8", "PROTEASOME SUBUNIT, BETA-TYPE, 8", "PROTEASOME SUBUNIT, BETA-TYPE, 8", "PROTEASOME SUBUNIT, BETA-TYPE, 8", "PSMB8, THR75MET", "PSMB8, GLY197VAL", "PSMB8, GLY201VAL", "PSMB8, CYS135TER", "PROTEASOME SUBUNIT, BETA-TYPE, 8", "PROTEASOME SUBUNIT, BETA-TYPE, 8", "PROTEASOME SUBUNIT, BETA-TYPE, 8", "PROTEASOME SUBUNIT, BETA-TYPE, 8", "PROTEASOME SUBUNIT, BETA-TYPE, 8", "PROTEASOME SUBUNIT, BETA-TYPE, 8", "PROTEASOME SUBUNIT, BETA-TYPE, 8", "PROTEASOME SUBUNIT, BETA-TYPE, 8"], "sib_relations": ["PSMB8, THR75MET", "PSMB8, GLY197VAL", "PSMB8, GLY201VAL", "PSMB8, CYS135TER"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C059167", "canonical_name": "2,2,4,4,6,8,8-heptamethylnonane", "aliases": ["isohexadecane", "2,2,4,4,6,8,8-heptamethylnonane"], "definition": "", "other_contexts": [], "par_relations": ["Alkanes"], "chd_relations": [], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "RXNORM:1154972", "canonical_name": "Ascorbic Acid / Biotin / Copper Sulfate / Docusate / Folic Acid / Iron Carbonyl / Vitamin B 12 / Vitamin E Pill", "aliases": ["ascorbic acid / biotin / copper sulfate / docusate / folic acid / iron carbonyl / vitamin b 12 / vitamin e pill"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": ["Ascorbic Acid / Biotin / Copper Sulfate / Docusate / Folic Acid / Iron Carbonyl / Vitamin B 12 / Vitamin E Extended Release Oral Tablet", "24 HR vit-C 500 MG / Biotin 0.15 MG / Copper Sulfate 3 MG / dl-alpha tocopheryl acetate 30 UNT / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 150 MG / Vitamin B 12 0.06 MG Extended Release Oral Tablet", "vit-C 500 MG / Biotin 0.15 MG / Copper Sulfate 3 MG / dl-alpha tocopheryl acetate 30 UNT / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 150 MG / Vitamin B 12 0.06 MG Extended Release Oral Tablet", "Hemax Pill"], "syn_relations": [], "sib_relations": ["Ascorbic Acid", "Biotin", "Folic Acid", "Vitamin B 12", "Vitamin E", "Copper Sulfate", "Iron Carbonyl", "Pill", "Docusate"]}}
{"label": 1, "source_ent": {"research_entity_id": "HPO:HP:0004631", "canonical_name": "Decreased cervical spine flexion due to contractures of posterior cervical muscles", "aliases": ["inability to touch chin to chest", "contracture of post-cervical muscles", "decreased cervical spine flexion due to contractures of posterior cervical muscles"], "definition": "", "other_contexts": [], "par_relations": ["Decreased cervical spine flexion due to contractures of posterior cervical muscles", "Flexion contracture"], "chd_relations": ["Decreased cervical spine flexion due to contractures of posterior cervical muscles"], "syn_relations": ["Decreased cervical spine flexion due to contractures of posterior cervical muscles", "Decreased cervical spine flexion due to contractures of posterior cervical muscles"], "sib_relations": ["Multiple joint contractures", "Congenital contracture", "Flexion contracture of digit", "Contractures of the large joints", "Restricted neck movement due to contractures", "Limb joint contracture", "Progressive flexion contractures", "Joint contractures involving the joints of the feet"]}, "target_ent": {"research_entity_id": "OMIM:MTHU015678", "canonical_name": "Decreased cervical spine flexion due to contractures of posterior cervical muscles", "aliases": ["decreased cervical spine flexion due to contractures of posterior cervical muscles"], "definition": "", "other_contexts": [], "par_relations": ["Spine"], "chd_relations": [], "syn_relations": [], "sib_relations": ["EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C065757", "canonical_name": "meloxicam", "aliases": ["meloxicam", "miloxicam", "reumoxicam", "masflex", "mobicox", "movicox", "uticox", "movalis", "mobic", "mobec", "parocin"], "definition": "", "other_contexts": ["saline ) , meloxicam ( 0.2 mg / kg ) , dipyrone ( 25 mg / kg ) or dipyrone - meloxicam ( 25 mg / kg and 0.2 mg / kg , respectively ) . Glasgow composite measure pain scale ( GCMPS ) and", "meloxicam ( TRAD WITHOUT ) , ( 2 ) castration without anesthesia or analgesia , but with meloxicam ( TRAD WITH ) , ( 3 ) handling without meloxicam ( SHAM WITHOUT ) , ( 4 ) handling with meloxicam (", "not to a significant degree ( p - value=0 . 564 ( . No side effect has been detected for meloxicam . This study did not prove meloxicam efficacy in vasospasm of SAH patients . But it demonstrated", "Comparative Efficacy of Meloxicam and Placebo in Vasospasm of Patients with Subarachnoid Hemorrhage Cerebral vasospasm considered to be a serious cause of morbidity and mortality following subarachnoid haemorrhage ( SAH).Despite several available therapeutic options , current protocols do not prevent major consequences of vasospasm .", "factor beta ( TGF-β ) , and tissue inhibitor of matrix metalloproteases ( TIMP-1 ) . Meloxicam mitigated CCl4-induced elevation in hepatic levels of nuclear factor kappa B ( NF-κB ) , tumor", "associated with castration . For castrated pigs , the joint use of lidocaine and meloxicam caused a significant decrease in cortisol concentration ; the combination of intratesticular", "equi-effective doses the overall safety of meloxicam to established non-steroidal anti-inflammatory drugs", "The overall mean (SD) systemic meloxicam exposure was 33 % lower for SoluMatrix meloxicam 10 mg [29,173.01 (11,042.09) ng*h/mL] vs meloxicam 15-mg tablets [40,875.6 (11,733.47) ng*h/mL].", ". The median time to maximum plasma meloxicam levels occurred earlier following SoluMatrix meloxicam 5 mg ( 2.0 h ) and 10 mg ( 2.0 h ) administration vs meloxicam 15-mg tablets ( 4.0 h ) . Few study", "72 ) between the two groups . MCA velocity were slightly less in patients who had received meloxicam , but not to a significant degree ( p - value=0 . 564 ( . No side effect has been detected for", "milk replacer 12h before cautery dehorning ( MEL - PRE ; n=10 ) , and calves receiving meloxicam administered as an oral bolus ( 1 mg / kg ) at the time of dehorning ( MEL - POST ; n=10 ) .", "adverse events ( AEs ) associated with nonsteroidal anti - inflammatory drugs , including meloxicam . This study investigated the pharmacokinetic ( PK ) properties of SoluMatrix meloxicam 5-mg (", "Glasgow Outcome Scale . Eighty - one patients enrolled in the study . ( 40 received meloxicam , 41 received placebo ) . Baseline characteristics were similar between the groups . There were no", "similar meloxicam mean ( standard deviation ( SD ) ) maximum plasma concentrations vs meloxicam 15-mg tablets [ 1288.8 ( 424.40 ) ng / mL ] . The overall mean ( SD ) systemic meloxicam exposure", "There were 16 patients with perforations , ulcerations or bleeding ( PUBs ) of the upper GI tract in the piroxicam group compared with seven in the meloxicam group ( relative risk piroxicam : meloxicam = 1.4 ) .", "There was a significant reduction in the total number of rescue treatments in the dypyrone ( n = 5 ) and dipyrone - meloxicam ( n = 5 ) groups when compared with the control ( n = 17 ) and meloxicam ( n = 19 ) groups .", "was 33 % lower for SoluMatrix meloxicam 10 mg [ 29,173.01 ( 11,042.09 ) ng*h / mL ] vs meloxicam 15-mg tablets [ 40,875.6 ( 11,733.47 ) ng*h / mL ] . The median time to maximum plasma meloxicam", "A total of 9323 patients received treatment ( 4635 and 4688 in the meloxicam and diclofenac groups , respectively ) .", "from the control group in bitches treated with meloxicam ( 70% ) or dipyrone - meloxicam ( 40% ) . There was a significant reduction in the total number of rescue treatments in the", "Meloxicam toxicity was induced by oral feeding of meloxicam at 1.2 mg/kg and 2.4 mg/kg body weight in G(2) and G(3) respectively for 28 days. Group G(4) and G(5) were fed with 1.2-mg/kg body weight and 2.4-mg/kg body weight of meloxicam along with 200 mg/kg body weight of aqueous extract of Ocimum sanctum.", "Meloxicam Large-scale International Study Safety Assessment.", "Four PUBs were complicated (perforations or bleedings); none of these occurred in the meloxicam group (relative risk piroxicam:meloxicam = 1.9).", "15-mg tablets ( 4.0 h ) . Few study - medication - related AEs were reported . SoluMatrix meloxicam 10 mg was more rapidly absorbed and associated with a lower overall exposure compared with", "Adverse events caused withdrawal from the study in 254 patients receiving meloxicam ( 5.48% ) compared to 373 ( 7.96% ) on diclofenac ( P < 0.001 ) .", "conditions , SoluMatrix meloxicam 10 mg [ 1252.8 ( 254.22 ) ng / mL ] produced similar meloxicam mean ( standard deviation ( SD ) ) maximum plasma concentrations vs meloxicam 15-mg tablets [ 1288.", "whether meloxicam in nanocapsules modifies stomach and liver damage caused by free meloxicam in mice . Male Swiss mice were treated with blank nanocapsules or meloxicam in nanocapsules or", "The Meloxicam Large-scale International Study Safety Assessment (MELISSA) trial reported here was therefore set up to investigate the tolerability of meloxicam, a preferential inhibitor of COX-2, compared to diclofenac.", "Male Swiss mice were treated with blank nanocapsules or meloxicam in nanocapsules or free meloxicam ( 10 mg / kg , intragastrically , daily for five days ) .", "nitric oxide ( NO ) , interleukin - l beta ( IL 1β ) , and prostaglandin E2 ( PGE2 ) . Meloxicam modulated CCl4-induced disturbance of liver cytochrome P450 subfamily 2E1 ( CYP2E1 ) and", "Analgesic and antihyperalgesic effects of dipyrone, meloxicam or a dipyrone-meloxicam combination in bitches undergoing ovariohysterectomy.", "Our objectives were to estimate the effectiveness of two protocols of local anesthesia ( lidocaine and the combination of lidocaine+bupivacaine ) as well as the use of meloxicam as a postoperative analgesic in alleviating castration - related pain , measured by acute physiological responses .", "Meloxicam modulated CCl4-induced disturbance of liver cytochrome P450 subfamily 2E1 (CYP2E1) and glutathione-S-transferase (GST).", "For castrated pigs, the joint use of lidocaine and meloxicam caused a significant decrease in cortisol concentration; the combination of intratesticular lidocaine and bupivacaine did not seem to be more effective than lidocaine alone.", "Meloxicam significantly abrogated CCl4-induced elevation of messenger RNA ( mRNA ) expressions for collagen I and alpha smooth muscle actin ( α-SMA ) and hepatic contents of hydroxyproline , transforming growth factor beta ( TGF-β ) , and tissue inhibitor of matrix metalloproteases ( TIMP-1 ) .", "The MELISSA trial confirms earlier studies suggesting that meloxicam has a significantly improved GI tolerability profile in comparison with other NSAIDs, including diclofenac.", "Meloxicam in nanocapsules did not have an ulcerogenic potential in the stomach or cause lipid peroxidation in the stomach and liver.", "In conclusion , polymeric nanocapsules can represent a technological alternative to reduce the toxicity caused by meloxicam .", "potential in the stomach or cause lipid peroxidation in the stomach and liver . Free meloxicam increased the ulcerogenic potential in the stomach and lipid peroxidation in the stomach and liver", "On the basis of these studies, international registration for meloxicam was granted with meloxicam 7.5 mg (NSAIDs), with diclofenac being among the least toxic NSAIDs and piroxicam [2] having a high ranking in being the recommended dose for the symptomatic treatment of acute flares of OA.", "anesthesia or analgesia , but with meloxicam ( TRAD WITH ) , ( 3 ) handling without meloxicam ( SHAM WITHOUT ) , ( 4 ) handling with meloxicam ( SHAM WITH ) , ( 5 ) castration after local", "treatment with corn oil ( negative control ) , CCl4 ( to induce liver fibrosis ) , and/or meloxicam . Meloxicam effectively ameliorated the CCl4-induced alterations in liver histology , liver weight", "No effect of timing of meloxicam administration on serum cortisol concentrations, SP concentrations, haptoglobin concentrations, maximum ocular temperature, or MNT was observed.", "calves had lower PgE2 concentrations for 3 d postdehorning . These findings support that meloxicam reduced cortisol , SP , and PgE2 after dehorning , but only PgE2 production was significantly", "In meloxicam toxicity elevated Lipid peroxidation values was noticed in liver and kidneys, while superoxide dismutase and glutathione did not revealed any change.", "+BUPI WITHOUT ) , ( 8) castration after local anesthesia with lidocaine+bupivacaine and meloxicam ( LIDO+BUPI WITH ) . Acute physiological responses measured included skin surface temperature and", "ulcerogenic potential in the stomach and lipid peroxidation in the stomach and liver . Meloxicam in nanocapsules caused less histological changes than free meloxicam . In conclusion , polymeric", "Meloxicam plasma concentrations were assessed through 96 h postdose .", "( n = 10 per group ) before ovariohysterectomy : control ( physiological saline ) , meloxicam ( 0.2 mg / kg ) , dipyrone ( 25 mg / kg ) or dipyrone - meloxicam ( 25 mg / kg and 0.2 mg / kg ,", "But it demonstrated that clinical trial of meloxicam in these patients is feasible and probably safe .", "Mechanical nociceptive threshold was higher in control calves at 1h after dehorning , but meloxicam - treated calves tended to have a higher MNT at 6h after dehorning . No effect of timing of", "Meloxicam mitigated CCl4-induced elevation in hepatic levels of nuclear factor kappa B ( NF-κB ) , tumor necrosis factor alpha ( TNF-α ) , total nitric oxide ( NO ) , interleukin - l beta ( IL 1β ) , and prostaglandin E2 ( PGE2 ) .", "The median time to maximum plasma meloxicam levels occurred earlier following SoluMatrix meloxicam 5 mg ( 2.0 h ) and 10 mg ( 2.0 h ) administration vs meloxicam 15-mg tablets ( 4.0 h ) .", "in calves . The purpose of this study was to determine the influence of timing of oral meloxicam administration on physiological responses in calves after dehorning . Thirty Holstein bull calves ,", "In this randomized , double - blind , placebo - controlled trial , SAH patients randomly received 7.5 mg meloxicam or placebo twice daily for 7 days .", "Nevertheless, significantly more patients discontinued meloxicam because of lack of efficacy (80 out of 4635 vs 49 out of 4688; P < 0.01).", ". Substance P concentrations were significantly higher in control calves compared with meloxicam - treated calves at 120 h after dehorning . Prostaglandin E2 concentrations were lower in", "50 subfamily 2E1 ( CYP2E1 ) and glutathione - S - transferase ( GST ) . The attenuation of meloxicam to liver fibrosis was associated with suppression of oxidative stress via reduction of lipid", "These results may in part reflect the preferential COX-2 selectivity of meloxicam, although the dose and other aspects of tolerability may be important.", "Following cautery dehorning, blood samples were collected to measure cortisol, substance P (SP), haptoglobin, ex vivo prostaglandin E2 (PgE2) production after lipopolysaccharide stimulation and meloxicam concentrations.", "conditions ) and 10-mg capsules ( fasting and fed conditions ) and compared SoluMatrix meloxicam 10-mg capsules with meloxicam 15-mg tablets under fasting conditions . This four - period", "by free meloxicam in mice . Male Swiss mice were treated with blank nanocapsules or meloxicam in nanocapsules or free meloxicam ( 10 mg / kg , intragastrically , daily for five days ) . On the", "British Journal of Rheumatology 1998;37:946–951 IMPROVEMENT IN GASTROINTESTINAL TOLERABILITY OF THE SELECTIVE CYCLOOXYGENASE (COX )-2 INHIBITOR, MELOXICAM, COMPARED WITH PIROXICAM: RESULTS OF THE SAFETY AND EFFICACY LARGE-SCALE EVALUATION OF COX-INHIBITING THERAPIES (SELECT ) TRIAL IN OSTEOARTHRITIS SUMMARY S is a large-scale, prospective, international, multicentre, double-blind, double-dummy, randomized, parallel-group trial.", "These findings support that meloxicam reduced cortisol , SP , and PgE2 after dehorning , but only PgE2 production was significantly affected by the timing of meloxicam administration .", "Free meloxicam increased the ulcerogenic potential in the stomach and lipid peroxidation in the stomach and liver.", "( fasting and fed conditions ) and compared SoluMatrix meloxicam 10-mg capsules with meloxicam 15-mg tablets under fasting conditions . This four - period crossover study randomized 28 healthy", "Male Swiss mice were treated with blank nanocapsules or meloxicam in nanocapsules or free meloxicam ( 10 mg / kg , intragastrically , daily for five days ) . On the seventh day , blood was collected", "with the control ( n = 17 ) and meloxicam ( n = 19 ) groups . Meloxicam and dipyrone - meloxicam significantly reduced the percentage of animals exhibiting severe pain during MNT measurements ( 30", "( lidocaine and the combination of lidocaine+bupivacaine ) as well as the use of meloxicam as a postoperative analgesic in alleviating castration - related pain , measured by acute", "Polymeric nanocapsules as a technological alternative to reduce the toxicity caused by meloxicam in mice.", "The effect of timing of oral meloxicam administration on physiological responses in calves after cautery dehorning with local anesthesia.", ") and dipyrone - meloxicam ( n = 5 ) groups when compared with the control ( n = 17 ) and meloxicam ( n = 19 ) groups . Meloxicam and dipyrone - meloxicam significantly reduced the percentage of", "Acute physiological responses to castration-related pain in piglets: the effect of two local anesthetics with or without meloxicam.", "2 after dehorning , but only PgE2 production was significantly affected by the timing of meloxicam administration .", "treated calves tended to have a higher MNT at 6h after dehorning . No effect of timing of meloxicam administration on serum cortisol concentrations , SP concentrations , haptoglobin concentrations ,", "MCA velocity were slightly less in patients who had received meloxicam, but not to a significant degree (p-value=0.", ". There was no significant difference in the biochemical markers in the plasma of mice . Meloxicam in nanocapsules did not have an ulcerogenic potential in the stomach or cause lipid peroxidation", "( 40 received meloxicam , 41 received placebo ) .", "Patients with exacerbation of osteoarthritis were treated with the recommended dose of meloxicam (7.5 mg) or piroxicam (20 mg) once daily for 28 days; 4320 patients were administered meloxicam and 4336 piroxicam.", "( SHAM WITH ) , ( 5 ) castration after local anesthesia with lidocaine but without meloxicam ( LIDO WITHOUT ) , ( 6 ) castration after local anesthesia with lidocaine and meloxicam ( LIDO", "fasting ) and 10-mg capsules ( fasting or fed ) and meloxicam tablets 15 mg ( fasting ) . Meloxicam plasma concentrations were assessed through 96 h postdose . Safety was assessed . Twenty - five", "meloxicam ( LIDO WITHOUT ) , ( 6 ) castration after local anesthesia with lidocaine and meloxicam ( LIDO WITH ) , ( 7 ) castration after local anesthesia with lidocaine+bupivacaine without", "Ocimum sanctum could reduce hepatotoxic activity of meloxicam in group G4 receiving meloxicam at lower dose rate along with Ocimum sanctum failed to regulate creatinine level in meloxicam treated groups.", "properties of low - dose SoluMatrix meloxicam in healthy adults SoluMatrix® meloxicam has been developed using SoluMatrix Fine Particle Technology™ to produce a meloxicam drug product", "Substance P concentrations were significantly higher in control calves compared with meloxicam - treated calves at 120 h after dehorning .", "of meloxicam against CCl4-induced liver fibrosis in rat . The antifibrotic mechanism of meloxicam could be through decreasing NF-κB level and subsequent proinflammatory cytokine production ( TNF-α", "= 5 ) groups when compared with the control ( n = 17 ) and meloxicam ( n = 19 ) groups . Meloxicam and dipyrone - meloxicam significantly reduced the percentage of animals exhibiting severe pain", "No endoscopically verified ulcer complication was detected in the meloxicam group compared to four with diclofenac .", "( 50% ) . Dipyrone produced superior analgesia ( reduced morphine consumption ) , while meloxicam produced better antihyperalgesia ( fewer episodes of severe pain ) in contrast to controls . When", "in the total number of rescue treatments in the dypyrone ( n = 5 ) and dipyrone - meloxicam ( n = 5 ) groups when compared with the control ( n = 17 ) and meloxicam ( n = 19 ) groups .", "The effectiveness of meloxicam on cerebral vasospasm has to be studied in larger trials .", "=0 . 564 ( . No side effect has been detected for meloxicam . This study did not prove meloxicam efficacy in vasospasm of SAH patients . But it demonstrated that clinical trial of meloxicam in", "This follows recognition of serious dose-dependent adverse events (AEs) associated with nonsteroidal anti-inflammatory drugs, including meloxicam.", "In short - and long - term treatment , meloxicam 15 mg showed , although not statistic - release ( SR ) 100 mg [ 1 ] .", "Antifibrotic effect of meloxicam in rat liver : role of nuclear factor kappa B , proinflammatory cytokines , and oxidative stress This study was aimed at investigating the antifibrotic effect of meloxicam in CCl4-induced liver fibrosis and elucidating its underlying mechanism .", "is a painful husbandry procedure that is commonly performed in dairy calves . Parenteral meloxicam combined with local anesthesia mitigates the physiological and behavioral effects of dehorning in", "efficacy in vasospasm of SAH patients . But it demonstrated that clinical trial of meloxicam in these patients is feasible and probably safe . The effectiveness of meloxicam on cerebral", "- five participants ( 89.3 % ) completed the study . Under fasting conditions , SoluMatrix meloxicam 10 mg [ 1252.8 ( 254.22 ) ng / mL ] produced similar meloxicam mean ( standard deviation ( SD ) )", "This study provides an evidence for antifibrotic effect of meloxicam against CCl4-induced liver fibrosis in rat.", "Ameliorative Effect of Ocimum Sanctum on Meloxicam Induced Toxicity in Wistar Rats An ameliorating effect of Ocimum sanctum on the toxic effect of meloxicam, a new non-steroidal anti-inflammatory drug was studied by evaluating haemato-biochemical parameters, oxidative stress, gross and histopathological changes in various organs of Wistar rats.", "This study did not prove meloxicam efficacy in vasospasm of SAH patients .", "0.001 ) with meloxicam compared to diclofenac .", "enhanced absorption properties to enable treatment at lower doses than available oral meloxicam drug products . This follows recognition of serious dose - dependent adverse events ( AEs )", "Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients .", "® meloxicam has been developed using SoluMatrix Fine Particle Technology™ to produce a meloxicam drug product with enhanced absorption properties to enable treatment at lower doses than available", "stomach and liver . Meloxicam in nanocapsules caused less histological changes than free meloxicam . In conclusion , polymeric nanocapsules can represent a technological alternative to reduce the", "Five patients on meloxicam experienced a perforation, ulcer or bleed vs seven on diclofenac (not significant).", ", but there were no significant differences from the control group in bitches treated with meloxicam ( 70% ) or dipyrone - meloxicam ( 40% ) . There was a significant reduction in the total number of", "There were five patient days of hospitalization in patients on meloxicam compared to 121 with diclofenac.", "The aim of this study was to compare the efficacy of meloxicam versus placebo on vasospasm in patients with SAH .", "Administration of local anesthetic or meloxicam did not prevent the decrease in skin surface temperature associated with castration.", "The attenuation of meloxicam to liver fibrosis was associated with suppression of oxidative stress via reduction of lipid peroxides along with induction of reduced glutathione content and enhancement of superoxide dismutase, glutathione peroxidase, and catalase activities.", "The outcome of S is consistent with that of the large - scale clinical trial of similar design and size which compared 7.5 mg meloxicam with 100 mg diclofenac in patients with osteoarthritis , and with a previous global analysis of the safety of meloxicam .", "SoluMatrix meloxicam 5-mg capsules ( fasting ) and 10-mg capsules ( fasting or fed ) and meloxicam tablets 15 mg ( fasting ) . Meloxicam plasma concentrations were assessed through 96 h postdose .", "recorded over the 11-day post - castration period . Administration of local anesthetic or meloxicam did not prevent the decrease in skin surface temperature associated with castration . Lidocaine", "Meloxicam and dipyrone - meloxicam significantly reduced the percentage of animals exhibiting severe pain during MNT measurements ( 30% and 0% , respectively ) compared with the control group ( 50% ) .", "Ocimum sanctum could restore the hemoglobin and PCV value in - group treated with meloxicam at low dose level .", ", ex vivo prostaglandin E2 ( PgE2 ) production after lipopolysaccharide stimulation and meloxicam concentrations . Maximum ocular temperature and mechanical nociceptive threshold ( MNT ) were also", "Thirty Holstein bull calves, 8 to 10 wk of age (28-70 kg), were randomly assigned to 1 of 3 treatment groups: placebo-treated control group (n=10), calves receiving meloxicam administered orally (1 mg/kg) in powdered milk replacer 12h before cautery dehorning (MEL-PRE; n=10), and calves receiving meloxicam administered as an oral bolus (1 mg/kg) at the time of dehorning (MEL-POST; n=10).", ", double - blind , placebo - controlled trial , SAH patients randomly received 7.5 mg meloxicam or placebo twice daily for 7 days . End points were , middle cerebral artery velocity obtained", "No side effect has been detected for meloxicam.", "This four - period crossover study randomized 28 healthy adult participants to receive single doses of SoluMatrix meloxicam 5-mg capsules ( fasting ) and 10-mg capsules ( fasting or fed ) and meloxicam tablets 15 mg ( fasting ) .", "- treated calves at 120 h after dehorning . Prostaglandin E2 concentrations were lower in meloxicam - treated calves compared with control calves . Mechanical nociceptive threshold was higher in", "Meloxicam effectively ameliorated the CCl4-induced alterations in liver histology, liver weight to body weight ratio, liver functions, and serum markers for liver fibrosis (hyaluronic acid, laminin, and PCIII).", "tolerability with selective cyclooxygenase (COX)-2 inhibitors, the present study was performed in conjunc-Significant advantages with regard to efficacy were observed for meloxicam 15 mg in one study compared tion with a separate study, with a similar design and size, comparing meloxicam 7.5 mg to diclofenac slow to piroxicam 20 mg [5].", "Clinical finding showed mild diarrhea from 23(rd) day onwards in-group treated with 2.4-mg/kg body of meloxicam.", "SoluMatrix meloxicam 10 mg was more rapidly absorbed and associated with a lower overall exposure compared with meloxicam 15-mg tablets in this study in healthy adults under fasting conditions .", "meloxicam . This study investigated the pharmacokinetic ( PK ) properties of SoluMatrix meloxicam 5-mg ( fasting conditions ) and 10-mg capsules ( fasting and fed conditions ) and compared", "15-mg tablets [ 40,875.6 ( 11,733.47 ) ng*h / mL ] . The median time to maximum plasma meloxicam levels occurred earlier following SoluMatrix meloxicam 5 mg ( 2.0 h ) and 10 mg ( 2.0 h )", "Meloxicam is a non - steroidal anti - inflammatory drug .", "meloxicam 15-mg tablets [ 1288.8 ( 424.40 ) ng / mL ] . The overall mean ( SD ) systemic meloxicam exposure was 33 % lower for SoluMatrix meloxicam 10 mg [ 29,173.01 ( 11,042.09 ) ng*h / mL ] vs", "The purpose of this study was to determine the influence of timing of oral meloxicam administration on physiological responses in calves after dehorning.", "study randomized 28 healthy adult participants to receive single doses of SoluMatrix meloxicam 5-mg capsules ( fasting ) and 10-mg capsules ( fasting or fed ) and meloxicam tablets 15 mg (", "nanocapsules can represent a technological alternative to reduce the toxicity caused by meloxicam .", "( TRAD WITH ) , ( 3 ) handling without meloxicam ( SHAM WITHOUT ) , ( 4 ) handling with meloxicam ( SHAM WITH ) , ( 5 ) castration after local anesthesia with lidocaine but without meloxicam (", "Parenteral meloxicam combined with local anesthesia mitigates the physiological and behavioral effects of dehorning in calves .", "Dipyrone produced superior analgesia (reduced morphine consumption), while meloxicam produced better antihyperalgesia (fewer episodes of severe pain) in contrast to controls.", ") were included in the study : ( 1 ) castration without anesthesia or analgesia , without meloxicam ( TRAD WITHOUT ) , ( 2 ) castration without anesthesia or analgesia , but with meloxicam ( TRAD", "Significantly fewer adverse events were reported by patients receiving meloxicam .", "undergoing ovariohysterectomy . The analgesic and antihyperalgesic effects of dipyrone , meloxicam or a dipyrone - meloxicam combination were compared in dogs undergoing elective ovariohysterectomy", "The analgesic and antihyperalgesic effects of dipyrone , meloxicam or a dipyrone - meloxicam combination were compared in dogs undergoing elective ovariohysterectomy .", "Individual GI events occurred significantly less often with meloxicam than piroxicam : dyspepsia ( 3 .", "Serum alkaline phosphatase , serum glutamic pyruvic transaminase , Serum glutamic oxaloacetic transaminase and total bilirubin were found elevated in meloxicam treated groups and indicated hepatotoxic activity of meloxicam .", "These differences were attributable to differences in reported GI adverse events ( 3.02% on meloxicam vs 6.14% on diclofenac ; P < 0.001 ) .", "Meloxicam in nanocapsules caused less histological changes than free meloxicam.", "noncompartmental pharmacokinetic analysis and repeated measures ANOVA models . Mean peak meloxicam concentrations were 3.61±0 0.21 and 3.27±0.14 μg / mL with average elimination half - lives of 38.6", ". Inflammation is believed to play an important role in post - haemorrhagic vasospasm . Meloxicam is a non - steroidal anti - inflammatory drug . The aim of this study was to compare the efficacy", "Eight groups (15 piglets/group) were included in the study: (1) castration without anesthesia or analgesia, without meloxicam (TRAD WITHOUT), (2) castration without anesthesia or analgesia, but with meloxicam (TRAD WITH), (3) handling without meloxicam (SHAM WITHOUT), (4) handling with meloxicam (SHAM WITH), (5) castration after local anesthesia with lidocaine but without meloxicam (LIDO WITHOUT), (6) castration after local anesthesia with lidocaine and meloxicam (LIDO WITH), (7) castration after local anesthesia with lidocaine+bupivacaine without meloxicam (LIDO+BUPI WITHOUT), (8) castration after local anesthesia with lidocaine+bupivacaine and meloxicam (LIDO+BUPI WITH).", "/ mL ] . The overall mean ( SD ) systemic meloxicam exposure was 33 % lower for SoluMatrix meloxicam 10 mg [ 29,173.01 ( 11,042.09 ) ng*h / mL ] vs meloxicam 15-mg tablets [ 40,875.6 ( 11,733.47 ) ng*", "Prostaglandin E2 concentrations were lower in meloxicam-treated calves compared with control calves.", "following SoluMatrix meloxicam 5 mg ( 2.0 h ) and 10 mg ( 2.0 h ) administration vs meloxicam 15-mg tablets ( 4.0 h ) . Few study - medication - related AEs were reported . SoluMatrix", "Hence , meloxicam comparison …", "for MEL - PRE and MEL - POST , respectively . Serum cortisol concentrations were lower in meloxicam - treated calves compared with control calves at 4 h postdehorning . Substance P concentrations", "Mean peak meloxicam concentrations were 3.61±0 0.21 and 3.27±0.14 μg / mL with average elimination half - lives of 38.62±5.87 and 35.81±6.26 h for MEL - PRE and MEL - POST , respectively .", "trial of meloxicam in these patients is feasible and probably safe . The effectiveness of meloxicam on cerebral vasospasm has to be studied in larger trials .", "to reduce the toxicity caused by meloxicam in mice . This study determined whether meloxicam in nanocapsules modifies stomach and liver damage caused by free meloxicam in mice . Male Swiss", "The antifibrotic mechanism of meloxicam could be through decreasing NF-κB level and subsequent proinflammatory cytokine production ( TNF-α , NO , IL-1 beta , and PGE2 ) and , hence , collagen deposition through inhibition of TIMP-1 and TGF-β. Abrogation of oxidative stress and modulation of liver - metabolizing enzymes ( CYP2E1 and GST ) were also involved .", "Pharmacokinetic properties of low - dose SoluMatrix meloxicam in healthy adults SoluMatrix® meloxicam has been developed using SoluMatrix Fine Particle Technology™ to produce a meloxicam drug product with enhanced absorption properties to enable treatment at lower doses than available oral meloxicam drug products .", "Forty male rats were equally randomized for 8-week treatment with corn oil ( negative control ) , CCl4 ( to induce liver fibrosis ) , and/or meloxicam .", ", and oxidative stress This study was aimed at investigating the antifibrotic effect of meloxicam in CCl4-induced liver fibrosis and elucidating its underlying mechanism . Forty male rats were", "This study determined whether meloxicam in nanocapsules modifies stomach and liver damage caused by free meloxicam in mice.", "The frequency of rescue analgesia was significantly ( P < 0.05 ) lower in the dipyrone group ( 30% ) than in controls ( 50% ) , but there were no significant differences from the control group in bitches treated with meloxicam ( 70% ) or dipyrone - meloxicam ( 40% ) .", "10 mg was more rapidly absorbed and associated with a lower overall exposure compared with meloxicam 15-mg tablets in this study in healthy adults under fasting conditions .", "anaesthetised with isoflurane received one of four intravenous treatments (n = 10 per group) before ovariohysterectomy: control (physiological saline), meloxicam (0.2 mg/kg), dipyrone (25 mg/kg) or dipyrone-meloxicam (25 mg/kg and 0.2 mg/kg, respectively).", "The Ocimum sanctum could only counteract the toxic effect of meloxicam in liver and gastrointestinal tract .", ", and catalase activities . This study provides an evidence for antifibrotic effect of meloxicam against CCl4-induced liver fibrosis in rat . The antifibrotic mechanism of meloxicam could be", "Serum cortisol concentrations were lower in meloxicam-treated calves compared with control calves at 4 h postdehorning.", ", and serum markers for liver fibrosis ( hyaluronic acid , laminin , and PCIII ) . Meloxicam significantly abrogated CCl4-induced elevation of messenger RNA ( mRNA ) expressions for collagen", "Under fasting conditions , SoluMatrix meloxicam 10 mg [ 1252.8 ( 254.22 ) ng / mL ] produced similar meloxicam mean ( standard deviation ( SD ) ) maximum plasma concentrations vs meloxicam 15-mg tablets [ 1288.8 ( 424.40 ) ng / mL ] .", "The incidence of adverse events was significantly lower in the meloxicam group ( 22.5% ) compared with the piroxicam group ( 27.9% ; P < 0.001 ) , mainly due to the significantly lower incidence of gastrointestinal ( GI ) adverse events in the meloxicam than in the piroxicam group ( 10.3% vs 15.4% ; P < 0.001 ) , while the efficacy of both drugs was equivalent .", "to 1 of 3 treatment groups : placebo - treated control group ( n=10 ) , calves receiving meloxicam administered orally ( 1 mg / kg ) in powdered milk replacer 12h before cautery dehorning ( MEL -", "steroidal anti - inflammatory drug . The aim of this study was to compare the efficacy of meloxicam versus placebo on vasospasm in patients with SAH . In this randomized , double - blind , placebo -", "Mechanical nociceptive threshold was higher in control calves at 1h after dehorning, but meloxicam-treated calves tended to have a higher MNT at 6h after dehorning.", "- related pain in piglets : the effect of two local anesthetics with or without meloxicam . Methods to reduce castration - related pain in piglets are still issues of concern and interest", ". The analgesic and antihyperalgesic effects of dipyrone , meloxicam or a dipyrone - meloxicam combination were compared in dogs undergoing elective ovariohysterectomy . In a double - blinded ,", "of meloxicam.", "corn oil ( negative control ) , CCl4 ( to induce liver fibrosis ) , and/or meloxicam . Meloxicam effectively ameliorated the CCl4-induced alterations in liver histology , liver weight to body", "( LIDO WITH ) , ( 7 ) castration after local anesthesia with lidocaine+bupivacaine without meloxicam ( LIDO+BUPI WITHOUT ) , ( 8) castration after local anesthesia with lidocaine+bupivacaine and", "This study investigated the pharmacokinetic ( PK ) properties of SoluMatrix meloxicam 5-mg ( fasting conditions ) and 10-mg capsules ( fasting and fed conditions ) and compared SoluMatrix meloxicam 10-mg capsules with meloxicam 15-mg tablets under fasting conditions .", "Patients received either meloxicam 7.5 mg or diclofenac 100 mg slow release , the recommended doses for the treatment of osteoarthritis ."], "par_relations": ["Anti-Inflammatory Agents, Non-Steroidal", "Thiazines", "Thiazoles", "Cyclooxygenase Inhibitors", "meloxicam", "meloxicam", "meloxicam", "meloxicam"], "chd_relations": ["meloxicam", "meloxicam", "meloxicam", "meloxicam"], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "RXNORM:1050786", "canonical_name": "Olay Acne Control", "aliases": ["olay acne control"], "definition": "", "other_contexts": [], "par_relations": ["Salicylic Acid"], "chd_relations": [], "syn_relations": [], "sib_relations": ["Salicylic Acid 20 MG/ML [Olay Acne Control]", "Salicylic Acid Medicated Liquid Soap [Olay Acne Control]", "Olay Blackhead Clearing Scrub 2 % Medicated Liquid Soap", "Olay Acne Control Soap Product"]}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0001374", "canonical_name": "Congenital hip dislocation", "aliases": ["congenital dislocation of the hip", "congenital hip anomaly", "congenital hip dislocation", "dislocated hip since birth", "congenital hip dislocations", "congenital dislocation of the hips"], "definition": "", "other_contexts": [], "par_relations": ["Hip dislocation"], "chd_relations": ["Congenital bilateral hip dislocation"], "syn_relations": ["Congenital hip dislocation", "Congenital hip dislocation", "Congenital hip dislocation", "Congenital hip dislocation", "Congenital hip dislocation", "Congenital hip dislocation", "Congenital hip dislocation", "Congenital hip dislocation", "Congenital hip dislocation", "Congenital hip dislocation"], "sib_relations": []}, "target_ent": {"research_entity_id": "MSH:C484510", "canonical_name": "SHN-1 protein, C elegans", "aliases": ["shn-1 protein, c elegans"], "definition": "", "other_contexts": [], "par_relations": ["Caenorhabditis elegans Proteins"], "chd_relations": [], "syn_relations": [], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:14652", "canonical_name": "parvin alpha", "aliases": ["parvin alpha", "parva gene", "flj12254", "flj10793", "parva"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["parvin alpha", "parvin alpha", "parvin alpha", "parvin alpha", "parvin alpha", "parvin alpha"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:603275", "canonical_name": "PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, ALPHA", "aliases": ["pip5k1a", "phosphatidylinositol 4-phosphate 5-kinase, type i, alpha"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, ALPHA", "PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, ALPHA"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0005947", "canonical_name": "Decreased sensitivity to hypoxemia", "aliases": ["decreased sensitivity to hypoxemia", "decreased sensitivity to hypoxaemia"], "definition": "Reduced tendency to respond to a reduced concentration of oxygen in the blood by increasing respiration. [HPO:probinson]", "other_contexts": [], "par_relations": ["Breathing dysregulation"], "chd_relations": [], "syn_relations": ["Decreased sensitivity to hypoxemia", "Decreased sensitivity to hypoxemia"], "sib_relations": ["Neonatal breathing dysregulation"]}, "target_ent": {"research_entity_id": "OMIM:100650", "canonical_name": "ALDEHYDE DEHYDROGENASE 2 FAMILY", "aliases": ["acetaldehyde dehydrogenase 2", "aldh2/hmgic fusion gene", "aldh, liver mitochondrial", "aldh2", "esophageal cancer, alcohol-related, susceptibility to", "aldehyde dehydrogenase 2 family", "sublingual nitroglycerin, susceptibility to poor response to", "alcohol dependence, protection against", "alcohol sensitivity, acute", "aldehyde dehydrogenase 2", "hangover, susceptibility to"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["ALDEHYDE DEHYDROGENASE 2 FAMILY", "ALDEHYDE DEHYDROGENASE 2 FAMILY", "ALDEHYDE DEHYDROGENASE 2 FAMILY", "ALDEHYDE DEHYDROGENASE 2 FAMILY", "ALDH2, GLU504LYS (dbSNP rs671)", "ALDEHYDE DEHYDROGENASE 2 FAMILY", "ALDEHYDE DEHYDROGENASE 2 FAMILY", "ALDEHYDE DEHYDROGENASE 2 FAMILY", "ALDEHYDE DEHYDROGENASE 2 FAMILY"], "sib_relations": ["Autosomal dominant", "Poor response to sublingual nitroglycerin or glyceryl trinitrate (in ALDH2*2 allele carriers)", "Susceptibility conferred by mutation in the mitochondrial aldehyde dehydrogenase 2 family gene (ALDH2, 100650.0001)", "Delayed oxidation of acetaldehyde Disulfiram insensitive", "Susceptibility to esophageal cancer (in alcohol drinkers with the ALDH2 A allele)", "ALDH2, GLU504LYS (dbSNP rs671)", "ALDH2, GLU504LYS (dbSNP rs671)", "ALDH2, GLU504LYS (dbSNP rs671)", "ALDH2, GLU504LYS (dbSNP rs671)", "ALDH2, GLU504LYS (dbSNP rs671)"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C564109", "canonical_name": "Male Pseudohermaphroditism due to Deficiency of Testicular 17,20-Desmolase", "aliases": ["male pseudohermaphroditism due to deficiency of testicular 17,20-desmolase"], "definition": "", "other_contexts": [], "par_relations": ["Gonadal Dysgenesis, 46,XY", "Steroid Hydroxylases"], "chd_relations": [], "syn_relations": [], "sib_relations": ["deficiency"]}, "target_ent": {"research_entity_id": "OMIM:233910", "canonical_name": "HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B", "aliases": ["hpabh4b", "dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive", "hyperphenylalaninemia, bh4-deficient, b", "hyperphenylalaninemia, tetrahydrobiopterin-deficient, due to gtp cyclohydrolase i deficiency", "gtp cyclohydrolase i deficiency"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B", "HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B", "HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B", "HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B", "HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B", "HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B"], "sib_relations": ["Swallowing difficulties", "Irritability", "Lethargy", "Mental retardation", "Rigidity", "Seizures", "Hypersalivation", "Tremor", "Choreoathetosis", "Hyperthermia, episodic", "Dystonia", "Psychomotor retardation", "Delayed development", "Autosomal recessive", "Abnormal ocular movements", "Poor feeding in infancy", "Hyperphenylalaninemia", "Onset in infancy", "Hypotonia, truncal", "Variable severity", "Defect in tetrahydrobiopterin (BH4) synthesis", "Treatment with BH4 is effective", "Neurotransmitter treatment with L-dopa and serotonin or precursors is effective", "Early treatment can reduce neurologic symptoms", "Hypertonia of the extremities", "Uncoordinated movements", "Decreased homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) in CSF", "Progressive neurologic deterioration if untreated", "Diurnal fluctuation of neurologic symptoms", "Decreased neopterin and biopterin in urine", "Decreased neopterin and biopterin in CSF", "Decreased or absent GCH1 activity", "Caused by mutation in the GTP cyclohydrolase 1 gene (GCH1, 600225.0017)", "Normal neonatal blood phenylalanine has been reported in rare patients", "Autosomal dominant dopa-responsive dystonia (DYT5, 128230) is an allelic disorder with overlapping features", "Hyperkinesia"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:D001254", "canonical_name": "Astrocytoma", "aliases": ["gliomas, astrocytic", "mixed oligoastrocytoma", "astrocytoma, intracranial", "astrocytomas, protoplasmic", "oligoastrocytomas, mixed", "astrocytoma, pilocytic", "intracranial astrocytoma", "astrocytomas, cerebral", "gemistocytic astrocytoma", "astrocytoma, protoplasmic", "astrocytoma, subependymal giant cell", "astrocytoma, anaplastic", "astrocytoma, juvenile pilocytic", "protoplasmic astrocytoma", "astrocytoma, childhood cerebral", "astrocytoma, grade ii", "cerebral astrocytoma, childhood", "astroglioma", "astrocytoma, fibrillary", "oligoastrocytoma, mixed", "astrocytic gliomas", "anaplastic astrocytoma", "protoplasmic astrocytomas", "astrocytoma, grade iii", "pilocytic astrocytomas", "pilocytic astrocytomas, juvenile", "astrocytoma, cerebral", "childhood cerebral astrocytoma", "glioma, astrocytic", "astrocytomas, anaplastic", "astrogliomas", "cerebral astrocytomas", "astrocytoma, gemistocytic", "childhood cerebral astrocytomas", "grade ii astrocytoma", "juvenile pilocytic astrocytoma", "fibrillary astrocytoma", "astrocytomas, gemistocytic", "grade iii astrocytoma", "astrocytic glioma", "juvenile pilocytic astrocytomas", "astrocytomas, juvenile pilocytic", "subependymal giant cell astrocytoma", "cerebral astrocytoma", "gemistocytic astrocytomas", "astrocytomas, grade i", "astrocytomas, childhood cerebral", "astrocytomas, grade ii", "fibrillary astrocytomas", "astrocytoma", "astrocytomas, fibrillary", "astrocytomas, pilocytic", "grade iii astrocytomas", "astrocytomas, intracranial", "pilocytic astrocytoma", "anaplastic astrocytomas", "astrocytomas, grade iii", "astrocytoma, grade i", "cerebral astrocytomas, childhood", "grade i astrocytoma", "pilocytic astrocytoma, juvenile", "grade i astrocytomas", "grade ii astrocytomas", "intracranial astrocytomas", "mixed oligoastrocytomas", "astrocytomas"], "definition": "Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082)", "other_contexts": ["Taken together, we may postulate that the decreased rCBV observed in PA tumors strongly suggests a decreased vascularity in this low-grade astrocytoma compared", "analysis showed that haplotype CCT and CTT were related with an increased risk of astrocytomas . We found that individual with variants of rs2071559*C and rs2305948*T might significantly", "The lipid - lactate in tumor / creatine in tumor ratios were significantly lower in pilocytic astrocytomas compared with high - grade astrocytomas ( 8.3 ± 11.2 versus 43.3 ± 59.2 ; P = .03 ) .", "Low Grade Astrocytomas Astrocytomas are tumors that are believed to arise from precursors of astrocytes – supportive cells of the brain named for their star-like shape.", "Compared to grade I astrocytoma , 173 ( 12.4% ) , 304 ( 14% ) , and 462 ( 21.2% ) proteins were aberrantly expressed in grades II , III , and IV , respectively .", "There are limited comparisons in the literature of the advanced MR imaging findings of pilocytic astrocytomas versus high-grade astrocytomas.", "is histologically and clinically classified into four grades ( I - IV ) : I ( pilocytic astrocytoma ) , II ( diffuse astrocytoma ) , III ( anaplastic astrocytoma ) , and IV ( glioblastoma multiforme", "cells . New molecular biomarkers are likely to be used for accurate classification of astrocytoma and likely to be the target for drug development .", "new insights into tyrosine nitration and its potential role in the pathogenesis of astrocytoma formation . Graphical Abstract ᅟ.", "compared with 14.3% of anaplastic astrocytomas ( P = 0.0001 ) , 7.7% of diffuse astrocytomas ( P = 0.0001 ) , and 33.3% of pilocytic astrocytomas ( P = 0.017 ) . Intratumorally , 85.7% of", "Grade III astrocytomas, also known as anaplastic astrocytomas, reproduce at an intermediate rate.", ", 21 anaplastic astrocytomas , 13 diffuse astrocytomas , and 18 pilocytic astrocytomas . The inflammatory infiltrate was classified based on microanatomic location as perivascular and", "RESULTS Perivascularly, CD68-positive infiltrate was noted in 71.4% of glioblastomas compared with 14.3% of anaplastic astrocytomas", "grading of astrocytomas . PATIENTS AND METHODS Thirty cases of histologically proven astrocytomas were studied . The histopathological grade was assessed using the 2007 WHO criteria .", "on the immunologic microenvironment of astrocytomas BACKGROUND The microenvironment of astrocytomas includes infiltrative inflammatory cells that are dynamic in nature , possibly reflecting tumor", "A CD20-positive infiltrate was only detected in the perivascular space of a single case of diffuse astrocytoma.", "CONCLUSIONS Lower relative cerebral blood volume and higher ADC values favor a diagnosis of pilocytic astrocytoma , while higher lipid - lactate in tumor / creatine in tumor ratios plus necrosis favor a diagnosis of high - grade astrocytomas .", "Histopathologic evaluation was performed by 2 experienced neuropathologists and was based on the WHO classification of astrocytomas : grade I , PA ; grade II , diffuse astrocytoma ; grade III , anaplastic astrocytoma ; and grade IV , glioblastoma multiforme ( GBM ) .", "Within them, matrix metalloproteinase-9 and metalloproteinase inhibitor 1 were upregulated in glioblastoma multiforme group; whereas fibulin-2 and -5 were downregulated in grade II/III/IV astrocytoma, and the negative expression was significantly associated with advanced clinical stage.", "The purpose of this study was to assess the MR imaging, PWI, DWI, and MR spectroscopy characteristics of pilocytic astrocytomas compared with high-grade astrocytomas.", "relative to controls and semiquantitatively increased nitration level in high - grade astrocytoma relative to control . Each nitroprotein was rationalized and related to the corresponding", "Subgroup analysis based on WHO tumor grade revealed that the C allele of rs2071559 had more influence with the risk of astrocytomas in the grade III–", "( P = 0.004 ) , 38.5% of diffuse astrocytomas ( P = 0.008 ) , and 33.3% of pilocytic astrocytomas ( P = 0.001 ) . Among diffusely infiltrating astrocytomas , intratumoral CD3-positive infiltrate", "Comparison of Perfusion, Diffusion, andMR Spectroscopy between Low-Grade Enhancing Pilocytic Astrocytomas and High-Grade Astrocytomas BACKGROUNDAND PURPOSE: The differentiation of pilocytic astrocytomas and high-grade astrocytomas is sometimes difficult.", "Given that differentiation of PAs and HGAs is sometimes challenging to both the neuroradiologist and the pathologist , advanced MR imaging techniques that add functional information to the anatomic MR imaging can be helpful in the characterization and grading of astrocytomas .", "Semiquantitative immune - based measurements of different sorcin expressions were found among different grades of astrocytomas relative to controls , and a semiquantitative increased nitration level in high - grade astrocytoma relative to control .", "Among diffusely infiltrating astrocytomas, intratumoral CD3-positive infiltrate was only associated with glioblastoma.", "% of glioblastomas exhibited CD68-positive infiltrate compared with 42.9% of anaplastic astrocytomas ( P = 0.004 ) , 38.5% of diffuse astrocytomas ( P = 0.008 ) , and 33.3% of pilocytic astrocytomas (", "AEG-1 expression had no correlation with the gender or age of astrocytoma patients .", "tissue . Anti - nitrotyrosine immunoreaction - positive proteins from a high - grade astrocytoma tissue were detected with two - dimensional gel electrophoresis ( 2DGE)-based nitrotyrosine", "Low-grade astrocytomas are relatively uncommon tumors when compared to their higher-grade counterparts; only about 1,500 are believed to occur in North America each year.", "Pilocytic astrocytomas are most often found in children.", "that higher AEG-1 level was significantly correlated with histological grade of astrocytomas . In addition , AEG-1 mRNA and protein expression was higher in HMAs than in LMAs . AEG-1", "AEG-1 expression in four pairs of matched astrocytomas tissues and 5 cell lines was detected by immunohistochemical and Western blot analysis .", "AIMS To establish whether MIB-1 and p53 staining are useful for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas.", "MATERIALS ANDMETHODS : Sixteen patients with pilocytic astrocytomas and 22 patients with high - grade astrocytomas ( 8–66 years of age ; mean , 36 17 years ) were evaluated by using a 1.5 T MR imaging unit .", "and to assess the relationship of Ki-67 staining with the histopathological grading of astrocytomas . PATIENTS AND METHODS Thirty cases of histologically proven astrocytomas were studied . The", "variables of astrocytomas . AEG-1 expression in four pairs of matched astrocytomas tissues and 5 cell lines was detected by immunohistochemical and Western blot analysis . In", "METHODS AND RESULTS Forty-five astrocytic tumours, including 18 pilocytic astrocytomas, 14 astrocytomas, four anaplastic astrocytomas and nine glioblastomas, from 45 children and young adults, between 1 and 29 years (mean 11 years) of age, were examined pathologically, and sections from paraffin-embedded blocks were used for MIB-1 and p53 immunostaining.", "We found that individual with variants of rs2071559*C and rs2305948*T might significantly elevate the risk of astrocytomas, while mutants of rs1870377*A was associated with the decreased risk of astrocytomas.", "The threshold values ≥1.33 for relative cerebral blood volume provide sensitivity, specificity, positive predictive values, and negative predictive values of 100%, 67%, 87%, and 100%, respectively, for differentiating high-grade astrocytomas from pilocytic astrocytomas.", "sections . P < 0.05 was considered statistically significant . RESULTS Thirty cases of astrocytomas studied showed a male preponderance ( M : F = 1.72:1 ) with a mean age of 48.1 years . Of these ,", "By bioinformatics analysis, the cell proliferation, invasion, and angiogenesis-related pathways increase from low- to high-grade of astrocytoma.", "Pilocytic astrocytomas have sharply defined boundaries.", "I to IV . The protein samples from clinical specimens of grades I , II , III , and IV astrocytoma were analyzed by two - dimensional liquid chromatography - tandem mass spectrometry and isobaric", "The aim of this was to study the proliferative activity using Ki-67 immunostaining and to assess the relationship of Ki-67 staining with the histopathological grading of astrocytomas .", "Each nitroprotein was rationalized and related to the corresponding functional system to provide new insights into tyrosine nitration and its potential role in the pathogenesis of astrocytoma formation.", "and the correlation between AEG-1 expression and clinicopathologic variables of astrocytomas . AEG-1 expression in four pairs of matched astrocytomas tissues and 5 cell lines was detected by", ", cell migration , and metastasis . Among those nitroproteins that might play a role in astrocytomas was nitro - sorcin , which is involved in drug resistance and metastasis and might play a role in", "II , ( n = 7 , 23.3% ) , Grade III ( n = 6 , 20% ) , and Grade IV ( n = 16 , 53.3% ) astrocytomas were analyzed . The mean Ki-67 labeling index ( LI ) in Grades I , II , III , and IV was 0.02 , 0.8", "( P = 0.004 ) , 38.5% of diffuse astrocytomas", "Diffuse astrocytoma typically arises in young adults, although they are also found in children and senior citizens.", "variety of cancers . This study aimed to investigate the expression of AEG-1 in human astrocytomas and the correlation between AEG-1 expression and clinicopathologic variables of astrocytomas . AEG-", "RESULTS The relative cerebral blood volume values were significantly lower in pilocytic astrocytomas compared with the high-grade astrocytomas (1.4 ± 0.9 versus 3.3 ± 1.4; P = .0008).", "SNP analysis , the C allele of rs2071559 was correlated with an increased risk of astrocytomas . However , individuals with mutant allele A and genotype TA + AA of rs1870377 showed a protective", "is more aggressive . In this study , we compared the differential proteome profile of astrocytoma from grades I to IV . The protein samples from clinical specimens of grades I , II , III , and IV", "immunoreactivity of β-tubulin showed increased expression among different grades of astrocytomas relative to controls and semiquantitatively increased nitration level in high - grade astrocytoma", "Low - grade astrocytomas can be further sub - grouped into three tumor types : pilocytic astrocytomas , pleomorphic xanthoastrocytomas , and diffuse astrocytomas .", "The aim of the study was to explore the relationship between KDR polymorphisms and risk of astrocytomas .", "Inserts Domain Receptor ( KDR ) Gene Are Associated with the Risk of Astrocytomas Astrocytomas is one of the most common central nervous system ( CNS ) tumors with high mortality rate . Kinase", "The lipid - lactate in tumor / creatine in tumor ratios were significantly lower in pilocytic astrocytomas compared with high - grade astrocytomas ( 8.3 11.2 versus 43.3 59.2 ; P .03 ) .", "measurements of different sorcin expressions were found among different grades of astrocytomas relative to controls , and a semiquantitative increased nitration level in high - grade", ". Protein tyrosine nitration is involved in the pathogenesis of highly fatal astrocytomas , a type of brain cancer . To understand the molecular mechanisms of astrocytomas and to discover", "CD20 was investigated in 21 glioblastomas , 21 anaplastic astrocytomas , 13 diffuse astrocytomas , and 18 pilocytic astrocytomas . The inflammatory infiltrate was classified based on", "The ADC values were significantly higher in pilocytic astrocytomas compared with high-grade astrocytomas (1.5 10 3 0.4 versus 1.2 10 3 0.3; P .01).", "The ADC values were significantly higher in pilocytic astrocytomas compared with high-grade astrocytomas (1.5 × 10(-3) ± 0.4 versus 1.2 × 10(-3) ± 0.3; P = .01).", "Anti-nitrotyrosine immunoreaction-positive proteins from a high-grade astrocytoma tissue were detected with two-dimensional gel electrophoresis (2DGE)-based nitrotyrosine immunoblots, and identified with liquid chromatography-tandem mass spectrometry (LC-MS/MS).", "Genetic Variations of Kinase Inserts Domain Receptor (KDR) Gene Are Associated with the Risk of Astrocytomas Astrocytomas is one of the most common central nervous system (CNS) tumors with high mortality rate.", "in 3 ( 10% ) cases . CONCLUSION Ki-67 LI varies considerably in different grades of astrocytomas and considerable overlaps can be observed between them . It can be of great help in situations", "( P = 0.0001 ) , 7.7% of diffuse astrocytomas ( P = 0.0001 ) , and 33.3% of pilocytic astrocytomas ( P = 0.017 ) . Intratumorally , 85.7% of glioblastomas exhibited CD68-positive infiltrate", "analysis showed that 128 of 172 ( 74.4% ) paraffin - embedded archival astrocytomas samples exhibited positive AEG-1 expression . Statistical analysis suggested that higher AEG-1", "In addition, AEG-1 protein expression was examined by immunohistochemical staining in 204 cases, including 32 normal brain tissues, 80 Low-malignant astrocytomas (LMAs) and 92 High-Malignant astrocytomas (HMAs).", "astrocytomas , a type of brain cancer . To understand the molecular mechanisms of astrocytomas and to discover new biomarkers / therapeutic targets , we sought to identify nitroproteins in", "MR imaging, PWI, DWI, and MR spectroscopy were used to determine the differences between pilocytic astrocytomas and high-grade astrocytomas.", "Determination of Ki-67 LI should constitute a part of routine investigations in patients with astrocytomas .", ", invasion , and angiogenesis - related pathways increase from low- to high - grade of astrocytoma . Five differentially expressed proteins were validated by Western blot . Within them , matrix", "08 ) , and 33.3% of pilocytic astrocytomas ( P = 0.001 ) . Among diffusely infiltrating astrocytomas , intratumoral CD3-positive infiltrate was only associated with glioblastoma . A CD20-positive", "infiltrate was noted in 71.4% of glioblastomas compared with 14.3% of anaplastic astrocytomas ( P = 0.0001 ) , 7.7% of diffuse astrocytomas ( P = 0.0001 ) , and 33.3% of pilocytic astrocytomas", "MATERIALS AND METHODS Sixteen patients with pilocytic astrocytomas and 22 patients with high-grade astrocytomas (8-66 years of age; mean, 36 ± 17 years) were evaluated by using a 1.5T MR imaging unit.", "mutant allele A and genotype TA + AA of rs1870377 showed a protective effect against astrocytomas . Subgroup analysis based on WHO tumor grade revealed that the C allele of rs2071559 had more", "and quantification . A total of 2,190 proteins were identified . Compared to grade I astrocytoma , 173 ( 12.4% ) , 304 ( 14% ) , and 462 ( 21.2% ) proteins were aberrantly expressed in grades II ,", "new biomarkers / therapeutic targets , we sought to identify nitroproteins in human astrocytoma tissue . Anti - nitrotyrosine immunoreaction - positive proteins from a high - grade astrocytoma", "Statistical analysis suggested that higher AEG-1 level was significantly correlated with histological grade of astrocytomas.", "To understand the molecular mechanisms of astrocytomas and to discover new biomarkers / therapeutic targets , we sought to identify nitroproteins in human astrocytoma tissue .", "proteomics analysis of low- and high - grade of astrocytoma using iTRAQ quantification Astrocytoma is one of the most common types of brain tumor , which is histologically and clinically classified", "Meanwhile , stratified analysis demonstrated that mutation of rs2071559 and rs2305948 could elevate the risk of astrocytomas more significantly in the subgroup of smokers than the nonsmokers .", "reaction - restriction fragment length polymorphism ( PCR - RFLP ) . We evaluated the astrocytomas risk caused by individual SNPs and haplotype using odds ratios ( ORs ) and their 95 % confidence", "(P = 0.008), and 33.3% of pilocytic astrocytomas", "As with pilocytic astrocytomas , surgery is the primary treatment .", "Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification Astrocytoma is one of the most common types of brain tumor, which is histologically and clinically classified into four grades (I-IV): I (pilocytic astrocytoma), II (diffuse astrocytoma), III (anaplastic astrocytoma), and IV (glioblastoma multiforme).", "This study was restricted to children and young adults under 30 years of age because of the differences in p53 mutations between paediatric and adult astrocytomas .", "Health Organization ( WHO ) . Ki-67 is a potent biological marker used in grading of astrocytomas , which estimates growth of the neoplasm quantitatively and will help in predicting prognosis", "In this retrospective study , primarily newly diagnosed , untreated astrocytomas ( 36/38 ) were included ; only 2 PA cases were studied after biopsy .", "Nitroproteins in Human Astrocytomas Discovered by Gel Electrophoresis and Tandem Mass Spectrometry .", "classified into four grades ( I - IV ) : I ( pilocytic astrocytoma ) , II ( diffuse astrocytoma ) , III ( anaplastic astrocytoma ) , and IV ( glioblastoma multiforme ) . A higher grade", "Further studies about ethnically diverse populations with larger sample size should be performed to confirm the correlation between KDR gene polymorphisms and risk of astrocytomas .", "of CD68 , CD3 , and CD20 was investigated in 21 glioblastomas , 21 anaplastic astrocytomas , 13 diffuse astrocytomas , and 18 pilocytic astrocytomas . The inflammatory infiltrate was", "Immunohistochemical analysis showed that 128 of 172 ( 74.4% ) paraffin - embedded archival astrocytomas samples exhibited positive AEG-1 expression .", "multiforme group ; whereas fibulin-2 and -5 were downregulated in grade II / III / IV astrocytoma , and the negative expression was significantly associated with advanced clinical stage .", "Very rarely, a PA may undergo spontaneous malignant transformation and become an anaplastic astrocytoma.", "Of these, Grade I, (n = 1, 3.33%), Grade II, (n = 7, 23.3%), Grade III (n = 6, 20%), and Grade IV (n = 16, 53.3%) astrocytomas were analyzed", "As the name implies , the borders of a diffuse astrocytoma tend to grown into surrounding normal brain tissue .", "be performed to confirm the correlation between KDR gene polymorphisms and risk of astrocytomas .", "drug resistance and metastasis and might play a role in the spread and treatment of an astrocytoma . Semiquantitative immune - based measurements of different sorcin expressions were found among", "This article reviews new developments in our understanding and treatment of low - grade astrocytomas .", "in HMAs than in LMAs . AEG-1 expression had no correlation with the gender or age of astrocytoma patients . In summary , our data suggest that AEG-1 may represent a novel prognostic marker for", "A South Indian study BACKGROUND Astrocytomas are the most common primary tumor of the central nervous system .", "of Ki-67 LI should constitute a part of routine investigations in patients with astrocytomas .", "PATIENTS AND METHODS Thirty cases of histologically proven astrocytomas were studied .", "staining in 204 cases , including 32 normal brain tissues , 80 Low - malignant astrocytomas ( LMAs ) and 92 High - Malignant astrocytomas ( HMAs ) . AEG-1 expression in 31 LMAs and 29 HMAs", "compared with 42.9% of anaplastic astrocytomas ( P = 0.004 ) , 38.5% of diffuse astrocytomas ( P = 0.008 ) , and 33.3% of pilocytic astrocytomas ( P = 0.001 ) . Among diffusely infiltrating", "Ki-67 immunostaining in astrocytomas: Association with histopathological grade –", "CONCLUSIONS : Lower relative cerebral blood volume and higher ADC values favor a diagnosis of pilocytic astrocytoma , while higher lipid - lactate in tumor / creatine in tumor ratios plus necrosis favor a diagnosis of high - grade astrocytomas . ABBREVIATIONS : GBM glioblastoma multiforme ; HGA high - grade astrocytoma ; HGG high - grade glioma ; LGG low - grade glioma ; Lip - Lac lipid - lactate ; n normal contralateral ; PA pilocytic astrocytoma ; rCBV relative cerebral blood volume ; ROC receiver operating characteristic analysis curve ; tu tumor ; WHO World Health Organization Pilocytic astrocytoma ( PA ) is the most common pediatric central nervous system glioma and one of the most common pediatric cerebellar tumors .", "The protein samples from clinical specimens of grades I , II , III , and IV astrocytoma were analyzed by two - dimensional liquid chromatography - tandem mass spectrometry and isobaric tags for relative and absolute quantitation and quantification .", "The threshold values 1.33 for relative cerebral blood volume provide sensitivity, specificity, positive predictive values, and negative predictive values of 100%, 67%, 87%, and 100%, respectively, for differentiating high-grade astrocytomas frompilocytic astrocytomas.", "brain tissues , 80 Low - malignant astrocytomas ( LMAs ) and 92 High - Malignant astrocytomas ( HMAs ) . AEG-1 expression in 31 LMAs and 29 HMAs samples was detected by RT - PCR and Western", "Grades I and II astrocytomas are the slowest growing tumors, and are also called low-grade astrocytomas.", "RESULTS Thirty cases of astrocytomas studied showed a male preponderance (M:F = 1.72:1) with a mean age of 48.1 years.", "CONCLUSIONS MIB-1 and p53 co - staining is very useful for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas .", "CONCLUSION Ki-67 LI varies considerably in different grades of astrocytomas and considerable overlaps can be observed between them .", "grade revealed that the C allele of rs2071559 had more influence with the risk of astrocytomas in the grade III – IV ( OR = 1.91 ) subgroup than the grade I – II ( OR = 1.47 ) group . Genotype", "Intratumorally, 85.7% of glioblastomas exhibited CD68-positive infiltrate compared with 42.9% of anaplastic astrocytomas", "IV ( HGA ) astrocytomas were included in this study .", "Blood samples were collected from 157 astrocytomas patients and 160 healthy controls.", "Among those nitroproteins that might play a role in astrocytomas was nitro - sorcin , which is involved in drug resistance and metastasis and might play a role in the spread and treatment of an astrocytoma .", "Diffuse astrocytomas are by far the most common.", "However, MIB-1 or p53 staining alone cannot differentiate pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas.", "TT of rs2305948 was found to be significantly associated with susceptibility of astrocytomas only in the grade III – IV subgroup . The protective effect of rs1870377 did not reveal", "However , in these cases , results using both MIB-1 and p53 stain differed from those for anaplastic astrocytomas and glioblastomas .", "In summary , our data suggest that AEG-1 may represent a novel prognostic marker for astrocytomas .", "Grade III and IV astrocytomas were allocated in a single group because their aggressive biologic behavior is quite often similar, but this will depend on many factors including genetic profile.", "New molecular biomarkers are likely to be used for accurate classification of astrocytoma and likely to be the target for drug development .", "BACKGROUND AND PURPOSE The differentiation of pilocytic astrocytomas and high-grade astrocytomas is sometimes difficult.", "( I - IV ) : I ( pilocytic astrocytoma ) , II ( diffuse astrocytoma ) , III ( anaplastic astrocytoma ) , and IV ( glioblastoma multiforme ) . A higher grade astrocytoma represents a worse prognosis", "RESULTS: The relative cerebral blood volume values were significantly lower in pilocytic astrocytomas comparedwith the high-grade astrocytomas (1.4 0.9 versus 3.3 1.4; P .0008).", "However , individuals with mutant allele A and genotype TA + AA of rs1870377 showed a protective effect against astrocytomas .", "relative to controls , and a semiquantitative increased nitration level in high - grade astrocytoma relative to control . Nitro-β-tubulin functions in cytoskeleton and cell migration .", "The MIB-1 labelling index and the frequency and intensity of p53 staining in both the pilocytic astrocytoma and the astrocytoma group were significantly lower than in the anaplastic astrocytoma plus glioblastoma group (P < 0.001).", "Perspectives on the immunologic microenvironment of astrocytomas BACKGROUND The microenvironment of astrocytomas includes infiltrative inflammatory cells that are dynamic in nature , possibly reflecting tumor biology .", "Ki-67 is a potent biological marker used in grading of astrocytomas, which estimates growth of the neoplasm quantitatively and will help in predicting prognosis accurately.", "Additionally , haplotype - specific analysis showed that haplotype CCT and CTT were related with an increased risk of astrocytomas .", "In the overall individual SNP analysis , the C allele of rs2071559 was correlated with an increased risk of astrocytomas .", "Grade IV astrocytomas, also called glioblastoma, are the most aggressive of the astrocytomas.", "Statistically significant difference was seen in the Ki-67 LI of low-grade (Grade II) and high-grade astrocytomas (Grades III and IV).", "aim of the study was to explore the relationship between KDR polymorphisms and risk of astrocytomas . Blood samples were collected from 157 astrocytomas patients and 160 healthy controls . Three tag", "MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults .", "( P = 0.0001 ) , 7.7% of diffuse astrocytomas", "In this study, we compared the differential proteome profile of astrocytoma from grades I to IV.", "infiltrate was only detected in the perivascular space of a single case of diffuse astrocytoma . CONCLUSION These data indicate a distinct immune profile in the glioblastoma microenvironment", "with variants of rs2071559*C and rs2305948*T might significantly elevate the risk of astrocytomas , while mutants of rs1870377*A was associated with the decreased risk of astrocytomas . Further", "Comparison of perfusion , diffusion , and MR spectroscopy between low - grade enhancing pilocytic astrocytomas and high - grade astrocytomas .", "Protein tyrosine nitration is involved in the pathogenesis of highly fatal astrocytomas, a type of brain cancer.", "We evaluated the astrocytomas risk caused by individual SNPs and haplotype using odds ratios (ORs) and their 95 % confidence intervals (CIs).", "difference was seen in the Ki-67 LI of low - grade ( Grade II ) and high - grade astrocytomas ( Grades III and IV ) . There was concordance between histopathological grading and Ki-67 LI in 27", "Genotype TT of rs2305948 was found to be significantly associated with susceptibility of astrocytomas only in the grade III–", "This study aimed to investigate the expression of AEG-1 in human astrocytomas and the correlation between AEG-1 expression and clinicopathologic variables of astrocytomas .", "MATERIALS AND METHODS Patients and Histopathologic Analysis MR imaging studies of 38 patients with astrocytomas were reviewed (16 patients with PAs and 22 patients with HGAs).", "Prognostic significance of astrocyte elevated gene-1 in human astrocytomas.", ") , III ( anaplastic astrocytoma ) , and IV ( glioblastoma multiforme ) . A higher grade astrocytoma represents a worse prognosis and is more aggressive . In this study , we compared the differential", "Semiquantitative immunoreactivity of β-tubulin showed increased expression among different grades of astrocytomas relative to controls and semiquantitatively increased nitration level in high-grade astrocytoma relative to control.", "In 11.1% ( two of 18 ) of pilocytic astrocytomas and 42.9% ( six of 14 ) of astrocytomas , immunoreactivity of either MIB-1 or p53 staining was of almost the same intensity as that of anaplastic astrocytomas and glioblastomas .", ": Association with histopathological grade – A South Indian study BACKGROUND Astrocytomas are the most common primary tumor of the central nervous system . The distinction between", "astrocytomas , while mutants of rs1870377*A was associated with the decreased risk of astrocytomas . Further studies about ethnically diverse populations with larger sample size should be performed", "demonstrated that mutation of rs2071559 and rs2305948 could elevate the risk of astrocytomas more significantly in the subgroup of smokers than the nonsmokers . Interestingly , the protective", "A higher grade astrocytoma represents a worse prognosis and is more aggressive .", "of Kinase Inserts Domain Receptor ( KDR ) Gene Are Associated with the Risk of Astrocytomas Astrocytomas is one of the most common central nervous system ( CNS ) tumors with high mortality", "KDR polymorphisms and risk of astrocytomas . Blood samples were collected from 157 astrocytomas patients and 160 healthy controls . Three tag - SNPs ( rs2071559C / T , rs2305948T / C , and rs1870", "METHODS Immunohistochemical expression of CD68, CD3, and CD20 was investigated in 21 glioblastomas, 21 anaplastic astrocytomas, 13 diffuse astrocytomas, and 18 pilocytic astrocytomas.", "(P = 0.0001), and 33.3% of pilocytic astrocytomas", ". In summary , our data suggest that AEG-1 may represent a novel prognostic marker for astrocytomas .", "Astrocytomas are the most common of the primary brain tumors."], "par_relations": ["Glioma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma"], "chd_relations": ["Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Glioblastoma", "Melanoma astrocytoma syndrome", "Cerebral astrocytoma, adult", "Desmoplastic cerebral astrocytoma of infancy"], "syn_relations": ["Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma", "Astrocytoma"], "sib_relations": ["Astrocytoma", "Ependymoma", "Medulloblastoma", "Oligodendroglioma", "Ganglioglioma", "Gliosarcoma", "Optic Nerve Glioma", "Astrocytoma"]}, "target_ent": {"research_entity_id": "OMIM:MTHU042823", "canonical_name": "Corneal clouding, progressive", "aliases": ["corneal clouding, progressive"], "definition": "", "other_contexts": [], "par_relations": ["Eyes"], "chd_relations": [], "syn_relations": [], "sib_relations": ["SCHEIE SYNDROME"]}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:18588", "canonical_name": "ankyrin repeat domain 7", "aliases": ["ankyrin repeat domain 7", "ankrd7", "tsa806", "testis-specific ankyrin motif containing protein", "ankrd7 gene"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["ankyrin repeat domain 7", "ankyrin repeat domain 7", "ankyrin repeat domain 7", "ankyrin repeat domain 7"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:611122", "canonical_name": "ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28", "aliases": ["phosphatase interactor targeting k protein", "kiaa0379", "ankyrin repeat domain-containing protein 28", "pitk", "ankrd28"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28", "ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28", "ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28", "ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28", "ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28", "ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28", "ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28", "ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0002140", "canonical_name": "Ischemic stroke", "aliases": ["ischemic stroke"], "definition": "", "other_contexts": ["acid and homovanillic acid in the urine as potential prognostic biomarkers in ischaemic stroke patients . BACKGROUND Suitable biomarkers that have prognostic values are one of the key points of", "biomarkers that have prognostic values are one of the key points of interest in ischaemic stroke . Increased sympathetic nervous system activity in ischaemic stroke causes multiple local and", "There has been a substantial and significant increase in patients hospitalized for ischaemic stroke with co - existing HIV infection . However , little is known about the mechanism of stroke in", "infarct topography of naturally occurring ischaemic stroke in pet dogs with human ischaemic stroke . METHODS Medical records and magnetic resonance imaging ( MRI ) of 27 dogs with spontaneous", "+ ve ischaemic stroke patients with HIV - ve and HIV + ve patients with and without ischaemic stroke respectively . METHODS A matched case control study in which a total of 52 HIV + ve patients with", "and with multiple risk factors , non - AF patients may have a risk of incident ischaemic stroke that is comparable or even higher than patients with AF , suggesting that the incremental stroke", "association for LRP6 rs2075241 was observed at a similar magnitude across ischaemic stroke subtypes , whilst the effects of rs23022685 , rs10492120 and rs10743980 were most apparent for", "After Ischaemic Stroke OBJECTIVES To determine the incidence of brain edema after ischaemic stroke and its impact on the outcome of patients in the acute phase of ischaemic stroke . PATIENTS AND", "and homovanillic acids positively correlated with functional outcome of ischaemic stroke . Favorable outcomes correlated with decreased values , on contrary to increased values , which", "METHODS A matched case control study in which a total of 52 HIV + ve patients with ischaemic stroke were prospectively compared with control groups for the presence of protein S , protein C", "of interest in ischaemic stroke . Increased sympathetic nervous system activity in ischaemic stroke causes multiple local and systemic effects that can be detrimental to the outcome . The mechanism", "the association between serum 25-hydroxyvitamin D levels and clinical outcomes of ischaemic stroke in the 3-month period of follow - up in all patients and in different lipid - level subgroups .", "ischaemic stroke . RESULTS In the Caucasian series , significant associations with ischaemic stroke were observed for LRP6 rs2075241 [ odds ratio ( OR ) 0.42 , P = 0.023 ] , rs2302685 ( OR 0.44 , P =", "ischaemic stroke . PATIENTS AND METHODS We retrospectively analyzed 114 patients . Ischaemic stroke and brain edema are verified by computed tomography . The severity of stroke was determined by", "Medical records and magnetic resonance imaging ( MRI ) of 27 dogs with spontaneous ischaemic stroke were retrospectively investigated with respect to clinical symptoms and infarct topography .", "37months . The future symptomatic ICH rate was 1.6% ( 16/990 ) , while recurrent ischaemic stroke rate was 5.9% ( 58/990 ) . Baseline CMB presence was associated with increased risk of symptomatic", "therapy . Amongst patients with no antithrombotic therapy , annual incidence of ischaemic stroke in PD patients was comparable with those non - CKD counterparts ( 9.32 vs. 9.30%/year ) . Similar", "cardiovascular risk factors ( besides AF ) contributes to a greater risk for ischaemic stroke , especially in the elderly population . If elderly and with multiple risk factors , non - AF", "ischaemic stroke was calculated amongst the individuals with no prior history of ischaemic stroke , in relation to age groups ( aged < 65 , 65 - 74 , ≥ 75 years old ; n = 348,431 , n = 56,952 , n =", "Spontaneously occurring ischaemic stroke in dogs share characteristics with human ischaemic stroke in terms of clinical symptoms and infarct topography . Investigating pet dogs with spontaneous", "Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation.", "According to multivariate Cox analysis, the strong independent risk factor for ischemic strokes in HCM was AF (p < 0.01), whereas in patients with AF they were HCM (p < 0.01) and age (p < 0.01).", "risk factors is unclear . In an individual patient with AF the mechanism of ischaemic stroke may be related directly to AF itself or to risk factors associated with AF . It was this study 's", "A total of 3181 ischaemic patients from China Antihypertensive Trial in Acute Ischaemic Stroke were included in this study and their baseline serum 25-hydroxyvitamin D levels were tested . They", ",242 ( 3.1% ) ischaemic strokes after 64,834 person - years follow - up . Overall , ischaemic stroke incidence ( per 100 person - years ) was 0.35 ( 95%CI 0.34 - 0.35 ) in the non - AF population and", "up for death , major disability and vascular events for 3 months after acute ischaemic stroke . A multivariable logistic model was used to evaluate the association between serum 25-", "of LRP1 and LRP6 gene variants with risk of ischaemic stroke as part of the Ischemic Stroke Genetics Study ( ISGS ) . METHODS A Caucasian series ( 434 stroke patients , 319 controls ) and an", "Primary endpoints (ischemic strokes or cardiac death, whichever occurred first) and ischemic strokes were examined by Kaplan-Meier curves.", "( 9.32 vs. 9.30%/year ) . Similar to non - CKD patients , annual incidence of ischaemic stroke increased with increasing CHA2DS2-VASc score ( CHA2DS2-VASc = 0 - 1 : 5.76 vs. 5.70%/year , P = 1.0", "- analysis of cohorts and anticoagulation decision schema . INTRODUCTION Whether ischaemic stroke patients with atrial fibrillation ( AF ) and cerebral microbleeds ( CMBs ) on MRI can be safely", "The clinical outcome and the incidence of ischemic strokes in patients with hypertrophic cardiomyopathy (HCM) with and without atrial fibrillation (AF) were examined.", "the effect of serum vitamin D especially its deficiency on the global outcome of ischaemic stroke stratified by individual lipid component level . METHODS A total of 3181 ischaemic patients from", "hyperhomocysteinaemia or protein S deficiency in HIV + ve patients with or without ischaemic stroke . Protein C deficiency was not noted to be significantly different between the cases and the two", "These results suggest that incidence of ischemic strokes in HCM is markedly increased if complicated by AF as compared with that in patients with AF alone.", "Similarly, the frequency of ischemic strokes in HCM was also much higher with AF than without AF (23.0% vs 5.9% at 5 years, p < 0.01).", "of these compounds in the urine is an easily available prognostic tool for the ischaemic stroke outcome , while also influencing potential therapeutic changes .", "whether these compounds can be used as potential prognostic biomarkers in ischaemic stroke , as a unique insight into the activity of the sympathetic nervous system . METHODS Urine samples", "atrial fibrillation ( AF ) . Our objective was to determine the risk of ischaemic stroke in a ' real - world ' cohort of PD patients with AF , and clinical benefit or harm of aspirin and", "in LRP1 and LRP6 has been linked with various factors that are related to risk of ischaemic stroke . The aim of this study was to examine the association of LRP1 and LRP6 gene variants with risk of", "to explore the association of hypercoagulability state in HIV + ve patients with ischaemic stroke . This was achieved by comparing hypercoagulability state markers between HIV + ve ischaemic", "no effect on survival in the acute phase . The existence of brain edema in acute ischaemic stroke significantly influence the degree of neurological deficit .", "associated with AF . It was this study 's objective to investigate incident ischaemic stroke in relation to age and increasing cardiovascular risk factor(s ) , and the incremental impact of", ". This was achieved by comparing hypercoagulability state markers between HIV + ve ischaemic stroke patients with HIV - ve and HIV + ve patients with and without ischaemic stroke respectively .", "approaches are therefore desirable . As humans , pet dogs suffer from spontaneous ischaemic stroke and may hence offer new ways of studying genuine stroke injury mechanisms . AIMS The objective of", "- up . RESULTS Four studies , with slightly heterogeneous design , including 990 ischaemic stroke patients were pooled in a meta - analysis ( crude CMBs prevalence : 25% ; 95%CI : 17%-33% ) . The", "was to compare clinical symptoms and infarct topography of naturally occurring ischaemic stroke in pet dogs with human ischaemic stroke . METHODS Medical records and magnetic resonance imaging (", "6 variants and three LRP1 variants were genotyped and assessed for association with ischaemic stroke . RESULTS In the Caucasian series , significant associations with ischaemic stroke were observed", "of the sympathetic nervous system . METHODS Urine samples of 96 patients with ischaemic stroke and transitory ischaemic attacks were analysed . Values of vanillylmandelic and homovanillic acids", "were reported in 15 of 27 cases ( 56% ) . CONCLUSIONS Spontaneously occurring ischaemic stroke in dogs share characteristics with human ischaemic stroke in terms of clinical symptoms and", "a higher risk of ICH . CONCLUSION In CKD patients on PD with AF , who had similar ischaemic stroke risk as non - CKD counterparts , warfarin therapy is associated with reduction in risk of", "matched for age and sex HIV - ve and HIV + ve patients with and without ischaemic stroke respectively . Data was analysed in contingency tables using Paired t- test , Chi square and", "( hypertension , vascular disease , diabetic , or heart failure ) had ischaemic stroke rates similar to an AF population with CHA2DS2-VASc ≥ 4 . In both non - AF and AF populations ,", "using Paired t- test , Chi square and conditional logistic regression . RESULTS Ischaemic stroke of undetermined aetiology occurred more frequently in HIV + ve compared to HIV - ve patients ( p <", "age 60 years ; 880 with AF , vs 424,720 non - AF ] , there were 13,242 ( 3.1% ) ischaemic strokes after 64,834 person - years follow - up . Overall , ischaemic stroke incidence ( per 100 person -", "non - CKD counterparts , warfarin therapy is associated with reduction in risk of ischaemic stroke without a higher risk of ICH .", "10492120 ( OR 0.62 , P = 0.036 ) and rs10743980 ( OR 0.66 , P = 0.037 ) . Risk of ischaemic stroke was significantly lower for carriers of any of these five protective LRP6 variants ( 24.0% of", "AF on warfarin , is associated with a 4-fold increase in subsequent ICH ( but not ischaemic stroke ) risk ( Class III evidence ) . These pooled estimates are useful for future trials design . We", ". RESULTS Vitamin D deficiency was associated with poor clinical outcomes only in ischaemic stroke patients with high density lipoprotein cholesterol ( HDLC ) < 1.04 mmol / l rather than all", "- 11.25 ; p=0.005 ) . There was no association between CMBs presence and recurrent ischaemic stroke risk . CONCLUSION We have shown that the presence of CMBs in cohorts of ischaemic stroke patients ,", "study provide evidence that LRP6 and LRP1 variants may be associated with risk of ischaemic stroke . Validation in larger studies is warranted .", "Vitamin D deficiency may be merely an independent risk factor of poor prognosis in ischaemic stroke patients with low HDLC level .", "significant correlation between brain edema and survival in patients after acute ischaemic stroke . Patients with brain edema had a significantly higher degree of neurological deficit as at", "clinical symptoms and infarct topography . Investigating pet dogs with spontaneous ischaemic stroke may provide an alternative approach to the research of stroke injury mechanisms as they occur", "( p = 0.04 , p = 0.004 ) . CONCLUSION The cerebral edema is common after acute ischaemic stroke and no effect on survival in the acute phase . The existence of brain edema in acute ischaemic", "factors . How atrial fibrillation ( AF ) incrementally contributes to the risk for ischaemic stroke with increasing age and multiple cardiovascular risk factors is unclear . In an individual patient", "fibrillation . An analysis of 425,600 Chinese individuals without prior stroke . Ischaemic stroke risk rises with the increasing cardiovascular risk factors . How atrial fibrillation ( AF )", "study was to examine the association of LRP1 and LRP6 gene variants with risk of ischaemic stroke as part of the Ischemic Stroke Genetics Study ( ISGS ) . METHODS A Caucasian series ( 434 stroke", "to investigated the association between CMBs presence at baseline MRI and ICH or ischaemic stroke during follow - up . RESULTS Four studies , with slightly heterogeneous design , including 990", "indicate that a lower vitamin D level is associated with a higher risk of poor ischaemic stroke prognosis . Whether this association is affected by lipid levels is unclear . Our aim was to", "stroke risk . CONCLUSION We have shown that the presence of CMBs in cohorts of ischaemic stroke patients , most with AF on warfarin , is associated with a 4-fold increase in subsequent ICH ( but", "study of Chinese patients with non - valvular AF . Hospitalizations with ischaemic stroke and intracranial haemorrhage ( ICH ) were recorded . Of 9810 patients from a hospital - based AF", "ischaemic stroke and its impact on the outcome of patients in the acute phase of ischaemic stroke . PATIENTS AND METHODS We retrospectively analyzed 114 patients . Ischaemic stroke and brain edema", "more than 10 million individuals , for the years 2001 to 2012 . The rate of ischaemic stroke was calculated amongst the individuals with no prior history of ischaemic stroke , in relation to", "kidney disease undergoing peritoneal dialysis . AIMS Little is known about the ischaemic stroke risk and benefit of warfarin therapy for stroke prevention in chronic kidney disease ( CKD )", "= 0.78 ) . Amongst PD patients , warfarin therapy was associated with lower risk of ischaemic stroke compared with aspirin [ Hazard ratio ( HR ) : 0.16 , 95% confidence interval ( CI ) : 0.04 - 0.66 ,", "deficiency and Hyperhomocysteinaemia were more prominent in HIV + ve than HIV - ve ischaemic stroke patients ( P = 0.011 ) . There was no difference in the presence of hyperhomocysteinaemia or"], "par_relations": ["Stroke", "Cerebral ischemia"], "chd_relations": [], "syn_relations": [], "sib_relations": ["Transient ischemic attack", "Stroke-like episodes"]}, "target_ent": {"research_entity_id": "OMIM:MTHU023753", "canonical_name": "Metacarpal aplasia", "aliases": ["metacarpal aplasia"], "definition": "", "other_contexts": [], "par_relations": ["Hands"], "chd_relations": [], "syn_relations": [], "sib_relations": ["ACHEIROPODY"]}}
{"label": 1, "source_ent": {"research_entity_id": "ICD10CM:C80", "canonical_name": "Malignant neoplasm without specification of site", "aliases": ["malignant neoplasm without specification of site"], "definition": "", "other_contexts": [], "par_relations": ["Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80)"], "chd_relations": ["Malignant neoplasm associated with transplanted organ", "Disseminated malignant neoplasm, unspecified", "Malignant (primary) neoplasm, unspecified"], "syn_relations": [], "sib_relations": ["Malignant neoplasm of other and ill-defined sites", "Secondary malignant neoplasm of respiratory and digestive organs", "Secondary and unspecified malignant neoplasm of lymph nodes", "Secondary malignant neoplasm of other and unspecified sites"]}, "target_ent": {"research_entity_id": "LNC:MTHU040703", "canonical_name": "Malignancy", "aliases": ["malignancy"], "definition": "", "other_contexts": ["Malignancies induced by chlorambucil .", "Malignancies following lung transplantation .", "Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer.", "Modern Prospection for Hepatic Arterial Infusion Chemotherapy in Malignancies with Liver Metastases Malignancy with liver metastasis plays an important role in daily oncology practice, especially for primary cancers of the gastrointestinal tract and hepatopancreatobiliary system.", "Does Chemotherapy for Gynecological Malignancies during Pregnancy Cause Fetal Growth Restriction?", "Second Primary Tumors after Radiotherapy for Malignancies Treatment - Related Parameters The aim of the present analysis was to identify radiotherapy - related parameters that influence the development of second malignancies .", "Do Concomitant Ascites Influence the Effectiveness of Palliative Surgical Management of Pleural Effusion in Patients with Malignancies?", "Surgical Resection of Malignancies Invading Inferior Vena Cava Level I and II.", "Malignancies involving the pericardium. Malignancies rarely arise from the pericardium.", "High Incidence of Malignancies in Persistent-estrous Rats.", "Malignancies may secondarily involve the pericardium by direct extension.", "Malignancies after lung transplantation represent an important problem ."], "par_relations": [], "chd_relations": [], "syn_relations": [], "sib_relations": ["Malignancy:Hx:Pt:^Patient:Ord:PhenX"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C564685", "canonical_name": "Spinocerebellar Ataxia 15", "aliases": ["spinocerebellar ataxia 15"], "definition": "", "other_contexts": [], "par_relations": ["Spinocerebellar Ataxias"], "chd_relations": [], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:602090.0002", "canonical_name": "LTBP3, 1-BP INS, 1858G", "aliases": ["ltbp3, 1-bp ins, 1858g"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 3"], "sib_relations": ["LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 3"]}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0012785", "canonical_name": "Flexion contracture of finger", "aliases": ["flexion contracture of finger"], "definition": "Chronic loss of joint motion in a finger due to structural changes in non-bony tissue. [HPO:probinson]", "other_contexts": [], "par_relations": ["Joint contracture of the hand", "Flexion contracture of digit"], "chd_relations": ["Flexion contracture of thumb", "Joint contracture of the 5th finger", "Flexion contracture of the 2nd finger", "Joint contracture of the 3rd finger", "Joint contracture of the 4th finger", "Interphalangeal joint contracture of finger"], "syn_relations": [], "sib_relations": ["Dupuytren contracture", "Camptodactyly", "Flexion contracture of toe", "Bethlem sign"]}, "target_ent": {"research_entity_id": "OMIM:MTHU054039", "canonical_name": "Joint contracture (in some patients)", "aliases": ["joint contracture (in some patients)"], "definition": "", "other_contexts": [], "par_relations": ["Limbs"], "chd_relations": [], "syn_relations": [], "sib_relations": ["MEESTER-LOEYS SYNDROME"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:D004422", "canonical_name": "Dystonia Musculorum Deformans", "aliases": ["dystonia deformans musculorum", "childhood tortion dis", "torsion dis childhood", "idiopathic torsion dystonias", "idiopathic torsion dystonia", "dystonias, torsion", "torsion spasm, progressive", "oppenheim ziehen disease", "torsion dystonia, idiopathic", "spasm, progressive torsion", "torsion disease of childhood", "progressive torsion spasm", "dystonia musculorum deformans", "childhood torsion disease", "oppenheim-ziehen disease", "dystonias, idiopathic torsion", "dystonia, idiopathic torsion", "torsion dystonia", "oppenheim ziehen dis", "torsion disease, childhood", "dystonia deformans progressiva"], "definition": "A condition characterized by focal DYSTONIA that progresses to involuntary spasmodic contractions of the muscles of the legs, trunk, arms, and face. The hands are often spared, however, sustained axial and limb contractions may lead to a state where the body is grossly contorted. Onset is usually in the first or second decade. Familial patterns of inheritance, primarily autosomal dominant with incomplete penetrance, have been identified. (Adams et al., Principles of Neurology, 6th ed, p1078)", "other_contexts": ["Sporadic adult onset primary torsion dystonia is a genetic disorder by the temporal discrimination test.", "We report a 12-year - old boy with idiopathic torsion dystonia .", "The role of DYT1 in a Swedish family with adult onset idiopathic torsion dystonia in four generations was examined .", "The high incidence and dominant inheritance of early-onset idiopathic torsion dystonia in Ashkenazi Jews suggests genetic homogeneity within this population, making it especially useful for linkage studies of this disorder.", "[ A case of idiopathic torsion dystonia showing blepharospasm at the onset ] .", "The allelic association observed between ASS / ABL and idiopathic torsion dystonia in Ashkenazi families in the USA was also present in British Jewish kindreds .", "Since a postmortem biochemical study and a genetic linkage study of idiopathic torsion dystonia suggested possible involvement of dopamine beta - hydroxylase ( DBH ) , we determined CSF DBH activities of Jewish and non - Jewish patients with childhood - onset idiopathic torsion dystonia and found no differences from a control population .", "The genetics of idiopathic torsion dystonia .", "The DYT1 gene region has been excluded in other families with adult onset and cervical or cranial onset idiopathic torsion dystonia from the United States, Great Britain, and France.", "Nineteen children with dystonia musculorum deformans and dystonic hyperkineses were treated by L-DOPA.", "We have found no evidence for genetic heterogeneity in the Ashkenazi Jewish families studied for linkage analysis , but there is at least one non - Jewish family with idiopathic torsion dystonia that is not linked to this region .", "Linkage analysis was performed in 27 (26 British, one French) small families with idiopathic torsion dystonia, three of which were Ashkenazi Jewish, using the highly polymorphic loci argininosuccinate synthetase (ASS) and Abelson oncogene (ABL) which map to 9q34.", "The results indicate the efficiency of L-DOPA in the treatment of dystonia musculorum deformans and dystonic hyperkineses against the residual organic background.", "A gene ( DYT1 ) for early onset idiopathic torsion dystonia was mapped to chromosome 9q34 in non - Jewish and Jewish families .", "Some patients with dystonic movements and postures not known to be caused by environmental or degenerative disorders can be segregated from classical - appearing idiopathic torsion dystonia on the basis of distinctive clinical and pharmacologic features .", "Idiopathic torsion dystonia is most commonly caused by an autosomal dominant gene or genes with reduced penetrance.", "Abnormal temporal discrimination thresholds were found in 1/61 (2%) control subjects, 27/32 (84%) patients with adult-onset primary torsion dystonia and 32/73 (44%) unaffected relatives [siblings (20/36; 56%), offspring (11/36; 31%) and one parent].", "His clinical course was not typical of idiopathic torsion dystonia and very rare in children .", "The results of segregation analysis applied to a family study of idiopathic torsion dystonia in Ashkenazi Jews are reported.", "Analysis of all the data using HOMOG showed significant heterogeneity, but evidence for linkage of an idiopathic torsion dystonia gene to 9q34 in a subset of families.", "The controversy regarding the mode of inheritance of idiopathic torsion dystonia in the Ashkenazi Jewish population has been resolved.", "The daughter, a 9-year-old girl, had since the age of 7 also shown a neurological disorder diagnosed as idiopathic torsion dystonia.", "Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance.", "[Experience with L-DOPA treatment of children with dystonia musculorum deformans and dystonic hyperkineses in infantile cerebral palsy].", "Dopamine beta - hydroxylase activity in cerebrospinal fluid of idiopathic torsion dystonia .", "These data suggest genetic heterogeneity in idiopathic torsion dystonia but indicate the existence of a locus for idiopathic torsion dystonia at 9q34 in both Jewish and non-Jewish kindreds in the UK.", "An idiopathic torsion dystonia locus has been mapped to chromosome 9q34 in one large non-Jewish and several Jewish kindreds in the USA.", "The authors emphasize the association of dyschromatosis symmetrica hereditaria , a rare cutaneous disease , with idiopathic torsion dystonia , a rare idiopathic neurological disease , in this young girl .", "The frequency of abnormal temporal discrimination thresholds in first-degree relatives of patients with sporadic adult-onset primary torsion dystonia is compatible with an autosomal dominant disorder and supports the hypothesis that apparently sporadic adult-onset primary torsion dystonia is genetic in origin.", "Clinical variants of idiopathic torsion dystonia .", "The temporal discrimination threshold is the shortest time interval at which two stimuli are detected to be asynchronous and has been shown to be abnormal in adult - onset primary torsion dystonia .", "Linkage analysis in British and French families with idiopathic torsion dystonia .", "A more marked positive effect was obtained in children with dystonia musculorum deformans.", "Adult-onset primary torsion dystonia is an autosomal dominant disorder with markedly reduced penetrance; patients with sporadic adult-onset primary torsion dystonia are much more prevalent than familial.", "The aim was to determine the frequency of abnormal temporal discrimination thresholds in patients with sporadic adult-onset primary torsion dystonia and their first-degree relatives.", "Adult onset idiopathic torsion dystonia is excluded from the DYT 1 region (9q34) in a Swedish family.", "Dyschromatosis symmetrica hereditaria associated with idiopathic torsion dystonia .", "Temporal discrimination thresholds were examined in 61 control subjects (39 subjects <50 years of age; 22 subjects >50 years of age), 32 patients with sporadic adult-onset primary torsion dystonia (cervical dystonia n = 30, spasmodic dysphonia n = 1 and Meige's syndrome n = 1) and 73 unaffected first-degree relatives (36 siblings, 36 offspring and one parent) using visual and tactile stimuli.", "Many of them should be considered within the family of dystonia, as clinical variants of idiopathic torsion dystonia, while others are better classified as being part of other families of dyskinesias."], "par_relations": ["Basal Ganglia Diseases", "Dystonic Disorders", "Heredodegenerative Disorders, Nervous System"], "chd_relations": ["Dystonia 6, torsion", "Dystonia 15, myoclonic", "Dystonia musculorum deformans 4", "Dystonia musculorum deformans type 2", "Whispering dysphonia, hereditary", "Dystonia musculorum deformans type 1"], "syn_relations": ["Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans", "Dystonia Musculorum Deformans"], "sib_relations": ["Dystonia", "Cockayne Syndrome", "Gerstmann-Straussler-Scheinker Disease", "Pantothenate Kinase-Associated Neurodegeneration", "Hepatolenticular Degeneration", "Huntington Disease", "Meige Syndrome", "Myotonic Dystrophy", "Myotonia Congenita", "Neuroleptic Malignant Syndrome", "Neuronal Ceroid-Lipofuscinoses", "Hereditary Sensory and Motor Neuropathy", "Hereditary Sensory and Autonomic Neuropathies", "Optic Atrophies, Hereditary", "Spinocerebellar Degenerations", "Supranuclear Palsy, Progressive", "Torticollis", "Tourette Syndrome", "Tuberous Sclerosis", "Neurofibromatoses", "Amyloid Neuropathies, Familial", "Canavan Disease", "Parkinsonian Disorders", "Chorea Gravidarum", "Alexander Disease", "Multiple System Atrophy", "Neuroacanthocytosis", "Spinal Muscular Atrophies of Childhood", "Basal Ganglia Cerebrovascular Disease", "Lafora Disease", "Unverricht-Lundborg Syndrome", "Hereditary Central Nervous System Demyelinating Diseases", "Mental Retardation, X-Linked", "Bulbo-Spinal Atrophy, X-Linked"]}, "target_ent": {"research_entity_id": "OMIM:608693", "canonical_name": "GOLGI REASSEMBLY STACKING PROTEIN 2", "aliases": ["golgi reassembly stacking protein 2", "grasp55", "gorasp2", "golgi reassembly stacking protein, 55-kd"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["GOLGI REASSEMBLY STACKING PROTEIN 2", "GOLGI REASSEMBLY STACKING PROTEIN 2", "GOLGI REASSEMBLY STACKING PROTEIN 2", "GOLGI REASSEMBLY STACKING PROTEIN 2", "GOLGI REASSEMBLY STACKING PROTEIN 2", "GOLGI REASSEMBLY STACKING PROTEIN 2"], "sib_relations": []}}
{"label": 1, "source_ent": {"research_entity_id": "MSH:D001409", "canonical_name": "Bacillus cereus", "aliases": ["bacillus cereus"], "definition": "A species of rod-shaped bacteria that is a common soil saprophyte. Its spores are widespread and multiplication has been observed chiefly in foods. Contamination may lead to food poisoning.", "other_contexts": [". 87:68 - 74 . 1964.-The l - alanine dehydrogenase from vegetative cells of Bacillus cereus strain T has been purified approximately 200-fold . The enzyme has a molecular weight of 248,000", "1963.-Cultures of Bacillus cereus strain T, grown in an unbuffered glucose-yeast extract-mineral salts medium and in the same medium buffered at pH 6.4, 7.0, or 7.4, were examined to determine the effect of pH on the production and utilization of metabolic intermediates during growth and sporulation.", "BIOLOGICAL SIGNIFICANCE Bacteria belonging to the Bacillus cereus group include B. cereus, a notorious food borne pathogen which causes gastroenteritis.", "UNLABELLED The pathogen, Bacillus cereus, is able to adapt its metabolism to various environmental conditions.", "Metabolic control of penicillinase biosynthesis in Bacillus cereus.", "and response surface methodology ( RSM ) . Among the isolated bacteria , an aerobic Bacillus cereus strain was recognized as the best lipase - producing bacteria ( 177.3 ± 20 U / ml ) . Given the", "1964.-Structural details in the outer envelope of spores, such as those of Bacillus cereus and B. anthracis, were studied by electron microscopy and by X-ray diffraction analysis.", "Effect of pH on intermediates produced during growth and sporulation of Bacillus cereus.", "CONCLUSION The study indicates both bacteria Bacillus cereus and Bacillus pumilus have anthelmintic activity indicating potential metabolites in them .", "and Sporulation Characteristics of an Organic Sulfur - requiring Auxotroph of Bacillus Cereus . Lundgren , D. G. ( Syracuse University , Syracuse , N.Y. ) and K. F. Bott . Growth and", "aspects of growth and sporulation of an organic sulfur - requiring auxotroph of Bacillus cereus ATCC 4342 . The wild type and B. cereus T were also studied for comparative purposes . Growth of", "1963.-This paper reports investigations of several aspects of growth and sporulation of an organic sulfur-requiring auxotroph of Bacillus cereus ATCC 4342.", "Arbor ) , and Edgar Ribi . Ultrastructure of the exosporium enveloping spores of Bacillus cereus . J. Bacteriol . 88:1774 - 1789 . 1964.-Structural details in the outer envelope of spores , such", "Pullman ) . Effect of pH on intermediates produced during growth and sporulation of Bacillus cereus . J. Bacteriol . 86:577 - 581 . 1963.-Cultures of Bacillus cereus strain T , grown in an", "Ultrastructure of the exosporium enveloping spores of Bacillus cereus .", "The lipase producing Bacillus cereus was isolated and RSM was used for the optimization of enzyme production.", "The production of penicillinase in the microconstitutive strain 5 of Bacillus cereus in response to treatment with CC was influenced by various inhibitors.", "In this study, the stereoselective hydrolysis of (R, S-1) was performed using the recombinant Bacillus cereus esterase which expressed in Escherichia coli BL21 (DE3).", "were measured 0.367 μM / min.mL and 5.3 mM , respectively . The lipase producing Bacillus cereus was isolated and RSM was used for the optimization of enzyme production . The CSE / yeast extract", "by APA . The production of penicillinase in the microconstitutive strain 5 of Bacillus cereus in response to treatment with CC was influenced by various inhibitors . 8-Azaguanine inhibited the", "and sporulation characteristics of an organic sulfur - requiring auxotroph of Bacillus cereus . J. Bacteriol . 86:462 - 472 . 1963.-This paper reports investigations of several aspects of", "adapt its metabolism to various environmental conditions . The reference strain , Bacillus cereus ATCC 14579 , harbors a linear plasmid , pBClin15 , which displays a cryptic prophage behavior .", "Bacillus cereus was identified by 16S rDNA method.", "Purification and properties of l - alanine dehydrogenase from vegetative cells of Bacillus cereus .", "Growth and sporulation characteristics of an organic sulfur - requiring auxotroph of Bacillus cereus . J. Bacteriol . 86:462 - 472 .", "Optimization of the production conditions of the lipase produced by Bacillus cereus from rice flour through Plackett-Burman Design (PBD) and response surface methodology (RSM).", "Evaluation of Bacillus cereus and Bacillus pumilus metabolites for anthelmintic activity OBJECTIVE To assess the anthelmintic acivity of Bacillus cereus and Bacillus pumilus metabolites .", "- 1789 . 1964.-Structural details in the outer envelope of spores , such as those of Bacillus cereus and B. anthracis , were studied by electron microscopy and by X - ray diffraction analysis .", "Among the isolated bacteria, an aerobic Bacillus cereus strain was recognized as the best lipase-producing bacteria (177.3 ± 20 U/ml).", "Shah , and Richard A. Day . Metabolic control of penicillinase biosynthesis in Bacillus cereus . J. Bacteriol . 88:297 - 308 . 1964.-Penicillinase production in strains 5 and 5/B of Bacillus", "positive bacteria from rice flour was carried out by Rhodamin B agar plate method . Bacillus cereus was identified by 16S rDNA method . Screening of the appropriate variables and optimization of the", "Rac-α-Ethyl-2-Oxo - Pyrrolidineacetic Acid Methyl Ester by Immobilized Recombinant Bacillus cereus Esterase . A new esterase - producing strain ( Bacillus cereus WZZ001 ) which exhibiting high", "sporulation of Bacillus cereus . J. Bacteriol . 86:577 - 581 . 1963.-Cultures of Bacillus cereus strain T , grown in an unbuffered glucose - yeast extract - mineral salts medium and in the same", "for anthelmintic activity OBJECTIVE To assess the anthelmintic acivity of Bacillus cereus and Bacillus pumilus metabolites . MATERIALS AND METHODS The successive solvent extractions with", ". Purification and properties of l - alanine dehydrogenase from vegetative cells of Bacillus cereus . J. Bacteriol . 87:68 - 74 . 1964.-The l - alanine dehydrogenase from vegetative cells of", ", D.C. ) and Linda Jones . Lethality for mice of vegetative and spore forms of Bacillus cereus and Bacillus cereus - like insect pathogens injected intraperitoneally and subcutaneously . J.", "Recombinant Bacillus cereus Esterase . A new esterase - producing strain ( Bacillus cereus WZZ001 ) which exhibiting high hydrolytic activity and excellent enantioselectivity on rac-α-ethyl-", "1964.-Penicillinase production in strains 5 and 5/B of Bacillus cereus in response to treatment by 6-aminopenicillanic acid (APA), penicillin G, (6-N-alpha-(p-benzyloxyphenoxy)-propionylamino-penicillanic acid, and cephalosporin C (CC) was found to be analogous to that seen in constitutive strains.", "The reference strain, Bacillus cereus ATCC 14579, harbors a linear plasmid, pBClin15, which displays a cryptic prophage behavior.", "1964.-The l-alanine dehydrogenase from vegetative cells of Bacillus cereus strain T has been purified approximately 200-fold.", "its host by high - throughput comparative proteomics . UNLABELLED The pathogen , Bacillus cereus , is able to adapt its metabolism to various environmental conditions . The reference strain ,", "Biocatalytic Resolution of Rac-α-Ethyl-2-Oxo-Pyrrolidineacetic Acid Methyl Ester by Immobilized Recombinant Bacillus cereus Esterase.", ". Bacteriol . 88:297 - 308 . 1964.-Penicillinase production in strains 5 and 5/B of Bacillus cereus in response to treatment by 6-aminopenicillanic acid ( APA ) , penicillin G , ( 6-N - alpha-(p -", "A new esterase-producing strain (Bacillus cereus WZZ001) which exhibiting high hydrolytic activity and excellent enantioselectivity on rac-α-ethyl-2-oxo-pyrrolidineacetic acid methyl ester (R, S-1) has been isolated from soil sample by our laboratory.", "Deciphering the interactions between the Bacillus cereus linear plasmid, pBClin15, and its host by high-throughput comparative proteomics.", "to the time exhibited by standard . CONCLUSION The study indicates both bacteria Bacillus cereus and Bacillus pumilus have anthelmintic activity indicating potential metabolites in them .", "to different ecologic niches . BIOLOGICAL SIGNIFICANCE Bacteria belonging to the Bacillus cereus group include B. cereus , a notorious food borne pathogen which causes gastroenteritis . The B.", ", the stereoselective hydrolysis of ( R , S-1 ) was performed using the recombinant Bacillus cereus esterase which expressed in Escherichia coli BL21 ( DE3 ) . Under the optimized conditions of pH 8.", "Jones . Lethality for mice of vegetative and spore forms of Bacillus cereus and Bacillus cereus - like insect pathogens injected intraperitoneally and subcutaneously . J. Bacteriol . 85:532 - 535", "Lethality for mice of vegetative and spore forms of Bacillus cereus and Bacillus cereus-like insect pathogens injected intraperitoneally and subcutaneously."], "par_relations": ["Bacillus"], "chd_relations": ["antibiotic 2252"], "syn_relations": [], "sib_relations": ["Bacillus anthracis", "Bacillus megaterium", "Bacillus subtilis", "Bacillus thuringiensis", "Bacillus pumilus", "Bacillus licheniformis", "Bacillus coagulans", "Bacillus firmus", "Bacillus amyloliquefaciens", "Bacillus clausii"]}, "target_ent": {"research_entity_id": "RXNORM:1311112", "canonical_name": "Bacillus cereus", "aliases": ["bacillus cereus"], "definition": "", "other_contexts": ["BIOLOGICAL SIGNIFICANCE Bacteria belonging to the Bacillus cereus group include B. cereus, a notorious food borne pathogen which causes gastroenteritis.", "UNLABELLED The pathogen, Bacillus cereus, is able to adapt its metabolism to various environmental conditions.", "and response surface methodology ( RSM ) . Among the isolated bacteria , an aerobic Bacillus cereus strain was recognized as the best lipase - producing bacteria ( 177.3 ± 20 U / ml ) . Given the", "Evaluation of Bacillus cereus and Bacillus pumilus metabolites for anthelmintic activity OBJECTIVE To assess the anthelmintic acivity of Bacillus cereus and Bacillus pumilus metabolites.", "1963.-Culture filtrates of Bacillus cereus contain a phosphatasemia factor (PF) that markedly increases blood alkaline phosphatase after intravenous injection into animals, and that releases alkaline phosphatase from epiphyseal bone slices in vitro.", ") and H. Orin Halvorson . Biochemical changes occurring during sporulation of Bacillus cereus T. II . Effect of esters of organic acids on sporulation . J. Bacteriol . 85:1386 - 1393 . 1963.-", "Metabolic control of penicillinase biosynthesis in Bacillus cereus.", "1963.-Sporulation of Bacillus cereus T in yeast extract-glucose-minerals medium was specifically inhibited by alpha-picolinic acid (APA), if the acid was added before the pH of the culture began to rise.", "pyruvate egg yolk mannitol bromothymol blue agar [ PEMBA ] , and Brillance Bacillus cereus agar [ BBC agar ] ) for Bacillus cereus ( B. cereus ) from pure culture and several food samples .", "Biodegradation of real petroleum wastewater by immobilized hyper phenol-tolerant strains of Bacillus cereus in a fluidized bed bioreactor Microbial bioremediation of petroleum wastewater by phenol-degrading-bacteria holds promise in circumventing the issue of petroleum-spill related pollution.", "CONCLUSION The study indicates both bacteria Bacillus cereus and Bacillus pumilus have anthelmintic activity indicating potential metabolites in them .", "and Sporulation Characteristics of an Organic Sulfur - requiring Auxotroph of Bacillus Cereus . Lundgren , D. G. ( Syracuse University , Syracuse , N.Y. ) and K. F. Bott . Growth and", "aspects of growth and sporulation of an organic sulfur - requiring auxotroph of Bacillus cereus ATCC 4342 . The wild type and B. cereus T were also studied for comparative purposes . Growth of", "1963.-This paper reports investigations of several aspects of growth and sporulation of an organic sulfur-requiring auxotroph of Bacillus cereus ATCC 4342.", "In this study , we compared the inclusivity , exclusivity , recoverability , and selectivity of the 3 selective agars ( mannitol yolk polymyxin B agar [ MYPA ] , polymyxin pyruvate egg yolk mannitol bromothymol blue agar [ PEMBA ] , and Brillance Bacillus cereus agar [ BBC agar ] ) for Bacillus cereus ( B. cereus ) from pure culture and several food samples", "Slein, Milton W. (U.S. Army Chemical Corps Biological Laboratories, Fort Detrick, Frederick, Md.) and Gerald F. Logan, Jr. Partial purification and properties of two phospholipases of Bacillus cereus.", "The lipase producing Bacillus cereus was isolated and RSM was used for the optimization of enzyme production.", "The production of penicillinase in the microconstitutive strain 5 of Bacillus cereus in response to treatment with CC was influenced by various inhibitors.", "In this study, the stereoselective hydrolysis of (R, S-1) was performed using the recombinant Bacillus cereus esterase which expressed in Escherichia coli BL21 (DE3).", "adapt its metabolism to various environmental conditions . The reference strain , Bacillus cereus ATCC 14579 , harbors a linear plasmid , pBClin15 , which displays a cryptic prophage behavior .", "were measured 0.367 μM / min.mL and 5.3 mM , respectively . The lipase producing Bacillus cereus was isolated and RSM was used for the optimization of enzyme production . The CSE / yeast extract", "by APA . The production of penicillinase in the microconstitutive strain 5 of Bacillus cereus in response to treatment with CC was influenced by various inhibitors . 8-Azaguanine inhibited the", "Growth and sporulation characteristics of an organic sulfur-requiring auxotroph of Bacillus cereus. J. Bacteriol. 86:462-472.", "Biochemical changes occurring during sporulation of Bacillus cereus T. II.", "and sporulation characteristics of an organic sulfur - requiring auxotroph of Bacillus cereus . J. Bacteriol . 86:462 - 472 . 1963.-This paper reports investigations of several aspects of", "Bacillus cereus was identified by 16S rDNA method.", "Herein, biodegradation of petroleum wastewater samples collected from oil refinery site was carried out in a fluidized bed bioreactor by Ca-alginate immobilized biomass of phenol-degrading strains of Bacillus cereus (AKG1 MTCC9817 and AKG2 MTCC9818).", "of Bacillus cereus . J. Bacteriol . 85:369 - 381 . 1963.-Culture filtrates of Bacillus cereus contain a phosphatasemia factor ( PF ) that markedly increases blood alkaline phosphatase after", "Gerald F. Logan , Jr. Partial purification and properties of two phospholipases of Bacillus cereus . J. Bacteriol . 85:369 - 381 . 1963.-Culture filtrates of Bacillus cereus contain a", "Among the isolated bacteria, an aerobic Bacillus cereus strain was recognized as the best lipase-producing bacteria (177.3 ± 20 U/ml).", "organic acids on sporulation . J. Bacteriol . 85:1386 - 1393 . 1963.-Sporulation of Bacillus cereus T in yeast extract - glucose - minerals medium was specifically inhibited by alpha - picolinic", "Shah , and Richard A. Day . Metabolic control of penicillinase biosynthesis in Bacillus cereus . J. Bacteriol . 88:297 - 308 . 1964.-Penicillinase production in strains 5 and 5/B of Bacillus", "Rac-α-Ethyl-2-Oxo - Pyrrolidineacetic Acid Methyl Ester by Immobilized Recombinant Bacillus cereus Esterase . A new esterase - producing strain ( Bacillus cereus WZZ001 ) which exhibiting high", "positive bacteria from rice flour was carried out by Rhodamin B agar plate method . Bacillus cereus was identified by 16S rDNA method . Screening of the appropriate variables and optimization of the", ", the stereoselective hydrolysis of ( R , S-1 ) was performed using the recombinant Bacillus cereus esterase which expressed in Escherichia coli BL21 ( DE3 ) . Under the optimized conditions of pH 8.", "Comparison of 3 selective media for enumeration of Bacillus cereus in several food matrixes.", "for anthelmintic activity OBJECTIVE To assess the anthelmintic acivity of Bacillus cereus and Bacillus pumilus metabolites . MATERIALS AND METHODS The successive solvent extractions with", "1964.-Penicillinase production in strains 5 and 5/B of Bacillus cereus in response to treatment by 6-aminopenicillanic acid (APA), penicillin G, (6-N-alpha-(p-benzyloxyphenoxy)-propionylamino-penicillanic acid, and cephalosporin C (CC) was found to be analogous to that seen in constitutive strains.", "Recombinant Bacillus cereus Esterase . A new esterase - producing strain ( Bacillus cereus WZZ001 ) which exhibiting high hydrolytic activity and excellent enantioselectivity on rac-α-ethyl-", "bioreactor by Ca - alginate immobilized biomass of phenol - degrading strains of Bacillus cereus ( AKG1 MTCC9817 and AKG2 MTCC9818 ) . Degradation performance of the system was evaluated by", "The reference strain, Bacillus cereus ATCC 14579, harbors a linear plasmid, pBClin15, which displays a cryptic prophage behavior.", "its host by high - throughput comparative proteomics . UNLABELLED The pathogen , Bacillus cereus , is able to adapt its metabolism to various environmental conditions . The reference strain ,", "Biocatalytic Resolution of Rac-α-Ethyl-2-Oxo-Pyrrolidineacetic Acid Methyl Ester by Immobilized Recombinant Bacillus cereus Esterase.", ". Bacteriol . 88:297 - 308 . 1964.-Penicillinase production in strains 5 and 5/B of Bacillus cereus in response to treatment by 6-aminopenicillanic acid ( APA ) , penicillin G , ( 6-N - alpha-(p -", "blue agar [ PEMBA ] , and Brillance Bacillus cereus agar [ BBC agar ] ) for Bacillus cereus ( B. cereus ) from pure culture and several food samples . BBC agar showed greater exclusivity and", "A new esterase-producing strain (Bacillus cereus WZZ001) which exhibiting high hydrolytic activity and excellent enantioselectivity on rac-α-ethyl-2-oxo-pyrrolidineacetic acid methyl ester (R, S-1) has been isolated from soil sample by our laboratory.", "Deciphering the interactions between the Bacillus cereus linear plasmid, pBClin15, and its host by high-throughput comparative proteomics.", "to the time exhibited by standard . CONCLUSION The study indicates both bacteria Bacillus cereus and Bacillus pumilus have anthelmintic activity indicating potential metabolites in them .", "to different ecologic niches . BIOLOGICAL SIGNIFICANCE Bacteria belonging to the Bacillus cereus group include B. cereus , a notorious food borne pathogen which causes gastroenteritis . The B.", "of real petroleum wastewater by immobilized hyper phenol - tolerant strains of Bacillus cereus in a fluidized bed bioreactor Microbial bioremediation of petroleum wastewater by phenol -", "Optimization of the production conditions of the lipase produced by Bacillus cereus from rice flour through Plackett-Burman Design (PBD) and response surface methodology (RSM).", "Partial purification and properties of two phospholipases of Bacillus cereus."], "par_relations": [], "chd_relations": [], "syn_relations": [], "sib_relations": []}}
{"label": 1, "source_ent": {"research_entity_id": "MSH:C565627", "canonical_name": "Trichohepatoenteric Syndrome", "aliases": ["diarrhea, fatal infantile, with trichorrhexis nodosa", "trichohepatoenteric syndrome", "diarrhea, syndromic"], "definition": "", "other_contexts": ["Trichohepatoenteric Syndrome or Syndromic Diarrhea — Report of Three Members in a Family , First Report from Iran Introduction .", "TTC37 genes in Malaysian children with trichohepatoenteric syndrome . Trichohepatoenteric syndrome ( THES ) is a rare autosomal recessive disorder that is classically associated with intractable", "with Immunodeficiency without Diarrhea : Extending the Phenotype of Trichohepatoenteric Syndrome Unbiased genetic diagnosis has increasingly associated seemingly unrelated somatic and", "but we identified Cdc42 as a potentially essential biomarker for trichohepatoenteric syndrome . CONCLUSION Our findings indicate that the loss of Myo5B induces a strong loss of enterocyte", "case of Trichohepatoenteric syndrome ( THE - S ) in South Africa Trichohepatoenteric syndrome ( THE - S ) or phenotypic diarrhoea of infancy is a rare autosomal recessive disorder", "IBD - Like Features in Syndromic Diarrhea / Trichohepatoenteric Syndrome . BACKGROUND Very early onset inflammatory bowel disease ( VEOIBD ) ( inflammatory bowel disease [ IBD ] before 6 years of age ) may manifest as a monogenic disease affecting the gastrointestinal tract .", "heterozygous mutations in the TTC37 gene , a known cause of the trichohepatoenteric syndrome ( THES ) . This case extends the known phenotype of THES and defines a potential subset for", "identifies a novel TTC37 mutation in the first reported case of Trichohepatoenteric syndrome ( THE - S ) in South Africa Trichohepatoenteric syndrome ( THE - S ) or phenotypic diarrhoea of", "with Immunodeficiency without Diarrhea : Extending the Phenotype of Trichohepatoenteric Syndrome [ This corrects the article on p. 2 in vol . 3 , PMID : 25688341 . ] ."], "par_relations": ["Diarrhea, Infantile", "Fetal Growth Retardation", "Hair Diseases", "Facies"], "chd_relations": [], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:222470", "canonical_name": "TRICHOHEPATOENTERIC SYNDROME 1", "aliases": ["thes1", "diarrhea, fatal infantile, with trichorrhexis nodosa", "diarrhea, syndromic", "trichohepatoenteric syndrome 1", "the syndrome"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["TRICHOHEPATOENTERIC SYNDROME 1", "TRICHOHEPATOENTERIC SYNDROME 1", "TRICHOHEPATOENTERIC SYNDROME 1", "TRICHOHEPATOENTERIC SYNDROME 1", "TRICHOHEPATOENTERIC SYNDROME 1", "TRICHOHEPATOENTERIC SYNDROME 1", "TRICHOHEPATOENTERIC SYNDROME 1", "TRICHOHEPATOENTERIC SYNDROME 1"], "sib_relations": ["Failure to thrive", "Intrauterine growth retardation", "Intrauterine growth retardation (IUGR)", "Hepatomegaly", "Polyhydramnios", "Hypertelorism", "Cholestatic jaundice", "Cirrhosis", "Low birth weight", "Large mouth", "Small mouth", "Islet cell hyperplasia", "Small ears", "Low-set ears", "Trichorrhexis nodosa", "Brittle hair", "Cleft uvula", "Neonatal hemochromatosis", "Woolly hair", "Downslanting palpebral fissures", "Simple ears", "Autosomal recessive", "Villous atrophy", "Curly hair", "Large placenta", "Elevated ferritin", "Mental impairment", "Flat, broad nose", "Prominent forehead", "Prominent eyes", "Upturned nose", "Ventricular septal defect (rare)", "Thin, sparse hair", "Flat supraorbital ridges", "Long philtrum", "Prominent cheeks", "Cortical microcysts", "Increased iron in hepatocytes", "Diarrhea, secretory, severe", "Square forehead", "Defective antibody response", "Defective antigen-specific skin response", "Galactosuria without galactosemia", "Hypermethioninemia, progressive", "Increased serum methionine (reported in 2 cases)", "Abnormal serum liver enzyme levels", "Decreased transferrin Increased serum iron", "Onset usually in first month of life", "Patients need lifelong total parenteral nutrition", "Often fatal due in infancy due to intractable diarrhea", "Progressive liver failure", "Tetralogy of Fallot (rare)", "Decreased height", "Liver fibrosis with nodular regeneration, cholestasis, ductular proliferation, and iron deposition", "Thrombocytosis (in some patients)", "Large platelets (in some patients)", "Aortic insufficiency (in some patients)", "Pulmonary stenosis (rare)", "Caused by mutation in the tetratricopeptide repeat domain 37 gene (TTC37, 614589.0001)", "Hypoalbuminemia"]}}
{"label": 1, "source_ent": {"research_entity_id": "HPO:HP:0000954", "canonical_name": "Single transverse palmar crease", "aliases": ["simian crease", "simian line", "single flexion crease", "single transverse palmar crease", "simian creases", "single transverse palmar creases", "single palmar crease", "transverse palmar crease", "single palmar creases"], "definition": "The distal and proximal transverse palmar creases are merged into a single transverse palmar crease. [HPO:probinson, pmid:19125433]", "other_contexts": [], "par_relations": ["Abnormality of the palmar creases"], "chd_relations": ["Bilateral single transverse palmar creases"], "syn_relations": ["Single transverse palmar crease", "Single transverse palmar crease", "Single transverse palmar crease", "Single transverse palmar crease", "Single transverse palmar crease", "Single transverse palmar crease", "Single transverse palmar crease", "Single transverse palmar crease", "Single transverse palmar crease", "Single transverse palmar crease", "Single transverse palmar crease", "Single transverse palmar crease", "Single transverse palmar crease", "Single transverse palmar crease", "Single transverse palmar crease", "Single transverse palmar crease"], "sib_relations": ["Deep palmar crease", "Multiple palmar creases", "Prominent palmar flexion creases", "Bridged palmar crease", "Sydney crease", "Aplasia/Hypoplasia of the palmar creases"]}, "target_ent": {"research_entity_id": "OMIM:MTHU007694", "canonical_name": "Single transverse palmar crease", "aliases": ["single transverse palmar crease"], "definition": "", "other_contexts": [], "par_relations": ["Hands", "Skin"], "chd_relations": [], "syn_relations": [], "sib_relations": ["DOWN SYNDROME", "AARSKOG-SCOTT SYNDROME", "FRYNS SYNDROME", "OPITZ-KAVEGGIA SYNDROME", "CORNELIA DE LANGE SYNDROME 1", "BRANCHIOOCULOFACIAL SYNDROME", "CATEL-MANZKE SYNDROME", "ACROFACIAL DYSOSTOSIS, CATANIA TYPE", "COFFIN-SIRIS SYNDROME 1"]}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0011521", "canonical_name": "Deuteranopia", "aliases": ["green-blind", "deuteranopia"], "definition": "Complete lack of the M photopigment, which is replaced with the L photopigment. Affected individuals tend to confuse red and green. [DDD:gblack]", "other_contexts": [], "par_relations": ["Red-green dyschromatopsia", "Dichromacy"], "chd_relations": [], "syn_relations": ["Deuteranopia", "Deuteranopia"], "sib_relations": ["Protanomaly", "Protanopia", "Deuteranomaly"]}, "target_ent": {"research_entity_id": "OMIM:604727", "canonical_name": "SERINE/THREONINE PROTEIN KINASE 17B", "aliases": ["dap kinase-related apoptosis-inducing protein kinase 2", "drak2", "serine/threonine protein kinase 17b", "stk17b"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["SERINE/THREONINE PROTEIN KINASE 17B", "SERINE/THREONINE PROTEIN KINASE 17B", "SERINE/THREONINE PROTEIN KINASE 17B", "SERINE/THREONINE PROTEIN KINASE 17B", "SERINE/THREONINE PROTEIN KINASE 17B", "SERINE/THREONINE PROTEIN KINASE 17B"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:7885", "canonical_name": "nephroblastoma overexpressed", "aliases": ["nephroblastoma overexpressed", "igfbp9", "nov gene", "ccn3", "nov"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["nephroblastoma overexpressed", "nephroblastoma overexpressed", "nephroblastoma overexpressed", "nephroblastoma overexpressed", "nephroblastoma overexpressed", "nephroblastoma overexpressed"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:300954", "canonical_name": "CHROMOSOME X OPEN READING FRAME 40A", "aliases": ["cxorf40a", "eola1", "chromosome x open reading frame 40a", "endothelial-overexpressed lipopolysaccharide-associated factor 1"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["CHROMOSOME X OPEN READING FRAME 40A", "CHROMOSOME X OPEN READING FRAME 40A", "CHROMOSOME X OPEN READING FRAME 40A", "CHROMOSOME X OPEN READING FRAME 40A", "CHROMOSOME X OPEN READING FRAME 40A", "CHROMOSOME X OPEN READING FRAME 40A"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0003040", "canonical_name": "Arthropathy", "aliases": ["arthropathy"], "definition": "", "other_contexts": ["Conversely, GH deficiency is a powerful protective mechanism against aging-associated degenerative joint disease [6].", "The anteroposterior view angulated 45 degrees from above gave the best visualization of the humeral osteophyte and , together with the axial view , doubled the incidence of moderate and severe arthropathy at follow - up ( mild in 40 , moderate in 11 , and severe in 5 ) .", "METHODS Concentrations of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), interleukin-6 (IL-6), prostaglandin E(2) (PGE(2)), thromboxane B(2) (TXB(2)), prostaglandin F1-alpha (PGF(1)-alpha), and leukotriene B(4) (LTB(4)), were measured in equine synovial fluid by immunoassay and categorized according to duration and degree of joint disease.", "Almost all adults with severe hemophilia , who have not received prophylaxis with FVIII since their early childhood , suffer from chronic arthropathy .", "RESULTS An arthropathy considered typical for HH , involving metacarpophalangeal joints 2 - 5 and bilateral specified large joints , was observed in 10 of 41 patients with definite or probable HH ( 24% ) , all of whom were homozygous for the C282Y mutation in the HFE gene , while only 2 of 62 patients with possible / unlikely HH had such an arthropathy ( P=0.0024 ) .", "CONCLUSION An arthropathy consistent with that commonly attributed to HH was found to occur in 24% of patients with definite/probable HH.", "CSD-associated arthropathy is an uncommon syndrome affecting mostly young and middle-age women.", "Of the shoulders without a recurrence, 18% had moderate/severe arthropathy.", "LTB(4) concentration appeared to be greater in severe acute joint disease than normal joints; this was not significant (P =.15) and correlated highly with synovial fluid white blood cell count (P =.0001).", "Multivariable Cox regression shows that, compared with Charcot arthropathy, foot ulcer was associated with 35% higher mortality risk (hazard ratio 1.35 [95% CI 1.18-1.54]) and diabetes alone with 23% lower risk (0.77 [0.66-0.90]).", "There was no significant association between arthropathy in definite/probable HH and a history of intensive physical labor (P=0.12).", "When the first dislocation occurred before age 23 years, the incidence of arthropathy was significantly lower than when it occurred in age 23 years or older (P = .006).", "PGE(2) would be a functional screening test for the presence of any joint disease and offers a differentiating feature because values were not influenced by white blood cell count.", "AIM The aim of this study was to compare the incidence , age at diagnosis and surgery for arthropathy and related hospitalizations between people with mild haemophilia and the general population in Sweden .", "Dislocation arthropathy after surgical treatment of recurrent anterior dislocation of the shoulder has been a subject of discussion over the years.", "ANIMALS OR SAMPLE POPULATION Client-owned or donated horses: 50 joints with no evidence of disease; 28 joints with acute disease; 32 joints with chronic disease; 9 joints with cartilage damage and no other signs of joint disease.", "Arthropathy was mild in 29%, moderate in 9%, and severe in 17%.", "Sixty - two surgically stabilized shoulders had less arthropathy than those that became stable over time ( P = .047 ) .", "This stage is likely to occur very early in the course of acromegaly and is fully reversible, as evidenced by the clinical course of arthropathy in patients with hypopituitarism overtreated with GH [8].", "We report the first case of such an arthropathy in an adult patient with CF.", "One hundred eighteen Bristow-Latarjet repairs for recurrent anterior dislocation of the shoulder prospectively followed for fifteen years: study II-the evolution of dislocation arthropathy.", "Acromegalic Arthropathy Arthropathy is one of the most frequent clinical complications of acromegaly .", "CONCLUSIONS It is likely that ciprofloxacin may produce arthropathy in adult as well as pediatric patients with CF.", "Among 841 CSD patients, 24 (2.9%) had rheumatoid factor-negative arthropathy that was often severe and disabling.", "TBX(2) concentrations below 31.5 pg/mL (S =.57; Sp =.61) were a very good predictor of joint disease (PPV =.72).", "Patients with Charcot arthropathy were matched to individuals in the other two groups using propensity score matching based on patient age , sex , race , marital status , diabetes duration , and diabetes control .", "The vicious circle of “trauma-growth-trauma” is thus turned on, and the disease acquires the characteristics and the features of degenerative joint disease.", "The understanding of the bi-phasic nature of arthropathy is important for designing appropriate therapeutic strategies.", "Global assessment of the operative result was not related to arthropathy at follow-up.", "Nineteen patients ( 79.2% ) recovered after a median duration of 6 weeks ( range 1 - 24 weeks ) , whereas 5 patients ( 20.8% ) developed chronic disease persisting 16 - 53 months ( median 30 months ) after the onset of arthropathy .", "Patients with moderate hemophilia ( FVIII activity 1 - 5% ) usually experience fewer joint bleeds than those with severe hemophilia and are thought to rarely develop a significant degree of chronic arthropathy .", "At presentation, some 60–70% of patients have involvement of large peripheral joints (shoulder, knee, hip) and about 50% have axial arthropathy affecting mainly the lumbar area [1–3].", "A trend toward more episodes requiring phlebotomy was also observed among those with arthropathy , but this was not statistically significant ( odds ratio 1.03 [ 95% confidence interval 0.99 - 1.06 ] , P=0.097 ) .", "Mild arthropathy at 10 years was associated with moderate / severe arthropathy at 25 years in 19 of 30 shoulders ( 63% ) compared with 13 of 146 ( 9% ) classified as normal at 10 years ( P < .001 ) .", "Of the patients with Charcot arthropathy , 63% experienced foot ulceration before or after the onset of the Charcot arthropathy .", "Joint incongruence at 10 years was associated with moderate / severe arthropathy at 25 years ( P = .001 ) .", "Arthropathy in definite/probable HH was more common with increasing age and was associated with ferritin concentrations>1,000 μg/liter at the time of diagnosis (odds ratio 14.0 [95% confidence interval 1.30-150.89], P=0.03).", "The association observed between this arthropathy, homozygosity for C282Y, and serum ferritin concentrations at the time of diagnosis suggests that iron load is likely to be a major determinant of arthropathy in HH and to be more important than occupational factors.", "The aim of this study was to compare the incidence , age at diagnosis and surgery for arthropathy and related hospitalizations between people with mild haemophilia and the general population in", "Five or more years after XRT , only 13% of patients were unaffected by arthropathy , and it actually became worse in 2/3 of the group .", "Both univariate and multivariate analyses identified female sex ( 67% of arthropathy patients versus 40% of controls ; relative risk [ RR ] 2.5 , P = 0.047 ) , age older than 20 years ( 100% of arthropathy patients versus 43% of controls ; RR 4.9 , P = 0.001 ) , and erythema nodosum ( 21% of arthropathy patients versus 2% of controls ; RR 7.9 , P = 0.001 ) as variables significantly associated with arthropathy .", "OBJECTIVE To report a case of possible ciprofloxacin - induced arthropathy in an adult patient with cystic fibrosis ( CF ) . CASE SUMMARY A 25-year - old man with CF received three separate courses of ciprofloxacin therapy at usual doses for acute pulmonary exacerbations of his disease .", "Other factors that correlated with moderate/severe arthropathy were age older than 25 years at primary dislocation (P = .01) and primary dislocation caused by high-energy sports activity (P = .009).", "Quinolones should be considered as a possible cause of arthropathy in adult CF patients .", "The burden of arthropathy in mild haemophilia has not been comprehensively described .", "Dislocation arthropathy was found on ordinary anteroposterior views in 46 of 115 shoulders (mild in 39, moderate in 5, and severe in 2).", "OBJECTIVE To determine the frequency and character of arthropathy in hereditary hemochromatosis ( HH ) and to investigate the relationship between this arthropathy , nodal interphalangeal osteoarthritis , and iron load .", "This is the first comprehensive study of arthropathy in CSD .", "Despite that seemingly salutary result, resolution of arthropathy was “seldom seen” even after a mean follow-up of 3.3 years.", "Arthropathy was determined by use of a predetermined clinical protocol , radiographs of the hands of all participants , and radiographs of other joints in which clinical criteria were met .", "CONCLUSION Age at primary dislocation, recurrence, high-energy sports, and alcohol abuse were factors associated with the development of arthropathy.", "In this systematic review of literature, the prevalence of overt arthropathy ranges between 15 and 77% in patients with moderate hemophilia and prophylactic replacement treatment is prescribed in approximately 30% of these patients, usually after diagnosis of clinically overt arthropathy.", "BACKGROUND Shoulder dislocation may cause arthropathy , but the natural history of this evolution is not well described .", "Any IL-6 in synovial fluid indicated joint disease and correlated highly with synovial fluid white blood cell count (P <.0001).", "( or earliest 1984 ) until death , emigration or end of the study in 2008 . Data on arthropathy were obtained from a national patient register . Negative binomial and competing risk regression", "The pathogenesis of arthropathy in acromegaly is comprised of two mechanisms : initial endocrine and subsequent mechanical changes .", "Layton et al. [3] were the first to examine the clinical response of acromegalic arthropathy to the potent GH-lowering agent, octreotide.", "Arthropathy in patients with moderate hemophilia a : a systematic review of the literature .", "PGE(2) was a good-excellent predictor of disease (positive predictive value [PPV] = 0.75), and the concentration indicating joint disease was >22.5 pg/mL. The diagnostic PGF(1)-alpha concentration indicating severe chronic joint disease was identified to be >16.5 pg/mL with very high sensitivity (S = 1) and specificity (Sp =.89).", "TNF-alpha and IL-1beta were no more effective than white blood cell count in screening for joint disease.", "5% CI : 6.7 - 36.5 ) increased incidence of arthropathy - related hospital admission and arthropathy diagnosis respectively . None in this cohort underwent surgery . Among participants with", "Furthermore, during the last two acute exacerbations of his CF, he did not receive ciprofloxacin and did not experience any symptoms of arthropathy.", "Patients with foot ulcers tended to have a higher prevalence of peripheral vascular disease and macrovascular diseases than patients with Charcot arthropathy .", "Currently , only little data are available about the prevalence of arthropathy , the degree of quality of life impairment , and the need for orthopedic care / aids in patients with moderate hemophilia .", "Moreover, because of the lack of imaging studies (magnetic resonance and/or ultrasound), the prevalence of subclinical arthropathy cannot be determined.", "( 95% CI : 1.7 - 17.8 ) respectively . CONCLUSION Our data suggested a higher burden of arthropathy among individuals with mild haemophilia compared to the general population . Further research", "Arthropathy may present as the earliest clinical symptom of acromegaly in a significant proportion of patients [ 7 ] , and its prevalence and severity worsen with the duration of uncontrolled disease [ 3 ] .", "surgery . Among participants with haemophilia born prior to 1984 , the rates of arthropathy diagnosis and surgery of the index joints ( knee , elbow , ankle ) were increased twofold ( 95% CI", "Mild haemophilia is a congenital bleeding disorder affecting males . The burden of arthropathy in mild haemophilia has not been comprehensively described . AIM The aim of this study was to", "The degree of restriction of outward rotation at 2 years did not influence the degree of arthropathy after 15 years .", "( 95% CI : 3.3 - 27.2 ) and 16-fold ( 95% CI : 6.7 - 36.5 ) increased incidence of arthropathy - related hospital admission and arthropathy diagnosis respectively . None in this cohort", "CSD patients without arthropathy served as controls.", "Ten patients (42%) had severe arthropathy in the weight-bearing joints, which substantially limited their ability to walk, and 4 of these patients were hospitalized.", "When follow-up studies of operated series of shoulder dislocations with the Bristow-Latarjet method are done, it is important to have the same radiologic views to compare the incidence of dislocation arthropathy correctly.", "Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient .", "Neer Award 2008: Arthropathy after primary anterior shoulder dislocation--223 shoulders prospectively followed up for twenty-five years.", "Shoulders that had not recurred had less arthropathy than shoulders classified as recurrent (P = .047) or stabilized over time (P = .007).", "CONCLUSIONS Charcot arthropathy was significantly associated with higher mortality risk than diabetes alone and with lower risk than foot ulcer.", "Seven of 221 patients ( 7 of 223 shoulders ) were considered alcoholic at 25 years and all had severe arthropathy ( P < .001 ) .", "Among participants with haemophilia born prior to 1984, the rates of arthropathy diagnosis and surgery of the index joints (knee, elbow, ankle) were increased twofold (95% CI: 1.0-3.2) and fivefold (95% CI: 1.7-17.8) respectively.", "Mortality Risk of Charcot Arthropathy Compared With That of Diabetic Foot Ulcer and Diabetes Alone OBJECTIVE The purpose of this study was to compare mortality risks of patients with Charcot arthropathy with those of patients with diabetic foot ulcer and those of patients with diabetes alone ( no ulcer or Charcot arthropathy ) .", "PGF(1)-alpha concentrations > 9.5 pg/mL had a good PPV (.69) and NPV (.6) for any joint disease.", "Synovial fluid cytokines and eicosanoids as markers of joint disease in horses.", "Comparative burden of arthropathy in mild haemophilia : a register - based study in Sweden .", "Stratified analyses suggest that Charcot arthropathy is associated with a significantly increased mortality risk independent of foot ulcer and other comorbidities.", "When all views were included, moderate or severe dislocation arthropathy was found in 14% of the shoulders, and a further 35% had mild arthropathy.", "PGF(1)-alpha values > 16.5 pg / mL identified chronic severe joint disease and may be clinically useful when there are minimal radiographic changes but substantial articular cartilage degradation .", "Whereas Lacks et al. [10] provided anecdotal evidence of resolution of arthropathy in 2 patients after pituitary surgery, Roelfsema et al.", "Also shoulders without a recurrence were associated with arthropathy.", "RESULTS TNF synovial fluid concentration as a predictor of joint disease was good, and the value of TNF (maximum S and Sp) indicating joint disease was >36 pg/mL. IL-1beta as a predictor of joint disease was good, and the value of IL-1beta indicating joint disease was >4.5 pg/mL. IL-6 concentration was an excellent predictor of joint disease.", "CONCLUSION Our data suggested a higher burden of arthropathy among individuals with mild haemophilia compared to the general population .", "CSD patients with arthropathy (arthritis/arthralgia) that limited or precluded usual activities of daily living constituted the study group.", "Of 38 shoulders with a postoperative position of the transferred coracoid process 2 to 4 mm medial to the glenoid rim and the screw and transplant parallel to the glenoid , 3 had moderate arthropathy ( 8% ) compared with 8 shoulders with moderate arthropathy and 5 with severe arthropathy out of 77 shoulders with a nonoptimal position of the coracoid ( 17% ) ( P = not significant ) .", "RESEARCH DESIGN AND METHODS A retrospective cohort of 1,050 patients with incident Charcot arthropathy in 2003 in a large health care system was compared with patients with foot ulcer and those with diabetes alone.", "IL-6 was the most sensitive and specific for joint disease and could be an excellent screening test for the presence of joint disease when lameness is difficult to identify or is intermittent.", "Data on arthropathy were obtained from a national patient register.", "Cat-scratch disease-associated arthropathy. OBJECTIVE To characterize the articular manifestations of cat-scratch disease (CSD) and to evaluate the long-term clinical outcome of those manifestations.", "The patient had no prior history of arthropathy .", "The objective of this prospective study was to evaluate the Bristow-Latarjet repair at 2 and 15 years after surgery with respect to arthropathy and to evaluate factors responsible for this development.", "Participants with haemophilia born between 1984 and 2008 had a ninefold ( 95% CI : 3.3 - 27.2 ) and 16-fold ( 95% CI : 6.7 - 36.5 ) increased incidence of arthropathy - related hospital admission and arthropathy diagnosis respectively .", "OBJECTIVE To evaluate the value of various synovial fluid cytokines and eicosanoids to diagnose joint disease or categories of joint disease.", "DISCUSSION Prior cases of quinolone-induced arthropathy involving pediatric CF patients or adult patients without CF have been reported in the literature.", "CONCLUSIONS The ability of a single value from a joint in an adult horse predicting the presence of joint disease was often good (.5-.75), and was excellent (> or =.75) for IL-6 and PGE(2).", "Chronic arthropathy is a major complication in severe hemophilia A ( Factor [ F ] VIII < 1% ) .", "RESULTS During follow - up , 28.0% of the sample died ; 18.8% with diabetes alone and 37.0% with foot ulcer died compared with 28.3% with Charcot arthropathy .", "Part of this discouraging outcome might have been due to the already irreversible nature of the joint disease , but persistently high IGF-1 levels were likely maintained , even in some patients with plasma GH below 2.5 microgram μ/L , perpetuating the progression of arthropathy .", "Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load."], "par_relations": ["Abnormal joint morphology"], "chd_relations": ["Neuropathic arthropathy", "Polyarticular arthropathy"], "syn_relations": [], "sib_relations": ["Arthralgia", "Arthritis", "Joint dislocation", "Joint hemorrhage", "Degenerative joint disease", "Osteochondrosis", "Pterygium", "Joint swelling", "Abnormality of the sacroiliac joint", "Chondrocalcinosis", "Enlarged joints", "Abnormality of lower limb joint", "Abnormality of upper limb joint", "Abnormality of joint mobility", "Abnormality of the synovia", "Progressive joint destruction"]}, "target_ent": {"research_entity_id": "MSH:D015419", "canonical_name": "Spastic Paraplegia, Hereditary", "aliases": ["spastic paraplegia, hereditary, autosomal recessive", "hereditary x linked recessive spastic paraplegia", "hmsn 5", "hereditary motor-sensory neuropathy with pyramidal signs", "spastic paraplegia, hereditary, autosomal dominant", "hereditary spastic paraplegia, autosomal recessive", "spastic paraplegia type 2", "paraplegia, spastic, hereditary", "spastic paraplegia, autosomal dominant, hereditary", "spastic paraplegia-hypertrophic motor-sensory neuropathy", "hereditary, spastic paraplegia, autosomal dominant", "hereditary spastic paraplegia", "spastic paraplegia 2", "hypertrophic motor-sensory neuropathy-spastic paraplegia", "paraplegias, hereditary spastic", "hereditary motor and sensory neuropathy v", "spastic paraplegia, hereditary, x-linked recessive", "x-linked recessive hereditary spastic paraplegia", "autosomal dominant hereditary spastic paraplegia", "hereditary spastic paraplegias", "type v, hmsn", "paraplegia, hereditary spastic", "hmsn type v", "type v hereditary motor and sensory neuropathy", "charcot-marie-tooth disease with pyramidal features, autosomal dominant", "autosomal recessive hereditary spastic paraplegia", "hereditary autosomal recessive spastic paraplegia", "spastic paraplegia, autosomal recessive, hereditary", "hereditary motor and sensory neuropathy 5", "peroneal muscular atrophy with pyramidal features, autosomal dominant", "spastic paraplegia, x-linked recessive, hereditary", "autosomal dominant spastic paraplegia hereditary", "hmsn v", "hereditary autosomal dominant spastic paraplegia", "spastic paraplegias, hereditary", "spastic paraplegia, hereditary", "spastic paraplegia hypertrophic motor sensory neuropathy", "hereditary x-linked recessive spastic paraplegia", "cmt with pyramidal features", "hmsn v (hereditary motor and sensory neuropathy type v)", "autosomal recessive spastic paraplegia, hereditary", "hereditary motor sensory neuropathy with pyramidal signs", "hypertrophic motor sensory neuropathy spastic paraplegia", "x linked recessive hereditary spastic paraplegia", "charcot marie tooth disease with pyramidal features, autosomal dominant", "hereditary, spastic paraplegia, x-linked recessive", "x-linked, spastic paraplegia, hereditary"], "definition": "A group of inherited diseases that share similar phenotypes but are genetically diverse. Different genetic loci for autosomal recessive, autosomal dominant, and x-linked forms of hereditary spastic paraplegia have been identified. Clinically, patients present with slowly progressive distal limb weakness and lower extremity spasticity. Peripheral sensory neurons may be affected in the later stages of the disease. (J Neurol Neurosurg Psychiatry 1998 Jan;64(1):61-6; Curr Opin Neurol 1997 Aug;10(4):313-8)", "other_contexts": ["The disease presentation in our patients with hereditary spastic paraplegia was dominated by an adult - onset lower - limb predominant spastic paraparesis .", "Gait evolution in hereditary spastic paraplegia with early symptoms had a tendency to improve gait until adolescence with adapted treatments and to decline in the adulthood.", "worsened their gait . CONCLUSIONS Gait alterations in a family with hereditary spastic paraplegia are heterogeneous . Gait evolution in hereditary spastic paraplegia with early symptoms had a", "The prevalence of depression in hereditary spastic paraplegia.", "Recently, the first de novo mutations in KIF1A were identified in patients with an early-onset severe form of complicated hereditary spastic paraplegia.", "Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).", "Infantile onset of hereditary spastic paraplegia caused by mutations in the spastin gene ( SPAST ) is very rare and previously was mostly associated with codominant mutations in this gene .", "METHODS Clinical gait analyses were performed in six hereditary spastic paraplegia patients from the same family with a follow-up of 4-15 years.", "METHODS This paper reviews the pathophysiology, diagnostic workup, and management of balance impairments in hereditary spastic paraplegia.", "paraplegia . BACKGROUND The degree of disability in patients with hereditary spastic paraplegia has been reported variable even in members of the same family ( same gene mutation ) . Moreover ,", "Moreover, it has been established that patients with hereditary spastic paraplegia should be treated differently from cerebral palsy patients due to the progressive nature of this disease.", "The sensitivity of the one-item interview in the hereditary spastic paraplegia group was 75% and specificity 75%.", "pyramidal dysfunction at onset , simulating a clinical picture of hereditary spastic paraplegia .", "However, the gait evolution of hereditary spastic paraplegia showing onset symptoms at an early age has been described as stable.", ". The most common causes of autosomal dominantly inherited hereditary spastic paraplegias are different mutations of the spastin gene with variable incidence in different ethnic groups ,", "Therefore, this study aims to evaluate the walking ability and the influence of treatments on gait evolution in a family with hereditary spastic paraplegia.", "CONCLUSIONS Our results show that mild depression is prevalent among people with hereditary spastic paraplegia .", "progressive nature of this disease . However , the gait evolution of hereditary spastic paraplegia showing onset symptoms at an early age has been described as stable . Therefore , this study aims", "Based on several case reports describing pyramidal dysfunction as the main symptom at onset, a clinical form resembling hereditary spastic paraplegia has been proposed.", "More interestingly, we also identified monoallelic ALDH18A1 mutations segregating in three independent families with autosomal dominant pure or complex hereditary spastic paraplegia, as well as in two sporadic patients.", "The most common causes of autosomal dominantly inherited hereditary spastic paraplegias are different mutations of the spastin gene with variable incidence in different ethnic groups, ranging between 15-40%.", "In a Bulgarian family with three siblings affected by complicated hereditary spastic paraplegia, we performed whole exome sequencing and homozygosity mapping and identified a homozygous p.", "leads to dominant and recessive hereditary spastic paraplegia . Hereditary spastic paraplegias are heterogeneous neurological disorders characterized by a pyramidal syndrome with symptoms", "We report two additional patients with novel de novo mutations in KIF1A, hereby expanding the genetic spectrum of KIF1A-related hereditary spastic paraplegia.", "and the influence of treatments on gait evolution in a family with hereditary spastic paraplegia . METHODS Clinical gait analyses were performed in six hereditary spastic paraplegia patients from", "SETTING People with hereditary spastic paraplegia identified from the epidemiological database who agreed to participate in the study.", "Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia.", "Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia.", "[Genetic testing in hereditary spastic paraplegia].", "Infantile onset of hereditary spastic paraplegia may be caused by mutations in multiple genes, and this phenotype does not reliably predict the genotype.", "Through exome sequencing and candidate gene screening, we report two families with autosomal recessive transmission of ALDH18A1 mutations, and predominant complex hereditary spastic paraplegia with marked cognitive impairment, without any cutaneous abnormality.", "in KIF1A , hereby expanding the genetic spectrum of KIF1A - related hereditary spastic paraplegia . Both children presented with spastic paraplegia and additional findings of optic nerve atrophy ,", "[The broad phenotypic spectrum of SCA-3: hereditary spastic paraplegia].", "Therefore, our report contributes to expanding the genotypic and phenotypic spectrum of hereditary spastic paraplegia caused by mutations in KIF1A.", "The five patients, in whom mutations were detected, represent 45.5% of all tested patients with hereditary spastic paraplegia, which is similar to those published in the international literature.", "CONCLUSIONS Intrathecal baclofen can offer an improvement in spasticity and in the walking performance in patients suffering from hereditary spastic paraplegia.", "mutations were detected , represent 45.5% of all tested patients with hereditary spastic paraplegia , which is similar to those published in the international literature . Molecular testing and", "spastic paraplegia . METHODS Sixteen patients diagnosed with hereditary spastic paraplegia ( mean age : 43 years ) were enrolled in this open prospective study . The main inclusion criteria", "hereditary spastic paraplegia are heterogeneous . Gait evolution in hereditary spastic paraplegia with early symptoms had a tendency to improve gait until adolescence with adapted treatments and", "Pediatric neurologists need to be aware of relatively frequent de novo mutations in hereditary spastic paraplegia genes and a possibility that this condition presents in infancy without a positive family history.", "paraplegia . METHODS Clinical gait analyses were performed in six hereditary spastic paraplegia patients from the same family with a follow - up of 4 - 15 years . RESULTS Based on the gait", "Gait evolution in a family with hereditary spastic paraplegia.", "BACKGROUND The degree of disability in patients with hereditary spastic paraplegia has been reported variable even in members of the same family (same gene mutation).", "Novel De Novo Mutations in KIF1A as a Cause of Hereditary Spastic Paraplegia With Progressive Central Nervous System Involvement .", "dysfunction as the main symptom at onset , a clinical form resembling hereditary spastic paraplegia has been proposed . We report here two further cases of MJD patients whose initial clinical", "Paraplegia With Progressive Central Nervous System Involvement . Hereditary spastic paraplegias are a clinically and genetically heterogeneous group of disorders characterized by lower extremity", "in patients with an early - onset severe form of complicated hereditary spastic paraplegia . We report two additional patients with novel de novo mutations in KIF1A , hereby expanding the", "Further analysis of 795 index cases with hereditary spastic paraplegia and related disorders revealed two additional families carrying truncating biallelic mutations in ATP13A2.", "Our biochemical and immunocytochemical experiments in COS-1 and HeLa cells and patient-derived fibroblasts demonstrated that the hereditary spastic paraplegia-associated mutations, similarly to the ones causing Kufor-Rakeb syndrome and neuronal ceroid lipofuscinosis, cause loss of ATP13A2 function due to transcript or protein instability and abnormal intracellular localization of the mutant proteins, ultimately impairing the lysosomal and mitochondrial function.", "INTRODUCTION Balance impairments are common in patients with hereditary spastic paraplegia and are among the most debilitating symptoms , as they frequently result in falls and fall - related injuries .", "Several features of hereditary spastic paraplegia contribute to balance impairments and multiple treatment options exist.", "RESULTS The epidemiological database consisted of 59 patients with clinically confirmed diagnosis of hereditary spastic paraplegia.", "METHODS Sixteen patients diagnosed with hereditary spastic paraplegia (mean age: 43 years) were enrolled in this open prospective study.", "transmission of ALDH18A1 mutations , and predominant complex hereditary spastic paraplegia with marked cognitive impairment , without any cutaneous abnormality . More interestingly , we", "Pathophysiology, diagnostic work-up and management of balance impairments and falls in patients with hereditary spastic paraplegia.", "amino acid chromatography in the clinico - genetic work - up of hereditary spastic paraplegia , particularly in dominant cases , as the associated phenotype is not distinct from other", "CONCLUSION Through diligent history - taking and clinical examination , followed by multidisciplinary treatment tailored to the identified underlying mechanisms , balance capacities can be improved in patients with hereditary spastic paraplegia and at least a proportion of falls can be prevented .", "Our study adds complicated hereditary spastic paraplegia ( SPG78 ) to the clinical continuum of ATP13A2-associated neurological disorders , which are commonly hallmarked by lysosomal and mitochondrial dysfunction .", "cases of MJD patients whose initial clinical presentation suggested hereditary spastic paraplegia , and a summary of the main findings of previously similar published reports . Our findings lent", "in three independent families with autosomal dominant pure or complex hereditary spastic paraplegia , as well as in two sporadic patients . Low levels of plasma ornithine , citrulline , arginine and", "Infantile onset of hereditary spastic paraplegia without a positive family history may cause difficulties in reaching the correct diagnosis and misdiagnosis as a diplegic form of cerebral palsy is particularly common.", "Only one of five patients with hereditary spastic paraplegia showed clinical indication of extrapyramidal involvement in the form of subtle bradykinesia and slight resting tremor.", "OBJECTIVE To evaluate the prevalence of depression and sensitivity and specificity of the single - item interview ' Are you depressed ? ' for people with hereditary spastic paraplegia in Estonia .", "We report here two further cases of MJD patients whose initial clinical presentation suggested hereditary spastic paraplegia, and a summary of the main findings of previously similar published reports.", "mutation ) . Moreover , it has been established that patients with hereditary spastic paraplegia should be treated differently from cerebral palsy patients due to the progressive nature of this", "INTRODUCTION Hereditary spastic paraplegia is the overall term for clinically and genetically diverse disorders characterized with progressive and variable severe lower extremity spasticity.", "The latter are associated with a potential trait biomarker; we therefore suggest including amino acid chromatography in the clinico-genetic work-up of hereditary spastic paraplegia, particularly in dominant cases, as the associated phenotype is not distinct from other causative genes.", "Our findings lent support to the proposal of a MJD subtype distinguished by a marked pyramidal dysfunction at onset, simulating a clinical picture of hereditary spastic paraplegia.", "Age of symptom onset of hereditary spastic paraplegia varies from infancy to the eighth decade .", "spasticity and in the walking performance in patients suffering from hereditary spastic paraplegia . The underlying residual motor function and the patient 's adherence to the rehabilitation", "contributes to expanding the genotypic and phenotypic spectrum of hereditary spastic paraplegia caused by mutations in KIF1A.", "of spasticity and gait improvement in patients suffering from hereditary spastic paraplegia . METHODS Sixteen patients diagnosed with hereditary spastic paraplegia ( mean age : 43 years )", "CONCLUSIONS Gait alterations in a family with hereditary spastic paraplegia are heterogeneous .", "OBJECTIVE We study the effectiveness and safety of intrathecal baclofen therapy for the treatment of spasticity and gait improvement in patients suffering from hereditary spastic paraplegia .", "Infantile onset of hereditary spastic paraplegia poorly predicts the genotype."], "par_relations": ["Hereditary Sensory and Motor Neuropathy", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary"], "chd_relations": ["Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic paraplegia 20, autosomal recessive", "Costeff optic atrophy syndrome", "Fitzsimmons-Guilbert syndrome", "MASA (Mental Retardation, Aphasia, Shuffling Gait, Adducted Thumbs) Syndrome", "Mental retardation spasticity ectrodactyly", "Spastic paraplegia 23", "Spastic paraplegia 9, autosomal dominant", "Spastic paraplegia 26, autosomal recessive", "Spastic Paraplegia 27, Autosomal Recessive", "Spastic paraplegia 6, autosomal dominant", "Spastic paraplegia 2, X-linked", "Spastic paraplegia with Kallmann syndrome", "Spastic paraplegia 16, X-linked", "Spastic Paraplegia 7, Autosomal Recessive", "Spastic paraplegia 19, autosomal dominant", "Spastic Paraplegia With Myoclonic Epilepsy", "Spastic Paraplegia 5a, Autosomal Recessive", "Spastic paraplegia 15, autosomal recessive", "Spastic diplegia infantile type", "Spastic Paraplegia 31, Autosomal Dominant", "Spastic Paraplegia 33, Autosomal Dominant", "Spastic paraplegia 13, autosomal dominant", "Spastic paraplegia 14, autosomal recessive", "Roy Maroteaux Kremp syndrome", "MAST Syndrome", "Limb Defects, Distal Transverse, with Mental Retardation and Spasticity", "Spastic paraplegia 29, autosomal dominant", "Spastic paraplegia 12, autosomal dominant", "Spastic paraplegia 11, autosomal recessive", "Spastic paraplegia 10, autosomal dominant", "Amyotrophic Dystonic Paraplegia", "Spastic Paraplegia Type 8", "Spastic Paraplegia, Optic Atrophy, Microcephaly, And Xy Sex Reversal", "Spastic Paraplegia And Evans Syndrome", "Spastic Paraplegia, Optic Atrophy, And Dementia", "Spastic paraplegia with precocious puberty", "Spastic paraplegia neuropathy poikiloderma", "Spastic Paraplegia With Associated Extrapyramidal Signs", "Spastic Paraplegia, Sensorineural Deafness, Mental Retardation, And Progressive Nephropathy", "Spastic paraplegia epilepsy mental retardation", "Spastic paraplegia 4, autosomal dominant", "Ataxia, Spastic, 3, Autosomal Recessive", "Ataxia, Spastic, 2, Autosomal Recessive", "Spastic Paraplegia 32, Autosomal Recessive", "Ataxia, Spastic, 1, Autosomal Dominant", "Spastic Paraplegia 42, Autosomal Dominant", "Spastic Paraplegia 38, Autosomal Dominant", "Spastic Paraplegia 39, Autosomal Recessive", "Spastic Paraplegia 34, X-Linked", "Fitzsimmons-McLachlan-Gilbert syndrome", "Spastic Paraplegia 18, Autosomal Recessive", "Spastic Paraplegia 44, Autosomal Recessive", "Spastic Paraplegia-50, Autosomal Recessive", "Spastic paraplegia 17", "Spastic paraplegia 24", "Spastic paraplegia 3, autosomal dominant", "Spastic paraplegia type 5A, recessive", "Spastic paraplegia type 5B, recessive", "Hereditary spastic paralysis, infantile onset ascending", "Arena syndrome", "Volcke Soekarman syndrome", "Bahemuka Brown syndrome", "Fitzsimmons Walson Mellor syndrome", "Nakamura Osame syndrome", "Spastic paraplegia 25, autosomal recessive", "Spastic Paraplegia 36, Autosomal Dominant", "Spastic Paraplegia 37, Autosomal Dominant", "Leukodystrophy, Dysmyelinating, And Spastic Paraparesis With Or Without Dystonia", "Spastic Paraplegia Type 7", "Spastic Paraplegia Type 4"], "syn_relations": ["Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary", "Spastic Paraplegia, Hereditary"], "sib_relations": ["Charcot-Marie-Tooth Disease", "Refsum Disease", "Alstrom Syndrome", "Giant Axonal Neuropathy"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C538324", "canonical_name": "3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency", "aliases": ["3-hydroxy-3-methylglutaric aciduria", "hmg-coa lyase deficiency", "hydroxymethylglutaric aciduria", "3-hydroxy 3-methyl glutaric aciduria", "3-hydroxy-3-methylglutaryl-coa lyase deficiency", "3-hydroxyl 3-methyl glutaric aciduria", "deficiency of hydroxymethylglutaryl-coa lyase", "hmg coa lyase deficiency", "3-hydroxy-3-methylglutaryl-coenzyme a lyase deficiency"], "definition": "", "other_contexts": [], "par_relations": ["Acetyl-CoA C-Acetyltransferase", "Amino Acid Metabolism, Inborn Errors"], "chd_relations": [], "syn_relations": [], "sib_relations": ["deficiency"]}, "target_ent": {"research_entity_id": "OMIM:266130", "canonical_name": "GLUTATHIONE SYNTHETASE DEFICIENCY", "aliases": ["gssd", "pyroglutamic aciduria", "glutathione synthetase deficiency", "5-oxoprolinuria"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["GLUTATHIONE SYNTHETASE DEFICIENCY", "GLUTATHIONE SYNTHETASE DEFICIENCY", "GLUTATHIONE SYNTHETASE DEFICIENCY", "GLUTATHIONE SYNTHETASE DEFICIENCY", "GLUTATHIONE SYNTHETASE DEFICIENCY", "GLUTATHIONE SYNTHETASE DEFICIENCY"], "sib_relations": []}}
{"label": 1, "source_ent": {"research_entity_id": "HPO:HP:0001519", "canonical_name": "Disproportionate tall stature", "aliases": ["marfanoid habitus", "reduced upper-lower segment ratio", "dolichostenomelia", "disproportionate tall stature", "marfanoid body habitus"], "definition": "A tall and slim body build with increased arm span to height ratio (>1.05) and a reduced upper-to-lower segment ratio (<0.85), i.e., unusually long arms and legs. The extremities as well as the hands and feet are unusually slim. [DDD:hfirth, HPO:probinson]", "other_contexts": [], "par_relations": ["Tall stature"], "chd_relations": [], "syn_relations": ["Disproportionate tall stature", "Disproportionate tall stature", "Disproportionate tall stature", "Disproportionate tall stature", "Disproportionate tall stature", "Disproportionate tall stature", "Disproportionate tall stature", "Disproportionate tall stature"], "sib_relations": ["Birth length greater than 97th percentile", "Overgrowth", "Slender build", "Proportionate tall stature"]}, "target_ent": {"research_entity_id": "OMIM:MTHU007296", "canonical_name": "Marfanoid habitus", "aliases": ["marfanoid habitus"], "definition": "", "other_contexts": [], "par_relations": ["Other"], "chd_relations": [], "syn_relations": [], "sib_relations": ["HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1", "ARTHROGRYPOSIS, DISTAL, TYPE 9", "EHLERS-DANLOS SYNDROME, TYPE VI", "BRITTLE CORNEA SYNDROME 1", "LUJAN-FRYNS SYNDROME", "STICKLER SYNDROME, TYPE I", "CHROMOSOME 5q12 DELETION SYNDROME"]}}
{"label": 1, "source_ent": {"research_entity_id": "HGNC:HGNC:10906", "canonical_name": "solute carrier family 10 member 2", "aliases": ["solute carrier family 10 member 2", "slc10a2", "slc10a2 gene"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["solute carrier family 10 member 2", "solute carrier family 10 member 2"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:601295", "canonical_name": "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "aliases": ["asbt", "bile acid malabsorption, primary", "ileal sodium/bile salt transporter", "isbt", "apical sodium-dependent bile acid transporter", "sodium/taurocholate cotransporting polypeptide, ileal", "ntcp2", "slc10a2", "apical sodium/bile salt transporter", "solute carrier family 10 (sodium/bile acid cotransporter family), member 2"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SLC10A2, LEU243PRO AND THR262MET", "SLC10A2, IVS3DS, AAg-CTt", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", "SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2"], "sib_relations": ["SLC10A2, LEU243PRO AND THR262MET", "SLC10A2, IVS3DS, AAg-CTt"]}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:32930", "canonical_name": "IGF like family member 3", "aliases": ["igf like family member 3", "igfl3", "unq483", "igfl3 gene"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["IGF like family member 3", "IGF like family member 3", "IGF like family member 3", "IGF like family member 3"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:602371", "canonical_name": "ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3", "aliases": ["acyl-coa synthetase long chain family, member 3", "fatty acid coa ligase, long chain 3", "facl3", "acsl3", "acyl-coa synthetase 3", "acs3"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3", "ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3", "ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3", "ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3", "ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3", "ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3", "ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3", "ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3", "ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3", "ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:D005884", "canonical_name": "Gingival Hemorrhage", "aliases": ["gingival hemorrhages", "gingival hemorrhage", "hemorrhage, gingival"], "definition": "The flowing of blood from the marginal gingival area, particularly the sulcus, seen in such conditions as GINGIVITIS, marginal PERIODONTITIS, injury, and ASCORBIC ACID DEFICIENCY.", "other_contexts": [], "par_relations": ["Gingival Diseases", "Oral Hemorrhage"], "chd_relations": ["Bazopoulou Kyrkanidou syndrome"], "syn_relations": ["Gingival Hemorrhage", "Gingival Hemorrhage"], "sib_relations": ["Gingival Neoplasms", "Gingival Recession", "Gingivitis", "Granuloma, Giant Cell", "Pericoronitis", "Gingival Overgrowth"]}, "target_ent": {"research_entity_id": "OMIM:124200", "canonical_name": "DARIER-WHITE DISEASE", "aliases": ["keratosis follicularis", "darier disease", "dd", "darier disease, segmental", "dar", "darier-white disease", "darier disease, acral hemorrhagic type"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["DARIER-WHITE DISEASE", "DARIER-WHITE DISEASE", "DARIER-WHITE DISEASE", "DARIER-WHITE DISEASE", "DARIER-WHITE DISEASE", "DARIER-WHITE DISEASE", "DARIER-WHITE DISEASE", "DARIER-WHITE DISEASE"], "sib_relations": ["Bipolar disorder", "Mental retardation, mild", "Schizophrenia", "Seizures", "Palmar pits", "Longitudinal ridging", "Autosomal dominant", "Nail fragility", "Recurrent parotid gland swelling", "Oral mucosal lesions (15% of patients)", "Brown, warty keratotic papules (trunk, scalp, forehead, flexural areas)", "Plantar pits", "Odoriferous,, hypertrophic plaques", "Keratotic plaques (palms)", "Hemorrhagic palmar and plantar macules (uncommon)", "Acrokeratosis verruciformis-like lesions on dorsum of hands", "Acantholysis (cell separation) in the suprabasal layer of the epidermis with premature differentiation and hyperkeratinization of the epidermis", "Loss of desmosomal attachments and perinuclear aggregation of keratin filaments", "Fingernails involved more often than toenails", "Longitudinal white or red subungual streaks", "Distal V-shaped notching", "Subungual hyperkeratotic fragments", "Caused by mutation in the ATPase, Ca++ dependent, slow-twitch, cardiac muscle-2 gene (ATP2A2, 108740.0001)", "Age of onset, 6-20 years", "Skin lesions exacerbated by heat, exercise (sweating), and sunlight", "Acral hemorrhagic variant", "Itch, pain, and body malodor often", "Allelic to acrokeratosis verruciformis (101900)"]}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:26617", "canonical_name": "mixed lineage kinase domain-like", "aliases": ["mixed lineage kinase domain-like", "flj34389", "mlkl gene", "mlkl"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["mixed lineage kinase domain-like", "mixed lineage kinase domain-like", "mixed lineage kinase domain-like", "mixed lineage kinase domain-like"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:300275.0003", "canonical_name": "NSDHL, GLN210TER", "aliases": ["nsdhl, gln210ter"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["NAD(P)H STEROID DEHYDROGENASE-LIKE PROTEIN"], "sib_relations": ["NAD(P)H STEROID DEHYDROGENASE-LIKE PROTEIN"]}}
{"label": 1, "source_ent": {"research_entity_id": "MSH:C535941", "canonical_name": "Chondrodysplasia punctata, brachytelephalangic", "aliases": ["brachytelephalangic chondrodysplasia punctata", "chondrodysplasia punctata, brachytelephalangic", "chondrodysplasia punctata, brachytelephalangic, autosomal", "chondrodysplasia punctata 1, x-linked recessive"], "definition": "", "other_contexts": [], "par_relations": ["Chondrodysplasia Punctata", "Genetic Diseases, X-Linked"], "chd_relations": [], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:300180", "canonical_name": "ARYLSULFATASE E", "aliases": ["chondrodysplasia punctata 1, x-linked recessive", "arylsulfatase e", "arse"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["ARYLSULFATASE E", "ARSE, ARG12SER", "ARSE, GLY117ARG", "ARSE, ARG111PRO", "ARSE, GLY137VAL", "ARSE, GLY245ARG", "ARSE, CYS492TYR", "ARSE, PRO578SER", "ARSE, TRP581TER", "ARYLSULFATASE E"], "sib_relations": ["ARSE, ARG12SER", "ARSE, GLY117ARG", "ARSE, ARG111PRO", "ARSE, GLY137VAL", "ARSE, GLY245ARG", "ARSE, CYS492TYR", "ARSE, PRO578SER", "ARSE, TRP581TER"]}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0001805", "canonical_name": "Thick nail", "aliases": ["dystrophic thickened nails", "thickened nails", "thick nail", "onychogryposis"], "definition": "Nail that appears thick when viewed on end. [pmid:19125433]", "other_contexts": [], "par_relations": ["Abnormality of the nail"], "chd_relations": ["Onychauxis", "Onychogryposis of fingernail", "Onychogryposis of toenails"], "syn_relations": ["Thick nail", "Thick nail", "Thick nail", "Thick nail", "Thick nail", "Thick nail"], "sib_relations": ["Ingrown nail", "Onycholysis", "Nail dystrophy", "Pterygium of nails", "Thin nail", "Nail bed hemorrhage", "Abnormal nail growth", "Nail dysplasia", "Nail bed telangiectasia", "Fragile nails", "Aplasia/Hypoplasia of the nails", "Abnormality of the toenails", "Abnormality of nail color", "Recurrent loss of toenails and fingernails", "Abnormality of the fingernails", "Neoplasm of the nail", "Abnormality of the periungual region", "Pyramidal skinfold extending from the base to the top of the nails", "Abnormality of the subungual region", "Chronic monilial nail infection", "Ski jump nail", "Beaked nails", "Ragged cuticle", "Absent lunula"]}, "target_ent": {"research_entity_id": "OMIM:MTHU041999", "canonical_name": "Thickened granular layer", "aliases": ["thickened granular layer"], "definition": "", "other_contexts": [], "par_relations": ["Skin, Electron Microscopy"], "chd_relations": [], "syn_relations": [], "sib_relations": ["PALMOPLANTAR KERATODERMA, NORRBOTTEN RECESSIVE TYPE"]}}
{"label": 0, "source_ent": {"research_entity_id": "ICD10CM:D68.0", "canonical_name": "Von Willebrand's disease", "aliases": ["factor viii deficiency with vascular defect", "angiohemophilia", "vascular hemophilia", "von willebrand's disease"], "definition": "", "other_contexts": [], "par_relations": ["Other coagulation defects"], "chd_relations": [], "syn_relations": ["Von Willebrand's disease", "Von Willebrand's disease", "Von Willebrand's disease", "Von Willebrand's disease", "Von Willebrand's disease", "Von Willebrand's disease", "Von Willebrand's disease", "Von Willebrand's disease"], "sib_relations": ["Acquired coagulation factor deficiency", "Coagulation defect, unspecified", "Hereditary factor XI deficiency", "Other specified coagulation defects", "Hereditary deficiency of other clotting factors", "Hemorrhagic disorder due to circulating anticoagulants", "Primary hypercoagulable states", "Other hypercoagulable states"]}, "target_ent": {"research_entity_id": "LNC:LP102435-7", "canonical_name": "Hepatitis B virus codon S202C &#x7C; Isolate", "aliases": ["hepatitis b virus codon s202c &#x7c; isolate"], "definition": "", "other_contexts": [], "par_relations": ["Hepatitis B virus codon 202"], "chd_relations": ["Hepatitis B virus codon S202C:PrThr:Pt:Isolate:Ord:Genotyping"], "syn_relations": [], "sib_relations": []}}
{"label": 1, "source_ent": {"research_entity_id": "ICD10CM:I99", "canonical_name": "Other and unspecified disorders of circulatory system", "aliases": ["other and unspecified disorders of circulatory system"], "definition": "", "other_contexts": [], "par_relations": ["Other and unspecified disorders of the circulatory system (I95-I99)"], "chd_relations": ["Other disorder of circulatory system", "Unspecified disorder of circulatory system"], "syn_relations": [], "sib_relations": ["Hypotension", "Gangrene, not elsewhere classified", "Intraoperative and postprocedural complications and disorders of circulatory system, not elsewhere classified"]}, "target_ent": {"research_entity_id": "LNC:MTHU020792", "canonical_name": "Other cardiovascular disease", "aliases": ["other cardiovascular disease"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": [], "sib_relations": ["Other cardiovascular disease:Find:Pt:^Patient:Ord:MDS"]}}
{"label": 1, "source_ent": {"research_entity_id": "HGNC:HGNC:12906", "canonical_name": "zinc finger protein 123, pseudogene", "aliases": ["znf123p", "zinc finger protein 123, pseudogene", "hzf-1", "znf123p gene"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["zinc finger protein 123, pseudogene", "zinc finger protein 123, pseudogene", "zinc finger protein 123, pseudogene", "zinc finger protein 123, pseudogene"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:194630", "canonical_name": "ZINC FINGER PROTEIN 123", "aliases": ["zinc finger protein 123", "znf123"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["ZINC FINGER PROTEIN 123", "ZINC FINGER PROTEIN 123"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0000682", "canonical_name": "Abnormality of dental enamel", "aliases": ["malformation of tooth enamel", "enamel abnormality", "defective tooth enamel", "abnormal tooth enamel", "abnormality of dental enamel", "dystrophic tooth enamel", "enamel abnormalities", "malformation of dental enamel"], "definition": "An abnormality of the dental enamel. [HPO:probinson]", "other_contexts": ["A combination of dental bleaching techniques, enamel microabrasion, and resin restorations was a successful and conservative choice for reestablishing the natural appearance of discolored teeth, improving the self-esteem of the patient.", "A skeletal sample of 296 individuals from a 19th century American poorhouse cemetery is examined for the frequency and chronological distribution of linear enamel hypoplasias on the mandibular canines and maxillary central incisors.", "Smile restoration through use of enamel microabrasion associated with tooth bleaching.", "The aim of this case report is to report esthetic rehabilitation with combined tooth bleaching , enamel microabrasion , and anterior restoration replacement in a 26-year - old man .", "Thus, patients can benefit from combined enamel microabrasion/tooth bleaching therapy, which yields attractive cosmetic results.", "Enamel abnormalities , presumably due to malabsorption of calcium , have been observed and reported in association with CD ( Smith and Miller 1979 ; Rasmussen and Espelid 1980 ; Aine 1986 ) .", "Esthetic improvement following enamel microabrasion on fluorotic teeth: a case report.", "The findings indicated that enamel cracks were extremely common in all three groups .", "Orthodontic / prosthetic treatment of enamel erosion resulting from bulimia : a case report .", "with extrarenal manifestations such as short stature , ocular abnormalities , enamel abnormalities , and migraine . Functional analyses of NBCe1 mutants using different expression systems suggest", "Esthetic rehabilitation with tooth bleaching, enamel microabrasion, and direct adhesive restorations.", "Enamel microabrasion can eliminate enamel irregularities and discoloration defects , improving the appearance of teeth .", "invasion of the pulp . There could be a relationship between XLH disease and enamel abnormalities .", "Enamel abnormalities related to the shape and irregular distribution of the crystals."], "par_relations": ["Abnormality of dental structure", "Abnormality of odontoid tissue", "Abnormality of dental enamel", "Abnormality of dental enamel", "Abnormality of dental enamel", "Abnormality of dental enamel"], "chd_relations": ["Abnormality of dental enamel", "Abnormality of dental enamel", "Abnormality of dental enamel", "Abnormality of dental enamel", "Amelogenesis imperfecta", "Hypoplasia of dental enamel", "Grayish enamel", "Dental enamel pits", "Hypomineralization of enamel"], "syn_relations": ["Abnormality of dental enamel", "Abnormality of dental enamel", "Abnormality of dental enamel", "Abnormality of dental enamel", "Abnormality of dental enamel", "Abnormality of dental enamel"], "sib_relations": ["Carious teeth", "Dentinogenesis imperfecta", "Hypoplasia of teeth", "Tooth abscess", "Abnormality of dentin", "Abnormality of the cementum", "Abnormality of dental color", "Abnormality of the dental pulp"]}, "target_ent": {"research_entity_id": "OMIM:608205", "canonical_name": "MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE", "aliases": ["nuclear receptor-binding factor 1", "nrbf1", "mecr", "2-enoyl thioester reductase", "dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities", "mitochondrial trans-2-enoyl-coa reductase", "trans-2-enoyl-coa reductase, mitochondrial"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE", "MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE", "MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE", "MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE", "MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE", "MECR, 4-BP DEL, NT247", "MECR, ARG258TRP", "MECR, TYR285CYS", "MECR, 1-BP INS, 830+2T", "MECR, TYR285TER", "MECR, GLY232GLU", "MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE", "MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE", "MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE", "MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE", "MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE"], "sib_relations": ["MECR, 4-BP DEL, NT247", "MECR, ARG258TRP", "MECR, TYR285CYS", "MECR, 1-BP INS, 830+2T", "MECR, TYR285TER", "MECR, GLY232GLU"]}}
{"label": 1, "source_ent": {"research_entity_id": "HGNC:HGNC:24142", "canonical_name": "TM2 domain containing 1", "aliases": ["tm2d1 gene", "tm2 domain containing 1", "tm2d1", "bbp"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["TM2 domain containing 1", "TM2 domain containing 1", "TM2 domain containing 1", "TM2 domain containing 1"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:610080", "canonical_name": "TM2 DOMAIN-CONTAINING PROTEIN 1", "aliases": ["beta-amyloid peptide-binding protein", "tm2 domain-containing protein 1", "tm2d1", "bbp"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["TM2 DOMAIN-CONTAINING PROTEIN 1", "TM2 DOMAIN-CONTAINING PROTEIN 1", "TM2 DOMAIN-CONTAINING PROTEIN 1", "TM2 DOMAIN-CONTAINING PROTEIN 1", "TM2 DOMAIN-CONTAINING PROTEIN 1", "TM2 DOMAIN-CONTAINING PROTEIN 1"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:D064747", "canonical_name": "Lansoprazole", "aliases": ["lansoprazol", "wyeth brand of lansoprazole", "lansoprazole wyeth brand", "ag1749", "promeco", "ulpax", "lansoprazole takeda brand", "ag 1749", "monolitum", "lansoprazole almirall brand", "agopton", "salvar brand of lansoprazole", "almirall brand of lansoprazole", "prezal", "hormona brand of lansoprazole", "lansoprazole tap brand", "lansol", "lansoprazoles", "zoton", "ogastro", "pro ulco", "lansoprazole sodium", "hoechst brand of lansoprazole", "lederle brand of lansoprazole", "vinas brand of lansoprazole", "tap brand of lansoprazole", "lansoprazole hormona brand", "takepron", "tecnobio brand of lansoprazole", "lansoprazole tecnobio brand", "promeco brand of lansoprazole", "lansoprazole salvar brand", "takeda brand of lansoprazole", "ag-1749", "bamalite", "ogast", "prevacid", "abbot brand of lansoprazole", "lansoprazole promeco brand", "lansoprazole", "lansoprazole hoechst brand", "lanzor", "sodium, lansoprazole", "lansoprazole abbot brand", "opiren", "2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole", "lansoprazole vinas brand", "lansoprazole lederle brand"], "definition": "A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.", "other_contexts": [], "par_relations": ["2-Pyridinylmethylsulfinylbenzimidazoles", "Anti-Ulcer Agents", "Proton Pump Inhibitors", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole"], "chd_relations": ["Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Dexlansoprazole", "Lansoprazole Sulfone"], "syn_relations": ["Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole", "Lansoprazole"], "sib_relations": ["Omeprazole", "Rabeprazole"]}, "target_ent": {"research_entity_id": "RXNORM:1182452", "canonical_name": "Protium brand of pantoprazole sodium Pill", "aliases": ["protium brand of pantoprazole sodium pill"], "definition": "", "other_contexts": [], "par_relations": ["pantoprazole Pill"], "chd_relations": ["Protium brand of pantoprazole sodium 40 MG Delayed Release Oral Tablet", "pantoprazole Delayed Release Oral Tablet [Protium brand of pantoprazole sodium]"], "syn_relations": [], "sib_relations": ["Protium brand of pantoprazole sodium", "Pill"]}}
{"label": 1, "source_ent": {"research_entity_id": "MSH:D004110", "canonical_name": "Diltiazem", "aliases": ["tiazac", "crd 401", "dilzem", "dilren", "diltiazem", "diltiazem hydrochloride", "cardizem", "dilacor", "biovail brand of diltiazem hydrochloride", "diltiazem malate", "crd401", "dilacor xr", "crd-401", "cardil", "1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, (2s-cis)-", "watson pharmaceuticals brand of diltazem", "aldizem"], "definition": "A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of CALCIUM ion on membrane functions.", "other_contexts": ["3) Low and high diltiazem concentration plus low isoflurane, halothane, or enflurane concentrations did not prolong AVCT more than the individual agents alone, but low or high diltiazem plus high isoflurane, halothane, or enflurane concentrations increased AVCT more than each anesthetic alone.", "Also, the delay of onset of the suppressive effect decreased with higher diltiazem concentrations.", "The purpose of this study was to examine the hypothesis that the calcium channel blocker, diltiazem, modulates catecholamine-induced arrhythmias through CNS mechanisms.", "In the present study we evaluated whether diltiazem could ameliorate or reverse the disease phenotype in cells and in vivo in an Mybpc3-targeted knock - in ( KI ) mouse model of HCM . Sarcomere shortening and Ca2 + transients were measured in KI and wild - type ( WT ) cardiomyocytes in basal conditions ( 1-Hz pacing ) and under stress conditions ( 30 nm isoprenaline , 5-Hz pacing ) with or without pre - treatment with 1 μm diltiazem .", "Furthermore, diltiazem reduced the contraction amplitude at 5 Hz but did not affect diastolic Ca2+ load and Ca2+ transient amplitude.", "During exercise testing in the diltiazem SR baseline phase, 77% of the patients did not experience angina, whereas 60% of the patients did not experience ST-segment depression.", "In five mechano-heat-sensitive C fibers, electrical stimulation via a microelectrode placed in the receptive field was used to demonstrate a diltiazem-dose-dependent (10(-5), 10(-4), 10(-3) M) progressive retardation of the nerve conduction velocity and an increase of the electrical threshold.", "The direct effects of isoflurane, halothane, and enflurane alone or combined with diltiazem were examined in 49 isolated perfused guinea pig hearts.", "In the two kidney transplant recipients, an increase in tacrolimus AUC(24) occurred following the 20 mg/day dosage of diltiazem (26 and 67%).", "The onset of ventricular arrhythmias , premature ventricular complexes , occurred at a significantly ( P less than 0.05 ) greater dose of epinephrine , after diltiazem , compared to the control group and in a dose - dependent manner , with the mean ( + /-", "4 ) In hearts paced at 5 and 6 Hz , AVCT increased above controls during a low or high concentrations of diltiazem , during enflurane , and during the low or high concentration of diltiazem plus enflurane ; AVCT increased more with the low concentration of diltiazem plus enflurane than with the low diltiazem concentration alone.(ABSTRACT TRUNCATED AT 400 WORDS )", "A similar trend was observed in patients randomized to diltiazem SR (n = 7), which suggested a training effect, and, therefore, equal efficacy between diltiazem SR and diltiazem CD.", "A comparative study of the steady - state pharmacokinetics of immediate - release and controlled - release diltiazem tablets We have studied the controlled - release properties and relative systemic availabilities of two dosages of the same controlled - release ( CR ) diltiazem tablet formulation by comparing them at steady state with those of an immediate - release formulation . We measured 24-hour plasma concentration profiles during 4-day treatments with diltiazem 90 mg CR tablet bd diltiazem 120 mg CR tablet bd , and conventional diltiazem 60 mg immediate - release ( IR ) tablet tid .", "Heat thresholds were still found to be significantly increased after treatment with diltiazem at 10(-3 ) and 10(-4 ) M concentrations ( and 10 min of wash out ) , but appeared unchanged after wash out of lower concentrations .", "Diltiazem did not affect the current flow through voltage-dependent Na+ channels.", "Hearts were also perfused with a low or high concentration of diltiazem (75 and 150 ng/ml) alone and during anesthetic exposure.", "conditions ( 30 nm isoprenaline , 5-Hz pacing ) with or without pre - treatment with 1 μm diltiazem . KI cardiomyocytes exhibited lower diastolic sarcomere length ( dSL ) at baseline , a tendency to", "and dysfunction , activation of the fetal gene program or fibrosis . In conclusion , diltiazem blunted the response to isoprenaline in WT and KI cardiomyocytes and improved diastolic relaxation", "Postmortem diltiazem and desacetyl - diltiazem concentrations , measured by gas chromatography - mass spectrometry , were as follows : 31.1 mg / mL diltiazem and 9.7 mg / mL desacetyl - diltiazem in blood ; 33.1 mg / g diltiazem and 13.7 mg / g desacetyl - diltiazem in brain ; 179.5 mg / g diltiazem and 47.5 mg / g desacetyl - diltiazem in lung ; 41.8 mg / g diltiazem and 10.1 mg / g desacetyl - diltiazem in heart ; 182.1 mg / g diltiazem and 47.3 mg / g desacetyl - diltiazem in liver ; 49.2 mg / g diltiazem and 22.6 mg / g desacetyl - diltiazem in kidney ; and 294.9 mg / mL diltiazem and 29.4 mg / mL desacetyl - diltiazem in bile .", "Lethal diltiazem poisoning.", "The blocking effects of 1 microM diltiazem on IDMPP were similar at different holding potentials ( inhibition by around 30% at -100 , -80 or -50 mV ) .", "not improve the phenotype of adult mice with a fully developed HCM . Our study shows that diltiazem has beneficial effects in HCM , but long - term treatment success is likely to depend on", "Significant findings of combined exposure were as follows: 1) the low isoflurane, halothane, or enflurane concentration plus a low or high diltiazem concentration decreased LVP compared with control and diltiazem alone; low isoflurane plus the high diltiazem concentration decreased LVP more than isoflurane alone.", "The increase at the maximum diltiazem dosages used ( 120 mg / day in one and 180 mg / day in the other ) was also lower ( 18 and 22% ) than that exhibited by the kidney transplant recipients .", "( Mybpc3-targeted knock - in ) , which is based on a mutation commonly found in patients . Diltiazem improved contractile function of isolated ventricular cardiomyocytes acutely , but chronic", "The results suggest that : ( a ) calcium channels on neurons in the CNS play an important role in the modulation of epinephrine - induced cardiac arrhythmias , ( b ) diltiazem can suppress arrhythmias through CNS mechanisms , ( c ) activation of the parasympathetic nervous system mediates some of the effect of diltiazem , but ( d ) the mechanism of action of diltiazem is modulated through endogenous opioids .", "The findings provide no indication that a transformed calcium channel specifically sensitive to diltiazem is involved in pH - induced sustained nociceptor excitation .", "The effect of the calcium channel antagonist diltiazem on pH - induced sustained nociceptor excitation was investigated in a rat skin - saphenous nerve preparation , in vitro , where receptive fields of identified and isolated single fibers were superfused at the corium side with controlled solutions to assess their chemosensitivity .", "or Ca2 + channel antagonists as pharmacological treatment . The Ca2 + channel blocker diltiazem recently showed promising beneficial effects in pre - clinical HCM , particularly in patients", "Patients who were switched from diltiazem SR to diltiazem CD (n = 28) experienced a 5% increase in time to termination (p = 0.0004) on the exercise tolerance test (ETT), as well as an 8% improvement in time to onset of angina (p < 0.0001) on the ETT.", "Diltiazem blocks the PH-induced excitation of rat nociceptors together with their mechanical and electrical excitability in vitro. 1.", "The antiarrythmic action of diltiazem could not be explained by alteration of the blood pressure or heart rate response to epinephrine .", "In contrast, the highest concentration of diltiazem used (10 microM) inhibited the response to high K+ (59 mM for 5 min) by only 25%.", "Diltiazem makes a logical tacrolimus - sparing agent because of the potential financial savings and therapeutic benefits .", "In conclusion , diltiazem blunted the response to isoprenaline in WT and KI cardiomyocytes and improved diastolic relaxation under stress conditions in KI cardiomyocytes .", "In vivo, the systemic clearance of infused diltiazem was lower than that estimated after i.v.", "The combination of naloxone plus atropine sulfate completely prevented the effect of diltiazem, 50 micrograms/kg, on arrhythmias.", "3. 45Ca2+ uptake into cells stimulated with DMPP (100 microM for 1 min) was also blocked by diltiazem in a concentration-dependent manner (IC50 = 0.4 microM).", "This beneficial effect of diltiazem in cells did not translate in therapeutic efficacy when applied chronically in KI mice.", "Rats, that had catheters previously inserted into the lateral cerebral ventricle and femoral artery, received diltiazem, 10 or 50 micrograms/kg or the diluent, into the lateral cerebral ventricle (i.c.v.).", "A 60-year - old man presented to an emergency department 2 h after the ingestion of 8 g of diltiazem ( about 40 slow - release capsules , 200 mg / each ) in a suicide attempt .", "This novel effect of diltiazem might have clinical relevance since it might reduce the sympathoadrenal drive to the heart and blood vessels, thus contributing to the well established antihypertensive and cardioprotective effects of the drug.", "It can be concluded from the results that the suppressive effect of diltiazem on pH - induced nociceptor excitation can be explained by a use - dependent axonal block , comparable with the action of local anesthetics and affecting all modalities of sensory responsiveness .", "In vitro, diltiazem Kmet was reduced in liver homogenates from rabbits that had received the infusion of diltiazem, but not in the intestine or lungs.", "relaxation under stress conditions in KI cardiomyocytes . This beneficial effect of diltiazem in cells did not translate in therapeutic efficacy when applied chronically in KI mice .", "The high isoflurane , halothane , or enflurane concentration plus the low or the high diltiazem concentration decreased LVP from control , anesthetics and diltiazem alone .", "The Ca2 + channel blocker diltiazem recently showed promising beneficial effects in pre - clinical HCM , particularly in patients carrying MYBPC3 mutations .", "No significant changes in the number of angina attacks , nitroglycerin use , or any hemodynamic - related parameters were observed following transfer to diltiazem CD .", "The blocking effects of diltiazem developed very quickly and did not exhibit use-dependence; thus the drug blocked the channel in its closed state.", "Notably , in many of these latter cases , the doses of diltiazem ingested were higher than those taken by our patient .", "The time to maximum plasma concentrations after oral administration of immediate - release formulations is approximately 3 to 4 h. The elimination half - life of diltiazem is 3.5–7 h , implying that frequent dosing is required to maintain effective plasma concentrations .", "These data are compatible with the idea that diltiazem has little effect on Ca2+ entry through voltage-dependent Ca2+ channels in bovine chromaffin cells.", "in patients carrying MYBPC3 mutations . In the present study we evaluated whether diltiazem could ameliorate or reverse the disease phenotype in cells and in vivo in an Mybpc3-targeted knock", "Therefore, a controlled-release formulation of diltiazem, designed to be taken twice daily, has been developed.", "The maximum increase in tacrolimus AUC(24 ) occurred at the maximum diltiazem dosage used ( 180 mg / day ) , when the increase was 48 and 177% .", "The increase in tacrolimus AUC(12 ) was similar to the increase in AUC(12 - 24 ) when diltiazem was given in the morning only ( dosages < or = 60 mg / day ) .", "The effects of diltiazem on various functional parameters were studied in bovine cultured adrenal chromaffin cells stimulated with the nicotinic receptor agonist dimethylphenylpiperazinium ( DMPP ) or with depolarizing Krebs - HEPES solutions containing high K+ concentrations .", "After serial blood sampling , the rabbits were sacrificed , and diltiazem , MA and M1 constant rates of metabolism ( Kmet ) were estimated in the 10,000 x g supernatants of the intestinal mucosa , liver and lungs .", "2 ) Diltiazem plus low or high isoflurane , halothane , or enflurane concentrations decreased spontaneous atrial rate from control and the agents alone , except the high isoflurane concentration plus the low diltiazem concentration was not greater than that of isoflurane alone .", "Diltiazem plus halothane or enflurane decreased LVP more than diltiazem plus isoflurane.", "in KI , and attenuated the positive inotropic effect of isoprenaline . Furthermore , diltiazem reduced the contraction amplitude at 5 Hz but did not affect diastolic Ca2 + load and Ca2 +", "The half - maximal blocking concentration ( IC50 ) was estimated to 1.1.10(-4 ) M diltiazem , the half - maximal concentration for gradual suppression of the pH response was 2.10(-5 ) M diltiazem .", "The release of [3H]-noradrenaline induced by DMPP (100 microM for 5 min) was gradually and fully inhibited by increasing concentrations of diltiazem (IC50 = 1.3 microM).", "Because several organs contribute to diltiazem metabolism, this study aimed to determine the effect of an infusion of diltiazem to steady state on the ability of the intestine, liver and lungs to metabolize diltiazem and its metabolites N-desmethyldiltiazem (MA) and desacetyldiltiazem (M1).", "After 10(-3) M diltiazem superfusion (and 10 min of wash-out), the responsiveness to mechanical stimulation of the majority of the fibers was still totally lost. 6.", "Before, after, and sometimes during the superfusion, the mechanical (von Frey) thresholds were determined and found to be significantly increased after partial wash out of diltiazem (10(-4) and 10(-3) M; P < 0.006 and P < 0.008, respectively).", "The diltiazem plasma concentration increased slowly from about 6 h after the evening dose of both CR tablets, resulting in relatively high plasma concentrations in the early morning hours.", "Whole - cell Ba2 + currents through Ca2 + channels in voltage - clamped chromaffin cells were inhibited by 3 - 10 microM diltiazem by 20 - 25% .", "The Kmet of MA was not affected by the infusion of diltiazem in any tissue studied ; however , the Kmet of M1 was reduced by the infusion in the three tissues tested .", "The kinetics of diltiazem were assessed after a single i.v.", "OBJECTIVE To study the dose-response relationship of the pharmacokinetic interaction between diltiazem and tacrolimus in kidney and liver transplant recipients.", "Endogenous opioids of the mu - type were implicated in this action of diltiazem , because the mu opioid antagonist naloxone , 1 mg / kg ( i.v . ) , significantly ( P less than 0.05 ) antagonized the antiarrhythmic effects of centrally administered diltiazem and the mu opioid agonist DAGO ( i.c.v . ) , did not further enhance the suppression of epinephrine - induced arrhythmias , produced by diltiazem , 50 micrograms / kg .", "The early morning rise of the diltiazem plasma concentration , which might lead to a lower incidence of ischaemic events , may be an important clinical advantage of both CR tablets .", "Rather , diltiazem acts directly on the neuronal nicotinic receptor ion channel and blocks ion fluxes , cell depolarization and the subsequent Ca2 + entry and catecholamine release .", "Organ-specific pattern of inhibition of diltiazem metabolism at steady state in rabbits.", "PATIENTS Stable kidney ( n = 2 ) and liver ( n = 2 ) transplant recipients maintained on oral tacrolimus twice daily but not taking diltiazem .", "Fibers responding to this acid pH condition ( n = 60 ; 77% ) were further stimulated for > or = 30 min and additionally treated with diltiazem in various concentrations ( 10(-6)-10(-3 ) M ) during the middle 10-min period .", "5 Hz but did not affect diastolic Ca2 + load and Ca2 + transient amplitude . Six months of diltiazem treatment of KI mice did not reverse cardiac hypertrophy and dysfunction , activation of the fetal", "Again , diltiazem blocked the K(+)-evoked 45Ca2 + uptake ( 70 mM K+ for 1 min ) only by 20% .", "Clinical efficacy and safety of once - daily diltiazem in patients with stable angina pectoris switched from twice - daily diltiazem .", "Pre-treatment of cardiomyocytes with 1 μm diltiazem reduced the drop in dSL and arrhythmia frequency in KI, and attenuated the positive inotropic effect of isoprenaline.", ". In this study , we tested if the non - dihydropyridine Ca2 + channel blocker diltiazem , which previously showed potential to stop disease progression , can improve the phenotype of a", "Diltiazem concentrations found in our case are notably higher than those reported in other studies , including those in which diltiazem ingestion resulted in the death of the patient .", "The whole-cell currents elicited by 100 microM DMPP (IDMPP) were inhibited in a concentration-dependent and reversible manner by diltiazem.", "Plasma levels of diltiazem , after its chronic administration , are usually higher than predicted .", "In this study , we tested if the non - dihydropyridine Ca2 + channel blocker diltiazem , which previously showed potential to stop disease progression , can improve the phenotype of a HCM mouse model ( Mybpc3-targeted knock - in ) , which is based on a mutation commonly found in patients .", "Diltiazem improved contractile function of isolated ventricular cardiomyocytes acutely, but chronic application did not improve the phenotype of adult mice with a fully developed HCM.", "Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.", "The calcium antagonist diltiazem has antiarrhythmic effects which are mediated in the brain through endogenous opioids.", "Our study shows that diltiazem has beneficial effects in HCM , but long - term treatment success is likely to depend on characteristics and cause of HCM and onset of treatment .", "Only during treatment with diltiazem CR 120 mg were the plasma concentrations of diltiazem maintained above the minimum therapeutic plasma concentration of 50 μg·1−1 throughout the full 24 h. In conclusion , twice - daily treatment with diltiazem CR tablets can replace thrice - daily treatment with the conventional diltiazem IR tablet .", "Neither, does diltiazem affect INa.", "The aim of this crossover study was to compare the systemic availability and steady - state pharmacokinetics of a controlled - release diltiazem tablet formulation ( 90 and 120 mg ) with those of a conventional diltiazem immediate - release tablet in healthy volunteers .", "Diltiazem dose - dependently and reversibly reduced the pH - induced sustained nociceptor discharge to a significant degree or completely abolished it .", "METHODS Patients were treated with seven incremental dosages of diltiazem ( 0 to 180 mg / day ) at > or = 2-weekly intervals .", "Patients with stable angina pectoris receiving twice - daily sustained - release ( SR ) diltiazem were switched to equivalent doses of once - daily controlled - delivery ( CD ) diltiazem or to diltiazem SR .", "Atropine sulfate , which crosses the blood - brain barrier and atropine methylnitrate , which does not enter the brain , each at 1 mg / kg ( i.v . ) , produced an equal and significant antagonism of the effect of diltiazem , 50 micrograms / kg , that was less than that of naloxone .", "Superfusion for 6 min of diltiazem 10(-5 ) M was sufficient to block axonal conduction as well as mechanosensitivity , which both recovered synchronously during wash out .", "These findings suggest that patients whose angina is controlled with twice-daily diltiazem SR can be safely and effectively switched to an equivalent daily dose of the once-daily diltiazem CD.", "In the presence of this toxin, diltiazem exhibited an additional small inhibitory effect, indicating that the compound was acting on L-type Ca2+ channels.", "injection (2 mg/kg) and after an infusion (1.4 mg/kg/hr over 15 hr) of diltiazem.", "The anti - ischaemic mechanism of diltiazem seems to result from an increase of myocardial oxygen supply and a reduction in myocardial oxygen demand , respectively by coronary artery dilatation and/or direct and indirect haemodynamic effects , such as afterload reduction and heart rate decrease ( Braunwald 1982 ) .", "Eleven percent of the patients receiving diltiazem CD experienced treatment-related adverse events, which were limited to headache and abdominal pain; these adverse events did not lead to discontinuation of treatment.", "injection of diltiazem, i.e., 54.4 +/-", "The development of fatal arrhythmias , mainly ventricular tachyarrhythmias , occurred at significantly ( P less than 0.05 ) greater concentrations of epinephrine with diltiazem , 50 and 10 micrograms / kg , 225 + /-", "After diltiazem, a partial recovery of the pH-induced discharge was achieved within 10 min depending on the degree of suppression.", "Six months of diltiazem treatment of KI mice did not reverse cardiac hypertrophy and dysfunction , activation of the fetal gene program or fibrosis .", "CONCLUSIONS The mean tacrolimus-sparing effect of diltiazem was similar in magnitude to the cyclosporin-sparing effect previously reported.", "Usually only one concentration of diltiazem was applied per fiber , although in some cases diltiazem was applied repeatedly and in increasing concentrations .", "Depression of atrial rate , atrioventricular nodal conduction , and cardiac contraction by diltiazem and volatile anesthetics in isolated hearts .", "Inhibition of nicotinic receptor - mediated responses in bovine chromaffin cells by diltiazem . 1 .", "towards arrhythmias under stress conditions . Pre - treatment of cardiomyocytes with 1 μm diltiazem reduced the drop in dSL and arrhythmia frequency in KI , and attenuated the positive inotropic", "At the end of each interval, 13 blood samples were taken over a 24-hour period to allow determination of morning (AUC(12)), evening (AUC(12-24)) and 24-hour (AUC(24)) areas under the concentration-time curve for tacrolimus, as well as AUC(24) for diltiazem and three of its metabolites.", "Diltiazem, a benzothiazepine, is a calcium antagonist used in the treatment of angina pectoris and hypertension.", "Following transfer to diltiazem CD, 79 and 61% of patients, respectively, remained angina- and ST-segment depression free.", "15 micrograms/kg in the groups treated with 50 and 10 micrograms/kg of diltiazem and the control groups, respectively.", "It is concluded that , in rabbits , long - term administration of diltiazem leads to an accumulation of diltiazem primarily because its N - demethylation is decreased in the liver , in addition , the demethylation of M1 is reduced in the small intestine , liver and lungs .", "Hence, diltiazem affects blood tacrolimus concentrations for longer than would be predicted from the half-life of diltiazem in plasma.", "Diltiazem plus halothane or enflurane decreased atrial rate more than diltiazem plus isoflurane .", "In the two liver transplant recipients, an increase in tacrolimus AUC(24) did not occur until a higher diltiazem dosage (60 to 120 mg/day) was given.", "In nonpaced hearts, AV block occurred only with high diltiazem plus low enflurane (23%) concentrations and the high enflurane concentration (31%).", "Pharmacokinetic interaction between tacrolimus and diltiazem : dose - response relationship in kidney and liver transplant recipients .", "For diltiazem CR 90 mg and diltiazem CR 120 mg , AUC84–96 ( night ) was approximately 75% of AUC72–84 ( daytime ) .", "Whether the lesser tacrolimus-sparing effect with diltiazem seen in the liver transplant recipients was due to functional differences in the transplanted liver is not known, but it was not due to lower plasma diltiazem concentrations.", "It is interesting to note that although several cases of acute diltiazem poisoning have been reported in literature , only a few were lethal ."], "par_relations": ["Diltiazem", "Benzazepines", "Antihypertensive Agents", "Calcium Channel Blockers", "Cardiovascular Agents", "Vasodilator Agents", "Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem"], "chd_relations": ["Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem", "deacetyldiltiazem", "N-monodemethyldiltiazem", "clentiazem", "RO 23-6152", "3-(4-azidobutyryloxy)diltiazem", "siratiazem", "TA 993", "MR 14134", "S 2150", "DTZ 323", "SAS 1310", "3-(4-azidobenzoyloxy)diltiazem", "3-(acetyloxy)-5-(2-(trimethylammonium)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one", "5-(2-(dimethylamino)ethyl)-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one", "deacetyl N-monodesmethyl diltiazem", "deacetyl-N-monodemethyldiltiazem", "metabolite MB3", "N,N-didesmethyldiltiazem"], "syn_relations": ["Diltiazem", "Diltiazem", "Diltiazem", "Diltiazem"], "sib_relations": ["Benzodiazepines", "Galantamine", "Harringtonines", "Fenoldopam", "2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine", "Varenicline"]}, "target_ent": {"research_entity_id": "RXNORM:220309", "canonical_name": "Tiazac", "aliases": ["tiazac"], "definition": "", "other_contexts": ["At steady - state , similar Cmax and AUC for the 24-hour dosing interval were found for Cardizem CD and Tiazac .", "After single doses , mean diltiazem maximum plasma concentration ( Cmax ) was 46% higher with the Tiazac formulation compared with Cardizem CD , and the mean area under the plasma concentration - time profile ( AUC ) was 19% higher with Tiazac .", "The pharmacokinetic profiles of the two pharmacologically active diltiazem metabolites , desacetyldiltiazem and N - desmethyldiltiazem , followed that of parent drug after single and multiple doses of Cardizem CD and Tiazac .", "From these results , it is concluded that the pharmacokinetic profiles of Tiazac and Cardizem CD are significantly different .", "The Study of Titration and Response to Tiazac ( START ) is an ongoing practice - based , open - label , multicenter study designed to evaluate the efficacy and safety profiles of Tiazac at greater - than - traditional doses in hypertensive patients and to assess the ability of Tiazac to decrease the rate - pressure product , a surrogate marker for cardiac workload .", "The purpose of this study was to determine the relative bioavailability of Cardizem CD compared to Tiazac after single and multiple doses .", "All subjects received a starting dose of Tiazac 180 mg or 240 mg once daily , and doses were titrated upward to 360 mg once daily as clinically indicated .", "The present study was conducted to compare the bioavailability of a new extended release diltiazem HCl capsule formulation ( Tiazac ) with 2 other currently marketed products ( Cardizem CD and Dilacor XR ) .", "Tiazac ( Forest Pharmaceuticals , Inc. , St. Louis , Missouri ) , a new , extended - release formulation of diltiazem , provides 24-hour blood pressure control with a single daily dose of up to 360 mg .", "ANOVA and multiple comparison tests showed the parent drug AUC0-tau to be significantly higher after daily dosing with Tiazac than with the other 2 marketed products , but the diltiazem Cmin values were not significantly different between the 3 formulations .", "However , Tiazac produced a 21% lower diltiazem minimum plasma concentration , a 28% lower trough concentration ( the concentration in the plasma sample obtained just before the daily dose was given ) , and a 1.5-times higher fluctuation in maximum to minimum diltiazem plasma concentration compared with Cardizem CD .", "We report the cases of a 71-year - old black male and a 49-year - old Hispanic male , who both presented with characteristic hyperpigmentation on sun - exposed areas after taking an extended - release form of diltiazem hydrochloride ( Tiazac ) .", "Relative bioavailability of Cardizem CD and Tiazac controlled - release diltiazem dosage forms after single and multiple dosing in healthy volunteers .", "Antihypertensive monotherapy with Tiazac was well tolerated ."], "par_relations": ["Diltiazem", "Diltiazem Hydrochloride"], "chd_relations": [], "syn_relations": [], "sib_relations": ["24 HR Tiazac 120 MG Extended Release Oral Capsule", "24 HR Tiazac 180 MG Extended Release Oral Capsule", "24 HR Tiazac 300 MG Extended Release Oral Capsule", "24 HR Tiazac 360 MG Extended Release Oral Capsule", "24 HR Tiazac 240 MG Extended Release Oral Capsule", "Tiazac 420 MG 24 HR Extended Release Oral Capsule", "Diltiazem Extended Release Oral Capsule [Tiazac]", "Diltiazem Hydrochloride 120 MG [Tiazac]", "Diltiazem Hydrochloride 180 MG [Tiazac]", "Diltiazem Hydrochloride 240 MG [Tiazac]", "Diltiazem Hydrochloride 300 MG [Tiazac]", "Diltiazem Hydrochloride 360 MG [Tiazac]", "Diltiazem Hydrochloride 420 MG [Tiazac]", "Tiazac 120 MG Extended Release Oral Capsule", "Tiazac 180 MG Extended Release Oral Capsule", "Tiazac 240 MG Extended Release Oral Capsule", "Tiazac 300 MG Extended Release Oral Capsule", "Tiazac 360 MG Extended Release Oral Capsule", "Tiazac 420 MG Extended Release Oral Capsule", "Tiazac Oral Product", "Tiazac Pill"]}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:20846", "canonical_name": "hornerin", "aliases": ["flg3", "filaggrin family member 3", "hrnr", "hornerin", "s100a18", "hrnr gene", "s100a16"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["hornerin", "hornerin", "hornerin", "hornerin", "hornerin", "hornerin", "hornerin", "hornerin"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:606471", "canonical_name": "NUCLEOLAR PROTEIN FAMILY A, MEMBER 3", "aliases": ["dyskeratosis congenita, autosomal recessive 1", "nola3", "nucleolar protein family a, member 3", "nop10", "nop10, s. cerevisiae, homolog of"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["NUCLEOLAR PROTEIN FAMILY A, MEMBER 3", "NUCLEOLAR PROTEIN FAMILY A, MEMBER 3", "NUCLEOLAR PROTEIN FAMILY A, MEMBER 3", "NOLA3, ARG34TRP", "NUCLEOLAR PROTEIN FAMILY A, MEMBER 3", "NUCLEOLAR PROTEIN FAMILY A, MEMBER 3", "NUCLEOLAR PROTEIN FAMILY A, MEMBER 3"], "sib_relations": ["NOLA3, ARG34TRP"]}}
{"label": 1, "source_ent": {"research_entity_id": "MSH:D012412", "canonical_name": "Rubella virus", "aliases": ["german measles virus", "rubella virus", "measles virus, german"], "definition": "The type (and only) species of RUBIVIRUS causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis.", "other_contexts": ["Hybrids between rubella virus and a latent virus of baby hamster kidney cell line BHK21: characterization of rubella virus and type 2 hybrid virus genomes and determination of their physical homology.", "the majority ( 90% ) had high school education or lower . The overall prevalence of Rubella virus IgG sero - positivity was 58.4% ( 1,161,129 ) ; geographical variation ranged from 92.5% in Jilin", "A high index of rubella virus antibody production was also found in the vitreous sample (GWC = 30.6).", "Rubella virus-specific IgG4 was found in low amounts in 7 of 35 samples from healthy immune donors.", "This study was conducted to find answers to the following questions: How much time after infection with rubella virus, the volume and surface area of the Vero cells and their nuclei get started to change?How is it possible to apply stereological methods to estimate the volume and surface area of the cultured cells using the invariator, nucleator, and surfactor techniques?", "Rubella virus immunization status in preconception period among Chinese women of reproductive age: A nation-wide, cross-sectional study.", "Rubella virus-positive patients presented more frequently with unilateral ocular disease (P < .001), keratic precipitates (KPs; P = .014), iris atrophy and/or heterochromia (P = .051), associated vitreous opacities (P = .024), and cataract (P = .004).", "and Prevention ( CDC ) . RESULTS The results from Focus Diagnostics were positive for rubella virus RNA . Real - time RT - PCR assays at CDC were also positive for rubella virus . A rubella virus", "Among these unique variations, C9306U is located within the recommended molecular window for rubella virus genotyping assignment, could be useful to confirm 1F viruses.", "The rubella genome was detected in two of nine patients, and rubella virus was isolated from one of nine patients with FHI.", "Subclass distribution of rubella virus-specific immunoglobulin G. An enzyme-linked immunosorbent assay was used to study the subclass distribution of rubella virus-specific immunoglobulin G (IgG) in 97 serum samples from healthy donors and from patients with recent or remote rubella infections.", "Rubella virus and type 2 hybrid virus RNA can serve as templates for avian myeloblastosis virus (AMV) reverse transcriptase, although they are inefficient.", "the vitreous fluid by Focus Diagnostics . Additional real - time RT - PCR assays for rubella virus detection and RT - PCR assays for generation of templates for sequencing were performed at the", "Self-reported vaccination status did not correlate with Rubella virus IgG seropositivity.", "These values indicate that the size of the type 2 hybrid virus genome is about 21% larger than that of the rubella virus genome.", "The genetic distance between 1F viruses and 10 other rubella virus genotypes (1a, 1B, 1C, 1D, 1E, 1G, 1J 2A, 2B, and 2C) ranged from 3.9% to 8.6% by pairwise comparison.", "Antiviral activity of hemolymph of Podalia against rubella virus.", "remains a clinical diagnosis , findings in this case support the association between rubella virus and the disease . Phylogenetic analysis provided evidence that this rubella virus was likely a", "BACKGROUND Many cases of Fuchs' uveitis have been associated with persistent rubella virus infection.", "Since the patient had rubella prior to 1955, this sequence is from the earliest rubella virus yet characterized.", "in the fetus causing multiple organ abnormalities . Potent antiviral activity against rubella virus ( RV ) has been observed in the hemolymph of Podalia sp . ( Lepidoptera : Megalopygidae ) . This", "These cDNA-RNA hybridization analyses of physical homology between type 2 hybrid virus and rubella virus genomes revealed that about 70% of the type 2 hybrid virus genome is derived from about an 85% portion of the rubella virus genome.", "Also, the combination of KPs, absence of posterior synechiae, cataract, and vitreous opacities occurred more often in the Rubella virus-positive group (P = .026) and the presence of three or four of these criteria occurred more frequently in the Rubella virus-positive group (P = .004).", "unique variations , C9306U is located within the recommended molecular window for rubella virus genotyping assignment , could be useful to confirm 1F viruses . Using the Bayesian Markov Chain", "Rubella virus-associated uveitis: clinical manifestations and visual prognosis.", "a therapeutic pars plana vitrectomy in May 2013 . A real - time RT - PCR assay for rubella virus was performed on the vitreous fluid by Focus Diagnostics . Additional real - time RT - PCR assays", "RESULTS Patients with Rubella virus-associated uveitis were younger at time of initial ophthalmologic presentation (P = .014).", "Comparisons to all available rubella virus sequences from GenBank identified 22 nucleotide variations exclusively in 1F viruses.", "Plastic beads coated with rubella antigen were incubated with test serum and then with monoclonal antibodies to the four human subclass of IgG. Rubella virus-specific IgG1 was present in all serum samples containing rubella virus-specific IgG antibodies.", "This serum was negative in all other assays for rubella virus-specific antibodies.", ") to 0.2% ( Qinghai ) . Self - reported vaccination status did not correlate with Rubella virus IgG seropositivity . CONCLUSIONS Prevalence of Rubella sero - positivity is low among Chinese", "RESULTS Of 2,120,131 women recruited to the study, Rubella virus IgG serology was available in 1,974,188 (99.3%).", "Genomic analysis of the Chinese genotype 1F rubella virus that disappeared after 2002 in China.", "Genomic characterization of a persistent rubella virus from a case of Fuch' uveitis syndrome in a 73 year old man.", "Rubella virus (genus Rubivirus, family Togaviridae) is a single stranded RNA virus of positive genome polarity.", "METHODS Clinical records of 30 patients with anterior uveitis positive for intraocular antibody production against Rubella virus by Goldmann-Witmer coefficient determination and/or polymerase chain reaction were reviewed and compared with clinical records of 13 patients with chronic anterior uveitis of undetermined origin.", "High absorbance in the assay for rubella virus-specific IgG4 was found in one serum.", "to find answers to the following questions : How much time after infection with rubella virus , the volume and surface area of the Vero cells and their nuclei get started to change?How is it", "Our laboratory data strongly suggest a relationship between FHI and rubella virus.", ", education and occupation ) and vaccination history was obtained by interviews . Rubella virus IgG sero - positivity was determined using venous blood samples . RESULTS Of 2,120,131 women", "Rubella virus is involved in the pathogenesis of Fuchs heterochromic uveitis and almost all cases in Europe show an active antibody production in the aqueous humor against rubella virus.", ", family Togaviridae ) is a single stranded RNA virus of positive genome polarity . Rubella virus infection of susceptible women during the first trimester of pregnancy often results in long -", "Only 4.6% (n=91,604) women reported to have had Rubella virus vaccination, and it varied from 18.6% (Guangdong) to 0.2% (Qinghai).", "Rubella Virus-associated Anterior Uveitis in a Vaccinated Patient: A Case Report.", "produce pharmacologically active molecules that interfere in human cell physiology . Rubella virus ( genus Rubivirus , family Togaviridae ) is a single stranded RNA virus of positive genome", "Potent antiviral activity against rubella virus (RV) has been observed in the hemolymph of Podalia sp.", "This population-based, cross-sectional, sero-survey of Rubella virus infection was a part of the National Free Preconception Health Examination Project covering all 31 provinces in Mainland China.", "In addition to laboratory examinations, medical history of rubella virus vaccination was also obtained.", "RNA . Real - time RT - PCR assays at CDC were also positive for rubella virus . A rubella virus sequence of 739 nucleotides was determined and phylogenetic analysis showed that the virus was the", "Rubella virus infection of susceptible women during the first trimester of pregnancy often results in long-term virus persistence in the fetus causing multiple organ abnormalities.", "Rubella virus as a possible etiological agent of Fuchs heterochromic iridocyclitis To determine whether rubella virus is involved in the pathogenesis of Fuchs heterochromic iridocyclitis (FHI).", "using venous blood samples . RESULTS Of 2,120,131 women recruited to the study , Rubella virus IgG serology was available in 1,974,188 ( 99.3% ) . Participating women were of young age ( median=", "Rubella virus IgG sero-positivity was determined using venous blood samples.", "Rubella virus-specific IgG2 was present in 1 of 35 samples from healthy donors that also contained specific IgG1.", "Ten patients with FHI examined showed intraocular synthesis of rubella virus antibodies (GWC > 3).", "METHODS The cultured Vero cells were infected with rubella virus.", "and Surface Area : Application of Stereological Methods on Vero Cells Infected by Rubella Virus BACKGROUND Morphological changes of the cells infected with rubella virus can not be observed", "CONCLUSIONS While FUS remains a clinical diagnosis, findings in this case support the association between rubella virus and the disease.", "for rubella virus RNA . Real - time RT - PCR assays at CDC were also positive for rubella virus . A rubella virus sequence of 739 nucleotides was determined and phylogenetic analysis showed that", "we report a case of a fully vaccinated patient with common variable immunodeficiency who developed unilateral Fuchs heterochromic uveitis secondary to rubella virus which was proven by intraocular fluid examination.", "six months . METHODS This population - based , cross - sectional , sero - survey of Rubella virus infection was a part of the National Free Preconception Health Examination Project covering all 31", "In this study , the volume and surface area of the Vero cells were reduced by rubella virus 48 hours after infection . Invariator is a more precise method compared to nucleator or surfactor .", ", and surfactor techniques ? METHODS The cultured Vero cells were infected with rubella virus . The cells of the control and experimental groups were harvested at 2 , 4 , 8 , 24 , and 48 hours", "was also the most variable region in the 1F genomes . Comparisons to all available rubella virus sequences from GenBank identified 22 nucleotide variations exclusively in 1F viruses . Among these", "The oligo(dT)-cellulose affinity column bound neither rubella virus nor type 2 hybrid virus RNA.", "immunodeficiency who developed unilateral Fuchs heterochromic uveitis secondary to rubella virus which was proven by intraocular fluid examination . Awareness of rubella associated anterior", "In this study, the volume and surface area of the Vero cells were reduced by rubella virus 48 hours after infection.", "man . BACKGROUND Many cases of Fuchs ' uveitis have been associated with persistent rubella virus infection . A 73-year - old male patient with typical Fuchs ' Uveitis Syndrome ( FUS ) first", "Aqueous humor (AH) samples from 14 FHI patients and one vitreous sample from a FHI patient were analyzed for intraocular antibody production against rubella virus by calculation of the Goldmann–", "A real-time RT-PCR assay for rubella virus was performed on the vitreous fluid by Focus Diagnostics.", "20.1% in Qinghai and 0.0% in Tibet . Only 4.6% ( n=91,604 ) women reported to have had Rubella virus vaccination , and it varied from 18.6% ( Guangdong ) to 0.2% ( Qinghai ) . Self - reported", "rubella virus and the disease . Phylogenetic analysis provided evidence that this rubella virus was likely a previously undetected genotype which is no longer circulating . Since the patient had", "Additional real-time RT-PCR assays for rubella virus detection and RT-PCR assays for generation of templates for sequencing were performed at the Centers for Disease Control and Prevention (CDC).", "1F and other rubella viruses . The genetic distance between 1F viruses and 10 other rubella virus genotypes ( 1a , 1B , 1C , 1D , 1E , 1 G , 1J 2A , 2B , and 2C ) ranged from 3.9% to 8.6% by", "Estimation of the Cultured Cells’ Volume and Surface Area: Application of Stereological Methods on Vero Cells Infected by Rubella Virus BACKGROUND Morphological changes of the cells infected with rubella virus cannot be observed easily.", "PURPOSE To investigate the clinical profile of patients with chronic anterior uveitis and intraocular analyses positive for intraocular Rubella virus infection and assess eventual similarities to Fuchs heterochromic uveitis (FHU).", "RESULTS The results from Focus Diagnostics were positive for rubella virus RNA.", "all cases in Europe show an active antibody production in the aqueous humor against rubella virus . Herein we report a case of a fully vaccinated patient with common variable immunodeficiency who", "The overall prevalence of Rubella virus IgG sero-positivity was 58.4% (1,161,129); geographical variation ranged from 92.5% in Jilin to 20.1% in Qinghai and 0.0% in Tibet.", "Co-sedimentation studies of these viral RNA by sucrose density gradient centrifugation confirmed that the molecular weight of type 2 hybrid virus RNA is 20% higher than that of rubella virus RNA.", "Phylogenetic analysis provided evidence that this rubella virus was likely a previously undetected genotype which is no longer circulating.", "The biochemical nature of rubella virus and type 2 hybrid virus, which is a recombinant between rubella virus and a latent retrovirus of BHK21 cells, has been characterized.", "Of 20 serum samples that were negative by other serological techniques, 8 gave absorbances above cutoff levels in the assays for rubella virus-specific total IgG and IgG1.", "Real-time RT-PCR assays at CDC were also positive for rubella virus.", "Infected by Rubella Virus BACKGROUND Morphological changes of the cells infected with rubella virus can not be observed easily . Estimation of the size of the cultured cells can be a valuable", "CONCLUSIONS Rubella virus causes a distinct clinical spectrum of ocular symptoms similar to the FHU syndrome, which suggests that Rubella virus might be involved in the pathogenesis of FHU.", ". Since the patient had rubella prior to 1955 , this sequence is from the earliest rubella virus yet characterized .", "A rubella virus sequence of 739 nucleotides was determined and phylogenetic analysis showed that the virus was the sole member of a new phylogenetic group when compared to reference virus sequences.", "Rubella virus-specific IgG3 was found in serum samples from patients with recent rubella infections but had disappeared by 6 months after the onset of symptoms."], "par_relations": ["Rubivirus"], "chd_relations": [], "syn_relations": ["Rubella virus", "Rubella virus"], "sib_relations": []}, "target_ent": {"research_entity_id": "RXNORM:1365969", "canonical_name": "Rubella virus", "aliases": ["rubella virus"], "definition": "", "other_contexts": ["Hybrids between rubella virus and a latent virus of baby hamster kidney cell line BHK21: characterization of rubella virus and type 2 hybrid virus genomes and determination of their physical homology.", "the majority ( 90% ) had high school education or lower . The overall prevalence of Rubella virus IgG sero - positivity was 58.4% ( 1,161,129 ) ; geographical variation ranged from 92.5% in Jilin", "A high index of rubella virus antibody production was also found in the vitreous sample (GWC = 30.6).", "Rubella virus-specific IgG4 was found in low amounts in 7 of 35 samples from healthy immune donors.", "Although rubella virus belongs to the same family as the mosquito-borne alphaviruses, in many respects it is more similar to other aerosol-transmitted human viruses such as the agents of measles and mumps.", "Rubella virus-positive patients presented more frequently with unilateral ocular disease (P < .001), keratic precipitates (KPs; P = .014), iris atrophy and/or heterochromia (P = .051), associated vitreous opacities (P = .024), and cataract (P = .004).", "This study was conducted to find answers to the following questions: How much time after infection with rubella virus, the volume and surface area of the Vero cells and their nuclei get started to change?How is it possible to apply stereological methods to estimate the volume and surface area of the cultured cells using the invariator, nucleator, and surfactor techniques?", "Rubella virus immunization status in preconception period among Chinese women of reproductive age: A nation-wide, cross-sectional study.", "and Prevention ( CDC ) . RESULTS The results from Focus Diagnostics were positive for rubella virus RNA . Real - time RT - PCR assays at CDC were also positive for rubella virus . A rubella virus", "Little is known about the three-dimensional organization of rubella virus, which causes a relatively mild measles-like disease in children but leads to serious congenital health problems when contracted in utero.", "Among these unique variations, C9306U is located within the recommended molecular window for rubella virus genotyping assignment, could be useful to confirm 1F viruses.", "The rubella genome was detected in two of nine patients, and rubella virus was isolated from one of nine patients with FHI.", "Subclass distribution of rubella virus-specific immunoglobulin G. An enzyme-linked immunosorbent assay was used to study the subclass distribution of rubella virus-specific immunoglobulin G (IgG) in 97 serum samples from healthy donors and from patients with recent or remote rubella infections.", "Rubella virus and type 2 hybrid virus RNA can serve as templates for avian myeloblastosis virus (AMV) reverse transcriptase, although they are inefficient.", "the vitreous fluid by Focus Diagnostics . Additional real - time RT - PCR assays for rubella virus detection and RT - PCR assays for generation of templates for sequencing were performed at the", "Self-reported vaccination status did not correlate with Rubella virus IgG seropositivity.", "These values indicate that the size of the type 2 hybrid virus genome is about 21% larger than that of the rubella virus genome.", "The genetic distance between 1F viruses and 10 other rubella virus genotypes (1a, 1B, 1C, 1D, 1E, 1G, 1J 2A, 2B, and 2C) ranged from 3.9% to 8.6% by pairwise comparison.", "remains a clinical diagnosis , findings in this case support the association between rubella virus and the disease . Phylogenetic analysis provided evidence that this rubella virus was likely a", "BACKGROUND Many cases of Fuchs' uveitis have been associated with persistent rubella virus infection.", "Since the patient had rubella prior to 1955, this sequence is from the earliest rubella virus yet characterized.", "Also, the combination of KPs, absence of posterior synechiae, cataract, and vitreous opacities occurred more often in the Rubella virus-positive group (P = .026) and the presence of three or four of these criteria occurred more frequently in the Rubella virus-positive group (P = .004).", "These cDNA-RNA hybridization analyses of physical homology between type 2 hybrid virus and rubella virus genomes revealed that about 70% of the type 2 hybrid virus genome is derived from about an 85% portion of the rubella virus genome.", "unique variations , C9306U is located within the recommended molecular window for rubella virus genotyping assignment , could be useful to confirm 1F viruses . Using the Bayesian Markov Chain", "Rubella virus-associated uveitis: clinical manifestations and visual prognosis.", "a therapeutic pars plana vitrectomy in May 2013 . A real - time RT - PCR assay for rubella virus was performed on the vitreous fluid by Focus Diagnostics . Additional real - time RT - PCR assays", "Functional and evolutionary insight from the crystal structure of rubella virus protein E1.", "RESULTS Patients with Rubella virus-associated uveitis were younger at time of initial ophthalmologic presentation (P = .014).", "Here we report the 1.8 Å resolution crystal structure of envelope glycoprotein E1, the main antigen and sole target of neutralizing antibodies against rubella virus.", "Comparisons to all available rubella virus sequences from GenBank identified 22 nucleotide variations exclusively in 1F viruses.", "Plastic beads coated with rubella antigen were incubated with test serum and then with monoclonal antibodies to the four human subclass of IgG. Rubella virus-specific IgG1 was present in all serum samples containing rubella virus-specific IgG antibodies.", "This serum was negative in all other assays for rubella virus-specific antibodies.", ") to 0.2% ( Qinghai ) . Self - reported vaccination status did not correlate with Rubella virus IgG seropositivity . CONCLUSIONS Prevalence of Rubella sero - positivity is low among Chinese", "RESULTS Of 2,120,131 women recruited to the study, Rubella virus IgG serology was available in 1,974,188 (99.3%).", "In addition, rubella virus E1 has an extensive membrane-fusion surface that includes a metal site, reminiscent of the T-cell immunoglobulin and mucin family of cellular proteins that bind phosphatidylserine lipids at the plasma membrane of cells undergoing apoptosis.", "Genomic analysis of the Chinese genotype 1F rubella virus that disappeared after 2002 in China.", "Genomic characterization of a persistent rubella virus from a case of Fuch' uveitis syndrome in a 73 year old man.", "METHODS Clinical records of 30 patients with anterior uveitis positive for intraocular antibody production against Rubella virus by Goldmann-Witmer coefficient determination and/or polymerase chain reaction were reviewed and compared with clinical records of 13 patients with chronic anterior uveitis of undetermined origin.", "High absorbance in the assay for rubella virus-specific IgG4 was found in one serum.", "to find answers to the following questions : How much time after infection with rubella virus , the volume and surface area of the Vero cells and their nuclei get started to change?How is it", "Our laboratory data strongly suggest a relationship between FHI and rubella virus.", ", education and occupation ) and vaccination history was obtained by interviews . Rubella virus IgG sero - positivity was determined using venous blood samples . RESULTS Of 2,120,131 women", "Rubella virus is involved in the pathogenesis of Fuchs heterochromic uveitis and almost all cases in Europe show an active antibody production in the aqueous humor against rubella virus.", "Only 4.6% (n=91,604) women reported to have had Rubella virus vaccination, and it varied from 18.6% (Guangdong) to 0.2% (Qinghai).", "Rubella Virus-associated Anterior Uveitis in a Vaccinated Patient: A Case Report.", "This population-based, cross-sectional, sero-survey of Rubella virus infection was a part of the National Free Preconception Health Examination Project covering all 31 provinces in Mainland China.", "In addition to laboratory examinations, medical history of rubella virus vaccination was also obtained.", "RNA . Real - time RT - PCR assays at CDC were also positive for rubella virus . A rubella virus sequence of 739 nucleotides was determined and phylogenetic analysis showed that the virus was the", "Rubella virus as a possible etiological agent of Fuchs heterochromic iridocyclitis To determine whether rubella virus is involved in the pathogenesis of Fuchs heterochromic iridocyclitis (FHI).", "Rubella virus IgG sero-positivity was determined using venous blood samples.", "using venous blood samples . RESULTS Of 2,120,131 women recruited to the study , Rubella virus IgG serology was available in 1,974,188 ( 99.3% ) . Participating women were of young age ( median=", "Rubella virus-specific IgG2 was present in 1 of 35 samples from healthy donors that also contained specific IgG1.", "Ten patients with FHI examined showed intraocular synthesis of rubella virus antibodies (GWC > 3).", "METHODS The cultured Vero cells were infected with rubella virus.", "and Surface Area : Application of Stereological Methods on Vero Cells Infected by Rubella Virus BACKGROUND Morphological changes of the cells infected with rubella virus can not be observed", "CONCLUSIONS While FUS remains a clinical diagnosis, findings in this case support the association between rubella virus and the disease.", "for rubella virus RNA . Real - time RT - PCR assays at CDC were also positive for rubella virus . A rubella virus sequence of 739 nucleotides was determined and phylogenetic analysis showed that", "we report a case of a fully vaccinated patient with common variable immunodeficiency who developed unilateral Fuchs heterochromic uveitis secondary to rubella virus which was proven by intraocular fluid examination.", "six months . METHODS This population - based , cross - sectional , sero - survey of Rubella virus infection was a part of the National Free Preconception Health Examination Project covering all 31", "In this study , the volume and surface area of the Vero cells were reduced by rubella virus 48 hours after infection . Invariator is a more precise method compared to nucleator or surfactor .", ", and surfactor techniques ? METHODS The cultured Vero cells were infected with rubella virus . The cells of the control and experimental groups were harvested at 2 , 4 , 8 , 24 , and 48 hours", "was also the most variable region in the 1F genomes . Comparisons to all available rubella virus sequences from GenBank identified 22 nucleotide variations exclusively in 1F viruses . Among these", "The oligo(dT)-cellulose affinity column bound neither rubella virus nor type 2 hybrid virus RNA.", "Structural comparisons show that the class II fusion proteins from alphaviruses and flaviviruses, despite belonging to different virus families, are closer to each other than they are to rubella virus E1.", "immunodeficiency who developed unilateral Fuchs heterochromic uveitis secondary to rubella virus which was proven by intraocular fluid examination . Awareness of rubella associated anterior", "In this study, the volume and surface area of the Vero cells were reduced by rubella virus 48 hours after infection.", "man . BACKGROUND Many cases of Fuchs ' uveitis have been associated with persistent rubella virus infection . A 73-year - old male patient with typical Fuchs ' Uveitis Syndrome ( FUS ) first", "It also shows that rubella virus E1 is a class II fusion protein, which had hitherto only been structurally characterized for the arthropod-borne alphaviruses and flaviviruses.", "Aqueous humor (AH) samples from 14 FHI patients and one vitreous sample from a FHI patient were analyzed for intraocular antibody production against rubella virus by calculation of the Goldmann–", "20.1% in Qinghai and 0.0% in Tibet . Only 4.6% ( n=91,604 ) women reported to have had Rubella virus vaccination , and it varied from 18.6% ( Guangdong ) to 0.2% ( Qinghai ) . Self - reported", "A real-time RT-PCR assay for rubella virus was performed on the vitreous fluid by Focus Diagnostics.", "rubella virus and the disease . Phylogenetic analysis provided evidence that this rubella virus was likely a previously undetected genotype which is no longer circulating . Since the patient had", "Additional real-time RT-PCR assays for rubella virus detection and RT-PCR assays for generation of templates for sequencing were performed at the Centers for Disease Control and Prevention (CDC).", "By contrast, in the absence of this constraint, the strictly human rubella virus seems to have drifted considerably into a unique niche as sole member of the Rubivirus genus.", "1F and other rubella viruses . The genetic distance between 1F viruses and 10 other rubella virus genotypes ( 1a , 1B , 1C , 1D , 1E , 1 G , 1J 2A , 2B , and 2C ) ranged from 3.9% to 8.6% by", "Estimation of the Cultured Cells’ Volume and Surface Area: Application of Stereological Methods on Vero Cells Infected by Rubella Virus BACKGROUND Morphological changes of the cells infected with rubella virus cannot be observed easily.", "PURPOSE To investigate the clinical profile of patients with chronic anterior uveitis and intraocular analyses positive for intraocular Rubella virus infection and assess eventual similarities to Fuchs heterochromic uveitis (FHU).", "RESULTS The results from Focus Diagnostics were positive for rubella virus RNA.", "all cases in Europe show an active antibody production in the aqueous humor against rubella virus . Herein we report a case of a fully vaccinated patient with common variable immunodeficiency who", "The overall prevalence of Rubella virus IgG sero-positivity was 58.4% (1,161,129); geographical variation ranged from 92.5% in Jilin to 20.1% in Qinghai and 0.0% in Tibet.", "Co-sedimentation studies of these viral RNA by sucrose density gradient centrifugation confirmed that the molecular weight of type 2 hybrid virus RNA is 20% higher than that of rubella virus RNA.", "Phylogenetic analysis provided evidence that this rubella virus was likely a previously undetected genotype which is no longer circulating.", "The biochemical nature of rubella virus and type 2 hybrid virus, which is a recombinant between rubella virus and a latent retrovirus of BHK21 cells, has been characterized.", "Of 20 serum samples that were negative by other serological techniques, 8 gave absorbances above cutoff levels in the assays for rubella virus-specific total IgG and IgG1.", "Real-time RT-PCR assays at CDC were also positive for rubella virus.", "Infected by Rubella Virus BACKGROUND Morphological changes of the cells infected with rubella virus can not be observed easily . Estimation of the size of the cultured cells can be a valuable", "CONCLUSIONS Rubella virus causes a distinct clinical spectrum of ocular symptoms similar to the FHU syndrome, which suggests that Rubella virus might be involved in the pathogenesis of FHU.", ". Since the patient had rubella prior to 1955 , this sequence is from the earliest rubella virus yet characterized .", "A rubella virus sequence of 739 nucleotides was determined and phylogenetic analysis showed that the virus was the sole member of a new phylogenetic group when compared to reference virus sequences.", "Rubella virus-specific IgG3 was found in serum samples from patients with recent rubella infections but had disappeared by 6 months after the onset of symptoms."], "par_relations": [], "chd_relations": [], "syn_relations": [], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C567034", "canonical_name": "Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress", "aliases": ["brain-lung-thyroid syndrome", "choreoathetosis and congenital hypothyroidism", "choreoathetosis, hypothyroidism, and neonatal respiratory distress"], "definition": "", "other_contexts": [], "par_relations": ["Athetosis", "Chorea", "Congenital Hypothyroidism", "Respiratory Distress Syndrome, Newborn"], "chd_relations": [], "syn_relations": [], "sib_relations": ["Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress", "Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress"]}, "target_ent": {"research_entity_id": "OMIM:600359.0004", "canonical_name": "KCNJ1, TRP58TER", "aliases": ["kcnj1, trp58ter"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 1"], "sib_relations": ["POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 1"]}}
{"label": 0, "source_ent": {"research_entity_id": "CPT:92533", "canonical_name": "Caloric vestibular test, each irrigation (binaural, bithermal stimulation constitutes 4 tests)", "aliases": ["assessment of balance system during irrigation of both ears", "caloric vestibular test each irrigation", "caloric vestibular test, each irrigation (binaural, bithermal stimulation constitutes 4 tests)", "caloric vestibular test", "caloric vestibular test"], "definition": "", "other_contexts": [], "par_relations": ["Vestibular Function Tests, Without Electrical Recording"], "chd_relations": [], "syn_relations": ["Caloric vestibular test, each irrigation (binaural, bithermal stimulation constitutes 4 tests)", "Caloric vestibular test, each irrigation (binaural, bithermal stimulation constitutes 4 tests)", "Caloric vestibular test, each irrigation (binaural, bithermal stimulation constitutes 4 tests)", "Caloric vestibular test, each irrigation (binaural, bithermal stimulation constitutes 4 tests)"], "sib_relations": ["Caloric vestibular test, each irrigation (binaural, bithermal stimulation constitutes 4 tests)", "Caloric vestibular test, each irrigation (binaural, bithermal stimulation constitutes 4 tests)", "Caloric vestibular test, each irrigation (binaural, bithermal stimulation constitutes 4 tests)", "Irrigation of implanted venous access device for drug delivery systems", "Spontaneous nystagmus, including gaze", "Positional nystagmus test", "Optokinetic nystagmus test", "Caloric vestibular test, each irrigation (binaural, bithermal stimulation constitutes 4 tests)"]}, "target_ent": {"research_entity_id": "MSH:D014724", "canonical_name": "Vestibular Function Tests", "aliases": ["vestibular function tests", "tests, vestibular function", "vestibular function test", "function test, vestibular", "test, vestibular function", "function tests, vestibular"], "definition": "A number of tests used to determine if the brain or balance portion of the inner ear are causing dizziness.", "other_contexts": ["Function Test for the Practicing Specialist ] .", "[instable Stationary Equipment for Thermal Vestibular Function Tests].", "the Autonomic Nervous System ] .", "(Supplement: Criterion for evaluation of the results of vestibular function test)].", "Studies on the correlation between vestibular function test and autonomic nervous system.", "[pendular Rotation Test as a Vestibular Function Test].", "[the Significance of the Vestibular Function Test for the Practicing Specialist].", "[studies on the Correlation between the Vestibular Function Test and the Autonomic Nervous System].", "Manifestation and Prognosis of Vestibular Migraine According to the Vestibular Function Test Results BACKGROUND AND OBJECTIVES ACCORDING TO PREVIOUS REPORTS , PATIENTS WITH VESTIBULAR", "We must consider how autonomic nervous system modifies or influences the results of the test in the vestibular function test.", "[role of Electronystagmography in Vestibular Function Tests].", "According to the Vestibular Function Test Results BACKGROUND AND OBJECTIVES ACCORDING TO PREVIOUS REPORTS, PATIENTS WITH VESTIBULAR MIGRAINE (VM) DISPLAY VARIABLE RESULTS FROM VESTIBULAR FUNCTION TESTS (VFT): central, peripheral, or normal.", ", PATIENTS WITH VESTIBULAR MIGRAINE ( VM ) DISPLAY VARIABLE RESULTS FROM VESTIBULAR FUNCTION TESTS ( VFT ) : central , peripheral , or normal . The aim of this study was to classify the VM patients", "Vestibular Function Tests ] .", "Vestibular function tests in children.", "Test as a Vestibular Function Test ] .", "Vestibular function tests were performed on a series of 57 children between the ages of 1 and 16 years.", ". ( Supplement : Criterion for evaluation of the results of vestibular function test ) ] .", "in Vestibular Function Tests ] .", "[ vestibular Function Test and Changes in Head Position ] ."], "par_relations": ["Diagnostic Techniques, Otological"], "chd_relations": ["Caloric Tests", "Electronystagmography", "Head Impulse Test"], "syn_relations": ["Vestibular Function Tests", "Vestibular Function Tests", "Vestibular Function Tests", "Vestibular Function Tests", "Vestibular Function Tests", "Vestibular Function Tests", "Vestibular Function Tests", "Vestibular Function Tests", "Vestibular Function Tests", "Vestibular Function Tests"], "sib_relations": ["Vestibular Evoked Myogenic Potentials", "Hearing Tests", "Otoscopy"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C566552", "canonical_name": "Parkinson Disease 3, Autosomal Dominant Lewy Body", "aliases": ["parkinson disease 3, autosomal dominant", "parkinson disease 3, autosomal dominant lewy body"], "definition": "", "other_contexts": [], "par_relations": ["Parkinson Disease"], "chd_relations": [], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:138990", "canonical_name": "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL DOMINANT TYPE", "aliases": ["granulomatous disease, chronic, autosomal dominant type"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": [], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0002862", "canonical_name": "Bladder carcinoma", "aliases": ["bladder carcinoma"], "definition": "The presence of a carcinoma of the urinary bladder. [HPO:probinson]", "other_contexts": [], "par_relations": ["Bladder neoplasm"], "chd_relations": ["Transitional cell carcinoma of the bladder"], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:607860", "canonical_name": "YY1 ASSOCIATED PROTEIN 1", "aliases": ["yap", "hcca2", "yy1 associated protein 1", "hepatocellular carcinoma-associated protein 2", "yy1-associated protein", "yy1ap1"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["YY1 ASSOCIATED PROTEIN 1", "YY1 ASSOCIATED PROTEIN 1", "YY1 ASSOCIATED PROTEIN 1", "YY1 ASSOCIATED PROTEIN 1", "YY1 ASSOCIATED PROTEIN 1", "YY1 ASSOCIATED PROTEIN 1", "YY1 ASSOCIATED PROTEIN 1", "YY1 ASSOCIATED PROTEIN 1", "YY1 ASSOCIATED PROTEIN 1", "YY1 ASSOCIATED PROTEIN 1"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C535468", "canonical_name": "Copper deficiency, familial benign", "aliases": ["copper deficiency, familial benign", "familial benign hypocupremia", "familial benign copper deficiency"], "definition": "", "other_contexts": [], "par_relations": ["Copper", "Hair Diseases", "Metabolism, Inborn Errors", "Dermatitis, Seborrheic", "Seizures"], "chd_relations": [], "syn_relations": [], "sib_relations": ["deficiency"]}, "target_ent": {"research_entity_id": "OMIM:276700", "canonical_name": "TYROSINEMIA, TYPE I", "aliases": ["tyrsn1", "hepatorenal tyrosinemia", "fumarylacetoacetase deficiency", "fah deficiency", "tyrosinemia, type i"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["TYROSINEMIA, TYPE I", "TYROSINEMIA, TYPE I", "TYROSINEMIA, TYPE I", "TYROSINEMIA, TYPE I", "TYROSINEMIA, TYPE I", "TYROSINEMIA, TYPE I", "TYROSINEMIA, TYPE I", "TYROSINEMIA, TYPE I"], "sib_relations": ["Ascites", "Hypertrophic cardiomyopathy", "Failure to thrive", "GI bleeding", "Hepatomegaly", "Hypoglycemia", "Cirrhosis", "Nephrocalcinosis", "Paralytic ileus", "Renal failure", "Rickets", "Splenomegaly", "Acute liver failure", "Glomerulosclerosis", "Elevated alpha-fetoprotein", "Tyrosinemia", "Methioninemia", "Renal Fanconi syndrome", "Autosomal recessive", "Nephromegaly", "Hypophosphatemia", "Pancreatic islet-cell hypertrophy", "Episodic paralysis", "Hypophosphatemic rickets", "Episodic peripheral neuropathy", "Fumarylacetoacetate hydrolase (FAH) deficiency", "Deficient hepatic 4-hydroxyphenylpyruvate dioxygenase", "Elevated plasma and urine succinylacetone", "Elevated hepatic transaminases", "Elevated urinary delta-aminolevulinic acid", "Abnormal blood coagulation studies (prolonged PT and PTT)", "High incidence in Saguenay-Lac St. Jean region of the province of Quebec, Canada and northern Europe", "Unusual cabbage-like odor", "Symptoms highly variable - rapidly progressive course leading to hepatic failure versus acute hepatic crisis", "Hepatocellular carcinoma", "Caused by mutation in the fumarylacetoacetase gene (FAH, 613871.0001)", "Chronic weakness"]}}
{"label": 1, "source_ent": {"research_entity_id": "HGNC:HGNC:24970", "canonical_name": "intermediate filament family orphan 1", "aliases": ["hom-tes-103", "iffo1", "intermediate filament family orphan 1", "iffo1 gene"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["intermediate filament family orphan 1", "intermediate filament family orphan 1", "intermediate filament family orphan 1", "intermediate filament family orphan 1"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:610495", "canonical_name": "HOM-TES-103 GENE", "aliases": ["hom-tes-103 gene"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": [], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C564209", "canonical_name": "Graying of Hair, Precocious", "aliases": ["graying of hair, precocious", "white hair, premature"], "definition": "", "other_contexts": [], "par_relations": ["Hair Color", "Pigmentation Disorders"], "chd_relations": [], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:MTHU002806", "canonical_name": "Cone-shaped epiphyses appear in early childhood and disappear with premature fusion of growth plate before puberty", "aliases": ["cone-shaped epiphyses appear in early childhood and disappear with premature fusion of growth plate before puberty"], "definition": "", "other_contexts": [], "par_relations": ["MISCELLANEOUS"], "chd_relations": [], "syn_relations": [], "sib_relations": ["ACROCAPITOFEMORAL DYSPLASIA"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C081643", "canonical_name": "candesartan", "aliases": ["2-ethoxy-7-carboxy-1-(2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole", "candesartan", "cv 11974", "cv11974", "cv-11974", "1h-benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-"], "definition": "", "other_contexts": ["Plasma angiotensin I and II concentrations and PRA were augmented after single doses and further increased after 1 week repeated candesartan cilexetil dosing.", "A total of 32 mg of candesartan was well tolerated both in combination therapy with HCT and in monotherapy.", "Further investigation in larger - scale prospective randomized studies is required to reach any conclusion as to the superiority of combination therapy of candesartan with amlodipine .", "The inhibitory effect of candesartan is more prolonged , suggesting a slow dissociation from the AT1-receptor .", "constriction to locally - formed Ang II than losartan . The inhibitory effect of candesartan is more prolonged , suggesting a slow dissociation from the AT1-receptor . Additionally ,", "is required to reach any conclusion as to the superiority of combination therapy of candesartan with amlodipine .", "In a multivariate analysis, combination therapy of candesartan with amlodipine was an independent predictor of reduced risk of MACE.", "Candesartan is a potent, long-acting, selective angiotensin II AT1 receptor blocker.", "more prolonged , suggesting a slow dissociation from the AT1-receptor . Additionally , candesartan was found to block the Ang II - induced constriction of renal microvessels in a surmountable", "The DBP-lowering effect of fimasartan 120 mg was also nonsignificantly larger than candesartan 8 mg (difference, 1.58 [8.27] mm Hg; P = 0.20).", "Furthermore , candesartan - HCT 32/25 mg is more effective than candesartan - HCT 32/12.5 mg in this population .", "Candesartan and irbesartan were more potent in antagonising the constriction to Ang I than losartan .", "These findings suggest novel mechanisms through the protective RAS axis , whereby candesartan may ameliorate diabetic nephropathy .", "In addition , candesartan was shown to improve LV function , in association with reduction of CPK release .", "However, plasma CPK was lower in the candesartan groups than in the control group.", "Our findings indicate that candesartan and irbesartan are more potent inhibitors of renal microvascular constriction to locally-formed Ang II than losartan.", "CONCLUSIONS Candesartan alone was as effective , safe , and tolerable as enalapril .", "patients with CAD compared to non - amlodipine - DHP - CCBs in combination therapy with candesartan . Further investigation in larger - scale prospective randomized studies is required to reach any", "the incidence of major adverse cardiovascular events ( MACE ) of patients treated with candesartan and amlodipine with that of those with candesartan and non - amlodipine CCBs in hypertensive", "The safety profile of the fimasartan 60 mg and 120 mg was similar to candesartan 8 mg, with a slightly higher, but statistically not significant, incidence of hepatic enzyme elevation in fimasartan 120 mg. IMPLICATIONS The antihypertensive effect of fimasartan, a newly available angiotensin II receptor type 1 blocker, is comparable, although not superior, to candesartan with a good safety profile.", "more potent in antagonising the constriction to Ang I than losartan . By contrast , candesartan and irbesartan differed only slightly in potency . After a washing period of 60 minutes with drug -", "amlodipine - CCBs and candesartan . In a multivariate analysis , combination therapy of candesartan with amlodipine was an independent predictor of reduced risk of MACE . CONCLUSIONS The results", "Blood pressure, heart rate, and hormones associated with the renin-angiotensin system, and safety of candesartan cilexetil administration were also assessed.", "This Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study, named CAESAR (Candesartan Effect in Second Stage Arterial Hypertension), enrolled 253 patients with stage II hypertension.", "The SBP - lowering effect of fimasartan 120 mg was statistically larger than candesartan 8 mg ( difference , 4.98 [ 13.99 ] mm Hg ; P = .02 ) .", "Aldosterone decreased (P<0.05) with combination therapy (23.2+/-5.3 pg/mL) at 17 but not 43 weeks compared with candesartan (0.7+/-7.8 pg/mL) or enalapril (-0.8+/-11.", "( MACE ) of patients treated with candesartan and amlodipine with that of those with candesartan and non - amlodipine CCBs in hypertensive patients with coronary artery disease ( CAD ) . METHODS", "In the present study, we compared the effects of candesartan, irbesartan and losartan on the renal microvascular constriction to locally-formed Ang II, using isolated, perfused hydronephrotic rat kidneys. Addition of 1 nmol/L angiotensin I (Ang I, the precursor of Ang II) significantly reduced the diameters of interlobular arteries (ILAs; -47.6±2.6%), afferent arterioles (AAs; -43.6±2.3%) and efferent arterioles (EAs; -31.6±2.4%).", "90 - 110 mm Hg ) were randomly assigned to 60 to 120 mg / d of fimasartan or 8 mg / d of candesartan after a 2-week placebo run - in period . Treatments were administered for 12 weeks without dosage", "We investigated the antihypertensive effects of fimasartan 60 and 120 mg and its safety in comparison to 8 mg of candesartan .", "The decrease in SBP was also nonsignificantly larger in the fimasartan 60 mg group compared with the candesartan 8 mg group ( difference , 3.50 [ 12.63 ] mm Hg ; P = .06 ) .", "CONCLUSION Candesartan - HCT 32/12.5 mg and candesartan - HCT 32/25 mg are highly effective and provide improved blood pressure reduction and blood pressure control relative to candesartan 32 mg monotherapy , with maintained tolerability , in hypertensive patients whose blood pressure is not optimally controlled with candesartan monotherapy .", "Pharmacokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers .", "Frequent blood samples were collected after the first single dose of candesartan cilexetil, and during the last dosing interval after 1 week repeated once-daily administration.", "In conclusion, candesartan increased apoptosis in the rat hearts after acute I-R, and this increase was possibly mediated by upregulation of p53 and bax gene expressions.", "METHODS AND RESULTS Seven hundred sixty - eight patients in New York Heart Association functional class ( NYHA - FC ) II to IV with ejection fraction ( EF ) < 0.40 and a 6-minute walk distance ( 6MWD ) < 500 m received either candesartan ( 4 , 8 , or 16 mg ) , candesartan ( 4 or 8 mg ) plus 20 mg of enalapril , or 20 mg of enalapril for 43 weeks .", "Antihypertensive efficacy and tolerability of candesartan - hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy .", "A Randomized , Double - blind , Candesartan - controlled , Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension .", "Both Cmax and AUC of candesartan were increased after single and repeated once - daily dosing in the elderly compared to younger subjects by approximately 50% .", "A greater proportion of patients (70.6%) attained the target BP in the candesartan-HCT combination therapy group than in the candesartan monotherapy group (53.2%, P = 0.014).", "In the candesartan group, a total of 335 patients were treated with DHP-CCBs (amlodipine: 170 and non-amlodipine-CCBs: 165) at the baseline.", "After 4 weeks , the candesartan dose was forced titrated to 32 mg in both groups .", "EF increased (P=NS) more with candesartan-plus-enalapril therapy (0.025+/-0.004) than with candesartan alone (0.015+/-0.004) or enalapril alone(0.015+/-0.005).", "angiotensin II receptor type 1 blocker , is comparable , although not superior , to candesartan with a good safety profile . ClinicalTrials.gov identifier : NCT01135212 .", "The combination of candesartan and enalapril was more beneficial for preventing left ventricular remodeling than either candesartan or enalapril alone .", ": intermediate - high dose candesartan is renoprotective , whereas ultra - high dose candesartan induces renal damage . Molecular processes associated with these effects involve differential", "Molecular processes associated with these effects involve differential modulation of the ACE2/AT2R/Mas axis: intermediate-high dose candesartan up-regulating RAS protective components and attenuating pro-fibrotic processes, and ultra-high doses having opposite effects.", "Serum concentrations of CV-15959 were much lower than candesartan, and reached peak serum concentrations later, about 4-9 h after dose intake.", "Treatment using amlodipine with candesartan reduced the risk of MACE by 38% ( hazard ratio , 0.62 ; 95% confidence interval , 0.41 - 0.94 , p=0.025 ) , as compared to patients treated with non - amlodipine - CCBs and candesartan .", "41 - 0.94 , p=0.025 ) , as compared to patients treated with non - amlodipine - CCBs and candesartan . In a multivariate analysis , combination therapy of candesartan with amlodipine was an", "Northern blot analysis showed that p53 mRNA was upregulated in the candesartan groups, in association with increased expression of bax mRNA.", "Our findings also highlight potential injurious renal effects of ultra-high dose candesartan in diabetes.", "Efficacy of the combination of amlodipine and candesartan in hypertensive patients with coronary artery disease: a subanalysis of the HIJ-CREATE study.", "However , a significant augmentation of vascular superoxide dismutase activity was observed in the candesartan plus amlodipine - treated group , but not in other groups .", "Candesartan cilexetil is rapidly and completely hydrolysed to the active compound candesartan during absorption from the gastrointestinal tract .", "CONCLUSIONS The candesartan - HCT combination was associated with a statistically significant lowering of BP compared with candesartan monotherapy .", "RESULTS Study patients were all Asians, mostly male (65.7%), with a mean (SD) age of 49.4 (10.6) years and a mean body weight of 68.9 (12.1) kg; there were no between-group variances in demographic profiles except that the mean age in the candesartan-HCT group (51.0 [10.2] years) was about 3.2 years higher than that in the candesartan monotherapy group (47.8 [10.7] years; P = 0.02) despite random allocation.", "We evaluated whether high / ultra - high doses of candesartan ( ARB ) up - regulate angiotensin - converting enzyme 2 ( ACE2)/Ang II type 2 receptor ( AT2R)/Mas receptor [ protective axis of the of the renin - angiotensin system ( RAS ) ] in diabetic mice .", "expression in db / db mice . Our study demonstrates dose - related effects of candesartan in diabetic nephropathy : intermediate - high dose candesartan is renoprotective , whereas ultra -", "- ARB - based standard therapy on MACE in 2049 hypertensive patients with CAD . In the candesartan group , a total of 335 patients were treated with DHP - CCBs ( amlodipine : 170 and non -", "The pharmacokinetics did not change on repeated dosing and, as expected from the half-life of candesartan of approximately 9 h in younger subjects, there was almost no accumulation after repeated once-daily dosing.", ") . The DBP - lowering effect of fimasartan 120 mg was also nonsignificantly larger than candesartan 8 mg ( difference , 1.58 [ 8.27 ] mm Hg ; P = 0.20 ) . The decrease in SBP was also", "In Korean adult patients with stage II hypertension , we evaluated the efficacy and tolerability of candesartan 16 mg / hydrochlorothiazide ( HCT ) 12.5 mg and candesartan 32 mg / HCT 12.5 mg compared with candesartan 16-mg and 32-mg monotherapy , respectively .", "The elimination of CV-15959 was somewhat slower than that of candesartan .", "By contrast , candesartan and irbesartan differed only slightly in potency .", "II - induced vascular constriction . In the present study , we compared the effects of candesartan , irbesartan and losartan on the renal microvascular constriction to locally - formed Ang II ,", "Three hundred sixty-two individuals were screened, and 290 patients aged 19 to 75 years with mild to moderate hypertension (diastolic blood pressure [DBP], 90-110 mm Hg) were randomly assigned to 60 to 120 mg/d of fimasartan or 8 mg/d of candesartan after a 2-week placebo run-in period.", "Candesartan cilexetil , the prodrug to candesartan , was not measurable in serum .", "Only mild adverse events were recorded, with 'headache' as the most commonly reported event, and no increase in the number of reported adverse events was observed with higher doses of candesartan cilexetil.", "At the end of the run - in phase , 1975 patients who still had DBP 90 - 114 mmHg were randomized to 8 weeks ' double - blind treatment with either candesartan 32 mg ( n=654 ) , or candesartan - HCT 32/12.5 mg ( n=656 ) , or candesartan - HCT 32/ 25 mg ( n=665 ) .", "Phase IV , 8-week , multicenter , randomized , active treatment - controlled , parallel group , efficacy , and tolerability study of high - dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension . OBJECTIVE The objective of this study was to evaluate the efficacy and tolerability of high - dose ( 32 mg ) candesartan in Asians .", "In this sub-analysis, we compared, among the participants allocated to candesartan regimen, the long-term effects of amlodipine and non-amlodipine CCBs that were concomitantly given with ARB, although the choice of CCB was not randomized.", "Lower doses candesartan did not influence SBP , but ultra - high doses reduced SBP in both groups .", "Differential renal effects of candesartan at high and ultra-high doses in diabetic mice", "effects of fimasartan 60 and 120 mg and its safety in comparison to 8 mg of candesartan . METHODS This clinical trial is a multicenter , randomized , double - blind , active comparator ,", "The half-life of candesartan in the elderly (9-12 h) was somewhat longer than in the younger healthy adult volunteers (approximately 9 h) and no gender-related differences in the disposition of candesartan were observed.", "METHODS HIJ-CREATE was a multicenter, prospective, randomized, controlled study that compared the effects of candesartan-based with those of non-ARB-based standard therapy on MACE in 2049 hypertensive patients with CAD.", "Treatment started with either candesartan 16 mg or candesartan 16 mg/HCT 12.5 mg.", "An angiotensin II type 1 receptor blocker , candesartan , increases myocardial apoptosis in rats with acute ischemia - reperfusion .", "Comparison of the AT1-receptor blockers candesartan , irbesartan and losartan for inhibiting renal microvascular constriction .", "- free medium , a second application of Ang I failed to induce vasoconstriction only in candesartan - treated kidneys . Pretreatment of hydronephrotic kidneys with candesartan , to further explore", "Brain natriuretic peptide decreased with combination therapy ( 5.8+/-2.7 pmol / L ; P<0.01 ) compared with candesartan ( 4 .", "The pharmacokinetics of candesartan were investigated after single and repeated once - daily doses of candesartan cilexetil in the dose range 2 - 16 mg in both younger ( 19 - 40 years ) and elderly ( 65 - 78 years ) healthy volunteers in five studies .", "Immunohistochemical analysis showed that p53 and bax immunoreactivity were increased in both of the candesartan groups .", "Systolic blood pressure ( SBP ) , albuminuria and expression / activity of RAS components were assessed in diabetic db / db and control db/+ mice treated with increasing candesartan doses ( intermediate , 1 mg / kg / d ; high , 5 mg / kg / d ; ultra - high , 25 and 75 mg / kg / d ; 4 weeks ) .", "OBJECTIVE The purpose of this post hoc subgroup analysis was to compare the incidence of major adverse cardiovascular events ( MACE ) of patients treated with candesartan and amlodipine with that of those with candesartan and non - amlodipine CCBs in hypertensive patients with coronary artery disease ( CAD ) .", "The number of apoptotic cells in the candesartan groups (497+/-204 and 543+/-254, respectively) was higher than that in the control group (287+/-166; p<0.05).", "The vascular protective effects of placebo , candesartan ( 1 mg kg(-1 ) per day ) monotherapy , candesartan ( 1 mg kg(-1 ) per day ) and amlodipine ( 1 mg kg(-1 ) per day ) combination therapy , and candesartan ( 1 mg kg(-1 ) per day ) and hydrochlorothiazide ( HCTZ ) ( 10 mg kg(-1 ) per day ) combination therapy for 2 weeks were compared in stroke - prone , spontaneously hypertensive rats .", "Our study demonstrates dose-related effects of candesartan in diabetic nephropathy: intermediate-high dose candesartan is renoprotective, whereas ultra-high dose candesartan induces renal damage.", "Candesartan and amlodipine combination therapy provides powerful vascular protection in stroke - prone spontaneously hypertensive rats .", "; high , 5 mg / kg / d ; ultra - high , 25 and 75 mg / kg / d ; 4 weeks ) . Lower doses candesartan did not influence SBP , but ultra - high doses reduced SBP in both groups . Plasma glucose and", "Thus, candesartan and amlodipine combination therapy could have a powerful protective effect in vascular tissues via the reduction of oxidative stress.", "BACKGROUND We investigated the effects of candesartan (an angiotensin II antagonist) alone, enalapril alone, and their combination on exercise tolerance, ventricular function, quality of life (QOL), neurohormone levels, and tolerability in congestive heart failure (CHF).", "afferent arterioles ( AAs ; -43.6±2.3% ) and efferent arterioles ( EAs ; -31.6±2.4% ) . Candesartan and irbesartan were more potent in antagonising the constriction to Ang I than losartan . By", "Candesartan was intravenously administered 30 min before ischemia .", ". Our findings also highlight potential injurious renal effects of ultra - high dose candesartan in diabetes .", "baseline . In this sub - analysis , we compared , among the participants allocated to candesartan regimen , the long - term effects of amlodipine and non - amlodipine CCBs that were concomitantly", "After 4 weeks, patients treated with candesartan 16 mg/HCT 12.5 mg showed significant decreases in SBP/DBP of 28.7 (17.5)/17.8 (10.2) mm Hg, and those in the candesartan 16 mg monotherapy group showed decreases of 20.5 (14.5)/14.1 (10.1) mm Hg (P < 0.01 between treatments for both SBP and DBP).", "Response rate ( DBP < 90 mm Hg or DBP lowering > 10 mm Hg at week 12 ) was also nonsignificantly greater in both fimasartan groups ( Fimasartan 60 mg , 81% ; fimasartan 120 mg , 72% ; candesartan 8 mg , 71% ) .", "were assessed in diabetic db / db and control db/+ mice treated with increasing candesartan doses ( intermediate , 1 mg / kg / d ; high , 5 mg / kg / d ; ultra - high , 25 and 75 mg / kg / d", "After forced titration of candesartan from 16 mg to 32 mg at week 8, there was an additional reduction in SBP/DBP of 4.1 (12.7)/3.8 (8.3) mm Hg in the candesartan-HCT combination therapy group and 4.0 (11.6)/2.0 (8.5) mm Hg in the candesartan monotherapy group (P < 0.001 for SBP and DBP in both groups compared with values at week 4).", "AIM To evaluate the efficacy and tolerability of candesartan cilexetil 32 mg in combination with hydrochlorothiazide ( HCT ) 12.5 mg or 25 mg in hypertensive patients not optimally controlled with candesartan monotherapy .", "risk of MACE . CONCLUSIONS The results suggest that the combination of amlodipine and candesartan is more beneficial in reducing MACE in hypertensive patients with CAD compared to non - amlodipine", "8 mg , 71% ) . The safety profile of the fimasartan 60 mg and 120 mg was similar to candesartan 8 mg , with a slightly higher , but statistically not significant , incidence of hepatic enzyme", "Compared with the candesartan - treated group , significant attenuation was observed in the candesartan plus amlodipine - treated group , but not in the candesartan plus HCTZ - treated group .", "= .06 ) . The SBP - lowering effect of fimasartan 120 mg was statistically larger than candesartan 8 mg ( difference , 4.98 [ 13.99 ] mm Hg ; P = .02 ) . Response rate ( DBP < 90 mm Hg or DBP", "LV -dp / dt was decreased after candesartan administration in candesartan group II .", "- related effects of candesartan in diabetic nephropathy : intermediate - high dose candesartan is renoprotective , whereas ultra - high dose candesartan induces renal damage . Molecular", "The time to peak candesartan concentrations after tablet intake was consistently approximately 4 h at all dose levels.", "It was reduced during the double - blind treatment phase by 6.1/5.6 mmHg in the candesartan 32 mg group , by 13.0/8.8 mmHg in the candesartan - HCT 32/12.5 mg group , and by 15.5/10.0 mmHg in the candesartan - HCT 32/25 mg group ( p<0.01 for all between treatment comparisons ) .", "involve differential modulation of the ACE2/AT2R / Mas axis : intermediate - high dose candesartan up - regulating RAS protective components and attenuating pro - fibrotic processes , and ultra -", "in SBP was also nonsignificantly larger in the fimasartan 60 mg group compared with the candesartan 8 mg group ( difference , 3.50 [ 12.63 ] mm Hg ; P = .06 ) . The SBP - lowering effect of", "Additionally, dose-response curves of Ang II were similar after short (10 minutes) and prolonged (60 minutes) preincubation with candesartan.", "Blood pressure decreased with combination therapy ( 6+/-1/4+/-1 mm Hg ) compared with candesartan or enalapril alone ( P<0.05 ) .", "prolonged ( 60 minutes ) preincubation with candesartan . Our findings indicate that candesartan and irbesartan are more potent inhibitors of renal microvascular constriction to locally - formed", "No differences in ACE activity or serum aldosterone concentrations were observed between subjects receiving candesartan cilexetil and placebo tablets.", "Immunohistological analysis showed that areas positive for 4-hydroxy-2-nonenal were significantly reduced in all therapeutic groups, but this reduction was significantly greater for the candesartan plus amlodipine-treated group than for the candesartan-treated group.", "Additionally , candesartan was found to block the Ang II - induced constriction of renal microvessels in a surmountable manner .", "multicenter , prospective , randomized , controlled study that compared the effects of candesartan - based with those of non - ARB - based standard therapy on MACE in 2049 hypertensive patients", "CONCLUSIONS The results suggest that the combination of amlodipine and candesartan is more beneficial in reducing MACE in hypertensive patients with CAD compared to non - amlodipine - DHP - CCBs in combination therapy with candesartan .", "2 was larger but not statistically significant in the fimasartan 60 mg compared with the candesartan 8 mg group with a mean ( SD ) difference of 1.72 ( 8.32 ) mm Hg ( 95% CI , -0.71 to 4.15 mm Hg ; P", "greater in both fimasartan groups ( Fimasartan 60 mg , 81% ; fimasartan 120 mg , 72% ; candesartan 8 mg , 71% ) . The safety profile of the fimasartan 60 mg and 120 mg was similar to candesartan 8", "PATIENTS AND METHODS A total of 3521 patients with treated or untreated hypertension and sitting diastolic blood pressure (DBP) 90-114 mmHg, entered a single-blind run-in phase with candesartan (16 mg for 2 weeks, followed by 32 mg for 6 weeks).", "were similar after short ( 10 minutes ) and prolonged ( 60 minutes ) preincubation with candesartan . Our findings indicate that candesartan and irbesartan are more potent inhibitors of renal", "Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study.", "The data showed that left ventricular (LV) systolic pressure and LV +dp/dt was decreased after administration of candesartan, but increased after reperfusion in the candesartan group II, compared with those in the candesartan group I and control group.", "Serum and plasma were analysed for candesartan cilexetil , candesartan and its inactive metabolite , CV-15959 , as well as angiotensin I and II , aldosterone , plasma renin activity ( PRA ) and angiotensin - converting enzyme ( ACE ) activity .", "The decrease in DBP at week 12 was larger but not statistically significant in the fimasartan 60 mg compared with the candesartan 8 mg group with a mean ( SD ) difference of 1.72 ( 8.32 ) mm Hg ( 95% CI , -0.71 to 4.15 mm Hg ; P = 0.17 ) .", "In diabetic mice treated with intermediate dose candesartan, renal tubular damage and albuminuria were ameliorated and expression of ACE2, AT2R and Mas and activity of ACE2 were increased, effects associated with reduced ERK1/2 phosphorylation, decreased fibrosis and renal protection.", "Pretreatment of hydronephrotic kidneys with candesartan , to further explore its antagonistic properties , shifted the dose - response curves of Ang II approximately 2 log units to the right without reducing the maximal Ang II - induced constriction of ILAs , AAs or EAs .", "mechanisms remain unclear . We evaluated whether high / ultra - high doses of candesartan ( ARB ) up - regulate angiotensin - converting enzyme 2 ( ACE2)/Ang II type 2 receptor ( AT2R)/Mas", "in db / db compared with db/+ mice . In diabetic mice treated with intermediate dose candesartan , renal tubular damage and albuminuria were ameliorated and expression of ACE2 , AT2R and Mas and", "End-diastolic (EDV) and end-systolic (ESV) volumes increased less with combination therapy (EDV 8+/-4 mL; ESV 1+/-4 mL; P<0.01) than with candesartan alone (EDV 27+/-4 mL; ESV 18+/-3 mL) or enalapril alone (EDV 23+/-7 mL; ESV 14+/-6 mL).", ". RESULTS The median follow - up was 3.9 years . Treatment using amlodipine with candesartan reduced the risk of MACE by 38% ( hazard ratio , 0.62 ; 95% confidence interval , 0.41 - 0.94 , p=0", "Furthermore , the relaxation was significantly stronger in the candesartan plus amlodipine - treated group than in the candesartan - treated group ; however , there was no significant difference between the candesartan- and candesartan plus HCTZ - treated groups .", "only in candesartan - treated kidneys . Pretreatment of hydronephrotic kidneys with candesartan , to further explore its antagonistic properties , shifted the dose - response curves of Ang II", ". These findings suggest novel mechanisms through the protective RAS axis , whereby candesartan may ameliorate diabetic nephropathy . Our findings also highlight potential injurious renal", "The primary and secondary objectives were to compare the blood pressure (BP) changes after 4 weeks and 8 weeks between candesartan-HCT combination therapy and candesartan monotherapy.", "Single and repeated doses of candesartan cilexetil were well tolerated in the younger and elderly volunteers.", "After a washing period of 60 minutes with drug - free medium , a second application of Ang I failed to induce vasoconstriction only in candesartan - treated kidneys .", "Candesartan monotherapy significantly reduced blood pressure, and both combination therapies were equally and significantly lower than the monotherapy.", "The present study was undertaken to investigate the effects of angiotensin receptor blockers (ARBs), candesartan, on the apoptosis of cardiac myocytes in rats after I-R. Rats were divided into a control group, a candesartan group I (0.015 mg/kg), and a candesartan group II (0.03 mg/kg).", "The AUC and Cmax of candesartan showed dose - proportional increases in the dose range of 2 - 16 mg candesartan cilexetil after both single and repeated once - daily tablet intake , indicating linear pharmacokinetics in both younger and elderly healthy subjects ."], "par_relations": ["candesartan", "Antihypertensive Agents", "Benzimidazoles", "Tetrazoles", "Angiotensin II Type 1 Receptor Blockers"], "chd_relations": ["candesartan"], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "RXNORM:1189258", "canonical_name": "Alanine / Arginine / Glycine / Histidine / Isoleucine / Leucine / Lysine / Magnesium Chloride / Methionine / Phenylalanine / Potassium Chloride / Proline / Serine / Sodium Chloride / Sodium Phosphate, Dibasic / Threonine / Tryptophan / Tyrosine / Valine Injectable Solution [Aminosyn 7 % with Electrolytes, Sulfite-Free]", "aliases": ["alanine / arginine / glycine / histidine / isoleucine / leucine / lysine / magnesium chloride / methionine / phenylalanine / potassium chloride / proline / serine / sodium chloride / sodium phosphate, dibasic / threonine / tryptophan / tyrosine / valine injectable solution [aminosyn 7 % with electrolytes, sulfite-free]"], "definition": "", "other_contexts": [], "par_relations": ["Alanine / Arginine / Glycine / Histidine / Isoleucine / Leucine / Lysine / Magnesium Chloride / Methionine / Phenylalanine / Potassium Chloride / Proline / Serine / Sodium Chloride / Sodium Phosphate, Dibasic / Threonine / Tryptophan / Tyrosine / Valine Injectable Solution", "Aminosyn 7 % with Electrolytes, Sulfite-Free Injectable Product"], "chd_relations": ["Aminosyn 7 % with Electrolytes, Sulfite-Free (alanine 9 MG/ML / arginine 6.9 MG/ML / glycine 9 MG/ML / histidine 2.1 MG/ML / isoleucine 5.1 MG/ML / leucine 6.6 MG/ML / lysine 5.1 MG/ML / magnesium chloride 0.005 MEQ/ML / methionine 2.8 MG/ML / phenylalanine 3.1 MG/ML / potassium chloride 0.065 MEQ/ML / proline 6.1 MG/ML / serine 3 MG/ML / sodium chloride 0.00479 MEQ/ML / sodium phosphate, dibasic 0.0299 MEQ/ML / threonine 3.7 MG/ML / tryptophan 1.2 MG/ML / tyrosine 0.44 MG/ML / valine 5.6 MG/ML) Injectable Solution"], "syn_relations": [], "sib_relations": ["Injectable Solution", "Aminosyn 7 % with Electrolytes, Sulfite-Free"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C010071", "canonical_name": "benzocaine, butyl aminobenzoate, tetracaine drug combination", "aliases": ["benzocaine, butyl aminobenzoate, tetracaine drug combination", "cetacaine", "benzocaine - butyl aminobenzoate - tetracaine"], "definition": "", "other_contexts": [], "par_relations": ["benzocaine, butyl aminobenzoate, tetracaine drug combination", "Anesthetics", "Benzalkonium Compounds", "Benzocaine", "Cetrimonium Compounds", "Drug Combinations", "Tetracaine"], "chd_relations": ["benzocaine, butyl aminobenzoate, tetracaine drug combination"], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "RXNORM:891373", "canonical_name": "LTA", "aliases": ["lta"], "definition": "", "other_contexts": ["We have investigated the ability of LTAs to stimulate human monocytes by using highly pure and structurally intact preparations of pneumococcal LTA and its two structural variants .", "Both Btk and PI3 K were activated by LTA stimulation and the LTA induced cytokine expression was differentially modulated by these kinases .", "In conclusion , LTA is a potent activator of human neutrophil cytokine generation , with the synthesis of the chemokine IL-8 being largely dependent on TNF - alpha generation in an autocrine fashion .", "Meanwhile , LTA also increased nitric oxide ( NO ) and PGE2 production in microglia .", "LTA and LPS mediated activation of protein kinases in the regulation of inflammatory cytokines expression in macrophages .", "This study was further aimed to evaluate the effects of propofol on LTA - induced iNOS gene expression in macrophages and its possible molecular mechanisms .", "Treatment of macrophages with LTA - induced iNOS mRNA and protein productions .", "CONCLUSIONS The LTA challenge provoked a dramatic release of cytokines , with an early appearance of TNF - alpha and IL-1beta and a delayed liberation of IL-8 .", "Bruton 's tyrosine kinase together with PI 3-kinase are part of Toll - like receptor 2 multiprotein complex and mediate LTA induced Toll - like receptor 2 responses in macrophages .", "Although Bruton 's tyrosine kinase ( Btk ) is biologically important molecule implicated in immune regulation and recently in TLR signaling its importance for LTA - TLR2 mediated responses has not been evaluated .", "Intact pneumococcal LTA and LTA-1 stimulated PBMC and CHO / CD14/TLR2 cells in a dose - dependent manner but did not stimulate CHO / CD14/TLR4 cells .", "Lipoteichoic acid ( LTA ) , a cell wall component of Gram - positive bacteria is an amphiphilic , negatively charged glycolipid .", "Although LTA is much less reported than that on LPS , LTA is regarded as the gram - positive equivalent to LPS in some aspects .", "In contrast , IL1-beta was not involved in LTA - induced IL-8 generation .", "The results showed that LL-37 was upregulated after LTA treatment .", "Stimulation with LPS or LTA resulted in a significantly decreased activation of p38 MAPK in neonatal compared with adult blood .", "It could inhibit LTA induced p38MAPK and Akt phosphorylation and attenuate TNF-α and IL-6 production in macrophages in some specific concentration .", "Moreover , LTA - induced increases of κB - DNA and AP-1-DNA binding activity were inhibited by p38 , JNK , and PI3-kinase inhibitors .", "LTA - mediated increase of AP-1 and NF - kappaB luciferase activity was inhibited by rottlerin and PP2 or TLR2 and PKCdelta siRNA or c - Src mutant .", "RESULTS Src , Lyn and MAPKs are involved in LTA and LPS signaling in murine macrophages .", "However , only NF-κB inhibitors reduced LTA - induced HO-1 expression in microglia .", "Although LTA failed to induce additional ERK1/2 phosphorylation , LPS stimulation mediated the moderately increased levels of activated ERK1/2 in neonatal monocytes .", "LTA induced inducible nitric oxide synthase ( iNOS ) and cyclooxygenase-2 ( COX-2 ) protein levels increase in a concentration- and time - dependent manner .", "Using antibodies that neutralize the activity of Toll - like receptor 2 ( TLR2 ) or 4 ( TLR4 ) , we also show that CD14-dependent , LTA - induced neutrophil activation did not proceed via TLR2- or TLR4-mediated pathways .", "LPS- and LTA - Induced Expression of IL-6 and TNF-α in Neonatal and Adult Blood : Role of MAPKs and NF-κB", "We also found that LTA - induced iNOS and COX-2 up - regulation were attenuated by p38 , JNK , and PI3-kinase inhibitors .", "The variants were pneumococcal LTA with only one acyl chain ( LTA-1 ) and completely deacylated LTA ( LTA-0 ) .", "However , antibodies to CD14 , TLR1 , or TLR2 suppressed tumor necrosis factor alpha ( TNF - alpha ) production by PBMCs in response to LTA or LTA-1 .", "We investigated the LTA - induced signal transduction and biological effects , as well as to compare the effect of LTA with that of LPS .", "The addition of the p38 MAPK inhibitor SB202190 significantly decreased IL-6 and TNF-α production upon LPS or LTA stimulation .", "LPS and LTA increased intracellular Ca²⁺ concentrations while Ca²⁺ chelation by BAPTA decreased LPS- and LTA - mediated cytokine responses .", "However , focal adhesion kinase ( FAK ) mutant and siRNA did not affect LTA - mediated IL-6 production .", "Co - treatment with propofol and TLR2 siRNA synergistically ameliorated LTA - induced iNOS mRNA expression and nitrite production .", "Excess teichoic acid , LTA-0 , antibodies to phosphocholine , or antibodies to TLR4 did not inhibit the LTA - induced TLR2 stimulation .", "Lipoteichoic acid ( LTA ) , an outer membrane component of Gram - positive bacteria , can induce septic shock .", "Lipoteichoic acid ( LTA ) of Gram - positive bacteria initiates innate immune responses via Toll - like receptor-2 ( TLR2 ) , resulting in the activation of intracellular signaling and production of inflammatory cytokines in macrophages .", "We assessed the ability of aMØs after brief exposure to acidified saline to elaborate proinflammatory cytokines in response to lipopolysaccharide ( LPS ) and lipoteichoic acid ( LTA ) stimulation , known ligands of TLR4 and TLR2 , respectively .", "Administration of TLR2 antagonist effectively inhibited LTA - induced NO , iNOS , and COX-2 expression .", "BAPTA blocked the effects of low pH stress on most of LPS - stimulated cytokines but not of LTA - stimulated responses .", "Whereas lipopolysaccharides ( LPSs ) are acknowledged as the principal immunostimulatory components of Gram - negative bacteria , the effect of the Gram - positive cell wall component lipoteichoic acid ( LTA ) is less well characterized .", "This LTA - induced effect was inhibited by IL-10 , dependent on CD14 , and independent of TLR 2 or 4 .", "Treatment of cells with NF-κB and AP-1 inhibitors antagonized LTA - induced iNOS and COX-2 expression .", "Pretreatment with PKCdelta inhibitor ( rottlerin ) , c - Src inhibitor ( PP2 ) , AP-1 inhibitor ( tanshinone IIA ) and NF - kappaB inhibitor ( PDTC and TPCK ) also inhibited the potentiating action of LTA .", "Analyses by an electrophoretic mobility shift and reporter gene further showed that propofol could alleviate LTA - induced transactivation of NFkappaB. Sequentially , propofol decreased phosphorylation of IKK , ERK1/2 , MEK1/2 , and Raf in LTA - stimulated macrophages .", "LTA induced the activation of nuclear factor kappaB ( NFkappaB ) , however , only Btk inhibition affected the LTA induced Ser536 phosphorylation and DNA - binding of NFkappaB.", "These results suggest that pneumococcal LTA with one or both acyl chains stimulates PBMCs primarily via TLR2 with the help of CD14 and TLR1 .", "In parallel , exposure to LTA increased translocation of nuclear factor - kappa B ( NFkappaB ) from the cytoplasm to nuclei .", "Low pH stress reduced LPS- and LTA - mediated cytokine release ( CINC-1 , MIP-2 , TNF-α , MCP-1 , and IFN-β ) .", "HO-1 activator CoPP IX dramatically reversed LTA - induced iNOS expression .", "Antimicrobial peptide LL-37 attenuates LTA induced inflammatory effect in macrophages .", "Our results provided mechanisms linking LTA and inflammation / anti - inflammation , and indicated that LTA plays a regulatory role in microglia activation .", "In the present study , we investigated the effect of highly purified LTA from Staphylococcus aureus on cytokine generation by isolated human neutrophils .", "We investigated the interaction between proinflammatory and inflammatory responses caused by Staphylococcus aureus - derived lipoteichoic acid ( LTA ) in primary cultured microglial cells and BV-2 microglia .", "BACKGROUND Lipoteichoic acid ( LTA ) and lipopolysaccharide ( LPS ) , the toxicants from bacteria , are potent inducers of inflammatory cytokines , such as tumor necrosis factor - alpha ( TNF ) and interleukin-1beta ( IL-1 ) .", "The role of Ca²⁺ in low pH stress - induced signaling is complex but appears to be distinct between LPS- and LTA - mediated responses .", "The present study is to investigate the role of LL-37 in LTA induced inflammatory reaction in macrophages .", "Pneumococcal LTA was about 100-fold less potent than Staphylococcus aureus LTA in stimulating the CHO / CD14/TLR2 cells and PBMCs .", "LTA increased the accumulation of p - c - Jun and p - p65 in the nucleus , as well as AP-1 and NF - kappaB luciferase activity .", "The first phase of IL-8 production was induced directly by LTA , whereas the second phase was endogenously mediated by TNF - alpha , as it was largely abrogated by neutralizing anti - TNF - alpha antibodies .", "When investigating the mechanism of LTA - induced cellular activation , activity - neutralizing antibodies demonstrated that CD14 was involved in LTA - mediated neutrophil cytokine generation .", "Stimulation of cells with LTA increased the PKCdelta and c - Src phosphorylation and kinase activity .", "As nuclear factor kappa B ( NF-κB ) and mitogen - activated protein kinases ( MAPKs ) seem to be critical mediators in the inflammatory response , we studied the effects of lipopolysaccharide ( LPS ) and lipoteichoic acid ( LTA ) on ( a ) the activation of NF-κB and MAPKs and ( b ) the expression of tumor necrosis factor alpha ( TNF-α ) and interleukin 6 ( IL-6 ) with or without the specific inhibitors of these intracellular signal transduction pathways in neonatal cord and adult blood . TNF-α and IL-6 concentrations showed a sharp increase in the supernatants of cord and adult whole blood after stimulation .", "LTA - mediated IL-6 production was attenuated by Toll - like receptor 2 ( TLR2 ) monoclonal antibody or siRNA .", "Even though pneumococcal LTA is structurally distinct from the LTA of other gram - positive bacteria , the immunological properties of pneumococcal LTA have not been well characterized .", "On the other hand , LTA - enhanced HO-1 expression was attenuated by p38 and PI3-kinase inhibitors .", "Application of toll - like receptor 2 ( TLR2 ) small interference ( si)RNA decreased the translation of this receptor and Raf phosphorylation in LTA - stimulated macrophages .", "Low pH Environmental Stress Inhibits LPS and LTA - Stimulated Proinflammatory Cytokine Production in Rat Alveolar Macrophages Gastric aspiration increases the risks for developing secondary bacterial pneumonia .", "Exposure of macrophages to LTA increased production of nitrite and intracellular reactive oxygen species , but propofol reduced such enhancements in concentration- and time - dependent manners .", "Pneumococcal lipoteichoic acid ( LTA ) is not as potent as staphylococcal LTA in stimulating Toll - like receptor 2 .", "Lipoteichoic acid ( LTA ) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent , Toll - like - receptor - independent mechanism : Autocrine role of tumor necrosis factor-[alpha ] in mediating LTA - induced interleukin-8 generation .", "Meanwhile , propofol at a clinically relevant concentration of 50 microM significantly inhibited LTA - caused augmentations of iNOS mRNA and protein syntheses .", "Moreover , treatment of cells with LTA caused a time - dependent activation of ERK , p38 , JNK , as well as AKT ."], "par_relations": ["Lidocaine", "Lidocaine Hydrochloride"], "chd_relations": [], "syn_relations": [], "sib_relations": ["LTA 360 4 % Mucous Membrane Topical Solution", "Lidocaine Hydrochloride 40 MG/ML [LTA]", "Lidocaine Mucous Membrane Topical Solution [LTA]", "LTA Mucosal Product"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:D003711", "canonical_name": "Demyelinating Diseases", "aliases": ["demyelinations", "demyelination", "clinically isolated cns demyelinating syndrome", "clinically isolated syndrome, cns demyelinating", "demyelinating disease", "demyelinating dis", "demyelinating diseases", "demyelinating disorder", "demyelinating disorders"], "definition": "Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system. The first region-restricted episode of CNS inflammatory demyelination in a patient. It is usually characterized by an acute monosymptomatic presentation of the optic nerves, brainstem, or spinal cord. It may not reoccur (isolated), or it may progress to MULTIPLE SCLEROSIS.", "other_contexts": ["In the cohort analysis, there was no increased risk of multiple sclerosis (crude incidence rates, 6.12 events/100,000 person-years [95% CI, 4.86-7.69] and 21.54 events/100,000 person-years [95% CI, 20.90-22.20] for the vaccinated and unvaccinated periods; adjusted rate ratio, 0.90 [95% CI, 0.70-1.15]) or other demyelinating diseases (crude incidence rates, 7.54 events/100,000 person-years [95% CI, 6.13-9.27] and 16.14 events/100,000 person-years [95% CI, 15.58-16.71]; adjusted rate ratio, 1.00 [95% CI, 0.80-1.26]) associated with qHPV vaccination.", "In the Danish anti-TNFα IBD cohort, 4 out of 651 patients developed demyelinating disorders after anti-TNFα treatment.", "The authors aimed to compare the opening pressures of children with demyelinating disease to children with primary intracranial hypertension .", "is frequent , can occur early and is highly inflammatory , and is specific to demyelinating disease .", "and is a suitable pharmacological model for reproducing some key features of demyelinating diseases , including multiple sclerosis .", "During follow - up , 4322 multiple sclerosis cases and 3300 cases of other demyelinating diseases were identified , of which 73 and 90 , respectively , occurred within the risk period .", "cuprizone - induced demyelination is a good experimental approach to study demyelinating diseases that has maintained its validity , and is a suitable pharmacological model for reproducing some", "OBJECTIVE To evaluate the prevalence of and associated factors impacting vitamin D insufficiency and deficiency in childhood versus adult-onset demyelinating disease.", ", suggesting age at disease onset is irrelevant to vitamin D status in demyelinating disease . Both race and obesity are independent factors associated with vitamin D insufficiency /", "Most importantly, administration of type I interferons to IFNγ-deficient mice during the innate immune response decreased the virus load in the CNS and decreased development of demyelinating disease.", "The focus of this review will be the current data on the antibodies mentioned above, and the recent discovery that some children have both a demyelinating disorder and autoimmune encephalitis.", "These results demonstrate that activating or enhancing the innate immune response can reduce the subsequent initiation and progression of the autoimmune response and demyelinating disease.", "Medical records were reviewed for a primary diagnosis of demyelinating disease , or primary intracranial hypertension .", "in HSE , AD and non - neurologic controls . Inflammation was greater in the demyelinating diseases compared to non - neurologic controls . Olfactory bulb / tract axonal loss was most severe in MS", "IMPORTANCE Case reports have suggested a link between human papillomavirus ( HPV ) vaccination and development of multiple sclerosis and other demyelinating diseases .", "Administration of IFN - beta , but not IFN - alpha , to TMEV- infected mice led to reduced myelin - specific CD4(+ ) T cell responses and reduced demyelinating disease , which was associated with decreased immune cell infiltration into the CNS and increased expression of IL-10 in the CNS .", "The mean cerebrospinal fluid white blood cell count was higher in the demyelinating disease group compared to primary intracranial hypertension ( P = .0002 ) .", "In addition , administration of poly(I : C ) , which is an innate immune agonist , to TMEV - infected mice during the innate immune response resulted in decreased myelin - specific CD4(+ ) T cell responses and reduced demyelinating disease .", "Olfactory Pathology in Central Nervous System Demyelinating Diseases.", "TMEV - infected mice depleted of CD11b(+)Ly6C(+ ) cells during the innate immune response developed a reduced demyelinating disease which was associated with a decreased myelin - specific CD4(+ ) T cell response and a decreased inflammatory immune response in the CNS .", "Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.", "Therefore , the cuprizone model allows to partially mimic the disease relapses of some demyelinating diseases .", "TMEV infection of resistant C57BL6 mice results in viral clearance without development of demyelinating disease.", "Five decades of cuprizone, an updated model to replicate demyelinating diseases.", "changes , impairs motor skills and affects mood as that observed in several demyelinating diseases . Upon cuprizone removal , the pathological and histological changes gradually revert . Therefore ,", "Olfactory bulb and tract pathology in MS and other demyelinating diseases remain unexplored.", "vitamin D insufficiency and deficiency in childhood versus adult - onset demyelinating disease . METHODS We conducted a retrospective , cross - sectional , chart - review , cohort study on", "TMEV infection of susceptible mice leads to a persistent virus infection of the central nervous system (CNS), which promotes the development of demyelinating disease associated with an inflammatory immune response in the CNS.", "Conversely , administration of antiserum to IFN - beta led to a more severe demyelinating disease .", "sclerosis and may have a role in the development of childhood - onset demyelinating disease .", "Among both comparisons, the cerebrospinal fluid opening pressure, glucose, protein and red blood cell counts in children with demyelinating disease were comparable to age- and sex-matched controls with primary intracranial hypertension.", "The primary outcomes were multiple sclerosis and a composite end point of other demyelinating diseases.", "We provide unequivocal evidence that olfactory bulb / tract demyelination is frequent , can occur early and is highly inflammatory , and is specific to demyelinating disease .", "- similar pediatric , young adult , and adult patients with a diagnosis of demyelinating disease identified at the University of Virginia from 2008 to 2013 . Group prevalence of vitamin D", "More recently, antibodies to myelin oligodendrocyte glycoprotein (MOG) have been described in children and adults diagnosed with NMOSD and seronegative for AQP4 antibodies, as well as in children with other acquired demyelinating disorders.", "Similarly , no increased risk was found using the self - controlled case - series design ( multiple sclerosis : incidence ratio , 1.05 [ 95% CI , 0.79 - 1.38 ] ; other demyelinating diseases : incidence ratio , 1.14 [ 95% CI , 0.88 - 1.47 ] ) .", "Interestingly, TMEV infection of resistant mice deficient in IFNγ leads to a persistent virus infection in the CNS and development of demyelinating disease.", "A human autopsy cohort of pathologically confirmed cases encompassing the spectrum of demyelinating disease ( MS ; n = 17 ) , neuromyelitis optica [ ( NMO ) ; n = 3 ] and acute disseminated encephalomyelitis [ ( ADEM ) ; n = 7 ] was compared to neuroinflammatory [ herpes simplex virus encephalitis ( HSE ) ; n = 3 ] , neurodegenerative [ Alzheimer 's disease ( AD ) ; n = 4 ] and non - neurologic ( n = 8) controls .", "INTRODUCTION It remains uncertain whether patients with inflammatory bowel disease ( IBD ) are at increased risk of developing demyelinating diseases , primarily multiple sclerosis ( MS ) and whether the introduction of biologic drugs in the treatment of IBD has altered this risk .", "TMEV - infected mice develop a demyelinating disease with clinical symptoms beginning around 35 days after infection , which is associated with development of myelin - specific , PLP(139 - 151 ) , CD4(+ ) T cell responses .", "These results suggest that CD11b(+)Ly6C(+ ) cells which infiltrate into the CNS during the innate immune response are myeloid - derived suppressor cells that suppress virus - specific T cell responses and contribute to the development of demyelinating disease .", "Cuprizone exposure also provokes behavioral changes, impairs motor skills and affects mood as that observed in several demyelinating diseases.", "We have previously shown that the innate immune response can affect the development and progression of demyelinating disease .", "First, patients with a first demyelinating event who are MOG antibody positive are unlikely to develop multiple sclerosis (MS); and second, the long-term persistence of MOG antibodies associates with recurrent non-MS demyelinating disorders such as NMOSD, recurrent optic neuritis or transverse myelitis, or multiphasic ADEM.", "Vitamin D status and age of onset of demyelinating disease.", ". TMEV infection of susceptible mice leads to a persistent virus infection of the CNS which contributes to development of demyelinating disease.", "In summary, the model of cuprizone-induced demyelination is a good experimental approach to study demyelinating diseases that has maintained its validity, and is a suitable pharmacological model for reproducing some key features of demyelinating diseases, including multiple sclerosis.", "MS and ADEM cases . Olfactory bulb / tract demyelination was frequent in all demyelinating diseases [ MS 12/17 ( 70.6% ) ; ADEM 3/7 ( 42.9% ) ; NMO 2/3 ( 66.7% ) ] but was absent in HSE , AD and non", "Antibodies in acquired demyelinating disorders in children The discovery that several demyelinating disorders in children may be associated with autoantibodies to astrocytes, myelin, and/or synaptic proteins has opened the possibility of their use as diagnostic and prognostic biomarkers.", "We examined the effect of the innate immune response on development of autoimmune demyelinating disease by altering the innate immune response through administration of innate immune cytokines, IFN-alpha or IFN-beta, or antiserum against the type I IFNs during the innate immune response to TMEV.", ", the cuprizone model allows to partially mimic the disease relapses of some demyelinating diseases . In summary , the model of cuprizone - induced demyelination is a good experimental approach to", "Multiple sclerosis (MS) is a human CNS autoimmune demyelinating disease.", "These results suggest that IFNγ plays an important role in the innate immune response to TMEV by enhancing the expression of innate immune cytokines , especially type I interferons , which directly affects the development of demyelinating disease .", "CONCLUSIONS Our findings demonstrate no difference in the prevalence of vitamin D insufficiency / deficiency between childhood and adult - onset demyelinating disease , suggesting age at disease onset is irrelevant to vitamin D status in demyelinating disease .", "RESULTS Four studies on the risk of demyelinating diseases in IBD were identified .", "Occurrence of demyelinating diseases after anti - TNFα treatment of inflammatory bowel disease : A Danish Crohn Colitis Database study .", "Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease is a relevant mouse model for the study of multiple sclerosis", "The authors compared 14 children with demyelinating disease to children with primary intracranial hypertension in 1:1 and 1:2 fashions.", "IFNγ influences type I interferon response and susceptibility to Theiler 's virus - induced demyelinating disease .", "DESIGN , SETTING , AND PARTICIPANTS Using nationwide registers we identified a cohort of all females aged 10 years to 44 years in Denmark and Sweden , followed up from 2006 to 2013 , information on qHPV vaccination , and data on incident diagnoses of multiple sclerosis and other demyelinating diseases .", "CONCLUSIONS AND RELEVANCE In this study with nationwide coverage of 2 Scandinavian countries, qHPV vaccination was not associated with the development of multiple sclerosis or other demyelinating diseases.", "OBJECTIVE To investigate if quadrivalent HPV ( qHPV ) vaccination is associated with an increased risk of multiple sclerosis and other demyelinating diseases .", "autopsy cohort of pathologically confirmed cases encompassing the spectrum of demyelinating disease ( MS ; n = 17 ) , neuromyelitis optica [ ( NMO ) ; n = 3 ] and acute disseminated", "Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease serves as a relevant mouse model for MS.", "Obesity , independent of gender , is significantly higher in children compared to adult patients diagnosed with multiple sclerosis and may have a role in the development of childhood - onset demyelinating disease .", "Comparison of Cerebrospinal Fluid Opening Pressure in Children With Demyelinating Disease to Children With Primary Intracranial Hypertension .", "METHODS We conducted a retrospective , cross - sectional , chart - review , cohort study on geographically - similar pediatric , young adult , and adult patients with a diagnosis of demyelinating disease identified at the University of Virginia from 2008 to 2013 .", "Theiler 's murine encephalomyelitis virus ( TMEV ) induces a demyelinating disease in susceptible SJL mice that has similarities to multiple sclerosis in humans .", "Diagnosis of demyelinating disease was made according to either the 2007 or 2012 International Pediatric Multiple Sclerosis Study Group criteria .", "A systematic MEDLINE literature search was conducted, medical files were scrutinized for identification and description of cohort patients with demyelinating disease, and risk of MS was calculated as a standardized morbidity ratio (SMR) using general population data for comparison.", "sclerosis ( MS ) . Olfactory bulb and tract pathology in MS and other demyelinating diseases remain unexplored . A human autopsy cohort of pathologically confirmed cases encompassing the", "Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.", "Therefore , we wanted to determine what role these cells play in development and progression of demyelinating disease .", "of vitamin D insufficiency / deficiency between childhood and adult - onset demyelinating disease , suggesting age at disease onset is irrelevant to vitamin D status in demyelinating disease .", "é syndrome , peripheral nerve polyneuropathy and others comprise a group of demyelinating diseases characterized by progressive ( and eventually irreversible ) loss of oligodendrocytes and myelin", "CONCLUSION The literature review revealed an up to four - fold increased risk of demyelinating diseases , in particular MS , in IBD patients in general .", "Olfactory bulb / tract demyelination was frequent in all demyelinating diseases [ MS 12/17 ( 70.6% ) ; ADEM 3/7 ( 42.9% ) ; NMO 2/3 ( 66.7% ) ] but was absent in HSE , AD and non - neurologic controls .", "Multiple sclerosis is a demyelinating disease associated with an inflammatory immune response in the CNS .", "Other antibodies , such as those targeting Kir 4.1 or the glycine receptor have also been described in association with pediatric MS and other demyelinating disorders but their clinical relevance , and existence , in the case of Kir 4.1 , is still under investigation .", "AIM AND METHODS The aim was to conduct a systematic review of literature on occurrence of demyelinating diseases in IBD patients, to assess a national Danish anti-TNFα treated IBD cohort in order to search for and describe the IBD cases with coexisting demyelinating diseases, and finally to compare the occurrence of MS in the anti-TNFα cohort to the occurrence in the general Danish population.", "Inflammation was greater in the demyelinating diseases compared to non-neurologic controls.", "These findings do not support concerns about a causal relationship between qHPV vaccination and demyelinating diseases .", "The presence of antibodies against targets related to demyelinating disorders (AQP4 or MOG) and those related to autoimmune encephalitis (e.g., N-methyl-D-aspartate receptor), supports the concurrence of two autoimmune disorders in these patients.", "The innate immune response affects the development of the autoimmune response in Theiler 's virus - induced demyelinating disease .", "We have previously shown that the innate immune response affects development of TMEV- induced demyelinating disease, thus we wanted to determine the role of IFNγ during the innate immune response.", "Multiple sclerosis, Guillain-Barré syndrome, peripheral nerve polyneuropathy and others comprise a group of demyelinating diseases characterized by progressive (and eventually irreversible) loss of oligodendrocytes and myelin sheaths in the white matter of the brain."], "par_relations": ["Demyelinating Diseases", "Nervous System Diseases", "Demyelinating Diseases"], "chd_relations": ["Demyelinating Diseases", "Leukoencephalopathy, Progressive Multifocal", "Polyradiculoneuropathy", "Myelinolysis, Central Pontine", "Ophthalmoplegic Migraine", "Subacute Combined Degeneration", "Marchiafava-Bignami Disease", "Demyelinating Autoimmune Diseases, CNS", "Hereditary Central Nervous System Demyelinating Diseases", "Groll Hirschowitz syndrome", "CAMFAK syndrome", "Hypotonia, congenital nystagmus, ataxia and abnormal auditory brainstem response", "Hamano Tsukamoto syndrome", "Boylan Dew Greco syndrome", "Demyelinating Diseases"], "syn_relations": ["Demyelinating Diseases", "Demyelinating Diseases", "Demyelinating Diseases", "Demyelinating Diseases", "Demyelinating Diseases", "Demyelinating Diseases", "Demyelinating Diseases", "Demyelinating Diseases"], "sib_relations": ["Central Nervous System Diseases", "Cranial Nerve Diseases", "Nervous System Neoplasms", "Neurologic Manifestations", "Neuromuscular Diseases", "Restless Legs Syndrome", "Neurotoxicity Syndromes", "Chronobiology Disorders", "Neurocutaneous Syndromes", "Nervous System Malformations", "Neurodegenerative Diseases", "Trauma, Nervous System", "Autoimmune Diseases of the Nervous System", "Autonomic Nervous System Diseases", "Sleep Wake Disorders"]}, "target_ent": {"research_entity_id": "OMIM:MTHU027444", "canonical_name": "Allelic disorders with overlapping phenotypes include Charcot-Marie-Tooth disease type 1 (CMT1B, 118200 and CMT1A, 118220) and Dejerine-Sottas syndrome (DSS, 145900)", "aliases": ["allelic disorders with overlapping phenotypes include charcot-marie-tooth disease type 1 (cmt1b, 118200 and cmt1a, 118220) and dejerine-sottas syndrome (dss, 145900)"], "definition": "", "other_contexts": [], "par_relations": ["MISCELLANEOUS"], "chd_relations": [], "syn_relations": [], "sib_relations": ["ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C496932", "canonical_name": "panobinostat", "aliases": ["farydak", "2-propenamide, n-hydroxy-3-(4-(((2-(2-methyl-1h-indol-3-yl)ethyl)amino) methyl)phenyl)-, (2e)-", "lbh 589", "lbh589", "panobinostat", "nvp-lbh589"], "definition": "", "other_contexts": ["CONCLUSION Panobinostat represents an important addition to the treatment armamentarium for patients with rrMM, and studies are underway evaluating its optimal dosing strategy and role in combination with other drugs used to treat this patient population.", "of the anti - angiogenic therapeutic effect of the pan - deacetylase inhibitor panobinostat by small animal PET in a mouse model of gastrointestinal cancers . INTRODUCTION Deacetylase", "III data obtained in the PANORAMA trial program for evaluation of the combination of panobinostat , bortezomib , and dexamethasone . Additional clinical trials have continued to explore optimal", "combination with bortezomib and dexamethasone in the treatment of rrMM . Approval of panobinostat was based on subgroup analysis of Phase III data obtained in the PANORAMA trial program for", "Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma Panobinostat, a potent pan-deacetylase inhibitor, improved progression-free survival (PFS) in patients with relapsed and refractory multiple myeloma when combined with bortezomib and dexamethasone in a phase 3 trial, PANORAMA-1.", "enzyme inducer should be avoided in future trials to prevent further reduction of panobinostat exposure .", "reduced tumor growth in vitro and in vivo . Mechanistically , we identified that panobinostat - but not gefitinib - inhibited TAZ transcription , and the combination of panobinostat and", "and the metabolites are either fecally or renally excreted with trace amount of intact panobinostat . Both cytochrome p450 ( CYP ) 3A4 and non - CYP mechanisms govern the clearance of panobinostat .", "-32 ) and by Western blot applying specific markers of apoptosis . RESULTS In vitro , panobinostat inhibited the proliferation of HepG2 and HT29 cells . Contrary to the situation in HepG2 tumors in", "Panobinostat plasma concentration–", "Apparent panobinostat exposure–AE and exposure–ORR relationships were observed when combined with bortezomib and dexamethasone in the treatment of patients with relapsed and refractory multiple myeloma.", "Panobinostat PK data from combination trials were contrasted with data from single-agent studies.", "myelomas and also shows potentiality in NSCLC . However , the therapeutic efficacy of panobinostat against gefitinib - resistant NSCLC is unclear . In this study , we demonstrated that panobinostat", "Mechanistically, we identified that panobinostat-but not gefitinib-inhibited TAZ transcription, and the combination of panobinostat and gefitinib synergistically downregulated TAZ and TAZ downstream targets, including EGFR and EGFR ligand.", "In this study, we demonstrated that panobinostat overcame resistance to gefitinib in KRAS-mutant/EGFR-wild-type NSCLC.", "approved histone deacetylase ( HDAC ) inhibitor . 2 . The pharmacokinetic data of panobinostat in patients with hematologic malignancies and advanced solid tumors have been collated and", "using small animal positron emission tomography ( PET ) . METHODS The effect of panobinostat on cell viability in vitro was assessed with a label - free impedance based real - time analysis .", "Overall survival data are not yet mature, although at the time of this analysis, median overall survival was 33·64 months (95% CI 31·34-not estimable) for the panobinostat group and 30·39 months (26·87-not estimable) for the placebo group (HR 0·87, 95% CI 0·69-1·10; p=0·26).", "total frequency of latently infected resting CD4 + T cells . Our data indicate that panobinostat treatment resulted in systemic increases in cellular levels of histone acetylation , a key", ", obtained from various clinical studies do not appear to limit the utility of panobinostat in the clinic .", "govern the clearance of panobinostat . CYP3A4-related drug - drug interactions with panobinostat have been documented with ketoconazole ( inhibitor ) and dexamethasone ( inducer ) . 4 . In", "Panobinostat has shown a manageable safety profile characterized primarily by hematologic toxicities (thrombocytopenia, neutropenia, lymphopenia, and anemia), gastrointestinal toxicities, notably diarrhea and nausea, as well as fatigue/asthenia, electrolyte abnormalities, and less commonly cardiac toxicities.", "In this article, we describe the in vitro and in vivo efficacy of a novel water-soluble nano-micellar formulation of panobinostat designed for administration by convection enhanced delivery (CED).", "panobinostat induces histone acetylation in human PBMCs . Further , we showed that panobinostat induced HIV RNA expression and allowed the outgrowth of replication - competent virus ex vivo from", "Patients were randomly assigned ( 1:1 ) via an interactive web - based and voice response system , stratified by number of previous treatment lines and by previous use of bortezomib , to receive 21 day cycles of placebo or panobinostat ( 20 mg ; on days 1 , 3 , 5 , 8 , 10 , 12 , orally ) , both in combination with bortezomib ( 1·3 mg / m(2 ) on days 1 , 4 , 8 , 11 , intravenously ) and dexamethasone ( 20 mg on days 1 , 2 , 4 , 5 , 8 , 9 , 11 , 12 , orally ) .", "INTERPRETATION Our results suggest that panobinostat could be a useful addition to the treatment armamentarium for patients with relapsed or relapsed and refractory multiple myeloma .", "Thus, PET imaging of angiogenesis using 2-[(18)F]FGlc-RGD could be a valuable tool to monitor panobinostat therapy in further preclinical studies.", ", electrolyte abnormalities , and less commonly cardiac toxicities . CONCLUSION Panobinostat represents an important addition to the treatment armamentarium for patients with rrMM , and", "Addition of the caspase-8 inhibitor z-IETD-FMK abolished the Sp1 reduction not only by panobinostat alone but also by its combination with bortezomib, suggesting caspase-8-mediated Sp1 degradation.", "After oral administration, most of the administered dose is extensively metabolized and the metabolites are either fecally or renally excreted with trace amount of intact panobinostat.", "vitro and in vivo efficacy of a novel water - soluble nano - micellar formulation of panobinostat designed for administration by convection enhanced delivery ( CED ) . MATERIALS AND METHODS The in", "At maximum tolerated dose (MTD), the geometric mean of panobinostat area under curve from 0 to 24 h (AUC0-24) was 47.5 ng h/mL (77 % CV), and maximum plasma concentration (Cmax) was 8.1 ng/mL (90 % CV).", "In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection The latent reservoir in resting CD4+ T cells presents a major barrier to HIV cure.", "RESULTS In vitro, panobinostat inhibited the proliferation of HepG2 and HT29 cells.", "However, panobinostat did not affect the levels of cell-associated HIV RNA, HIV DNA, or latently infected resting CD4+ T cells.", "MATERIALS AND METHODS The in vitro efficacy of panobinostat - loaded nano - micelles against rat F98 , human U87-MG and M059 K glioma cells and against patient - derived glioma stem cells was measured using a cell viability assay .", ", patient care strategies , and role of the agent in treating rrMM patients . RESULTS Panobinostat belongs to the class of drugs known as histone deacetylase inhibitors , and has high activity", "METHODS The effect of panobinostat on cell viability in vitro was assessed with a label-free impedance based real-time analysis.", "ADVANCES IN KNOWLEDGE AND IMPLICATIONS FOR PATIENT CARE When successfully translated to the clinical surrounding, PET imaging of angiogenesis could therefore facilitate therapy planning and monitoring of therapy success with panobinostat in hepatocellular carcinoma.", "The proportion of patients achieving an overall response did not differ between treatment groups (235 [60·7%, 95% CI 55·7-65·6] for panobinostat vs 208 [54·6%, 49·4-59·7] for placebo; p=0·09); however, the proportion of patients with a complete or near complete response was significantly higher in the panobinostat group than in the placebo group (107 [27·6%, 95% CI 23·2-32·4] vs 60 [15·7%, 12·2-19·8]; p=0·00006).", "to further clarify the optimal role of panobinostat in the arsenal of drugs for rrMM . Panobinostat has shown a manageable safety profile characterized primarily by hematologic toxicities (", "agents . Here , we have investigated the in vitro and systemic in vivo effect of panobinostat , a clinically relevant HDACi , on HIV latency . We showed that panobinostat induces histone", "The pharmacokinetic data of panobinostat in patients with hematologic malignancies and advanced solid tumors have been collated and reviewed from the various published clinical studies for over a decade.", "Panobinostat induced activation of caspase-8, which was inversely correlated with reduction of Sp1 protein levels in MM cells.", "days in cycle 2 , leading to selection of 25 mg lenalidomide on days 1 to 21 and 15 mg panobinostat TIW for the phase II dose . In all 24 patients , Grade 3 to 4 toxicities consisted of neutropenia (", "Panobinostat is a recently approved histone deacetylase (HDAC) inhibitor.", "CONCLUSION CED of nano-micellar panobinostat represents a potential novel therapeutic option for malignant glioma and warrants translation into the clinic.", "of the caspase-8 inhibitor z - IETD - FMK abolished the Sp1 reduction not only by panobinostat alone but also by its combination with bortezomib , suggesting caspase-8-mediated Sp1 degradation .", "Contrary to the situation in HepG2 tumors in vivo , where panobinostat treatment is known to reduce proliferation and vascularization resulting in a decreased tumor growth , HT29 tumors did not show any effect on these parameters .", "with that of untreated and vehicle - only - treated controls . RESULTS Nano - micellar panobinostat is cytotoxic to rat and human glioma cells in vitro in a dose - dependent manner following short -", "Median duration of response (partial response or better) was 13·14 months (95% CI 11·76-14·92) in the panobinostat group and 10·87 months (9·23-11·76) in the placebo group, and median time to response (partial response or better) was 1·51 months (1·41-1·64) in the panobinostat group and 2·00 months (1·61-2·79) in the placebo group.", "We compared the survival of the bioluminescent syngenic F98/Fischer344 rat glioblastoma model treated by acute CED of panobinostat-loaded nano-micelles with that of untreated and vehicle-only-treated controls.", "of HepG2 and HT29 cells . Contrary to the situation in HepG2 tumors in vivo , where panobinostat treatment is known to reduce proliferation and vascularization resulting in a decreased tumor", "of Sp1 , a critical transcription factor for myeloma cell growth and survival , by panobinostat and proteasome inhibitors Panobinostat , a pan - deacetylase inhibitor , synergistically elicits", "combination with the proteasome inhibitor bortezomib . Because precise mechanisms for panobinostat 's anti - MM action still remain elusive , we aimed to clarify the mechanisms of anti - MM effects", "injections of 10mg/kg panobinostat for 4 weeks.", "levels of histone acetylation , a key biomarker for in vivo activity . However , panobinostat did not affect the levels of cell - associated HIV RNA , HIV DNA , or latently infected resting CD4", "Further perspectives and anticipated challenges in the clinical therapy with panobinostat are discussed in the review.", "are discussed in the review . 3 . Regardless of intravenous or oral dosing , panobinostat showed a high degree of inter - patient variability in the pharmacokinetics . After oral", "not show any effect on these parameters . We demonstrated by Western blotting , that panobinostat induced apoptosis in HT29 tumors in vivo . Longitudinal PET imaging studies in HepG2 tumor -", "FINDINGS 768 patients were enrolled between Jan 21, 2010, and Feb 29, 2012, with 387 randomly assigned to panobinostat, bortezomib, and dexamethasone and 381 to placebo, bortezomib, and dexamethasone.", "dosing regimens and novel combination regimens to further clarify the optimal role of panobinostat in the arsenal of drugs for rrMM . Panobinostat has shown a manageable safety profile", "3 trial , PANORAMA-1 . This study aims to explore exposure – response relationship for panobinostat in this combination in a phase 1 trial , B2207 and contrast with data from historical single -", "Next , we demonstrated that panobinostat induced systemic histone acetylation in vivo in the tissues of BLT humanized mice .", ". No DLTs were observed but 2 patients who received 25 mg lenalidomide and 20 mg panobinostat experienced neutropenia and thrombocytopenia > 14 days in cycle 2 , leading to selection of 25 mg", "Administration was not associated with any toxicity when compared to controls . CED of panobinostat - loaded nano - micelles was associated with significantly improved survival when compared to", "This study aims to explore exposure – response relationship for panobinostat in this combination in a phase 1 trial , B2207 and contrast with data from historical single - agent studies .", "effect of panobinostat , a clinically relevant HDACi , on HIV latency . We showed that panobinostat induces histone acetylation in human PBMCs . Further , we showed that panobinostat induced HIV RNA", "We therefore investigated the effect of the pan - deacetylase inhibitor panobinostat ( LBH589 ) on gastrointestinal cancer models and the suitability of 2-[(18)F]FGlc - RGD as a specific agent for imaging integrin αvβ3 expression during tumor angiogenesis using small animal positron emission tomography ( PET ) .", "BACKGROUND Panobinostat is a potent oral pan-deacetylase inhibitor that in preclinical studies has synergistic anti-myeloma activity when combined with bortezomib and dexamethasone.", "imaging of angiogenesis using 2-[(18)F]FGlc - RGD could be a valuable tool to monitor panobinostat therapy in further preclinical studies . ADVANCES IN KNOWLEDGE AND IMPLICATIONS FOR PATIENT CARE", "in the treatment of relapsed or relapsed and refractory multiple myeloma : impact of panobinostat , the first - in - class histone deacetylase inhibitor BACKGROUND Panobinostat is a new agent for", "response on post - mortem histological examination . CONCLUSION CED of nano - micellar panobinostat represents a potential novel therapeutic option for malignant glioma and warrants translation into", "were 3.8 and 16.4 months , respectively . CONCLUSION Although the combination of panobinostat and lenalidomide appears safe in patients with relapsed / refractory HL , the limited efficacy and", "single - agent studies . At maximum tolerated dose ( MTD ) , the geometric mean of panobinostat area under curve from 0 to 24 h ( AUC0 - 24 ) was 47.5 ng h / mL ( 77 % CV ) , and maximum plasma", "Panobinostat is a clinically available histone deacetylase inhibitor for treating myelomas and also shows potentiality in NSCLC.", ", a novel histone deacetylase ( HDAC ) inhibitor : review and perspectives . 1 . Panobinostat is a recently approved histone deacetylase ( HDAC ) inhibitor . 2 . The pharmacokinetic data of", "However, the therapeutic efficacy of panobinostat against gefitinib-resistant NSCLC is unclear.", ") and dexamethasone ( inducer ) . 4 . In summary , the clinical pharmacokinetic data of panobinostat , a promising HDAC inhibitor , obtained from various clinical studies do not appear to limit the", "We demonstrated by Western blotting , that panobinostat induced apoptosis in HT29 tumors in vivo .", "Overall response rates ( ORR ) and major adverse events ( AE ) by panobinostat exposure were investigated in the B2207 trial .", "resistance to gefitinib in KRAS - mutant / EGFR - wild - type NSCLC . Combined panobinostat and gefitinib synergistically reduced tumor growth in vitro and in vivo . Mechanistically , we", "Combination with a strong enzyme inducer should be avoided in future trials to prevent further reduction of panobinostat exposure.", "Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial.", "Minimal responses were noted in 23 (6%) patients in the panobinostat group and in 42 (11%) in the placebo group.", "The addition of dexamethasone facilitated best response even though plasma exposure of panobinostat was reduced.", "study using HT29 tumor - bearing animals did not reveal any response of the tumors to panobinostat treatment . CONCLUSIONS Small - animal PET imaging using 2-[(18)F]FGlc - RGD was successfully", "available . We therefore investigated the effect of the pan - deacetylase inhibitor panobinostat ( LBH589 ) on gastrointestinal cancer models and the suitability of 2-[(18)F]FGlc - RGD as a", "Clinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitor BACKGROUND Panobinostat is a new agent for the treatment of relapsed and refractory multiple myeloma (rrMM) as part of a combination regimen.", "Collectively , caspase-8-mediated post - translational Sp1 degradation appears to be among major mechanisms for synergistic anti - MM effects of panobinostat and proteasome inhibitors in combination .", "patients on suppressive antiretroviral therapy ( ART ) . Next , we demonstrated that panobinostat induced systemic histone acetylation in vivo in the tissues of BLT humanized mice . Finally , in", ". Finally , in HIV - infected , ART - suppressed BLT mice , we evaluated the effect of panobinostat on systemic cell - associated HIV RNA and DNA levels and the total frequency of latently infected", "of panobinostat , the first - in - class histone deacetylase inhibitor BACKGROUND Panobinostat is a new agent for the treatment of relapsed and refractory multiple myeloma ( rrMM ) as part of a", "could therefore facilitate therapy planning and monitoring of therapy success with panobinostat in hepatocellular carcinoma .", "Both cytochrome p450 (CYP) 3A4 and non-CYP mechanisms govern the clearance of panobinostat.", ". Both cytochrome p450 ( CYP ) 3A4 and non - CYP mechanisms govern the clearance of panobinostat . CYP3A4-related drug - drug interactions with panobinostat have been documented with ketoconazole", "1 degradation appears to be among major mechanisms for synergistic anti - MM effects of panobinostat and proteasome inhibitors in combination .", "TAZ and TAZ downstream targets , including EGFR and EGFR ligand . Inhibition of TAZ by panobinostat or short hairpin RNA sensitized KRAS - mutant / EGFR - wild - type NSCLC to gefitinib through", "In the phase I trial, previously treated patients with classical or lymphocyte-predominant HL received escalating doses of lenalidomide on days 1 to 21 and panobinostat 3 times a week (TIW) every 28 days.", ". Thus , new strategies have emerged for targeting KRAS downstream signaling . Panobinostat is a clinically available histone deacetylase inhibitor for treating myelomas and also shows", "We showed that panobinostat induces histone acetylation in human PBMCs.", "bearing HT29 and HepG2 tumors were treated with daily i.p . injections of 10mg / kg panobinostat for 4 weeks . During this time , tumor size was determined with a calliper and mice were", "A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma.", "Combined panobinostat and gefitinib synergistically reduced tumor growth in vitro and in vivo.", "Panobinostat sensitizes KRAS-mutant non-small-cell lung cancer to gefitinib by targeting TAZ. Mutation of KRAS in non-small-cell lung cancer (NSCLC) shows a poor response to epidermal growth factor receptor (EGFR) inhibitors and chemotherapy.", "- predominant HL received escalating doses of lenalidomide on days 1 to 21 and panobinostat 3 times a week ( TIW ) every 28 days . Dose - limiting toxicity ( DLT ) was defined during cycle 1", "in Patients With Relapsed or Refractory Hodgkin Lymphoma . BACKGROUND Lenalidomide and panobinostat have shown single - agent efficacy of 14% to 50% and 27% to 58% , respectively , in Hodgkin", "RESULTS Nano - micellar panobinostat is cytotoxic to rat and human glioma cells in vitro in a dose - dependent manner following short - time exposure to drug .", "maximum tolerated dose ( MTD ) , safety , and efficacy of lenalidomide combined with panobinostat in relapsed / refractory HL . PATIENTS AND METHODS In the phase I trial , previously treated", "Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model BACKGROUND The pan-histone deacetylase inhibitor panobinostat is a potential therapy for malignant glioma, but it is water insoluble and does not cross the blood-brain barrier when administered systemically.", "CYP3A4-related drug-drug interactions with panobinostat have been documented with ketoconazole (inhibitor) and dexamethasone (inducer).", "terameprocol induced MM cell death in parallel with reduction of IRF4 and cMyc . Panobinostat induced activation of caspase-8 , which was inversely correlated with reduction of Sp1 protein", "Here , we have investigated the in vitro and systemic in vivo effect of panobinostat , a clinically relevant HDACi , on HIV latency .", "successfully applied to the non - invasive monitoring of the HepG2-tumor response to panobinostat in nude mice early after begin of treatment . Thus , PET imaging of angiogenesis using 2-[(18)F]", "Median progression-free survival was significantly longer in the panobinostat group than in the placebo group (11·99 months [95% CI 10·33-12·94] vs 8·08 months [7·56-9·23]; hazard ratio [HR] 0·63, 95% CI 0·52-0·76; p<0·0001).", "Because precise mechanisms for panobinostat's anti-MM action still remain elusive, we aimed to clarify the mechanisms of anti-MM effects of panobinostat and its synergism with proteasome inhibitors.", "Regardless of intravenous or oral dosing, panobinostat showed a high degree of inter-patient variability in the pharmacokinetics.", "Although the combination of panobinostat and lenalidomide appears safe in patients with relapsed / refractory HL , the limited efficacy and significant rates of neutropenia and febrile neutropenia observed do not support further evaluation of this combination in HL .", "response rates and higher incidences of diarrhea and thrombocytopenia . Apparent panobinostat exposure – AE and exposure – ORR relationships were observed when combined with bortezomib and", "The panobinostat-mediated effects were further potentiated to effectively induce MM cell death in combination with bortezomib or carfilzomib even at suboptimal concentrations as a single agent.", "phase 1 trial , B2207 and contrast with data from historical single - agent studies . Panobinostat plasma concentration – time profiles were obtained in patients from PANORAMA-1 ( n = 12 ) and B2207", "against gefitinib - resistant NSCLC is unclear . In this study , we demonstrated that panobinostat overcame resistance to gefitinib in KRAS - mutant / EGFR - wild - type NSCLC . Combined", "Further, we showed that panobinostat induced HIV RNA expression and allowed the outgrowth of replication-competent virus ex vivo from resting CD4+ T cells of HIV-infected patients on suppressive antiretroviral therapy (ART).", "We aimed to compare panobinostat, bortezomib, and dexamethasone with placebo, bortezomib, and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma.", "bioluminescent syngenic F98/Fischer344 rat glioblastoma model treated by acute CED of panobinostat - loaded nano - micelles with that of untreated and vehicle - only - treated controls . RESULTS", "Clinical pharmacokinetics of panobinostat, a novel histone deacetylase (HDAC) inhibitor: review and perspectives. 1.", "The comparative PET study using HT29 tumor-bearing animals did not reveal any response of the tumors to panobinostat treatment.", "- agent trials , likely due to enzyme induction by dexamethasone . Higher levels of panobinostat exposure were associated with higher response rates and higher incidences of diarrhea and", "still remain elusive , we aimed to clarify the mechanisms of anti - MM effects of panobinostat and its synergism with proteasome inhibitors . Although the transcription factor Sp1 was", "CED of panobinostat-loaded nano-micelles was associated with significantly improved survival when compared to controls (n=8 per group; log-rank test, P<0.001).", "RESULTS Panobinostat belongs to the class of drugs known as histone deacetylase inhibitors, and has high activity against Class I, II, and IV nonhistone deacetylases and histone deacetylases.", "BACKGROUND Lenalidomide and panobinostat have shown single-agent efficacy of 14% to 50% and 27% to 58%, respectively, in Hodgkin lymphoma (HL).", "and dexamethasone in patients with relapsed and relapsed / refractory multiple myeloma Panobinostat , a potent pan - deacetylase inhibitor , improved progression - free survival ( PFS ) in patients", "4 + T cells . We have demonstrated robust levels of systemic histone acetylation after panobinostat treatment of BLT humanized mice ; and we did not observe a detectable change in the levels of cell", "Additional clinical trials have continued to explore optimal dosing regimens and novel combination regimens to further clarify the optimal role of panobinostat in the arsenal of drugs for rrMM.", "Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors Panobinostat, a pan-deacetylase inhibitor, synergistically elicits cytotoxic activity against myeloma (MM) cells in combination with the proteasome inhibitor bortezomib.", "This phase I/II study was conducted to determine the maximum tolerated dose (MTD), safety, and efficacy of lenalidomide combined with panobinostat in relapsed/refractory HL.", "adverse events ( AE ) by panobinostat exposure were investigated in the B2207 trial . Panobinostat PK data from combination trials were contrasted with data from single - agent studies . At maximum", "No DLTs were observed but 2 patients who received 25 mg lenalidomide and 20 mg panobinostat experienced neutropenia and thrombocytopenia > 14 days in cycle 2 , leading to selection of 25 mg lenalidomide on days 1 to 21 and 15 mg panobinostat TIW for the phase II dose .", "for myeloma cell growth and survival , by panobinostat and proteasome inhibitors Panobinostat , a pan - deacetylase inhibitor , synergistically elicits cytotoxic activity against myeloma ( MM )", "The addition of dexamethasone facilitated best response even though plasma exposure of panobinostat was reduced . Combination with a strong enzyme inducer should be avoided in future trials to", "Approval of panobinostat was based on subgroup analysis of Phase III data obtained in the PANORAMA trial program for evaluation of the combination of panobinostat , bortezomib , and dexamethasone .", "7 ( n = 12 ) trials . Overall response rates ( ORR ) and major adverse events ( AE ) by panobinostat exposure were investigated in the B2207 trial . Panobinostat PK data from combination trials were", "In summary , the clinical pharmacokinetic data of panobinostat , a promising HDAC inhibitor , obtained from various clinical studies do not appear to limit the utility of panobinostat in the clinic .", "Inhibition of TAZ by panobinostat or short hairpin RNA sensitized KRAS-mutant/EGFR-wild-type NSCLC to gefitinib through abrogating AKT/mammalian target of rapamycin (mTOR) signaling.", "Serious adverse events were reported in 228 (60%) of 381 patients in the panobinostat group and 157 (42%) of 377 patients in the placebo group.", "Our data indicate that panobinostat treatment resulted in systemic increases in cellular levels of histone acetylation, a key biomarker for in vivo activity.", "Median follow-up was 6·47 months (IQR 1·81-13·47) in the panobinostat group and 5·59 months (2·14-11·30) in the placebo group.", "convection enhanced delivery ( CED ) . MATERIALS AND METHODS The in vitro efficacy of panobinostat - loaded nano - micelles against rat F98 , human U87-MG and M059 K glioma cells and against", "In vivo monitoring of the anti-angiogenic therapeutic effect of the pan-deacetylase inhibitor panobinostat by small animal PET in a mouse model of gastrointestinal cancers.", "CONCLUSIONS Small-animal PET imaging using 2-[(18)F]FGlc-RGD was successfully applied to the non-invasive monitoring of the HepG2-tumor response to panobinostat in nude mice early after begin of treatment.", "- but not gefitinib - inhibited TAZ transcription , and the combination of panobinostat and gefitinib synergistically downregulated TAZ and TAZ downstream targets , including EGFR and", ", which was inversely correlated with reduction of Sp1 protein levels in MM cells . The panobinostat - mediated effects were further potentiated to effectively induce MM cell death in combination", "Common grade 3-4 laboratory abnormalities and adverse events (irrespective of association with study drug) included thrombocytopenia (256 [67%] in the panobinostat group vs 118 [31%] in the placebo group), lymphopenia (202 [53%] vs 150 [40%]), diarrhoea (97 [26%] vs 30 [8%]), asthenia or fatigue (91 [24%] vs 45 [12%]), and peripheral neuropathy (67 [18%] vs 55 [15%]).", "Higher levels of panobinostat exposure were associated with higher response rates and higher incidences of diarrhea and thrombocytopenia.", "Finally, in HIV-infected, ART-suppressed BLT mice, we evaluated the effect of panobinostat on systemic cell-associated HIV RNA and DNA levels and the total frequency of latently infected resting CD4+ T cells.", "We have demonstrated robust levels of systemic histone acetylation after panobinostat treatment of BLT humanized mice; and we did not observe a detectable change in the levels of cell-associated HIV RNA, HIV DNA, or latently infected resting CD4+ T cells in HIV-infected, ART-suppressed BLT mice.", "in the F98 rat glioma model BACKGROUND The pan - histone deacetylase inhibitor panobinostat is a potential therapy for malignant glioma , but it is water insoluble and does not cross the", "decade . Further perspectives and anticipated challenges in the clinical therapy with panobinostat are discussed in the review . 3 . Regardless of intravenous or oral dosing , panobinostat showed a"], "par_relations": ["panobinostat", "Antineoplastic Agents", "Hydroxamic Acids", "Indoles", "Histone Deacetylase Inhibitors", "panobinostat"], "chd_relations": ["panobinostat", "panobinostat"], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "RXNORM:1162313", "canonical_name": "Promethazine Pill", "aliases": ["promethazine pill"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": ["Promethazine Hydrochloride 12.5 MG Oral Tablet", "Promethazine Hydrochloride 50 MG Oral Tablet", "Promethazine Hydrochloride 10 MG Oral Tablet", "Promethazine Hydrochloride 20 MG Oral Tablet", "Promethazine Hydrochloride 25 MG Oral Tablet", "Promethazine Oral Tablet", "Promethazine 28 MG Oral Tablet", "Promethazine 100 MG Oral Tablet", "Phenergan Nightime Pill", "Phenergan Pill", "Promacot Pill"], "syn_relations": [], "sib_relations": ["Promethazine", "Pill"]}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0001575", "canonical_name": "Mood changes", "aliases": ["mood changes", "mood alterations"], "definition": "", "other_contexts": [], "par_relations": ["Abnormal emotion/affect behavior"], "chd_relations": [], "syn_relations": ["Mood changes", "Mood changes"], "sib_relations": ["Depression", "Mood swings", "Emotional lability", "Anhedonia", "Emotional blunting", "Diminished motivation", "Happy demeanor", "Irritability", "Abnormal fear/anxiety-related behavior", "Conspicuously happy disposition", "Abnormal aggressive, impulsive or violent behavior"]}, "target_ent": {"research_entity_id": "OMIM:171800.0001", "canonical_name": "ALPP, MULTIPLE CHANGES", "aliases": ["alpp, multiple changes"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["ALKALINE PHOSPHATASE, PLACENTAL"], "sib_relations": ["ALKALINE PHOSPHATASE, PLACENTAL", "ALKALINE PHOSPHATASE, PLACENTAL"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:D017085", "canonical_name": "alpha-Thalassemia", "aliases": ["a-thalassemia", "hemoglobin h dis", "hemoglobin h disease", "alpha-thalassemia", "thalassemia alpha", "disease, hemoglobin h", "thalassemia, alpha", "alpha-thalassemias", "alpha thalassemia", "thalassemia-alpha"], "definition": "A disorder characterized by reduced synthesis of the alpha chains of hemoglobin. The severity of this condition can vary from mild anemia to death, depending on the number of genes deleted.", "other_contexts": ["Alpha thalassemia allelic frequency in Lebanon.", "quantified by high performance liquid chromatography and the influence of alpha thalassemia BACKGROUND In sickle cell disease , the quantification of Hb A2 is important for the differential", "HbSD with alpha thalassemia was associated with hypohromic and microcytic features of red blood cells.", "case of detecting -αMED instead of any other deletion from Pakistan . CONCLUSION Alpha thalassemia deletions ( -α3.7 , -α4.2 ) are the common co - inherited deletions found in beta thalassemia", "values for individuals with Hb SS and heterozygous ( n=28 ) or homozygous for alpha thalassemia ( n=3 ) were 3.98±0.64% and 4.73±0.25% , respectively . The mean Hb A2 of all the Hb SC patients (", "Furthermore, since in each family alpha thalassaemia was present in association with the gene for the sickle cell mutation we have determined the proportion of Hb S in the peripheral blood of individuals with the alpha alpha/alpha alpha, -alpha/alpha alpha and -alpha/-alpha genotype who are also heterozygous for the betas mutation.", "All patients homozygous for alpha thalassemia had Hb A2 levels above 3.5% .", "type . Analysis of variance was used to compare the mean Hb A2 values between the alpha thalassemia groups . RESULTS The mean ( ±standard deviation ) Hb A2 concentrations in the Hb SS group ( n=135 )", "This study has enabled us to clearly correlate the phenotype of alpha thalassaemia with the genotype in this population.", "OBJECTIVE To determine Hb A2 levels as quantified by high performance liquid chromatography in patients with sickle cell anemia (Hb SS) and with the SC hemoglobinopathy, with or without concomitant alpha thalassemia.", "Six different mutations of alpha thalassemia gene were identified.", "The hemoglobin was evaluated using high performance liquid chromatography and alpha thalassemia [3.7kb deletion (-α(3.7))] was detected by polymerase chain reaction.", "The homozygous alpha-thalassemia 2 showed similar red cell parameters to the alpha-thalassemia 1 trait.", "Molecular genetics of alpha thalassemia.", "In conclusion, we can screen the alpha-thalassemia 1 trait and homozygous alpha-thalassemia 2 by using the simple red cell parameters such as the MCV and RDW; however, they must be confirmed for alpha-thalassemic genes.", "Alpha thalassemia had no influence on the frequency of VOC and severity of hemolysis in HbSD.", "cases without any α and β mutations or deletions were made by using extended alpha thalassemia deletions panel . The main objective of this study was to determine the prevalence and to study", "Alpha thalassemia deletions found in suspected cases of beta thalassemia major in Pakistani population BACKGROUND & OBJECTIVE Alpha ( α ) thalassemia is a hereditary disorder and is caused by deletions or mutations in globin genes .", "RESULTS Co-inheritance of alpha thalassemia (-α3.7, -α4.2) with homozygous beta thalassemia was detected in 30% cases of studied cohort (37 out of 121).", "Red cell parameters in alpha-thalassemia with and without beta-thalassemia trait or hemoglobin E trait.", "are elevated in patients with Hb S or Hb C , and are directly influenced by the alpha thalassemia genotypes .", "There was no significant difference in the mean level of Hb A2 in alpha-thalassaemia heterozygotes (2.0+/0SD 0.6) compared with that of the control group (2.1+/0SD0.5).", "Decreased alpha globine mRNA in nucleated red cell precursors in alpha thalassemia.", "Qiagen extraction kit . The primers for determination of different subsets of alpha thalassemia deletions were included . PCR amplification was performed and result interpreted on agarose gel .", "Hemoglobin A2 values in sickle cell disease patients quantified by high performance liquid chromatography and the influence of alpha thalassemia BACKGROUND", "The most common deletion reported in alpha thalassemia in Pakistani population was -α3.7 with a frequency of 8.3%, and the rare forms were -α4.2 (0.2%) and αααanti3.7 (0.9%).", "Alpha thalassemia is the most common single gene mutation worldwide.", "Alpha-thalassaemia trait in various racial groups in the United Kingdom: characterization of a variant of alpha-thalassaemia in Indians.", "In Thailand there exists 15-30% alpha-thalassemia carriers distributed throughout the country.", "was performed and result interpreted on agarose gel . RESULTS Co - inheritance of alpha thalassemia ( -α3.7 , -α4.2 ) with homozygous beta thalassemia was detected in 30% cases of studied cohort ( 37", ". The hemoglobin was evaluated using high performance liquid chromatography and alpha thalassemia [ 3.7 kb deletion ( -α(3.7 ) ) ] was detected by polymerase chain reaction . Patients were", "Using a combination of techniques we identified two alpha thalassaemia phenotypes which resemble the severe (alpha thalassaemia 1) and mild (alpha thalassaemia 2) determinants previously described in Orientals.", "of this study was to determine the prevalence and to study the spectra of alpha thalassemia gene deletions in beta thalassemia patients with the use of an extended panel including --SEA , --", "for alpha thalassemia ( n=7 ) , respectively . All patients homozygous for alpha thalassemia had Hb A2 levels above 3.5% . However , Hb A2 values above 5.2% were seen in patients with Hb SS", "In alpha thalassemia trait cells, no such controls appeared to be active and globin chain synthesis was directly proportional to the amount of alpha and beta globin mRNA in the cells.", "The alpha-thalassemia 1 trait had heterogeneity in red cell population as shown by increased red cell distribution width (RDW), the increased percent microcytic red cell (%Micro) and decreased mean cell volume (MCV).", "In contrast, only one alpha-globin gene is deleted in alpha-thalassemia 2 of which two types have been detected, one involving a deletion of 4.2 kb of DNA (leftward type, -alpha 4.2) and another of 3.7 kb (rightward type, -alpha 3.7); the latter being more common than the former in Thailand.", "Reports of alpha thalassemia gene mutations from the Lebanese population are limited.", "Fetal hemoglobin and alpha thalassemia modulate the phenotypic expression of HbSD-Punjab.", "The total hemoglobin level and hematocrit were significantly high, and the MCV and MCH were significantly low in HbSD with alpha thalassemia.", "Patients with alpha-thalassaemia trait had a reduced rate of synthesis of the alpha-chains, with a mean alpha/beta specific activity ratio of 0.79+/-SD 0.07.", "The main objective of this study was to determine the prevalence and to study the spectra of alpha thalassemia gene deletions in beta thalassemia patients with the use of an extended panel including --SEA, --FIL, --MED, --20.5, --THAI in addition to -α3.7, -α4.2 & -αααanti3.7.", "CONCLUSION We determined the mutational spectrum of alpha thalassemia which might be used in the future for molecular investigations of the disease in susceptible patients in our population.", "Linked duplicate genes in Chromosome 16 condition the production not only of alpha-globin chains in the Hemoglobin A (HbA) molecule, but also of the varied forms of alpha thalassemia in human subjects.", "PROCEDURE We investigated the spectrum of alpha thalassemia mutations in a sample of 70 unrelated Lebanese families .", "This is the first sutdy to characterize alpha-thalassaemia trait in Indians, in whom it appears to be a common disorder.", "The number of alpha - globin chains in the HbA molecule , and the absence as well as the varied forms of alpha thalassemia are inherited quantitatively as follows : four alpha - globin chains and the absence of alpha thalassemia result from GbGbGcGc ; either GbGbGcOc or GbObGcGc yields three alpha - globin chains and asymptomatic alpha thalassemia minor ; any one of three genotypes , GbGbOcOc , GbObGcOc or ObObGcGc , yields two alpha - globin chains and mild alpha thalassemia minor ; either GbObOcOc or ObObGcOc yields one alpha - globin chain and severe alpha thalassemia minor ; ObObOcOc produces no alpha - globin chain and the fetal alpha thalassemia major .", "Further, we evaluated the influence of HbF concentration and alpha thalassemia on the phenotypic expressions of HbSD, namely the frequency of VOC and degree of hemolysis.", "anemia ( Hb SS ) and with the SC hemoglobinopathy , with or without concomitant alpha thalassemia . METHODS This is a retrospective study of 242 children aged between two and six years with", "The mean Hb A2 of all the Hb SC patients (n=107) was 4.01±0.507 with 4.29±0.41% and 4.91±0.22% in individuals heterozygous (n=23) and homozygous for alpha thalassemia (n=7), respectively.", "It is well established that Mediterranean and Arab countries are high risk areas for thalassemia in general, and for alpha thalassemia in particular.", "In our study, diagnosis of severe anemia cases without any α and β mutations or deletions were made by using extended alpha thalassemia deletions panel.", "thalassemia major patients . On the basis of results , we propose an extended alpha thalassemia genetic mutation panel should be used for screening of children presenting with anemia with", "CONCLUSION Hb A2 levels are elevated in patients with Hb S or Hb C, and are directly influenced by the alpha thalassemia genotypes.", "% of thalassemic chromosomes . CONCLUSION We determined the mutational spectrum of alpha thalassemia which might be used in the future for molecular investigations of the disease in susceptible", "Red cell parameters in alpha-thalassemia 2 trait and HbCS trait were not significantly different from normal.", "The molecular basis of alpha-thalassemia in Thailand.", "in a sample of 70 unrelated Lebanese families . Six different mutations of alpha thalassemia gene were identified . RESULTS The most prevalent mutations were the single gene deletion -α(3.7 )", ", and the MCV and MCH were significantly low in HbSD with alpha thalassemia . Alpha thalassemia had no influence on the frequency of VOC and severity of hemolysis in HbSD . CONCLUSION HbF", "of VOC but had no influence on the hemolytic markers in HbSD . HbSD with alpha thalassemia was associated with hypohromic and microcytic features of red blood cells .", "Comparison of data from patients with alpha- and beta-thalassaemia traits showed that alpha-thalssaemia trait is the milder disorder, in terms of its effects of red-cell morphology, red-cell indices and degree of globin chain imbalance. Amongst individual patients with alpha-thalassaemia trait, there was no correlation between the alpha/beta specific activity ratio and the red-blood-cell(RBC) d the red-blood-cell (RBC) count, mean corpuscular volume (MCV) and mean corpuscular haemoglobin (MCH).", "The cases with coinheritance of alpha-thalassemia trait with beta-thalassemia trait or with HbE trait showed variation in their red cell parameters: one case showed less abnormal red cell parameters than those of uncomplicated alpha-thalassemia but the other two cases showed unimproved values.", ", sex , and caste . Further , we evaluated the influence of HbF concentration and alpha thalassemia on the phenotypic expressions of HbSD , namely the frequency of VOC and degree of hemolysis .", "The genetics and molecular basis of alpha thalassaemia in association with Hb S in Jamaican Negroes. We have studied seven Jamaican Negro families in whom the genes for alpha thalassaemia and the sickle cell mutation (betas) were independently segregated.", "Restriction mapping data in the alpha thalassaemia 2 homozygotes from this population shows that the (-alpha/) haplotype results from a deletion of one of the linked pair of alpha globin genes and that this has probably arisen by an unequal crossover between non-homologous alpha genes.", "Haematologically, alpha-thalassaemia trait in Indians is milder than that seen in Chinese and the fact that haemoglobin Bart's hydrops fetalis does not occur in Indians makes it likely that the genetics of Indian alpha-thalassaemia differ from those of the Chinese disease.", "DNA analysis by Southern blot hybridization reveals that the two major alpha-thalassemia alleles, alpha-thalassemia 1 and alpha-thalassemia 2 have different extents of alpha-globin gene deletion.", "We have found no instances of the genotype --/alpha alpha in this population which may explain the rarity of the severe alpha thalassaemia syndromes in Jamaica.", "These results indicated that , in both HbH disease and alpha thalassemia trait , there was decreased alpha globin mRNA present in both nucleated red cell precursors and reticulocytes .", "2 values above 5.2% were seen in patients with Hb SS and Hb SC , independently of alpha thalassemia . CONCLUSION Hb A2 levels are elevated in patients with Hb S or Hb C , and are directly influenced", "On the basis of results, we propose an extended alpha thalassemia genetic mutation panel should be used for screening of children presenting with anemia with suspicion of haemoglobinopathy.", "Patients whose red-cell indices are suggestive of thalassaemia trait, but who have a normal haemoglobin electrophoretic pattern, may be carriers of alpha-thalassaemia.", "We found 45 cases out of 85 were alpha-thalassemia trait with A2A typing, 10 were normal, 7 were alpha-thalassemia trait complicated by beta-thalassemia trait or HbE trait, 18 were HbH disease or HbH with Hb Constant Spring (HbH/CS), and 5 were AE Bart's disease.", "for thalassemia in general , and for alpha thalassemia in particular . Reports of alpha thalassemia gene mutations from the Lebanese population are limited . PROCEDURE We investigated the spectrum", "The mean values for individuals with Hb SS and heterozygous ( n=28 ) or homozygous for alpha thalassemia ( n=3 ) were 3.98±0.64% and 4.73±0.25% , respectively .", "A possible genetic model for Indian alpha-thalassaemia is discussed and the identification of the homozygote is seen as the first step in the determination of the underlying molecular defect.", "CONCLUSION Alpha thalassemia deletions (-α3.7, -α4.2) are the common co-inherited deletions found in beta thalassemia major patients.", "4.29±0.41% and 4.91±0.22% in individuals heterozygous ( n=23 ) and homozygous for alpha thalassemia ( n=7 ) , respectively . All patients homozygous for alpha thalassemia had Hb A2 levels above 3.5%", "In the intact cells of two patients with alpha thalassemia trait, the alpha/beta ratios were also decreased and were similar in marrow cells and reticulocytes.", "The inheritance of any combination of active and null alleles, and of the associated forms of alpha thalassemia, is deducible from the alpha-globin as well as the disease phenotypes and/or genotypes of parental subjects.", "Upon interacting with alpha-thalassemia 1 gene they can lead to HbH disease.", "In alpha-thalassemia 1, approximately 20 kb of DNA including the two linked alpha 1-and alpha 2-genes are removed and only the alpha-globin gene is intact.", "A diagnosis of alpha-thalassaemia trait was made in 44 such patients, using the incorporation of [3H]leucine by reticulocytes to measure the relative rates of synthesis of the alpha- and beta-chains of adult haemoglobin.", "Compound heterozygosity for alpha-thalassemia 1 and alpha-thalassemia 2 results in HbH disease while homozygosity for alpha-thalassemia 1 leads to Hb Bart's hydrops fetalis, the most severe form of thalassemic disease.", "The primers for determination of different subsets of alpha thalassemia deletions were included.", "acid ( EDTA ) vacutainers . A total of 156 samples were analyzed for alpha thalassemia mutations . This cohort included 121 samples of beta thalassemia major , nine samples of beta", "The alpha thalassemias are associated with a decrease in alpha chain synthesis.", "Hemoglobin H ( HbH ) disease is a moderately severe form of alpha thalassemia characterized by the production of 5%--20% of HbH , while alpha thalassemia trait is a milder form of alpha thalassemia .", "Unfortunately, red cell parameters of alpha-thalassemia 2 trait or HbCS trait were not different from those of normal subjects.", "Analysis of variance was used to compare the mean Hb A2 values between the alpha thalassemia groups.", "and Arab countries are high risk areas for thalassemia in general , and for alpha thalassemia in particular . Reports of alpha thalassemia gene mutations from the Lebanese population are", "Genetic analysis in these families shows that in each case subjects with the alpha thalassaemia 1 phenotype are homozygous for the alpha thalassaemia 2 defect (-alpha/-alpha).", "were significantly high , and the MCV and MCH were significantly low in HbSD with alpha thalassemia . Alpha thalassemia had no influence on the frequency of VOC and severity of hemolysis in HbSD .", "the Lebanese population are limited . PROCEDURE We investigated the spectrum of alpha thalassemia mutations in a sample of 70 unrelated Lebanese families . Six different mutations of alpha", "The diagnostic value of the haemoglobin H(Hb H) preparation was assessed in proven alpha-thalassaemia heterozygotes of various races.", "However, Hb A2 values above 5.2% were seen in patients with Hb SS and Hb SC, independently of alpha thalassemia.", "A total of 156 samples were analyzed for alpha thalassemia mutations.", "- East Asia or Mediterranean countries . The most common deletion reported in alpha thalassemia in Pakistani population was -α3.7 with a frequency of 8.3% , and the rare forms were -α4.2 ( 0.2% )"], "par_relations": ["Thalassemia"], "chd_relations": ["Hydrops Fetalis", "Alpha-Thalassemia Myelodysplasia Syndrome", "Alpha-Thalassemia Mental Retardation Syndrome, Deletion-Type", "ATR-X syndrome"], "syn_relations": ["alpha-Thalassemia", "alpha-Thalassemia", "alpha-Thalassemia", "alpha-Thalassemia", "alpha-Thalassemia", "alpha-Thalassemia", "alpha-Thalassemia", "alpha-Thalassemia", "alpha-Thalassemia", "alpha-Thalassemia"], "sib_relations": ["Hemoglobin H", "beta-Thalassemia", "delta-Thalassemia"]}, "target_ent": {"research_entity_id": "OMIM:187550", "canonical_name": "THALASSEMIA, BETA+, SILENT ALLELE", "aliases": ["thalassemia, beta+, silent allele"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": [], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:3516", "canonical_name": "exostosin-like glycosyltransferase 2", "aliases": ["extl2 gene", "exostosin-like glycosyltransferase 2", "alpha-1,4-n-acteylhexosaminyltransferase", "extl2"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["exostosin-like glycosyltransferase 2", "exostosin-like glycosyltransferase 2"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:182380.0003", "canonical_name": "SLC5A1, ARG558HIS", "aliases": ["slc5a1, arg558his"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 1"], "sib_relations": ["SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 1"]}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0002970", "canonical_name": "Genu varum", "aliases": ["genua vara", "genu varum", "genu vara"], "definition": "A positional abnormality marked by outward bowing of the legs in which the knees stay wide apart when a person stands with the feet and ankles together. [HPO:probinson]", "other_contexts": [], "par_relations": ["Bowing of the legs", "Abnormality of the knee"], "chd_relations": ["Wind-swept deformity of the knees"], "syn_relations": ["Genu varum", "Genu varum", "Genu varum", "Genu varum"], "sib_relations": ["Knee dislocation", "Ankle clonus", "Knee flexion contracture", "Knee osteoarthritis", "Genu recurvatum", "Genu valgum", "Tibial bowing", "Limited knee flexion", "Limited knee extension", "Femoral bowing", "Absent knee epiphyses", "Limitation of knee mobility", "Abnormality of the patella", "Fibular bowing", "Hyperextensibility of the knee", "Flattened knee epiphyses", "Large knee"]}, "target_ent": {"research_entity_id": "OMIM:137370", "canonical_name": "GENU VALGUM, ST. HELENA FAMILIAL", "aliases": ["genu valgum, hereditary pubertal", "genu valgum, st. helena familial"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["GENU VALGUM, ST. HELENA FAMILIAL", "GENU VALGUM, ST. HELENA FAMILIAL"], "sib_relations": ["Autosomal dominant", "Genu valgum", "Malaligned elbows and wrists", "Hypoplasia of bony condyles of knees", "Degenerative osteoarthropathy, progressive", "Male-limited trait"]}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:23028", "canonical_name": "dipeptidase 2", "aliases": ["dpep2", "dipeptidase 2", "dpep2 gene"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["dipeptidase 2", "dipeptidase 2"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:609305", "canonical_name": "LATEXIN", "aliases": ["endogenous carboxypeptidase inhibitor", "lxn", "latexin", "eci", "tissue carboxypeptidase inhibitor", "tci"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["LATEXIN", "LATEXIN", "LATEXIN", "LATEXIN", "LATEXIN", "LATEXIN", "LATEXIN", "LATEXIN", "LATEXIN", "LATEXIN"], "sib_relations": []}}
{"label": 1, "source_ent": {"research_entity_id": "HGNC:HGNC:10942", "canonical_name": "solute carrier family 1 member 4", "aliases": ["slc1a4 gene", "asct1", "satt", "slc1a4", "solute carrier family 1 member 4", "alanine/serine/cysteine/threonine transporter"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["solute carrier family 1 member 4", "solute carrier family 1 member 4", "solute carrier family 1 member 4", "solute carrier family 1 member 4", "solute carrier family 1 member 4", "solute carrier family 1 member 4"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:600229", "canonical_name": "SOLUTE CARRIER FAMILY 1 (GLUTAMATE/NEUTRAL AMINO ACID TRANSPORTER), MEMBER 4", "aliases": ["spastic tetraplegia, thin corpus callosum, and progressive microcephaly", "asct1", "slc1a4", "solute carrier family 1 (glutamate/neutral amino acid transporter), member 4", "neutral amino acid transporter"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["SOLUTE CARRIER FAMILY 1 (GLUTAMATE/NEUTRAL AMINO ACID TRANSPORTER), MEMBER 4", "SOLUTE CARRIER FAMILY 1 (GLUTAMATE/NEUTRAL AMINO ACID TRANSPORTER), MEMBER 4", "SLC1A4, ARG457TRP", "SLC1A4, 2-BP DEL, 944TT", "SLC1A4, GLU256LYS (dbSNP rs201278558)", "SOLUTE CARRIER FAMILY 1 (GLUTAMATE/NEUTRAL AMINO ACID TRANSPORTER), MEMBER 4", "SOLUTE CARRIER FAMILY 1 (GLUTAMATE/NEUTRAL AMINO ACID TRANSPORTER), MEMBER 4", "SOLUTE CARRIER FAMILY 1 (GLUTAMATE/NEUTRAL AMINO ACID TRANSPORTER), MEMBER 4", "SOLUTE CARRIER FAMILY 1 (GLUTAMATE/NEUTRAL AMINO ACID TRANSPORTER), MEMBER 4"], "sib_relations": ["SLC1A4, ARG457TRP", "SLC1A4, 2-BP DEL, 944TT", "SLC1A4, GLU256LYS (dbSNP rs201278558)"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C565360", "canonical_name": "MASP2 Deficiency", "aliases": ["masp2 deficiency"], "definition": "", "other_contexts": [], "par_relations": ["Immunologic Deficiency Syndromes", "Mannose-Binding Protein-Associated Serine Proteases"], "chd_relations": [], "syn_relations": [], "sib_relations": ["deficiency"]}, "target_ent": {"research_entity_id": "OMIM:230800", "canonical_name": "GAUCHER DISEASE, TYPE I", "aliases": ["gba deficiency", "gd i", "glucocerebrosidase deficiency", "acid beta-glucosidase deficiency", "gaucher disease, type i", "gaucher disease, noncerebral juvenile"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["GAUCHER DISEASE, TYPE I", "GAUCHER DISEASE, TYPE I", "GAUCHER DISEASE, TYPE I", "GAUCHER DISEASE, TYPE I", "GAUCHER DISEASE, TYPE I", "GAUCHER DISEASE, TYPE I", "GAUCHER DISEASE, TYPE I", "GAUCHER DISEASE, TYPE I", "GAUCHER DISEASE, TYPE I", "GAUCHER DISEASE, TYPE I"], "sib_relations": ["Anemia", "Dyspnea", "Epistaxis", "Pathologic fractures", "Hepatomegaly", "Hypersplenism", "Pulmonary hypertension", "Osteonecrosis", "Pancytopenia", "Splenomegaly", "Thrombocytopenia", "Bone pain", "Hyperpigmentation", "Interstitial lung disease", "Vertebral compression", "Osteolytic lesions", "Avascular necrosis of femoral head", "Macular atrophy", "Autosomal recessive", "Erlenmeyer flask' deformity of the femurs", "Brown accumulation of Gaucher cells at corneoscleral limbus", "White deposits in corneal epithelium, anterior chamber angle, ciliary body, and pupillary margin", "Perimacular grayness", "Increased retinal vascular permeability", "Increased risk for multiple myeloma", "Increased risk for monoclonal gammopathy", "Bone crises", "Increased bone serum acid phosphatase", "Gaucher cells in the bone marrow", "Pulmonary infiltrates, diffuse (less than 5% of patients)", "Restrictive impairment", "Caused by mutation in the acid beta glucosidase gene (GBA, 606463.0001)", "Age at onset most often in childhood (first decade)", "Onset and diagnosis may occur later (after age 20 years)", "Highly variable phenotype, some adults may be asymptomatic", "Increased frequency in Ashkenazi Jews (carrier frequency 1 in 14)", "Acid beta-glucosidase deficiency"]}}
{"label": 1, "source_ent": {"research_entity_id": "MSH:D024482", "canonical_name": "Vitamin K 2", "aliases": ["menaquinones", "vitamin k a 02", "vitamin k2", "vitamin k 2", "vitamin k quinone", "menaquinone"], "definition": "A group of substances similar to VITAMIN K 1 which contains a ring of 2-methyl-1,4-naphthoquinione and an isoprenoid side chain of varying number of isoprene units. In vitamin K 2, each isoprene unit contains a double bond. They are produced by bacteria including the normal intestinal flora.", "other_contexts": ["0.85 to 1.40 , P(trend ) 0.41 ) for the highest versus lowest quartile . For intake of menaquinones similar results were found , with an HR(Q4 versus Q1 ) of 0.99 ( 95% CI : 0.75 to 1.29 , P(trend )", "in gut microbiota composition may provide a feasible approach for altering gut menaquinone content . This trial was registered at the Chinese Clinical Trials Registry as ChiCTR - TRC-0900035", "For intake of menaquinones similar results were found, with an HR(Q4 versus Q1) of 0.99 (95% CI: 0.75 to 1.29, P(trend) 0.82).", "composition and to improve cardiometabolic biomarkers . RESULTS Covariance among menaquinones within individual fecal samples partitioned individuals into 2 distinct groups , herein introduced", "Vitamin K2 Ameliorates Damage of Blood Vessels by Glucocorticoid : a Potential Mechanism for Its Protective Effects in Glucocorticoid - induced Osteonecrosis of the Femoral Head in a Rat Model Glucocorticoid has been reported to decrease blood vessel number and harm the blood supply in the femoral head , which is recognized to be an important mechanism of glucocorticoid - induced osteonecrosis of the femoral head ( ONFH ) .", "When cells were grown anaerobically with trimethylamine - N - oxide as the terminal electron acceptor , all the menaquinone mutants showed wild - type levels of CT reduction .", "We conclude that a derivative of DHNA , that is distinct from menaquinone , is involved in the reduction of CT by aerobically grown S. oneidensis MR-1 .", "However , factors influencing menaquinone biosynthesis by the gut microbiota and associations with cardiometabolic health have not been examined .", "The menB, menA and menG mutants are all blocked towards the end of the pathway, being unable to produce 1,4-dihydroxy-2-naphthoic acid (DHNA), demethyl-menaquinone and menaquinone , respectively.", "Disruption of o251 in a wild-type parental strain produced a mutant with defects in growth on succinate and in both ubiquinone and menaquinone synthesis.", "Studies investigating the association between phylloquinone intake and risk of stroke are scarce, and the relation with menaquinones has not been investigated to date.", "High dietary menaquinone intake is associated with reduced coronary calcification .", ": 0.75 to 1.29 , P(trend ) 0.82 ) . When specifying hemorrhagic and ischemic stroke or menaquinone subtypes , no significant associations were detected . CONCLUSION In our study , neither dietary", "important role in bone metabolism ; however , few studies have focused on the effect of Vitamin K2 on new vascular formation . Thus , this study aimed to investigate whether Vitamin K2 promoted new", ". OBJECTIVE The objective of this study was to identify associations between fecal menaquinone profiles , gut microbiota composition , and biomarkers of cardiometabolic health . DESIGN The", "CONCLUSIONS The FFQ is reproducible to rank subjects for phylloquinone and menaquinone intake.", "Vitamin K2 ( menaquinone ) Supplementation and its Benefits in Cardiovascular Disease , Osteoporosis , and Cancer Dr. Shuler serves on the editorial committee of the Marshall Journal of Medicine .", "Angiogenesis-related proteins both in EAhy926 and MG63 were also upregulated by Vitamin K2 when cotreated with dexamethasone.", "METHODS We investigated the association of intake of phylloquinone and menaquinone, including its subtypes (MK4-MK10), with coronary calcification in a cross-sectional study among 564 post-menopausal women.", "The distal heme center in Bacillus subtilis succinate : quinone reductase is crucial for electron transfer to menaquinone .", "The factor produced under anaerobic growth conditions is not a product of the menaquinone biosynthetic pathway.", "Plasma dpucMGP was negatively but weakly correlated with phylloquinone intake ( rs=-0.09 ( -0.18 ; -0.01 ) ) and long - chain menaquinones ( rs=-0.13 ( -0.21 ; -0.04 ) ) , but not with short - chain menaquinones ( rs=-0.04 ( -0.13 ; 0.05 ) ) .", "The relative validity of our FFQ, compared with 24HDR, to estimate intake of phylloquinone and short-chain menaquinones was low, but the relative validity for long-chain menaquinones was good.", "Thus , this study aimed to investigate whether Vitamin K2 promoted new blood vessel formation in the presence of glucocorticoids , both in vitro and in vivo .", "Collectively , Vitamin K2 has the ability to promote angiogenesis in vitro and to ameliorate vessels of the femoral head in glucocorticoid - treated rats in vivo , indicating that Vitamin K2 is a promising drug that may be used to prevent steroid - induced ONFH .", ", or inflammation . CONCLUSIONS These findings suggest that variability in fecal menaquinone content is predominantly determined by relatively few genera within the gut microbiota and that", "formation in the presence of glucocorticoids , both in vitro and in vivo . The effect of Vitamin K2 on viability , migration , in vitro tube formation , and VEGF , vWF , CD31 , KDR , Flt and PDGFB", "abundance of > 100 OTUs were associated with altered fecal content of ≥1 individual menaquinone . The strongest and most consistent relations were between Prevotella spp . and MK5 and MK11-MK13 ,", "The relative validity of our FFQ, compared with plasma phylloquinone and dpucMGP, was relatively low for both phylloquinone and menaquinone intake.", "Menaquinone at physiologic levels ( 0.01 μg / ml MH ) significantly increased ( p < 0.05 ) biofilm formation on plastic in a manner that was bacterial population size dependent .", "BACKGROUND Emerging evidence supports novel roles for vitamin K in cardiometabolic health, some of which may be unique to the bacterially synthesized vitamin K forms known as menaquinones.", "Menaquinone ’s effect on biofilm formation on fibronectin - coated surfaces appears to be regulated by sarA. These findings are the first to demonstrate that a vitamin at concentrations reported in humans affects S. aureus virulence - associated phenotypes .", "This review discusses the physiology of menaquinone, its clinical benefits in cardiovascular disease, osteoporosis, and cancer, and how it may interact with certain medications.", "Phylloquinone and menaquinone intake was estimated using a food-frequency questionnaire.", "In vitro studies showed that Vitamin K2 significantly protected endothelial cells from dexamethasone - induced apoptosis , promoted endothelial cell migration and in vitro tube formation .", "were detected . CONCLUSION In our study , neither dietary phylloquinone nor dietary menaquinones intake were associated with stroke risk .", "CONCLUSION In our study , neither dietary phylloquinone nor dietary menaquinones intake were associated with stroke risk .", "CONCLUSIONS These findings suggest that variability in fecal menaquinone content is predominantly determined by relatively few genera within the gut microbiota and that diet - mediated alterations in gut microbiota composition may provide a feasible approach for altering gut menaquinone content .", "The succinate : menaquinone reductases all contain two heme groups in the membrane anchor of the enzyme : a proximal heme ( heme b(P ) ) located close to the negative side of the membrane and a distal heme ( heme b(D ) ) located close to the positive side of the membrane .", "ONFH , medication that promotes both bone formation and angiogenesis would be ideal . Vitamin K2 has been revealed to play an important role in bone metabolism ; however , few studies have", "METHODS AND RESULTS We investigated the association between intake of phylloquinone and menaquinones and stroke in a prospective cohort of 35,476 healthy subjects.", "The results support a model in which menaquinone is reduced on the positive side of the membrane and the transmembrane electrochemical potential provides driving force for electron transfer from succinate via heme b(P ) and heme b(D ) to menaquinone .", "Long-chain menaquinones showed good relative validity (rs=0.60-0.69).", "Some enzymes in vivo reduce ubiquinone ( exergonic reaction ) whereas others reduce menaquinone ( endergonic reaction ) .", "Strains of Escherichia coli with mutations in the ubiE gene are not able to catalyze the carbon methylation reaction in the biosynthesis of ubiquinone (coenzyme Q) and menaquinone (vitamin K2), essential isoprenoid quinone components of the respiratory electron transport chain.", "Intake of Dietary Phylloquinone and Menaquinones and Risk of Stroke BACKGROUND Dietary vitamin K intake is thought to decrease the risk of cardiovascular disease (CVD) by reducing vascular calcification, although vitamin K is also involved in coagulation.", "This may be due to different effects of vitamin K(1 ) ( phylloquinone ) and vitamin K(2 ) ( menaquinone , MK ) , but few studies included both .", "The relative validity , compared with 24HDR , for intake of short - chain menaquinones were ranging between 0.30 and 0.34 .", "Neither individual menaquinones nor menaquinotypes were longitudinally associated with markers of glycemia, insulin resistance, or inflammation.", "The H113 M mutant enzyme contains heme b(D ) with raised midpoint potential and is impaired in electron transfer to menaquinone .", "A C - methyltransferase involved in both ubiquinone and menaquinone biosynthesis : isolation and identification of the Escherichia coli ubiE gene .", "The authors conclude that menaquinone supplementation has been shown to improve carboxylation of osteocalcin and matrix - Gla protein to their active forms , two proteins that possess important roles in calcium distribution .", "between phylloquinone intake and risk of stroke are scarce , and the relation with menaquinones has not been investigated to date . METHODS AND RESULTS We investigated the association between", "Menaquinone ( Vitamin K2 ) Enhancement of Staphylococcus aureus Biofilm Formation During infection , Staphylococcus aureus is exposed to exogenous menaquinone which is essential for the human blood clotting cascade .", "In cancer, menaquinone intake has been shown to reduce overall incidence and mortality; clinical trials have suggested that it may have a role in reducing recurrence and death from hepatocellular carcinoma.", "The effect of Vitamin K2 on viability , migration , in vitro tube formation , and VEGF , vWF , CD31 , KDR , Flt and PDGFB in EAhy926 incubated with or without dexamethasone were elucidated .", "In addition, menaquinone (0.05 4 μg/ml) significantly increased (p < 0.05) biofilm formation on fibronectin-coated surfaces for four MSSA strains and one MRSA strain by two to six-fold as compared to medium controls.", "In addition, blood vessels of the femoral head in rats administered with or without methylprednisolone and Vitamin K2 were evaluated using angiography and CD31 staining.", "Aerobically grown mutants unable to produce the menaquinone precursor DHNA (menF and menB mutants) showed a distinctly different CT transformation profile than mutants able to produce DHNA but unable to produce menaquinone (menA and menG mutants).", "K2 were evaluated using angiography and CD31 staining . In vitro studies showed that Vitamin K2 significantly protected endothelial cells from dexamethasone - induced apoptosis , promoted", "In osteoporosis , menaquinone has been shown in numerous randomized controlled trials to decrease the rate of bone loss at the lumbar spine and forearm and reduce the risk of fracture .", "The data presented identify the E. coli UbiE polypeptide and provide evidence that it is required for the C methylation reactions in both ubiquinone and menaquinone biosynthesis.", "Reproducibility and relative validity of a food frequency questionnaire to estimate intake of dietary phylloquinone and menaquinones.", "DESIGN The menaquinone profile and gut microbiota structure were periodically measured in fecal samples collected from 77 overweight Chinese adults who consumed a prescribed diet previously shown to alter gut microbiota composition and to improve cardiometabolic biomarkers.", ". Angiogenesis - related proteins both in EAhy926 and MG63 were also upregulated by Vitamin K2 when cotreated with dexamethasone . In vivo studies showed enhanced blood vessel volume and CD31-", "BACKGROUND/OBJECTIVES This study aims to investigate the reproducibility and relative validity of the Dutch food frequency questionnaire (FFQ), to estimate intake of dietary phylloquinone and menaquinones compared with 24-h dietary recalls (24HDRs) and plasma markers of vitamin K status.", "The effect of exogenous menaquinone on S. aureus phenotypic expression is not known .", "AND RESULTS We investigated the association between intake of phylloquinone and menaquinones and stroke in a prospective cohort of 35,476 healthy subjects . Information on occurrence of", "OBJECTIVE The objective of this study was to identify associations between fecal menaquinone profiles, gut microbiota composition, and biomarkers of cardiometabolic health.", "compared to rats treated with methylprednisolone only . Collectively , Vitamin K2 has the ability to promote angiogenesis in vitro and to ameliorate vessels of the femoral head in", "When specifying hemorrhagic and ischemic stroke or menaquinone subtypes, no significant associations were detected.", "Adequate menaquinone intakes could therefore be important to prevent cardiovascular disease.", "However , menaquinone had no effect on capsule production or cell - associated carotenoid levels .", ", some of which may be unique to the bacterially synthesized vitamin K forms known as menaquinones . However , factors influencing menaquinone biosynthesis by the gut microbiota and associations", "To test whether menaquinone affects expression of virulence-associated phenotypes, methicillin-sensitive (MSSA) and -resistant (MRSA) S. aureus strains (n = 8) were grown in the presence of menaquinone (0.001 12 μg/ml).", "The transformation of a strain harboring the ubiE401 mutation with o251 on an expression plasmid restored both the growth of this strain on succinate and its ability to synthesize both ubiquinone and menaquinone .", "A derivative of the menaquinone precursor 1,4-dihydroxy-2-naphthoate is involved in the reductive transformation of carbon tetrachloride by aerobically grown Shewanella oneidensis MR-1 Transformation of carbon tetrachloride ( CT ) by Shewanella oneidensis MR-1 has been proposed to involve the anaerobic respiratory - chain component menaquinone .", "Lastly , more research is needed to determine how menaquinone supplementation interacts with medications such as warfarin , bile - acid sequestrants , orlistat , mineral oil and CYP3A4 substrates .", "vessels of the femoral head in rats administered with or without methylprednisolone and Vitamin K2 were evaluated using angiography and CD31 staining . In vitro studies showed that Vitamin K2", "In the setting of cardiovascular disease , menaquinone intake has been shown to lower the risk of coronary calcification and coronary heart disease , and a randomized controlled trial has demonstrated that it can reduce arterial stiffness .", "To investigate this hypothesis a series of menaquinone mutants were constructed .", ", gut microbiota composition , and biomarkers of cardiometabolic health . DESIGN The menaquinone profile and gut microbiota structure were periodically measured in fecal samples collected from 77", "Fecal menaquinone profiles of overweight adults are associated with gut microbiota composition during a gut microbiota-targeted dietary intervention.", "MK9 and MK10 , and between Escherichia / Shigella spp . and MK8 . Neither individual menaquinones nor menaquinotypes were longitudinally associated with markers of glycemia , insulin resistance ,", "Heme b(D) is a distinctive feature of the succinate:menaquinone reductases, but the role of this heme in electron transfer to quinone has not previously been analyzed. His28 and His113 are the axial ligands to heme b(D) in Bacillus subtilis succinate:menaquinone reductase.", "Menaquinotypes were characterized by differences in menaquinone (MK) 5 and MK9-MK13 and differences in the relative abundance of several operational taxonomic units (OTUs) delineated at the species level, predominantly within the genera Prevotella spp. and Bacteroides spp.", "of Vitamin K2 on new vascular formation . Thus , this study aimed to investigate whether Vitamin K2 promoted new blood vessel formation in the presence of glucocorticoids , both in vitro and in vivo", "Abstract Vitamin K is known to play an essential role in the coagulation cascade; however, a growing body of research has found that a subtype of this vitamin, vitamin K2 (menaquinone), may have a beneficial effect in osteoporosis, cardiovascular disease, and cancer.", "The purpose of this article is to provide a comprehensive review of recent literature regarding menaquinone and its role in human health .", "The menF mutant is blocked at the start of the menaquinone biosynthetic pathway.", "Vitamin K2 has been revealed to play an important role in bone metabolism ; however , few studies have focused on the effect of Vitamin K2 on new vascular formation .", "CONCLUSION This study shows that high dietary menaquinone intake, but probably not phylloquinone, is associated with reduced coronary calcification.", "Our combined experimental data show that the heme b(D) center, into which we include a quinone binding site, is crucial for succinate:menaquinone reductase activity.", "However , in all clinical settings , more large randomized controlled trials are needed to definitively determine the clinical benefits of menaquinone supplementation , as many studies have failed to show any significant benefit .", "menaquinotypes of the human gut . Menaquinotypes were characterized by differences in menaquinone ( MK ) 5 and MK9-MK13 and differences in the relative abundance of several operational taxonomic", "synthesized vitamin K forms known as menaquinones . However , factors influencing menaquinone biosynthesis by the gut microbiota and associations with cardiometabolic health have not been", "RESULTS Covariance among menaquinones within individual fecal samples partitioned individuals into 2 distinct groups, herein introduced as menaquinotypes of the human gut.", "In B. subtilis the ubiE homolog is likely to be required for menaquinone biosynthesis and is located within the gerC gene cluster , known to be involved in spore germination and normal vegetative growth .", "Menaquinone intake was associated with decreased coronary calcification with an RR of 0.80 ( 95%-CI : 0.65 - 0.98 ; p(trend)=0.03 ) .", "vessels of the femoral head in glucocorticoid - treated rats in vivo , indicating that Vitamin K2 is a promising drug that may be used to prevent steroid - induced ONFH .", "Fecal MK4 , MK6 , and MK8 decreased during the intervention ( P < 0.05 ) ; and longitudinal changes in the relative abundance of > 100 OTUs were associated with altered fecal content of ≥1 individual menaquinone ."], "par_relations": ["Naphthoquinones", "Vitamin K", "Antifibrinolytic Agents", "Vitamins"], "chd_relations": ["2,3-epoxymenaquinone", "2-trifluoromethyl-3-geranyl-1,4-naphthoquinone", "demethylmenaquinone", "menaquinone 6", "menatetrenone", "vitamin MK 7", "vitamin MK 8", "menaquinone 9", "menahydroquinone-4", "tetrahydromenaquinone", "menadione dimethylpyrimidinol bisulfite", "1'-oxomenaquinone-7", "menatetrenone epoxide"], "syn_relations": ["Vitamin K 2", "Vitamin K 2"], "sib_relations": ["Vitamin K 3", "Vitamin K 1", "Atovaquone"]}, "target_ent": {"research_entity_id": "RXNORM:42781", "canonical_name": "Vitamin K 2", "aliases": ["vitamin k 2"], "definition": "", "other_contexts": ["0.85 to 1.40 , P(trend ) 0.41 ) for the highest versus lowest quartile . For intake of menaquinones similar results were found , with an HR(Q4 versus Q1 ) of 0.99 ( 95% CI : 0.75 to 1.29 , P(trend )", "in gut microbiota composition may provide a feasible approach for altering gut menaquinone content . This trial was registered at the Chinese Clinical Trials Registry as ChiCTR - TRC-0900035", "For intake of menaquinones similar results were found, with an HR(Q4 versus Q1) of 0.99 (95% CI: 0.75 to 1.29, P(trend) 0.82).", "composition and to improve cardiometabolic biomarkers . RESULTS Covariance among menaquinones within individual fecal samples partitioned individuals into 2 distinct groups , herein introduced", "Menaquinotypes were characterized by differences in menaquinone ( MK ) 5 and MK9-MK13 and differences in the relative abundance of several operational taxonomic units ( OTUs ) delineated at the species level , predominantly within the genera Prevotella spp . and Bacteroides spp .", "DESIGN The menaquinone profile and gut microbiota structure were periodically measured in fecal samples collected from 77 overweight Chinese adults who consumed a prescribed diet previously shown to alter gut microbiota composition and to improve cardiometabolic biomarkers .", "Vitamin K2 Ameliorates Damage of Blood Vessels by Glucocorticoid : a Potential Mechanism for Its Protective Effects in Glucocorticoid - induced Osteonecrosis of the Femoral Head in a Rat Model Glucocorticoid has been reported to decrease blood vessel number and harm the blood supply in the femoral head , which is recognized to be an important mechanism of glucocorticoid - induced osteonecrosis of the femoral head ( ONFH ) .", "Lastly, more research is needed to determine how menaquinone supplementation interacts with medications such as warfarin, bile-acid sequestrants, orlistat, mineral oil and CYP3A4 substrates.", "When cells were grown anaerobically with trimethylamine - N - oxide as the terminal electron acceptor , all the menaquinone mutants showed wild - type levels of CT reduction .", "Abstract Vitamin K is known to play an essential role in the coagulation cascade ; however , a growing body of research has found that a subtype of this vitamin , vitamin K2 ( menaquinone ) , may have a beneficial effect in osteoporosis , cardiovascular disease , and cancer .", "Menaquinone intake was associated with decreased coronary calcification with an RR of 0.80 (95%-CI: 0.65-0.98; p(trend)=0.03).", "The menB, menA and menG mutants are all blocked towards the end of the pathway, being unable to produce 1,4-dihydroxy-2-naphthoic acid (DHNA), demethyl-menaquinone and menaquinone , respectively.", "Disruption of o251 in a wild-type parental strain produced a mutant with defects in growth on succinate and in both ubiquinone and menaquinone synthesis.", "Studies investigating the association between phylloquinone intake and risk of stroke are scarce, and the relation with menaquinones has not been investigated to date.", "High dietary menaquinone intake is associated with reduced coronary calcification .", ": 0.75 to 1.29 , P(trend ) 0.82 ) . When specifying hemorrhagic and ischemic stroke or menaquinone subtypes , no significant associations were detected . CONCLUSION In our study , neither dietary", "important role in bone metabolism ; however , few studies have focused on the effect of Vitamin K2 on new vascular formation . Thus , this study aimed to investigate whether Vitamin K2 promoted new", "We conclude that a derivative of DHNA, that is distinct from menaquinone, is involved in the reduction of CT by aerobically grown S. oneidensis MR-1.", "Our combined experimental data show that the heme b(D ) center , into which we include a quinone binding site , is crucial for succinate : menaquinone reductase activity .", ". OBJECTIVE The objective of this study was to identify associations between fecal menaquinone profiles , gut microbiota composition , and biomarkers of cardiometabolic health . DESIGN The", "CONCLUSIONS The FFQ is reproducible to rank subjects for phylloquinone and menaquinone intake.", "In the setting of cardiovascular disease, menaquinone intake has been shown to lower the risk of coronary calcification and coronary heart disease, and a randomized controlled trial has demonstrated that it can reduce arterial stiffness.", "Vitamin K2 ( menaquinone ) Supplementation and its Benefits in Cardiovascular Disease , Osteoporosis , and Cancer Dr. Shuler serves on the editorial committee of the Marshall Journal of Medicine .", "METHODS AND RESULTS We investigated the association between intake of phylloquinone and menaquinones and stroke in a prospective cohort of 35,476 healthy subjects .", "METHODS We investigated the association of intake of phylloquinone and menaquinone, including its subtypes (MK4-MK10), with coronary calcification in a cross-sectional study among 564 post-menopausal women.", "Intake of Dietary Phylloquinone and Menaquinones and Risk of Stroke BACKGROUND Dietary vitamin K intake is thought to decrease the risk of cardiovascular disease ( CVD ) by reducing vascular calcification , although vitamin K is also involved in coagulation .", "The distal heme center in Bacillus subtilis succinate : quinone reductase is crucial for electron transfer to menaquinone .", "The factor produced under anaerobic growth conditions is not a product of the menaquinone biosynthetic pathway.", "Plasma dpucMGP was negatively but weakly correlated with phylloquinone intake ( rs=-0.09 ( -0.18 ; -0.01 ) ) and long - chain menaquinones ( rs=-0.13 ( -0.21 ; -0.04 ) ) , but not with short - chain menaquinones ( rs=-0.04 ( -0.13 ; 0.05 ) ) .", "Menaquinone at physiologic levels (0.01 μg/ml MH) significantly increased (p < 0.05) biofilm formation on plastic in a manner that was bacterial population size dependent.", "Vitamin K2 has been revealed to play an important role in bone metabolism; however, few studies have focused on the effect of Vitamin K2 on new vascular formation.", "Thus , this study aimed to investigate whether Vitamin K2 promoted new blood vessel formation in the presence of glucocorticoids , both in vitro and in vivo .", "The relative validity of our FFQ , compared with 24HDR , to estimate intake of phylloquinone and short - chain menaquinones was low , but the relative validity for long - chain menaquinones was good .", "Collectively , Vitamin K2 has the ability to promote angiogenesis in vitro and to ameliorate vessels of the femoral head in glucocorticoid - treated rats in vivo , indicating that Vitamin K2 is a promising drug that may be used to prevent steroid - induced ONFH .", ", or inflammation . CONCLUSIONS These findings suggest that variability in fecal menaquinone content is predominantly determined by relatively few genera within the gut microbiota and that", "formation in the presence of glucocorticoids , both in vitro and in vivo . The effect of Vitamin K2 on viability , migration , in vitro tube formation , and VEGF , vWF , CD31 , KDR , Flt and PDGFB", "In vitro studies showed that Vitamin K2 significantly protected endothelial cells from dexamethasone-induced apoptosis, promoted endothelial cell migration and in vitro tube formation.", "abundance of > 100 OTUs were associated with altered fecal content of ≥1 individual menaquinone . The strongest and most consistent relations were between Prevotella spp . and MK5 and MK11-MK13 ,", "The relative validity of our FFQ, compared with plasma phylloquinone and dpucMGP, was relatively low for both phylloquinone and menaquinone intake.", "BACKGROUND Emerging evidence supports novel roles for vitamin K in cardiometabolic health, some of which may be unique to the bacterially synthesized vitamin K forms known as menaquinones.", "Menaquinone ’s effect on biofilm formation on fibronectin - coated surfaces appears to be regulated by sarA. These findings are the first to demonstrate that a vitamin at concentrations reported in humans affects S. aureus virulence - associated phenotypes .", "This review discusses the physiology of menaquinone, its clinical benefits in cardiovascular disease, osteoporosis, and cancer, and how it may interact with certain medications.", "The H113M mutant enzyme contains heme b(D) with raised midpoint potential and is impaired in electron transfer to menaquinone.", "were detected . CONCLUSION In our study , neither dietary phylloquinone nor dietary menaquinones intake were associated with stroke risk .", "The succinate : menaquinone reductases all contain two heme groups in the membrane anchor of the enzyme : a proximal heme ( heme b(P ) ) located close to the negative side of the membrane and a distal heme ( heme b(D ) ) located close to the positive side of the membrane .", "ONFH , medication that promotes both bone formation and angiogenesis would be ideal . Vitamin K2 has been revealed to play an important role in bone metabolism ; however , few studies have", "Long-chain menaquinones showed good relative validity (rs=0.60-0.69).", "The effect of Vitamin K2 on viability, migration, in vitro tube formation, and VEGF, vWF, CD31, KDR, Flt and PDGFB in EAhy926 incubated with or without dexamethasone were elucidated.", "The authors conclude that menaquinone supplementation has been shown to improve carboxylation of osteocalcin and matrix-Gla protein to their active forms, two proteins that possess important roles in calcium distribution.", "This may be due to different effects of vitamin K(1 ) ( phylloquinone ) and vitamin K(2 ) ( menaquinone , MK ) , but few studies included both .", "The relative validity , compared with 24HDR , for intake of short - chain menaquinones were ranging between 0.30 and 0.34 .", "Neither individual menaquinones nor menaquinotypes were longitudinally associated with markers of glycemia, insulin resistance, or inflammation.", "Fecal MK4, MK6, and MK8 decreased during the intervention (P < 0.05); and longitudinal changes in the relative abundance of >100 OTUs were associated with altered fecal content of ≥1 individual menaquinone.", "A C - methyltransferase involved in both ubiquinone and menaquinone biosynthesis : isolation and identification of the Escherichia coli ubiE gene .", "The menF mutant is blocked at the start of the menaquinone biosynthetic pathway .", "Phylloquinone and menaquinone intake was estimated using a food - frequency questionnaire .", "between phylloquinone intake and risk of stroke are scarce , and the relation with menaquinones has not been investigated to date . METHODS AND RESULTS We investigated the association between", "Menaquinone ( Vitamin K2 ) Enhancement of Staphylococcus aureus Biofilm Formation During infection , Staphylococcus aureus is exposed to exogenous menaquinone which is essential for the human blood clotting cascade .", "The results support a model in which menaquinone is reduced on the positive side of the membrane and the transmembrane electrochemical potential provides driving force for electron transfer from succinate via heme b(P) and heme b(D) to menaquinone.", "In addition, blood vessels of the femoral head in rats administered with or without methylprednisolone and Vitamin K2 were evaluated using angiography and CD31 staining.", "Angiogenesis - related proteins both in EAhy926 and MG63 were also upregulated by Vitamin K2 when cotreated with dexamethasone .", "Aerobically grown mutants unable to produce the menaquinone precursor DHNA (menF and menB mutants) showed a distinctly different CT transformation profile than mutants able to produce DHNA but unable to produce menaquinone (menA and menG mutants).", "K2 were evaluated using angiography and CD31 staining . In vitro studies showed that Vitamin K2 significantly protected endothelial cells from dexamethasone - induced apoptosis , promoted", "In osteoporosis , menaquinone has been shown in numerous randomized controlled trials to decrease the rate of bone loss at the lumbar spine and forearm and reduce the risk of fracture .", "Reproducibility and relative validity of a food frequency questionnaire to estimate intake of dietary phylloquinone and menaquinones.", "CONCLUSION In our study, neither dietary phylloquinone nor dietary menaquinones intake were associated with stroke risk.", ". Angiogenesis - related proteins both in EAhy926 and MG63 were also upregulated by Vitamin K2 when cotreated with dexamethasone . In vivo studies showed enhanced blood vessel volume and CD31-", "BACKGROUND/OBJECTIVES This study aims to investigate the reproducibility and relative validity of the Dutch food frequency questionnaire (FFQ), to estimate intake of dietary phylloquinone and menaquinones compared with 24-h dietary recalls (24HDRs) and plasma markers of vitamin K status.", "CONCLUSIONS These findings suggest that variability in fecal menaquinone content is predominantly determined by relatively few genera within the gut microbiota and that diet-mediated alterations in gut microbiota composition may provide a feasible approach for altering gut menaquinone content.", "The effect of exogenous menaquinone on S. aureus phenotypic expression is not known .", "AND RESULTS We investigated the association between intake of phylloquinone and menaquinones and stroke in a prospective cohort of 35,476 healthy subjects . Information on occurrence of", "OBJECTIVE The objective of this study was to identify associations between fecal menaquinone profiles, gut microbiota composition, and biomarkers of cardiometabolic health.", "compared to rats treated with methylprednisolone only . Collectively , Vitamin K2 has the ability to promote angiogenesis in vitro and to ameliorate vessels of the femoral head in", "When specifying hemorrhagic and ischemic stroke or menaquinone subtypes , no significant associations were detected .", "In cancer , menaquinone intake has been shown to reduce overall incidence and mortality ; clinical trials have suggested that it may have a role in reducing recurrence and death from hepatocellular carcinoma .", "Adequate menaquinone intakes could therefore be important to prevent cardiovascular disease.", "However , menaquinone had no effect on capsule production or cell - associated carotenoid levels .", ", some of which may be unique to the bacterially synthesized vitamin K forms known as menaquinones . However , factors influencing menaquinone biosynthesis by the gut microbiota and associations", "To test whether menaquinone affects expression of virulence-associated phenotypes, methicillin-sensitive (MSSA) and -resistant (MRSA) S. aureus strains (n = 8) were grown in the presence of menaquinone (0.001 12 μg/ml).", "The transformation of a strain harboring the ubiE401 mutation with o251 on an expression plasmid restored both the growth of this strain on succinate and its ability to synthesize both ubiquinone and menaquinone .", "CONCLUSION This study shows that high dietary menaquinone intake , but probably not phylloquinone , is associated with reduced coronary calcification .", "vessels of the femoral head in rats administered with or without methylprednisolone and Vitamin K2 were evaluated using angiography and CD31 staining . In vitro studies showed that Vitamin K2", "To investigate this hypothesis a series of menaquinone mutants were constructed .", ", gut microbiota composition , and biomarkers of cardiometabolic health . DESIGN The menaquinone profile and gut microbiota structure were periodically measured in fecal samples collected from 77", "Fecal menaquinone profiles of overweight adults are associated with gut microbiota composition during a gut microbiota-targeted dietary intervention.", "Some enzymes in vivo reduce ubiquinone (exergonic reaction) whereas others reduce menaquinone (endergonic reaction).", "MK9 and MK10 , and between Escherichia / Shigella spp . and MK8 . Neither individual menaquinones nor menaquinotypes were longitudinally associated with markers of glycemia , insulin resistance ,", "Heme b(D) is a distinctive feature of the succinate:menaquinone reductases, but the role of this heme in electron transfer to quinone has not previously been analyzed. His28 and His113 are the axial ligands to heme b(D) in Bacillus subtilis succinate:menaquinone reductase.", "In addition , menaquinone ( 0.05 4 μg / ml ) significantly increased ( p < 0.05 ) biofilm formation on fibronectin - coated surfaces for four MSSA strains and one MRSA strain by two to six - fold as compared to medium controls .", "A derivative of the menaquinone precursor 1,4-dihydroxy-2-naphthoate is involved in the reductive transformation of carbon tetrachloride by aerobically grown Shewanella oneidensis MR-1 Transformation of carbon tetrachloride (CT) by Shewanella oneidensis MR-1 has been proposed to involve the anaerobic respiratory-chain component menaquinone.", "of Vitamin K2 on new vascular formation . Thus , this study aimed to investigate whether Vitamin K2 promoted new blood vessel formation in the presence of glucocorticoids , both in vitro and in vivo", "The purpose of this article is to provide a comprehensive review of recent literature regarding menaquinone and its role in human health .", "However, factors influencing menaquinone biosynthesis by the gut microbiota and associations with cardiometabolic health have not been examined.", "However , in all clinical settings , more large randomized controlled trials are needed to definitively determine the clinical benefits of menaquinone supplementation , as many studies have failed to show any significant benefit .", "The data presented identify the E. coli UbiE polypeptide and provide evidence that it is required for the C methylation reactions in both ubiquinone and menaquinone biosynthesis .", "menaquinotypes of the human gut . Menaquinotypes were characterized by differences in menaquinone ( MK ) 5 and MK9-MK13 and differences in the relative abundance of several operational taxonomic", "synthesized vitamin K forms known as menaquinones . However , factors influencing menaquinone biosynthesis by the gut microbiota and associations with cardiometabolic health have not been", "RESULTS Covariance among menaquinones within individual fecal samples partitioned individuals into 2 distinct groups, herein introduced as menaquinotypes of the human gut.", "In B. subtilis the ubiE homolog is likely to be required for menaquinone biosynthesis and is located within the gerC gene cluster , known to be involved in spore germination and normal vegetative growth .", "Strains of Escherichia coli with mutations in the ubiE gene are not able to catalyze the carbon methylation reaction in the biosynthesis of ubiquinone ( coenzyme Q ) and menaquinone ( vitamin K2 ) , essential isoprenoid quinone components of the respiratory electron transport chain .", "vessels of the femoral head in glucocorticoid - treated rats in vivo , indicating that Vitamin K2 is a promising drug that may be used to prevent steroid - induced ONFH ."], "par_relations": [], "chd_relations": [], "syn_relations": [], "sib_relations": ["Vitamin K 2 0.09 MG", "Cholecalciferol / Vitamin K 2 Disintegrating Oral Tablet", "Cholecalciferol / Vitamin K 2", "Cholecalciferol / Vitamin K 2 Oral Product", "Cholecalciferol / Vitamin K 2 Pill", "Cholecalciferol / Vitamin K 2 Disintegrating Oral Product", "Vitamin K 2 0.04 MG", "Vitamin K 2 Oral Tablet", "Vitamin K 2 Pill", "Vitamin K 2 Oral Product", "Vitamin K 2 0.1 MG", "Vitamin K 2 Oral Capsule"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:D044905", "canonical_name": "beta-Mannosidosis", "aliases": ["mannosidosis, beta a, lysosomal", "beta mannosidase deficiency", "beta-mannosidase deficiency", "beta-mannosidase deficiencies", "beta mannosidosis", "lysosomal beta-mannosidase deficiency", "beta-mannosidosis", "lysosomal beta a mannosidosis", "lysosomal beta-mannosidase deficiencies", "beta mannosidase defic", "lysosomal beta mannosidase deficiency", "beta-mannosidoses"], "definition": "An inborn error of metabolism marked by a defect in the lysosomal isoform of BETA-MANNOSIDASE that results in lysosomal accumulation of mannose-rich intermediate metabolites containing 1,4-beta linkages. The human disease occurs through autosomal recessive inheritance and manifests in the form of a variety of symptoms that depend upon the type of gene mutation.", "other_contexts": ["This investigation was designed to characterize accumulated kidney oligosaccharides in bovine beta-mannosidosis.", "The results indicate that the plasma beta-mannosidase level is a reasonably good indicator of carrier status and confirm that the disease beta-mannosidosis is inherited in a recessive manner and is not X-linked.", "Plasma beta-mannosidase activities were determined for Salers cattle from 8 herds as an evaluation of this method for detection of beta-mannosidosis heterozygotes.", "To more fully understand the molecular pathology of this disease, the mutation associated with bovine beta-mannosidosis was identified by sequence analysis of cDNA from an affected calf.", "The complete sequence of the caprine beta-mannosidase cDNA coding region has been determined, and a mutation that is associated with caprine beta-mannosidosis has been identified.", "CONCLUSIONS To our knowledge, this is the first case of beta-mannosidosis reported in Japan and the second report in which a gene mutation is identified.", "Oligosaccharides accumulated in the bovine beta-mannosidosis kidney.", "Thin-layer chromatography and quantitation of oligosaccharides revealed the presence of tri- and disaccharides, typical of beta-mannosidosis, only in V385.", "Angiokeratoma corporis diffusum in human beta-mannosidosis: Report of a new case and a novel mutation.", "Analysis of the prenatal development of lesions will help clarify the pathogenesis of dysmyelinogenesis in beta-mannosidosis.", "Morphological analysis revealed cytoplasmic vacuolation typical of beta-mannosidosis in V385; in thyroid, spinal cord, and kidney, the pattern of vacuolation was similar to, but less severe than, that observed previously in newborn affected goats.", "Bovine plasma beta-mannosidase activity and its potential use for beta-mannosidosis carrier detection.", "An aberrant beta-mannosidosis phenotype in a 5-month-old triplet goat kid was characterized by a late postnatal onset of mild neurological symptoms.", "These results indicate that the pathogenetic process leading to cellular abnormalities and myelin deficits in beta-mannosidosis has been initiated prior to 124 days gestation, during an early stage of myelination in the goat optic nerve.", "The importance of angiokeratoma corporis diffusum as the clue to the diagnosis of beta-mannosidosis and other lysosomal storage diseases is emphasized.", "CONCLUSIONS A new case of human beta-mannosidosis is presented and the first MANBA gene mutation from Arab ancestry is reported.", "Several biological factors, such as age, gender, herd, and risk of being a beta-mannosidosis carrier, were considered in this study.", "As in caprine beta-mannosidosis, oligosaccharides with terminal beta-mannose residues and cleaved as well as uncleaved chitobiose linkages were identified in bovine beta-mannosidosis kidney.", "A single-base deletion at position 1398 of the coding sequence was identified in the cDNA isolated from a goat affected with beta-mannosidosis.", "The phenotype of bovine beta-mannosidosis (beta-mannosidase deficiency), recently identified in Salers cattle, is similar to the caprine form of the disease (Abbitt et al., 1991).", "BACKGROUND Human beta-mannosidosis, a rare disorder of oligosaccharide catabolism, results from a deficiency of beta-mannosidase activity.", "Plasma levels of beta-mannosidase activity were measured in the phenotypically normal members of a family of goats in which 12 cases of beta-mannosidosis have been reported.", "To clarify its pathogenesis we did electron microscopic, biochemical and molecular biological investigations of a Japanese patient with beta-mannosidosis.", "To aid commercial breeders of Salers cattle, a PCR-based test was developed to detect the mutation for beta-mannosidosis carrier screening.", "Variable engraftment of donor stem cells, resulting from transplacental transfusion of stem cells from a normal sibling during the immunotolerant period, may have modified the expected severe beta-mannosidosis phenotype.", "Inheritance of beta-mannosidosis in goats.", "Kidney, brain grey matter and brain white matter contained 33%, 12% and 4%, respectively, of the oligosaccharides expected in the organs of beta-mannosidosis animals.", "Beta-mannosidase deficiency results in beta-mannosidosis, a severe neurodegenerative lysosomal storage disease identified in cattle, goats, and humans.", "An assay, developed to determine the presence or absence of this mutation, confirmed that animals affected with beta-mannosidosis were homozygous for the mutation and that obligate carriers in a caprine beta-mannosidosis colony were heterozygous.", "Plasma beta-mannosidase analysis provides important information for intraherd selection of Salers cattle that are heterozygous for beta-mannosidosis.", "Biochemical and morphological expression of early prenatal caprine beta-mannosidosis.", "Dysmyelinogenesis in caprine beta-mannosidosis: ultrastructural and morphometric studies in fetal optic nerve.", "beta-Mannosidosis (MANB1; OMIM248510), first reported in humans in 1986, is a rare hereditary lysosomal storage disease caused by a deficiency of the enzyme beta-mannosidase.", "The severity of the bovine beta-mannosidosis phenotype suggests that the 22 C-terminal amino acids of beta-mannosidase play an important role in the function of this enzyme.", "The accumulating oligosaccharides in tissue were thus identical in bovine and caprine beta-mannosidosis; however, the source of the novel oligosaccharides remains to be determined.", "Caprine beta-mannosidase: sequencing and characterization of the cDNA and identification of the molecular defect of caprine beta-mannosidosis.", "OBJECTIVES We report here a 36-year-old Arab female with beta-mannosidosis who presented with mental retardation and multiple angiokeratomas.", "Identification of a bovine beta-mannosidosis mutation and detection of two beta-mannosidase pseudogenes.", "The optic nerves from a goat fetus affected with beta-mannosidosis and a control fetus were analysed morphologically in order to investigate developmental aspects of beta-mannosidosis-associated myelin deficits.", "Out of six fetuses delivered at 62 days of gestation, one (V385) was identified by measurement of beta-mannosidase activity as the only fetus affected with beta-mannosidosis.", "Morphological and biochemical studies of human beta-mannosidosis: identification of a novel beta-mannosidase gene mutation.", "Possible beta-mannosidosis chimera.", "Similar data were collected on a number of other small families unrelated to the one with beta-mannosidosis.", "These data indicate that bovine beta-mannosidosis is characterized by a gene dosage effect.", "Three pairs of obligate carrier goats from the beta-mannosidosis colony were mated.", "Necropsy examination revealed relatively normal myelination; however, the distribution of cytoplasmic vacuolation in the kidney and brain was similar to that observed in neonatal beta-mannosidosis.", "The assay also confirmed chimerism in a goat with an atypically mild beta-mannosidosis phenotype."], "par_relations": ["Mannosidase Deficiency Diseases"], "chd_relations": [], "syn_relations": ["beta-Mannosidosis", "beta-Mannosidosis", "beta-Mannosidosis", "beta-Mannosidosis", "beta-Mannosidosis", "beta-Mannosidosis", "beta-Mannosidosis", "beta-Mannosidosis", "beta-Mannosidosis", "beta-Mannosidosis", "beta-Mannosidosis", "beta-Mannosidosis", "beta-Mannosidosis", "beta-Mannosidosis"], "sib_relations": ["beta-Mannosidase", "alpha-Mannosidosis"]}, "target_ent": {"research_entity_id": "OMIM:233700", "canonical_name": "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "aliases": ["cdg1", "ncf1, deficiency of", "neutrophil cytosol factor 1, deficiency of", "p47-phox, deficiency of", "granulomatous disease, chronic, due to ncf1 deficiency", "soc2, deficiency of", "cgd, autosomal recessive cytochrome b-positive, type i", "granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i", "soluble oxidase component ii, deficiency of"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I", "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I"], "sib_relations": ["Eczematoid dermatitis", "E. coli infections", "Hepatomegaly", "Klebsiella infections", "Lymphadenitis", "Splenomegaly", "Autosomal recessive", "Lymphadenopathy", "Aspergillus infections", "Serratia marcescens infections", "Staphylococcus aureus infections", "Burkholderia cepacia infections", "Hepatic abscesses due to immunodeficiency", "Perirectal abscesses due to immunodeficiency", "Cellulitis due to immunodeficiency", "Bacterial infections, recurrent", "Fungal infections, recurrent", "Absence of bactericidal oxidative 'respiratory burst' in phagocytes", "Abscess formation in any organ", "Tissue biopsy shows granulomas", "Biopsy shows lipid-laden macrophages", "Negative nitroblue tetrazolium (NBT) reduction test", "Decreased activity of NADPH oxidase", "Dermatitis, infectious, due to immunodeficiency Impetigo", "Discoid lupus in carriers or adults with mild disease", "Pneumonia due to immunodeficiency", "Onset usually in first decade", "Four types of CGD with basically identical clinical phenotypes", "Autosomal recessive cytochrome b-negative CGD (233690)", "Presence of cytochrome b(-245)", "Deficiency or absence of p47-phox protein (type I)", "Caused by mutation in the neutrophil cytosolic factor-1 gene, p47-phox (NCF1, 608512.0001)", "Autosomal recessive cytochrome b-positive CGD, type I", "X-linked recessive cytochrome b-negative CGD (306400)", "Autosomal recessive cytochrome b-positive CGD, type II (233710)", "Osteomyelitis due to immunodeficiency"]}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:13902", "canonical_name": "serpin family B member 7", "aliases": ["serpinb7 gene", "megsin", "serpinb7", "serpin family b member 7"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["serpin family B member 7", "serpin family B member 7", "serpin family B member 7", "serpin family B member 7"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:610060.0005", "canonical_name": "POLR1C, ARG279TRP", "aliases": ["polr1c, arg279trp"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["POLYMERASE I, RNA, SUBUNIT C"], "sib_relations": ["POLYMERASE I, RNA, SUBUNIT C"]}}
{"label": 1, "source_ent": {"research_entity_id": "HPO:HP:0006380", "canonical_name": "Knee flexion contracture", "aliases": ["contractures of the knees", "flexion deformity of the knee", "knee flexion contractures", "flexion contractures at both knees", "flexion contractures of knees", "flexion contracture of knees", "knee flexion deformity", "contractures of knees", "knee contractures", "knee flexion contracture", "knee contracture"], "definition": "A bent (flexed) knee joint that cannot be straightened actively or passively. [HPO:probinson]", "other_contexts": [], "par_relations": ["Contractures of the joints of the lower limbs", "Abnormality of the knee"], "chd_relations": [], "syn_relations": ["Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture", "Knee flexion contracture"], "sib_relations": ["Knee dislocation", "Ankle clonus", "Contractures involving the joints of the feet", "Hip contracture", "Knee osteoarthritis", "Hamstring contractures", "Genu varum", "Genu recurvatum", "Genu valgum", "Ankle contracture", "Limited knee flexion", "Limited knee extension", "Absent knee epiphyses", "Adductor longus contractures", "Limitation of knee mobility", "Abnormality of the patella", "Hyperextensibility of the knee", "Congenital foot contractures", "Flattened knee epiphyses", "Large knee"]}, "target_ent": {"research_entity_id": "OMIM:MTHU038619", "canonical_name": "Flexion contractures at both knees", "aliases": ["flexion contractures at both knees"], "definition": "", "other_contexts": [], "par_relations": ["Limbs"], "chd_relations": [], "syn_relations": [], "sib_relations": ["MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1"]}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0002900", "canonical_name": "Hypokalemia", "aliases": ["low blood potassium levels", "hypokalemia"], "definition": "An abnormally decreased potassium concentration in the blood. [HPO:probinson]", "other_contexts": [], "par_relations": ["Abnormality of potassium homeostasis"], "chd_relations": ["Episodic hypokalemia"], "syn_relations": ["Hypokalemia", "Hypokalemia"], "sib_relations": ["Hyperkalemia"]}, "target_ent": {"research_entity_id": "MSH:C004810", "canonical_name": "Hyparez", "aliases": ["yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 1(2h)-phthalazinone hydrazone and potassium chloride (kcl)", "hyparez"], "definition": "", "other_contexts": [], "par_relations": ["Drug Combinations", "Hydralazine", "Hydrochlorothiazide", "Potassium Chloride", "Reserpine"], "chd_relations": [], "syn_relations": [], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:D012516", "canonical_name": "Osteosarcoma", "aliases": ["osteogenic sarcoma", "sarcomas, osteogenic", "osteogenic sarcomas", "osteosarcoma tumor", "sarcoma, osteogenic", "osteosarcoma tumors", "tumors, osteosarcoma", "tumor, osteosarcoma", "osteosarcomas", "osteosarcoma"], "definition": "A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)", "other_contexts": ["BACKGROUND Radiation-induced bone sarcoma has been associated with high doses of ionizing radiation from therapeutic or occupation-related exposures.", "In this multicentre , retrospective study , a total of 106 conventional high - grade osteosarcomas , across all age groups were re - examined for hotspot mutations in the H3.3 coding genes H3F3A and H3F3B. H3.3 mutant osteosarcomas were re - evaluated in a multidisciplinary manner and analyzed for genome - wide DNA - methylation patterns and DNA copy number aberrations alongside H3.3 wild - type osteosarcomas and H3F3A G34W / L mutant GCTBs .", "Osteosarcomas occur from exposures to bone-seeking, alpha-particle-emitting isotopes, particularly plutonium.", "Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated cases Histone 3.3 (H3.3) hotspot mutations in bone tumors occur in the vast majority of giant cell tumors of bone (GCTBs; 96%), chondroblastomas (95%) and in a few cases of osteosarcomas.", "Male and female dogs that underwent gonadectomy before 1 year of age had an approximate one in four lifetime risk for bone sarcoma and were significantly more likely to develop bone sarcoma than dogs that were sexually intact [RR ±95% CI = 3.8 (1.5–9.2) for males; RR ±95% CI = 3.1 (1.1–8.3) for females].", "For the first time the genomic chaos of osteosarcoma is characterized so thoroughly and delivered new insights in mechanisms involved in osteosarcoma development and may contribute to new diagnostic and therapeutic strategies .", "PURPOSE Although metastasis is the primary determinant of poor survival of patients with osteogenic sarcoma , some patients live much longer than others , indicating metastatic heterogeneity underlying survival outcome .", "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "This paper reports the occurrence of osteogenic sarcoma in four siblings.", "Osteosarcomas carrying H3F3A G34W/R mutations are associated with epigenetic dysregulation of KLLN/PTEN and HIST1H2BB.", "Chi(2 ) test for trend showed a highly significant inverse dose - response relationship between duration of lifetime gonadal exposure and incidence rate of bone sarcoma ( P = 0.008 for males , P = 0.006 for females ) .", "The purpose of the investigation was to identify genes underlying survival outcome of patients with osteogenic sarcoma metastasis .", "To determine whether there was an association between endogenous sex hormones and risk of bone sarcoma , relative risk ( RR ) of incidence rates and hazard ratios for bone sarcoma were calculated for dogs subdivided on the basis of lifetime gonadal hormone exposure .", "H3.3 mutations in osteosarcomas may occur in H3F3A at mutational hotspots.", "One hundred percent (42 of 42) of low-grade osteogenic sarcoma specimens expressed no WT1 as determined by immunostaining; however, 24% (12 of 49) of the high-grade specimens showed intense staining.", "These results also support the experimental paradigm that plutonium osteosarcomas have a preference for well vascularized cancellous bone sites .", "The two cases were diagnosed pathologically as osteolytic osteogenic sarcoma.", "This distribution of osteosarcomas is quite different from the distributions of naturally occurring osteosarcomas for both species.", "of pathognomonic translocations . We here report hundreds of genomic rearrangements in osteosarcoma cell lines , showing clear characteristics of microhomology - mediated break - induced replication", "Controversy prevails over the need for chemotherapy in periosteal osteosarcomas, which are intermediate grade lesions.", "METHODS A cohort analysis based on the Life Span Study ( n = 120,321 ) was performed to assess the development of bone sarcoma in atomic - bomb survivors of Hiroshima and Nagasaki followed from 1958 to 2001 .", "Two cases of osteogenic sarcoma have also been documented.", "Endogenous Gonadal Hormone Exposure and Bone Sarcoma Risk1 Although experimental and clinical evidence suggest that endogenous sex hormones influence bone sarcoma genesis, the hypothesis has not been adequately tested in an appropriate animal model.", "All splice variants of WT1 mRNA, including a hitherto unknown variant (lacking exons 4 and 5), were found to be expressed in osteogenic sarcoma.", ", possibly oncogenic , events are present . For the first time the genomic chaos of osteosarcoma is characterized so thoroughly and delivered new insights in mechanisms involved in osteosarcoma", "RESULTS Microarray analysis revealed 5.3-fold more expression of WT1 mRNA in osteogenic sarcoma compared with normal bone and >2-fold overexpression in 143B and LM8 cells compared with SAOS.", "response . Thus , TP53 rearrangements are the major mechanism of p53 inactivation in osteosarcoma . Together with active MMBIR and MMEJ , this inactivation probably contributes to the exceptional", "Comparisons of the skeletal locations of putative plutonium - induced osteosarcomas in humans with those in beagle dogs and with naturally occurring tumors in both species .", "Although experimental and clinical evidence suggest that endogenous sex hormones influence bone sarcoma genesis, the hypothesis has not been adequately tested in an appropriate animal model.", "We conclude that the subset of Rottweiler dogs that undergo early gonadectomy represent a unique, highly accessible target population to further study the gene:environment interactions that determine bone sarcoma risk and to test whether interventions can inhibit the spontaneous development of bone sarcoma.", "CONCLUSIONS On the basis of what we believe is one of the longest and largest prospective studies assessing the development of bone sarcoma in individuals exposed to ionizing radiation , it appears that the development of radiation - induced bone sarcoma may be associated with exposure to much lower doses of ionizing radiation than have previously been reported .", "RESULTS Nineteen cases of bone sarcoma ( in eleven males and eight females ) were identified among the 80,181 subjects who met the inclusion criteria , corresponding to an incidence of 0.9 per 100,000 person - years .", "Barry (1961) reported osteogenic sarcoma arising in members of the same family in association with Paget’s disease.", "Three patients had osteogenic sarcoma diagnosed, one with myelodysplastic syndrome, one with colon carcinoma, and one with a soft tissue sarcoma.", "We conducted a historical cohort study of Rottweiler dogs because they frequently undergo elective gonadectomy and spontaneously develop appendicular bone sarcomas , which mimic the biological behavior of the osteosarcomas that affect children and adolescents .", "Before this Werner (1930) reported osteogenic sarcoma developing in three members of a family whose members were prone to multiple fractures.", "Endogenous gonadal hormone exposure and bone sarcoma risk .", "High WT1 expression is associated with very poor survival of patients with osteogenic sarcoma metastasis.", "Speculation is made regarding the nature of the molecular defect leading to the association of DBA and osteogenic sarcoma.", "In the Cooperative Osteosarcoma Study Group in humans (1,736 osteosarcomas from all ages), over 91% of the tumors occurred in the peripheral skeleton.", "Unlike a single osteosarcoma with a H3F3A K27M mutation, the DNA methylation profiles of H3F3A G34W/R mutant osteosarcomas were clearly different from H3.3 wild-type osteosarcomas, but more closely related to GCTBs.", "Parosteal osteosarcomas, being low grade lesions, can be treated by upfront wide excision without adjuvant systemic therapy.", "CONCLUSION There appears to be an association of osteogenic sarcoma with DBA.", "An almost identical distribution of plutonium - induced osteosarcomas was reported for dogs injected with 239Pu as young adults .", "Copy number aberrations that are commonly encountered in high - grade osteosarcomas also occurred in H3F3A mutant osteosarcomas .", "No mutations were found in H3F3B. All patients with H3F3A mutant osteosarcoma were older than 30 years with a median age of 65 years .", "in these tumors . Although rampant rearrangements appear to be a phenotype of osteosarcomas , we demonstrate that among the huge number of probable passenger rearrangements , specific", "Osteosarcoma was the most commonly identified bone sarcoma .", "Although rampant rearrangements appear to be a phenotype of osteosarcomas, we demonstrate that among the huge number of probable passenger rearrangements, specific recurrent, possibly oncogenic, events are present.", "Three major groups of surface osteosarcomas are parosteal, periosteal and the high grade surface osteosarcomas.", "Thus , TP53 rearrangements are the major mechanism of p53 inactivation in osteosarcoma .", "The skeletal distribution of putative 239Pu-induced osteosarcomas reported in Mayak Metallurgical and Radiochemical Plutonium Plant workers is compared with those observed in canine studies, and these are compared with distributions of naturally occurring osteosarcomas in both species.", "Osteogenic sarcoma in four siblings.", "The distribution of naturally occurring osteosarcomas in the canine is similar to that in the adult human.", "The most differentially methylated promoters between H3F3A G34W/R mutant and H3.3 wild-type osteosarcomas were in KLLN/PTEN (p < 0.00005) and HIST1H2BB (p < 0.0005).", "CONCLUSION WT1 seems to be associated with very poor survival of patients with osteogenic sarcoma metastasis.", "Mean survival of patients with high-grade metastatic osteogenic sarcoma but low WT1 staining (27 of 37) was 96.5 +/-", "The most common bone sarcoma site was the pelvis.", "Neo-adjuvant chemotherapy is the standard of care for high grade surface osteosarcomas.", "Male and female dogs that underwent gonadectomy before 1 year of age had an approximate one in four lifetime risk for bone sarcoma and were significantly more likely to develop bone sarcoma than dogs that were sexually intact [RR +/-95%", "A young age at presentation may be a feature of DBA-associated osteogenic sarcoma.", "Finally, expression of the selected gene was assessed by immunostaining of osteogenic sarcoma samples with known survival outcome.", "129.3 months , whereas mean survival of patients with high - grade metastatic osteogenic sarcoma having intense staining ( 10 of 37 ) was 18.3 + /-", "Risk for bone sarcoma was significantly influenced by age at gonadectomy.", "Exposure to ionizing radiation and development of bone sarcoma : new insights based on atomic - bomb survivors of Hiroshima and Nagasaki .", "The similarities of the distributions of plutonium-associated osteosarcomas in the Mayak workers with those found in experimental studies suggest that many of the reported osteosarcomas may have been associated with plutonium exposures.", "In this report fibrosarcoma and osteogenic sarcoma were included : one tumour was diagnosed as fibrosarcoma, one as sclerosing osteogenic sarcoma, and one as round-cell osteogenic sarcoma.", "Because of the immaturity of the database, the actuarial risk for osteogenic sarcoma and other cancers in individuals with DBA cannot be ascertained.", "53 aberrations In contrast to many other sarcoma subtypes , the chaotic karyotypes of osteosarcoma have precluded the identification of pathognomonic translocations . We here report hundreds of", "In contrast to many other sarcoma subtypes , the chaotic karyotypes of osteosarcoma have precluded the identification of pathognomonic translocations .", "is characterized so thoroughly and delivered new insights in mechanisms involved in osteosarcoma development and may contribute to new diagnostic and therapeutic strategies .", "In 1935 Roberts and Roberts reported the occurrence of osteogenic sarcoma in nonidentical siblings ( one brother and two sisters ) with no previous chronic bone disorder .", "A year later the occurrence of osteogenic sarcoma in two sisters was reported by Pohle , Stovall and Boyer ( 1936 ) .", "However, clinical presentation, histopathological features, and additional molecular characteristics of H3.3 mutant osteosarcomas are largely unknown.", "Surface osteosarcomas occur at a later age as compared to conventional osteosarcomas .", "Six osteosarcomas (6/106) carried H3F3A hotspot mutations.", "Surface osteosarcomas: Diagnosis, treatment and outcome Surface osteosarcomas are a rare form of osteosarcomas accounting for around 3-6% of all osteosarcomas.", "Parosteal and periosteal osteosarcomas are distinct clinical entities and it is important to identify the clinicoradiological differences between the two types.", "χ2 test for trend showed a highly significant inverse dose-response relationship between duration of lifetime gonadal exposure and incidence rate of bone sarcoma (P = 0.008 for males, P = 0.006 for females).", "Such new insights may potentially improve bone sarcoma prevention measures and broaden our understanding of the role of ionizing radiation from various sources on the development of malignant tumors.", "In the Mayo Clinic group of older individuals (>40 years old), over 60% of the osteosarcomas appeared in the peripheral skeleton.", "They are overall rare , but become more frequent in osteosarcoma patients older than 30 years .", "In the Mayak workers, 29% and 71% of the osteosarcomas were in the peripheral and central skeleton, respectively, with the spine having the most tumors (36%).", "However , the development of bone sarcoma following exposure to lower doses of ionizing radiation remains speculative .", "Furthermore, WT1 mRNA was absent in normal bone (10 of 10) by reverse transcription-PCR but present in osteogenic sarcoma-derived cell lines (5 of 8).", "EXPERIMENTAL DESIGN We have used microarray to first compare mRNA expression between normal bone and osteogenic sarcoma specimens, identified genes overexpressed in osteogenic sarcoma, and compared expression of the selected gene between a poorly metastatic (SAOS) and two highly metastatic cell lines (LM8 and 143B)."], "par_relations": ["Neoplasms, Bone Tissue", "Sarcoma"], "chd_relations": ["Osteosarcoma, Juxtacortical", "Sarcoma, Ewing", "Oslam syndrome", "Premature aging, Okamoto type", "Osteosarcoma, Retinoblastoma-Related"], "syn_relations": ["Osteosarcoma", "Osteosarcoma", "Osteosarcoma", "Osteosarcoma", "Osteosarcoma", "Osteosarcoma", "Osteosarcoma", "Osteosarcoma", "Osteosarcoma", "Osteosarcoma", "Osteosarcoma", "Osteosarcoma"], "sib_relations": ["Adenosarcoma", "Carcinosarcoma", "Chondrosarcoma", "Phyllodes Tumor", "Fibrosarcoma", "Hemangiosarcoma", "Leiomyosarcoma", "Liposarcoma", "Lymphangiosarcoma", "Myosarcoma", "Myxosarcoma", "Osteoblastoma", "Osteochondroma", "Osteoma", "Sarcoma, Experimental", "Sarcoma, Kaposi", "Sarcoma, Synovial", "Sarcoma, Myeloid", "Giant Cell Tumor of Bone", "Fibroma, Ossifying", "Sarcoma, Clear Cell", "Sarcoma, Small Cell", "Sarcoma, Alveolar Soft Part", "Desmoplastic Small Round Cell Tumor", "Histiocytoma, Malignant Fibrous", "Endometrial Stromal Tumors", "Mixed Tumor, Mesodermal"]}, "target_ent": {"research_entity_id": "OMIM:MTHU006088", "canonical_name": "Sudden death", "aliases": ["sudden death"], "definition": "", "other_contexts": ["Suddendeath events duringdialysis are uncommon, estimated to occur between four and seven times per 100,000 dialysis treatments (5); therefore, the risk of sudden death during the dialysis treatment is very low.", "Therefore , we assessed risk factors , including parental sudden death , associated with the occurrence of sudden death in a long - term cohort study .", "It appears , however , that parental history of sudden death has not been investigated yet as a risk factor for sudden death .", "Proportional Risk Model ( SPRM ) to estimate the proportion of total mortality due to sudden death . We prospectively validated the model in HF - ACTION and tested whether the ICD benefit varied", "Cardiovascular diseases are the main known reason of sudden death and more than 75% of sudden deaths in athletes are assigned to it.", "Does the Implantable Cardioverter - Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients ?", "Formany years, we have known that lower calcium dialysate concentrations are associated with a prolongation of the QT interval and QT dispersion (2)—both risk factors for sudden death (3).", "(5) had previously shown that lower calcium dialysate was associated with an increased risk of sudden death during the dialysis procedure.", "? BACKGROUND Prediction of which heart failure patients are most likely to die of sudden death vs. non - sudden death is an important factor in determining who will benefit the most from an ICD", "CONCLUSIONS In an ambulatory NYHA II-IV HF population and EF ≤35%, the SPRM was predictive of the proportional risk of sudden vs. non-sudden death.", "Interestingly, sudden death can ever sometimes occur in pilots who undergo regular physical examinations.", "death in MSA . METHODS We reviewed the literature on the mechanisms and prevention of sudden death in patients with MSA . RESULTS Sudden death in MSA is hypothesized to be a consequence of", "The existence of familial risk factors for sudden death may help provide better identification of subjects at high risk of and early prevention of sudden death .", "Lower dialysate calcium concentrations seem to increase the risk of sudden death, and their use may not be preferred.", "death that happens within less than one hour of first symptom occurrence is called sudden death . Cardiovascular diseases are the main known reason of sudden death and more than 75% of sudden", "In this symposium , we presented and explained the condition that is known as sudden death and the current state of treatment of sudden death in emergency medicine , cardiovascular medicine , cardiovascular surgery and neurosurgery departments of the Hokkaido University Graduate School of Medicine in October , 2015 .", "( 1 ) increase our understanding about the risk of sudden death associated with lower calciumdialysate concentrations .", "Thirty-six percent of patients with sudden death but no patient with VT had two separate areas of infarction.", "Predicting Sudden Death in the Population Background—", "( P=0.001 ) , with a greater benefit in those with a higher conditional probability of sudden death . CONCLUSIONS In an ambulatory NYHA II - IV HF population and EF ≤35% , the SPRM was predictive of", "BACKGROUND The risk of sudden death from cardiac causes in the general population peaks from 6 a.m. to noon and has a nadir from midnight to 6 a.m. Obstructive sleep apnea is highly prevalent and associated with neurohormonal and electrophysiological abnormalities that may increase the risk of sudden death from cardiac causes , especially during sleep .", "Here we reported the autopsy results of all cases with sudden death following exercise that were referred to forensic center of Tehran , Iran , from 2009 to 2014 .", "CONCLUSION Various factors may be involved in the mechanism of sudden death in MSA .", "To determine whether left ventricular function , coronary anatomy , or electrophysiologic characteristics could differentiate patients with sudden death from those with VT without sudden death , we compared results of cardiac angiography and programmed electrical stimulation in 42 patients referred for evaluation of sustained VT or surviving \" aborted \" sudden death for more than 9 days after myocardial infarction .", "The ICD benefit varied with the SPRM for all-cause mortality (P=0.001), with a greater benefit in those with a higher conditional probability of sudden death.", "The relative risk of-sudden death during and up to 30 minutes after vigorous exertion was 16.9 (95 percent confidence interval, 10.5 to 27.0; P<0.001).", "People with obstructive sleep apnea have a peak in sudden death from cardiac causes during the sleeping hours , which contrasts strikingly with the nadir of sudden death from cardiac causes during this period in people without obstructive sleep apnea and in the general population .", "In 2015, it was reported that sudden death occurred in an American pilot and that the co-pilot was forced to make an emergency landing.", "RESULTS Sudden death in MSA is hypothesized to be a consequence of disordered central respiration, suffocation caused by sputum and food, upper airway obstruction from NPPV acting on a floppy epiglottis, cardiac autonomic disturbance, or a combination of these factors.", "during physical activities , should be screened regarding common probable causes of sudden death .", "Therefore, we assessed risk factors, including parental sudden death, associated with the occurrence of sudden death in a long-term cohort study.", "The increased risk of sudden death occurs at the end of the weekend interval immediately before dialysis or within 12 hours of the start of a dialysis session ( 6 ) .", "BACKGROUND Sudden death in multiple system atrophy (MSA) usually occurs during sleep and was therefore attributed to suffocation resulting from vocal cord abductor paralysis, a characteristic laryngeal finding of MSA.", "The study revealed that low calcium dialysate ( , 2.5 mEq / L ) was associated with a twofold increased risk of sudden death during the dialysis procedure ( 95% confidence interval51.4–2.9 ) .", "Alkalemia is well known to lower serum calcium , and the combination of increased alkalemia with a high calcium gradient could lead to an even higher calcium gradient and risk of sudden death .", "The base-line level of exercise was not associated with the overall risk of subsequent sudden death.", "Another possibility is that hemodialysis patients with higher serum calcium levels—who have been reported to have decreased survival compared with patients with normal serum calcium levels (7)—have increased cardiac dysfunction at baseline that puts them at risk of sudden death.", "We similarly analyzed sudden death from cardiac causes during three time intervals that correlate with usual sleep-wake cycles.", "For each interval , we assessed the median apnea - hypopnea index and the relative risk of sudden death from cardiac causes .", "epiglottis . Therefore , it is important to determine the mechanisms and prevention of sudden death in MSA . METHODS We reviewed the literature on the mechanisms and prevention of sudden death in", "After the acute phase of myocardial infarction , patients who develop sustained ventricular arrhythmias present with either sudden death or ventricular tachycardia ( VT ) .", "METHODS We reviewed the literature on the mechanisms and prevention of sudden death in patients with MSA .", "RESULTS 14 cases were registered as sudden death following exercise in forensic medicine profiles during the study period. Exploring the files of the mentioned deceased, revealed five non-compatible cases in this regard.", "(1) extended their findings to show that the higher the gradient between serum calcium and dialysate calcium, themore likely it is that sudden death will occur.", "Mechanisms and prevention of sudden death in multiple system atrophy .", "[ The clinical condition and treatment of diseases associated with sudden death ] .", "By univariate analysis there were no differences between patients with sudden death and those with VT in age, time from myocardial infarction to VT or sudden death, ejection fraction (0.31 +/-", "mechanism of sudden death in MSA . A multidisciplinary approach is needed to prevent sudden death , and this requires an organized system of several medical specialties . Neurologists require a", "Sudden death was found to share the same set of usual risk factors as coronary events and therefore could not be specifically predicted in the population.", "For people with obstructive sleep apnea , the relative risk of sudden death from cardiac causes from midnight to 6 a.m. was 2.57 ( 95 percent confidence interval , 1.87 to 3.52 ) .", "For four intervals of the day , we compared the rates of sudden death from cardiac causes among people with obstructive sleep apnea and the following : the rates among people without obstructive sleep apnea , the rates in the general population , and the expectations according to chance .", "Although current evidence suggests that VT frequently precedes ventricular fibrillation (VF) in patients presenting with sudden death, the factors resulting in rapid deterioration of VT to VF have not been delineated in humans.", "However, the absolute risk of sudden death during any particular episode of vigorous exertion was extremely low (1 sudden death per 1.51 million episodes of exertion).", "CONCLUSIONS These prospective data from a study of U.S. male physicians suggest that habitual vigorous exercise diminishes the risk of sudden death during vigorous exertion .", "We hypothesize that the incidence of sudden death tends to increase in line with the incidence of metabolic syndrome.", "However, the role of physical activity in precipitating or preventing sudden death has not been assessed prospectively in a large number of subjects. METHODS We used a prospective, nested case-crossover design within the Physicians' Health Study to compare the risk of sudden death during and up to 30 minutes after an episode of vigorous exertion with that during periods of lighter exertion or none.", "When adjusted for confounding variables , including parental history of myocardial infarction , relative risk of sudden death associated with parental sudden death was 1.80 ( 95% CI , 1.11 to 2.88 ) .", "Numerous diseases and conditions are associated with sudden death , including : acute myocardial infarction , irregular pulse , cardiac insufficiency , cerebrovascular disease , aortic dissection and choking .", "and EF ≤35% , the SPRM was predictive of the proportional risk of sudden vs. non - sudden death . ICDs were associated with a decreased risk of all - cause mortality by 37% and the ICD benefit", "People with sudden death from cardiac causes from midnight to 6 a.m. had a significantly higher apnea - hypopnea index than those with sudden death from cardiac causes during other intervals , and the apnea - hypopnea index correlated directly with the relative risk of sudden death from cardiac causes from midnight to 6 a.m.", "We hope that the symposium will help the citizen audience to understand the condition and treatment of sudden death , and also to help prevent sudden death .", "During programmed electrical stimulation , a sustained ventricular arrhythmia was initiated in 100% of patients with VT and 73% of patients with sudden death and rapidly produced syncope in 67% of patients with sudden death but in only 5% of those with VT .", "However, sudden death and cardiac events are the most significant cause of mortality in the dialysis population.", "11.11% ) had a positive history of sudden death in relatives . CONCLUSION Although most sudden death victims are asymptomatic until the event , all those who suffer from symptoms such as chest pain ,", "Therefore , it is important to determine the mechanisms and prevention of sudden death in MSA .", "CONCLUSIONS Parental sudden death is an independent risk factor for sudden death in middle-aged men.", "on the mechanisms and prevention of sudden death in patients with MSA . RESULTS Sudden death in MSA is hypothesized to be a consequence of disordered central respiration , suffocation caused", "Triggering of sudden death from cardiac causes by vigorous exertion.", ", syncope , or loss of consciousness . 1 case ( 11.11% ) had a positive history of sudden death in relatives . CONCLUSION Although most sudden death victims are asymptomatic until the event ,", "In addition , the relation of vigorous exercise to the overall risk of sudden death and nonsudden death from coronary heart disease was assessed .", "Predicting sudden death in the population : the Paris Prospective Study I. BACKGROUND Sudden death was found to share the same set of usual risk factors as coronary events and therefore could not be specifically predicted in the population .", "tests were available for 7 cases , one of which was positive for tramadol . Sudden death following football was reported most frequently ( 44.4% ) . Only 3 ( 33.3% ) cases had herald", "69 msec ) when monomorphic VT was induced in the group with sudden death .", "Parental sudden death is an independent risk factor for sudden death in middle - aged men .", "CRT - D ) was present prior to death in 1204 patients ( 62% ) . SPRM was predictive of sudden death vs. non - sudden death in those without an ICD ( P=0.002 ) . The hazard ratio representing ICD", "Day-night pattern of sudden death in obstructive sleep apnea.", "BACKGROUND Retrospective and cross-sectional data suggest that vigorous exertion can trigger cardiac arrest or sudden death and that habitual exercise may diminish this risk.", "to death in 1204 patients ( 62% ) . SPRM was predictive of sudden death vs. non - sudden death in those without an ICD ( P=0.002 ) . The hazard ratio representing ICD versus no ICD was 0.63 for", "athletes are assigned to it . Here we reported the autopsy results of all cases with sudden death following exercise that were referred to forensic center of Tehran , Iran , from 2009 to 2014 .", "Habitual vigorous exercise attenuated the relative risk of sudden death that was associated with an episode of vigorous exertion ( P value for trend=0.006 ) .", "METHODS In this cross sectional study all subjects who were registered to forensic medicine center of Tehran , Iran , from 2009 to 2014 , as a case of sudden death following exercise were evaluated .", "and noninvasive positive pressure ventilation ( NPPV ) for the prevention of sudden death . However , neither method has been able to prevent sudden death , and both have occasionally", "of these factors . CONCLUSION Various factors may be involved in the mechanism of sudden death in MSA . A multidisciplinary approach is needed to prevent sudden death , and this requires an", "Cardioverter - Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients ? BACKGROUND Prediction of which heart failure patients are most likely", "We then evaluated whether habitual vigorous exercise modified the risk of sudden death that was associated with vigorous exertion.", "This symposium was carried out in order to inform citizens about the condition known as sudden death.", "Results were reported using descriptive analysis . RESULTS 14 cases were registered as sudden death following exercise in forensic medicine profiles during the study period . Exploring the files of", "Only 3 (33.3%) cases had herald signs such as chest pain, syncope, or loss of consciousness. 1 case (11.11%) had a positive history of sudden death in relatives.", "We are of the opinion that the frequency of sudden death is very high in the fields of emergency medicine , cardiovascular medicine , cardiovascular surgery and neurosurgery .", "However, neither method has been able to prevent sudden death, and both have occasionally precipitated treatment-related complications, including central sleep apneas and exacerbation of floppy epiglottis.", "Themost likely possibility is that the larger serum - to - dialysate calcium gradient results in a larger calcium shift with increasing QT dispersion and risk of sudden death .", "BACKGROUND Prediction of which heart failure patients are most likely to die of sudden death vs. non-sudden death is an important factor in determining who will benefit the most from an ICD.", "is called sudden death . Cardiovascular diseases are the main known reason of sudden death and more than 75% of sudden deaths in athletes are assigned to it . Here we reported the autopsy", "Clinical implications of the relationship between low calcium concentration dialysate and sudden death.", "For 95.5% of the men, vital status was obtained from specific inquiries until retirement, then by death certificates. Resting heart rate, systolic or diastolic blood pressure, tobacco consumption, body mass index, diabetes status, serum cholesterol, and parental history of sudden death were independent factors associated with sudden death during", "OBJECTIVE We developed the Seattle Proportional Risk Model (SPRM) to estimate the proportion of total mortality due to sudden death.", "Sudden death following football was reported most frequently (44.4%).", "When adjusted for confounding variables, including parental history of myocardial infarction, relative risk of sudden death associated with parental sudden death was 1.80 (95% CI, 1.11 to 2.88).", "RESULTS From midnight to 6 a.m., sudden death from cardiac causes occurred in 46 percent of people with obstructive sleep apnea, as compared with 21 percent of people without obstructive sleep apnea (P=0.01), 16 percent of the general population (P<0.001), and the 25 percent expected by chance (P<0.001).", "to forensic medicine center of Tehran , Iran , from 2009 to 2014 , as a case of sudden death following exercise were evaluated . Demographic data and medical history as well as autopsy and", "The theme of this year is \" The clinical condition and treatment of diseases associated with sudden death \" in view of the above mentioned situation .", "Although most sudden death victims are asymptomatic until the event, all those who suffer from symptoms such as chest pain, shortness of breath, dizziness, fatigue and irregular heart rate during physical activities, should be screened regarding common probable causes of sudden death.", "Sudden Death Following Exercise ; a Case Series INTRODUCTION Natural and unexpected death that happens within less than one hour of first symptom occurrence is called sudden death .", "Clinical, angiographic, and electrophysiologic findings in patients with aborted sudden death as compared with patients with sustained ventricular tachycardia after myocardial infarction.", "A multidisciplinary approach is needed to prevent sudden death, and this requires an organized system of several medical specialties.", "This led to the use of tracheostomy and noninvasive positive pressure ventilation ( NPPV ) for the prevention of sudden death .", "For 95.5% of the men , vital status was obtained from specific inquiries until retirement , then by death certificates . Resting heart rate , systolic or diastolic blood pressure , tobacco consumption , body mass index , diabetes status , serum cholesterol , and parental history of sudden death were independent factors associated with sudden death during follow - up ( 23 years on average ) .", "for the prevention of sudden death . However , neither method has been able to prevent sudden death , and both have occasionally precipitated treatment - related complications , including central", "SPRM was predictive of sudden death vs. non-sudden death in those without an ICD (P=0.002).", "of which heart failure patients are most likely to die of sudden death vs. non - sudden death is an important factor in determining who will benefit the most from an ICD . OBJECTIVE We"], "par_relations": ["Heart", "MISCELLANEOUS"], "chd_relations": [], "syn_relations": [], "sib_relations": ["COSTELLO SYNDROME", "BRUGADA SYNDROME 1", "VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY", "CARDIOMYOPATHY, DILATED, 1D", "NAXOS DISEASE", "PROGRESSIVE FAMILIAL HEART BLOCK, TYPE II", "PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA", "VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2", "VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3", "CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1", "VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C563564", "canonical_name": "Cerebelloparenchymal Disorder VI", "aliases": ["cerebelloparenchymal disorder vi"], "definition": "", "other_contexts": [], "par_relations": ["Cerebellar Diseases", "Hamartoma Syndrome, Multiple"], "chd_relations": [], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:617245", "canonical_name": "HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 2", "aliases": ["nedd4-like e3 ubiquitin-protein ligase 2", "nedl2", "hecw2", "neurodevelopmental disorder with hypotonia, seizures, and absent language", "hect, c2, and ww domains-containing e3 ubiquitin-protein ligase 2", "kiaa1301"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 2", "HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 2", "HECW2, GLU1445GLY", "HECW2, ARG1330TRP", "HECW2, PHE1193VAL", "HECW2, ARG1191GLN", "HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 2", "HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 2", "HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 2", "HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 2", "HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 2", "HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 2"], "sib_relations": ["HECW2, GLU1445GLY", "HECW2, ARG1330TRP", "HECW2, PHE1193VAL", "HECW2, ARG1191GLN"]}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0001891", "canonical_name": "Iron deficiency anemia", "aliases": ["iron-deficiency anemia", "ferropenic", "iron deficiency anemia"], "definition": "", "other_contexts": ["1c levels are inconsistent . We conducted a study to analyze the effects of iron deficiency anemia on HbA1c levels and to assess whether treatment of iron deficiency anemia affects HbA1c levels .", "CONCLUSION Tumors of the gastrointestinal tract are the most common cause of sideropenic anemia, due to which the patients often first contact Counseling center for hematology.", "determined best equations for probability prediction of β-thal trait against iron deficiency anemia in our population . We compared diagnostic values and receiver operative characteristic ( ROC )", "Sideropenic anemia is most common in men after 50 years of age.", "Iron therapy in iron deficiency anemia in pregnancy: intravenous route versusoral route.", "Duodenal biopsy did not identify any causes other than coeliac disease for iron deficiency anaemia , suggesting that biopsy avoidance in Simtomax negative anaemic patients is unlikely to miss other anaemia - related pathologies .", "The study was completed by Sixty four (64) women with iron deficiency anemia during pregnancy and hemoglobin level below 10 gm/dl after informed consent and assigned into two groups thirty two (32) women in each group by a randomization table (13 women were suffering from parasitic infestation, 9 women in oral group discontinued treatment because of side effects and 6 women did not continue IV therapy because of travelling and preterm labour).", "study subjects ( 10.11% ) had iron deficiency anaemia . The prevalence of iron deficiency anaemia was significantly higher among younger age group than in the older age group ( 19.1% Vs 2.1% , p =", "equation with high accuracy for differential diagnosis of β-thal trait and iron deficiency anemia for the Sistan and Baluchestan population by logistic regression analysis . We selected 77 iron", "Mishra et al.11 concluded that parenteral iron therapy in iron deficiency anemia is recommended in patients where oral iron therapy is ineffective due to malabsorption states and noncompliance.", ", Gujarat , Karnataka , West Bengal , Assam and Punjab , were studied . Iron deficiency anemia was evaluated by measuring zinc protoporphyrin ( ZPP ) and hemoglobin ( Hb ) levels , while β-thal", "Abhilashini GD, Sagili H, Reddi R. Intravenous iron sucrose and oral iron for the treatment of iron deficiency anaemia inpregnancy.", "CONCLUSION Profound degree of iron deficiency anemia can present with thrombocytopenia and severe menorrhagia .", "Hb A2 levels in β-thal carriers were not greatly reduced in the presence of iron deficiency anemia .", ". OBJECTIVE To investigate the role of clinical pharmacists in managing iron deficiency anaemia patients . METHODS A prospective parallel randomised controlled trial conducted in an outpatient", "‘ Pre - endoscopy point of care test ( Simtomax- IgA / IgG - Deamidated Gliadin Peptide ) for coeliac disease in iron deficiency anaemia : diagnostic accuracy and a cost saving economic model’ BACKGROUND International guidelines recommend coeliac serology in iron deficiency anaemia , and duodenal biopsy for those tested positive to detect coeliac disease .", "Al Momen and colleagues9 compared 52 women treated with intravenous iron sucrose to 59 women treated with 300 mg oral iron sulfate in treatment of iron deficiency anemia during pregnancy .", "The prevalence of iron deficiency anaemia was significantly higher among younger age group than in the older age group (19.1% Vs 2.1%, p = 0.022).", "Iron Therapy in Treatment of Iron Deficiency Anemia", "In this case report we discuss a triad of symptoms seen in the African American population: Iron deficiency anemia, menorrhagia and thrombocytopenia.", ". The most common differential diagnosis of β-thalassemia ( β-thal ) trait is iron deficiency anemia . Several red blood cell equations were introduced during different studies for differential", "7.3% in the three groups . A significant reduction in Hb levels was seen when iron deficiency anemia was associated with hemoglobinopathies . However , the Hb A2 levels in β-thal carriers were not", "METHODS A prospective parallel randomised controlled trial conducted in an outpatient clinic enrolled adult iron deficiency anaemia patients .", "Also , Al Ragip et al.14 compared intravenous iron sucrose with oral iron polymaltose complex ( 300 mg elemental iron per day ) in women with iron deficiency anemia .", "Al Momen and colleagues; 9 concluded that iron sucrose was a safe and effective alternative in treatment of iron deficiency anemia during pregnancy.", "antibodies were compared in 133 prospectively recruited patients with iron deficiency anaemia attending for a gastroscopy . The sensitivities were measured against duodenal histology as the", "CONCLUSIONS In contrast to the observations of previous studies, ours showed that HbA1c levels and absolute HbA1c levels increased with treatment of iron deficiency anemia.", "Iron deficiency anemia: assessment, prevention and control.", "prevalence of iron deficiency anaemia among study subjects was 10.11% . Iron deficiency anaemia was more common in children aged two years and below . Weight - for - age and weight - for -", "The primary outcome measured was iron deficiency anaemia established based on the following criteria: hemoglobin <11.0 g/dl1 plus 2 or more of the following: MCV <70fl, transferrin saturation <10% or serum ferritin <15ng/dL. Statistical analysis included Pearson Chi square analysis and logistic regression analysis.", "Iron Deficiency Anemia in Pregnancy: Intravenous Versus Oral Route.", "is more common in men as also the number of digestive tract cancers in men . Sideropenic anemia has a significant place in the diagnosis of gastrointestinal tract tumors . Sideropenic anemia is", "undertaken to screen college / university students and pregnant women for iron deficiency anemia and various hemoglobinopathies . Fifty - six thousand , seven hundred and seventy - two subjects", "We used binary logistic regression analysis and determined best equations for probability prediction of β-thal trait against iron deficiency anemia in our population.", "Intravenous iron sucrose complex in the treatment of iron deficiency anemiaduring pregnancy.", "The aim of this study was to determine a native equation with high accuracy for differential diagnosis of β-thal trait and iron deficiency anemia for the Sistan and Baluchestan population by logistic regression analysis.", "Iron deficiency anemia was evaluated by measuring zinc protoporphyrin (ZPP) and hemoglobin (Hb) levels, while β-thal and other hemoglobinopathies were detected by measuring the red cell indices and by Hb analysis using high performance liquid chromatography (HPLC).", "A randomised control trial to evaluate the clinical pharmacist 's role in managing iron deficiency anaemia patients .", "CONCLUSION The prevalence of adult ADHD is higher than those reported for general population in patients with iron deficiency anemia.", "intravenous and oral iron supplements . Two months following treatment of iron deficiency anemia , the triad of manifestations resolved and patient remained stable . CONCLUSION Profound degree of", ". Group 3 : the duodenal histology of 153 patients presenting to a separate iron deficiency anaemia clinic were retrospectively reviewed . RESULTS In group 1 , serology was available in 361 ( 33.8 %", "Conclusions: Iron (III) Hydroxide Saccharate Complex (Iron Saccharate) appears to be a safe and effective treatment for iron deficiency anemia during pregnancy, to reduce the need for blood transfusion.", "saturation confirmed the diagnosis of iron deficiency anemia . Treatment for iron deficiency anemia was initiated with intravenous and oral iron supplements . Two months following treatment of iron", "We selected 77 iron deficiency anemia and 100 β-thal trait cases.", ". Duodenal biopsy did not identify any causes other than coeliac disease for iron deficiency anaemia , suggesting that biopsy avoidance in Simtomax negative anaemic patients is unlikely to miss other", "College boys (2.2%), college girls (14.3%) and antenatal women (27.0%) without any hemoglobinopathies had iron deficiency anemia.", "Abhilashini et al.10 compared the efficacy and safety of intravenous iron sucrose and oral iron administration for treatment of iron deficiency anemia in pregnancy.", "practice . The exact mechanism of the occurrence of thrombocytopenia in iron deficiency anemia remains unclear . In this case report we discuss a triad of symptoms seen in the African American", ", and epithelial dysplasia as a precancerous lesion . Strong link between sideropenic anemia and gastrointestinal tract cancers recommend that patients with sideropenic anemia without a clear", "METHODS Eighty-three newly diagnosed iron deficiency anemia patients and 70 healthy controls were included in this study.", "A Case Report and Literature Review INTRODUCTION Thrombocytosis is a common disorder in patients diagnosed with iron deficiency anemia.", "and Baluchestan population by logistic regression analysis . We selected 77 iron deficiency anemia and 100 β-thal trait cases . We used binary logistic regression analysis and determined best", "Interaction of iron deficiency anemia and hemoglobinopathies among college students and pregnant women: a multi center evaluation in India.", "had iron deficiency anemia . Among the β-thal carriers , the prevalence of iron deficiency anemia was 17.3% in college boys , 38.1% in college girls and 55.9% in pregnant women , while in the Hb E", "Group 2 : the sensitivities of Simtomax , endomysial and tissue - transglutaminase antibodies were compared in 133 prospectively recruited patients with iron deficiency anaemia attending for a gastroscopy .", "cell distribution width and low iron saturation confirmed the diagnosis of iron deficiency anemia . Treatment for iron deficiency anemia was initiated with intravenous and oral iron supplements .", "Patients and methods: Sixty four (64) women between 24-30 weeks gestation with iron deficiency anemia during pregnancy and hemoglobin level below 10 gm/dl were randomized in this study to receive either; Iron Saccharate in intravenous group (IV group) or oral ferrous Fumarate in oral group (PO group).", "today . OBJECTIVE To estimate the prevalence and associated factors for iron deficiency anaemia among pre - school children in Lagos . METHODOLOGY The study was conducted from December 2009 to", "Among the β-thal carriers, the prevalence of iron deficiency anemia was 17.3% in college boys, 38.1% in college girls and 55.9% in pregnant women, while in the Hb E [β26(B8)Glu→Lys; HBB: c.79G>A] carriers, it was 7.3% in college boys, 25.4% in college girls and 78.0% in antenatal women.", "Nine of the study subjects ( 10.11% ) had iron deficiency anaemia .", "Two months following treatment of iron deficiency anemia , the triad of manifestations resolved and patient remained stable .", "that HbA1c levels and absolute HbA1c levels increased with treatment of iron deficiency anemia . This could be attributable to nutritional deficiency and/or certain unknown variables . Further", "We suggest that to get the best equation and cut-off in each region, one needs to evaluate specific information of each region, specifically in areas where populations are homogeneous, to provide a specific formula for differentiating between β-thal trait and iron deficiency anemia.", "students and pregnant women : a multi center evaluation in India . Although iron deficiency anemia is very common in India , systematic large studies on the prevalence and hematological", "However, the Hb A2 levels in β-thal carriers were not greatly reduced in the presence of iron deficiency anemia.", "CONCLUSION Simtomax had excellent diagnostic accuracy in iron deficiency anaemia and was comparable to conventional serology .", "They also, concluded that intravenous iron results in much more rapid resolution of iron deficiency anemia with minimal adverse reactions compared to oral iron.", "has a significant place in the diagnosis of gastrointestinal tract tumors . Sideropenic anemia is most common in men after 50 years of age . The most common tumors of the gastrointestinal tube", "BACKGROUND Iron deficiency, and specifically iron deficiency anaemia, remains one of the most severe and important nutritional deficiencies in the world today.", "Also, Shafi et al.4 concluded that the hemoglobin level elevated and iron stores restored rapidly when women with iron deficiency anemia during pregnancy was treated parenterally with iron sucrose compared to oral ferrous ascorbate.", "Z scores below minus two standard scores were strongly associated with iron deficiency anaemia .", "High prevalence of iron deficiency anemia among women in developing countries is of concern and maternal anemia is still a cause of considerable perinatal morbidity and mortality.3 Anemia is responsible for adverse obstetric outcome in a large number of women in developing countries.", "iron deficiency without anaemia . Nine of the study subjects ( 10.11% ) had iron deficiency anaemia . The prevalence of iron deficiency anaemia was significantly higher among younger age group than", "with iron deficiency anemia . The decreased platelet counts commonly found iron deficiency anemia is rarely reported in clinical practice . The exact mechanism of the occurrence of", "Saccharate Complex (Iron Saccharate) is a safe, effective alternative for treatment of iron deficiency anemia during pregnancy, beinggiven in outpatient settings and able to reduce the need for blood transfusion.", "Early diagnose and treatment of adult ADHD may positively contribute to the patients with iron deficiency anemia.", "and another 10 published equations in discriminating β-thal trait and iron deficiency anemia . The binary logistic regression analysis determined the best equation for best probability", "This study was designed to compare the efficacy and safety of intravenous versus oral iron in treatment of iron deficiency anemia during pregnancy and before delivery.", ". CONCLUSION Tumors of the gastrointestinal tract are the most common cause of sideropenic anemia , due to which the patients often first contact Counseling center for hematology . Sideropenic", "Treatment for iron deficiency anemia was initiated with intravenous and oral iron supplements.", "RESULTS The study included 100 subjects ( 50 from counseling center for hematology that came due to sideropenic anemia and 50 patients from the Clinic for Gastroenterology who had gastrointestinal tract cancer ) .", "coeliac disease . CONCLUSION Simtomax had excellent diagnostic accuracy in iron deficiency anaemia and was comparable to conventional serology . Duodenal biopsy did not identify any causes other", "Complete blood picture (CBC), hemoglobin concentration (gm/dl), Mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCH), serum ferritin (ug/l) and reticulocytes count (106/mm3) were checked to confirm the diagnosis of iron deficiency anemia during pregnancy before inclusion in this study.", "The prevalence of iron deficiency anaemia was significantly higher among subjects with weight-for-age, and weight-for-height Z scores below two standard scores (83.3% and 75.0% respectively, p = <0.001 and 0.001 respectively).", "The decreased platelet counts commonly found iron deficiency anemia is rarely reported in clinical practice.", "the best equation for best probability prediction of β-thal trait against iron deficiency anemia with area under curve ( AUC ) 0.998 . Based on ROC curves and AUC , Green & King , England &", "OBJECTIVE To estimate the prevalence and associated factors for iron deficiency anaemia among pre-school children in Lagos.", "during different studies for differential diagnosis between β-thal trait and iron deficiency anemia . Due to genetic variations in different regions , these equations can not be useful in all", "A significant reduction in Hb levels was seen when iron deficiency anemia was associated with hemoglobinopathies.", "anemia affects HbA1c levels . METHODS Fifty patients confirmed to have iron deficiency anemia were enrolled in this study . HbA1c and absolute HbA1c levels were measured both at baseline and", "p = < 0.001 and 0.001 respectively ) . CONCLUSION The overall prevalence of iron deficiency anaemia among study subjects was 10.11% . Iron deficiency anaemia was more common in children aged two", "METHODS Fifty patients confirmed to have iron deficiency anemia were enrolled in this study . HbA1c and", "model’ BACKGROUND International guidelines recommend coeliac serology in iron deficiency anaemia , and duodenal biopsy for those tested positive to detect coeliac disease . However , pre -", "ConclusionsIron (III) Hydroxide Saccharate Complex (Iron Saccharate) appears to be an effective treatment for iron deficiency anemia duringpregnancy, which produces a rapid increase in hemoglobin concentration and serum ferritin levels without serious side effectsindicated in women who cannot tolerate oral iron preparations and for replacement of depleted iron stores.", "The exact mechanism of the occurrence of thrombocytopenia in iron deficiency anemia remains unclear.", "of iron deficiency anemia on HbA1c levels and to assess whether treatment of iron deficiency anemia affects HbA1c levels . METHODS Fifty patients confirmed to have iron deficiency anemia were", "In the study, 22.9% of patients with iron deficiency anemia and 12.9% of healthy controls were found to have WURS scores 36 and above.", "Iron deficiency anaemia among apparently healthy pre-school children in Lagos, Nigeria.", "INTRODUCTION Thrombocytosis is a common disorder in patients diagnosed with iron deficiency anemia . The decreased platelet counts commonly found iron deficiency anemia is rarely reported in", "( Simtomax- IgA / IgG - Deamidated Gliadin Peptide ) for coeliac disease in iron deficiency anaemia : diagnostic accuracy and a cost saving economic model’ BACKGROUND International guidelines", "In individuals with Hb E disease, the prevalence of iron deficiency anemia varied from 31.2-77.3% in the three groups.", ".0% in antenatal women . In individuals with Hb E disease , the prevalence of iron deficiency anemia varied from 31.2 - 77.3% in the three groups . A significant reduction in Hb levels was seen when", "resolved and patient remained stable . CONCLUSION Profound degree of iron deficiency anemia can present with thrombocytopenia and severe menorrhagia . Iron replacement should be the main", "The binary logistic regression analysis determined the best equation for best probability prediction of β-thal trait against iron deficiency anemia with area under curve (AUC) 0.998.", "Several red blood cell equations were introduced during different studies for differential diagnosis between β-thal trait and iron deficiency anemia.", "OBJECTIVE To investigate the role of clinical pharmacists in managing iron deficiency anaemia patients .", "However, reports on the effects of iron deficiency anemia on HbA1c levels are inconsistent.", "serum ferritin were assayed in subjects . The primary outcome measured was iron deficiency anaemia established based on the following criteria : hemoglobin < 11.0 g / dl1 plus 2 or more of the", "Treatments for iron deficiency anemia in pregnancy: RHL commentary.", "we discuss a triad of symptoms seen in the African American population : Iron deficiency anemia , menorrhagia and thrombocytopenia . CASE PRESENTATION A 40 year old multiparous African -", "in the older age group ( 19.1% Vs 2.1% , p = 0.022 ) . The prevalence of iron deficiency anaemia was significantly higher among subjects with weight - for - age , and weight - for - height Z", "Bencaiova G , von Mandach U , Zimmermann R. Iron prophylaxis in pregnancy : intravenous route versus oral route .", "children in Lagos , Nigeria . BACKGROUND Iron deficiency , and specifically iron deficiency anaemia , remains one of the most severe and important nutritional deficiencies in the world today .", "CONCLUSION The overall prevalence of iron deficiency anaemia among study subjects was 10.11%.", "control trial to evaluate the clinical pharmacist 's role in managing iron deficiency anaemia patients . OBJECTIVE To investigate the role of clinical pharmacists in managing iron deficiency", "Discussion Iron deficiency anemia is common during pregnancy and deserves special attention because of its potential consequences.", "( 14.3% ) and antenatal women ( 27.0% ) without any hemoglobinopathies had iron deficiency anemia . Among the β-thal carriers , the prevalence of iron deficiency anemia was 17.3% in college boys ,", "Anemia in the Diagnosis of Gastrointestinal Tract Tumors INTRODUCTION Sideropenic anemia is a hypochromic , microcytic anemia caused by insufficient iron level in the body . This is the", "INTRODUCTION The aim of this study was to investigate symptoms and diagnoses of Adult-Attention Deficit/Hyperactivity Disorder (ADHD) in women with iron deficiency anemia, to evaluate relationship between ADHD with clinical features and to compare with the women without iron deficiency anemia.", ", to provide a specific formula for differentiating between β-thal trait and iron deficiency anemia .", "anemia and gastrointestinal tract cancers recommend that patients with sideropenic anemia without a clear indication underwent same gastroscopic and colonoscopy examination . The goals", "100 subjects ( 50 from counseling center for hematology that came due to sideropenic anemia and 50 patients from the Clinic for Gastroenterology who had gastrointestinal tract cancer ) .", "same gastroscopic and colonoscopy examination . The goals were to prove sideropenic anemia , diagnose and histologically confirm tumors , tumors location and correlates anemia with tumor", "Iron (III) Hydroxide Saccharate Complex (Iron Saccharate) seems to be treatment of choice without serious side effects for iron deficiency anemia during pregnancy to avoid risks of blood transfusion.", "Group 3: the duodenal histology of 153 patients presenting to a separate iron deficiency anaemia clinic were retrospectively reviewed.", "Although iron deficiency anemia is very common in India, systematic large studies on the prevalence and hematological consequences of iron deficiency among carriers of β-thalassemia (β-thal) and other hemoglobinopathies are lacking.", "The Investigation of Symptoms and Diagnoses of Adult-Attention Deficit/ Hyperactivity Disorder in Women with Iron Deficiency Anemia.", "Fifteen patients ( 18.1% ) in iron deficiency anemia group and two patients ( 2.9% ) in control group had adult ADHD , when they were evaluated with Adult ADD / ADHD Evaluation Scale and interviewed according to DSM-5 criteria ( p=0.007 ) .", "A multi center project was undertaken to screen college/university students and pregnant women for iron deficiency anemia and various hemoglobinopathies.", "pharmaceutical care services and worked closely with physicians to manage iron deficiency anaemia . Patients in the control group received the usual medical care . KEY FINDINGS One hundred and", "The goals were to prove sideropenic anemia, diagnose and histologically confirm tumors, tumors location and correlates anemia with tumor anemia or show the dependence of anemia on tumor.", "We compared diagnostic values and receiver operative characteristic (ROC) curve related to this equation and another 10 published equations in discriminating β-thal trait and iron deficiency anemia.", "The patients with iron deficiency anemia had significantly higher WURS scores compared to controls (p=0.002).", "Weight - for - age and weight - for - height Z scores below minus two standard scores were strongly associated with iron deficiency anaemia .", "Triad of Iron Deficiency Anemia, Severe Thrombocytopenia and Menorrhagia—", ", pregnancy , and acute blood loss . However , reports on the effects of iron deficiency anemia on HbA1c levels are inconsistent . We conducted a study to analyze the effects of iron deficiency", "A local equation for differential diagnosis of β-thalassemia trait and iron deficiency anemia by logistic regression analysis in Southeast Iran.", "We conducted a study to analyze the effects of iron deficiency anemia on HbA1c levels and to assess whether treatment of iron deficiency anemia affects HbA1c levels.", "Patients in the intervention group were followed closely by a clinical pharmacist who offered pharmaceutical care services and worked closely with physicians to manage iron deficiency anaemia.", "After excluding other causes of thrombocytopenia and anemia , increased red cell distribution width and low iron saturation confirmed the diagnosis of iron deficiency anemia .", "controlled trial conducted in an outpatient clinic enrolled adult iron deficiency anaemia patients . Patients were randomised into either an intervention or a control group . Patients in", "The most common differential diagnosis of β-thalassemia (β-thal) trait is iron deficiency anemia.", "In the group of patients from Counseling center for hematology with sideropenic anemia was found 11 cancerous processes, mostly in form of gastric and colon cancer.", "( 83.9% ) . CONCLUSION Clinical pharmacist interventions improved iron deficiency anaemia patients ' outcomes .", "Abhilashini GD , Sagili H , Reddi R. Intravenous iron sucrose and oral iron for the treatment of iron deficiency anaemia in < lb > pregnancy .", "Strong link between sideropenic anemia and gastrointestinal tract cancers recommend that patients with sideropenic anemia without a clear indication underwent same gastroscopic and colonoscopy examination.", "CONCLUSION Clinical pharmacist interventions improved iron deficiency anaemia patients' outcomes.", "Effect of Iron Deficiency Anemia on Hemoglobin A1c Levels BACKGROUND Iron deficiency anemia is the most common form of anemia in India.", "due to which the patients often first contact Counseling center for hematology . Sideropenic anemia is more common in men as also the number of digestive tract cancers in men . Sideropenic anemia", "markers . In the group of patients from Counseling center for hematology with sideropenic anemia was found 11 cancerous processes , mostly in form of gastric and colon cancer . In the group of"], "par_relations": ["Hypochromic anemia"], "chd_relations": [], "syn_relations": ["Iron deficiency anemia", "Iron deficiency anemia", "Iron deficiency anemia", "Iron deficiency anemia"], "sib_relations": ["Hypochromic microcytic anemia"]}, "target_ent": {"research_entity_id": "OMIM:608272.0015", "canonical_name": "NEU1, ALA298VAL", "aliases": ["neu1, ala298val"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["NEURAMINIDASE 1"], "sib_relations": ["NEURAMINIDASE 1"]}}
{"label": 1, "source_ent": {"research_entity_id": "HGNC:HGNC:19660", "canonical_name": "solute carrier family 36 member 4", "aliases": ["pat4", "slc36a4", "flj38932", "solute carrier family 36 member 4", "slc36a4 gene"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["solute carrier family 36 member 4", "solute carrier family 36 member 4", "solute carrier family 36 member 4", "solute carrier family 36 member 4", "solute carrier family 36 member 4", "solute carrier family 36 member 4"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:613760", "canonical_name": "SOLUTE CARRIER FAMILY 36, MEMBER 4", "aliases": ["pat4", "solute carrier family 36, member 4", "slc36a4", "proton/amino acid transporter 4"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["SOLUTE CARRIER FAMILY 36, MEMBER 4", "SOLUTE CARRIER FAMILY 36, MEMBER 4", "SOLUTE CARRIER FAMILY 36, MEMBER 4", "SOLUTE CARRIER FAMILY 36, MEMBER 4", "SOLUTE CARRIER FAMILY 36, MEMBER 4", "SOLUTE CARRIER FAMILY 36, MEMBER 4"], "sib_relations": []}}
{"label": 1, "source_ent": {"research_entity_id": "GO:GO:0008152", "canonical_name": "metabolic process", "aliases": ["metabolism resulting in cell growth", "metabolic process resulting in cell growth", "metabolic process", "metabolism"], "definition": "The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation. [GOC:go_curators, ISBN:0198547684]", "other_contexts": [], "par_relations": ["biological_process", "metabolic process", "metabolic process"], "chd_relations": ["metabolic process", "metabolic process", "methylation", "biosynthetic process", "hormone metabolic process", "catabolic process", "wax metabolic process", "nitrogen compound metabolic process", "primary metabolic process", "cellular metabolic process", "multi-organism metabolic process", "organic substance metabolic process", "tyrocidine metabolic process", "single-organism metabolic process", "hydrogen metabolic process", "catalytic activity"], "syn_relations": ["metabolic process", "obsolete fat body metabolic process (sensu Insecta)", "metabolic process resulting in cell growth", "metabolic process"], "sib_relations": ["regulation of metabolic process", "regulation of metabolic process", "negative regulation of metabolic process", "negative regulation of metabolic process", "positive regulation of metabolic process", "positive regulation of metabolic process", "behavior", "cell aggregation", "growth", "locomotion", "detoxification", "reproduction", "reproductive process", "response to stimulus", "cell killing", "biological regulation", "cellular process", "multicellular organismal process", "developmental process", "rhythmic process", "multi-organism process", "localization", "immune system process", "biological adhesion", "cellular component organization or biogenesis", "signaling", "single-organism process", "biological phase", "presynaptic process involved in synaptic transmission"]}, "target_ent": {"research_entity_id": "MSH:D008660", "canonical_name": "Metabolism", "aliases": ["metab process", "metab", "metabolism concepts", "metabolism concept", "metabolic concepts", "phenomena, metabolic", "phenomenon, metabolic", "concept, metabolism", "concept, metabolic", "processes metab", "anabolism", "metabolic phenomena", "metabolic processes", "processes, metabolic", "metabolic concept", "concepts, metabolism", "process, metabolic", "metabolism", "metabolism phenomena", "process metab", "metabolic process", "phenomena, metabolism", "catabolism", "concepts, metabolic", "metab processes", "metabolic phenomenon"], "definition": "The chemical reactions in living organisms by which energy is provided for vital processes and activities and new material is assimilated.", "other_contexts": ["Further, the metabolic process enrichment scores were integrated with the transcriptome profiles of HCC.", "Seasonal variations in energy levels and metabolic processes of two dominant Acropora species (A. spicifera and A. digitifera) at Ningaloo Reef Seasonal variations in coral health indices reflecting autotrophic activity (chlorophyll a and zooxanthellae density), metabolic rates (RNA/DNA ratio and protein) and energy storage (ratio of storage: structural lipids or lipid ratios) were examined for two dominant Acropora species [Acropora digitifera (AD) and Acropora spicifera (AS)] at Ningaloo Reef (north-western Australia).", "Our results imply different metabolic processes in A. digitifera and A. spicifera as well as a strong impact of extreme events on coral physiology.", "Such detailed investigation of metabolic processes is important background, with regard to understanding the vulnerability of corals to environmental change.", "Integrative analysis shows three distinct metabolic deregulations: i) hepatocyte function related molecular processes involving lipid/fatty acid/bile acid synthesis, ii) inflammatory processes with cytokine, sphingolipid & chondriotin sulphate metabolism and iii) enriched nucleotide metabolic process involving purine/pyrimidine & glucose mediated catabolic process, in hepatocarcinogenesis.", "The three distinct metabolic processes were found to occur both in tumor and liver cancer cell line profiles.", "Integrative functional genomic analysis unveils the differing dysregulated metabolic processes across hepatocellular carcinoma stages.", "largest categories included proteins involved in defense response ( 24.2% ) , protein metabolism ( 24.2% ) , carbohydrate metabolism ( 19.4% ) , and amino acid metabolism ( 14.5% ) . Exogenous", "One of the end products and processes of the central dogma being the metabolites and metabolic processes mediate the cellular functions.", "Systems Biology Approach to Discovery of Phenotype-Specific Metabolic Processes for Engineering Bacterial Bio-Hydrogen 37831 Biological hydrogen is one of the most promising alternative energy and fuel resource today.", "To improve upon current technological applications, biological and metabolic engineering approaches are underway to optimize metabolic processes involved in hydrogen production.", "/ damaged proteins , activation of stress defense , and the promotion of carbohydrate metabolism to generate more energy .", "rearrangement . Put also increased the abundance of proteins involved in amino acid metabolism . Meanwhile , physiological analysis showed that Put could further up - regulated the levels of", "proteins as key regulators were significantly involved in carbon metabolism , lipid metabolism , and signal transduction . Comparable gene expression was used to identify the genes that", "The data obtained suggest the existence of a genetically determined predisposition of the mitochondrial metabolic processes in the offspring of the alcoholized rats to the effects of ethanol and to the toxic effects of acetaldehyde, formed during ethanol metabolism.", "removal of waste products . Malignant cells show a pronounced increase in metabolic processes where the 10- to 15-fold rise in glucose consumption is only the tip of the iceberg . Aerobic", "an enhancement in energy generation . Proteins involved in defense response and protein metabolism were differently regulated by Put , which indicated the roles of Put in stress resistance and", "to Mercury Methylation and Dissimilatory Metal Reduction Reveals Changes in Respiratory Metabolism in Geobacter sulfurreducens PCA . Geobacter sulfurreducens PCA can reduce , sorb , and methylate", "involved in defense response ( 24.2% ) , protein metabolism ( 24.2% ) , carbohydrate metabolism ( 19.4% ) , and amino acid metabolism ( 14.5% ) . Exogenous Put up - regulated most identified", "extracellular matrix ( ECM ) is the result of a delicate balance between metabolic processes and proton production , proton transportation , chemical buffering , and vascular removal of waste", "The Investment in Scent: Time-Resolved Metabolic Processes in Developing Volatile-Producing Nigella sativa L. Seeds The interplay of processes in central and specialized metabolisms during seed development of Nigella sativa L. was studied by using a high-throughput metabolomics technology and network-based analysis.", "This study opens perspectives for accurately simulating bone metabolic processes using a fully integrated computational workflow leading to a better understanding of the musculoskeletal system function from multiple length scales as well as to provide new informative data for clinical decision support and industrial applications.", "14.5% ) . Exogenous Put up - regulated most identified proteins involved in carbohydrate metabolism , implying an enhancement in energy generation . Proteins involved in defense response and protein", "The objective of this present work was to develop a new fully integrated computational workflow for simulating bone metabolic processes at multi-scale levels.", "Transcriptional Profiles of Drought-Related Genes in Modulating Metabolic Processes and Antioxidant Defenses in Lolium multiflorum", "antioxidants ( HPTs , GGT , AP , 6-PGD , and G6PDH ) function as antioxidant in lipid metabolism and signal transduction pathways , which have indispensable and promoting roles in drought", "Unsupervised hierarchical clustering of the metabolic processes along with clinical sample information has identified two major clusters based on AFP (alpha-fetoprotein) and metastasis.", "observation supports the hypothesis that the function of HgcA and HgcB is linked to C1 metabolism through the folate branch of the acetyl - CoA pathway by providing methyl groups required for Hg", "Advanced computational workflow for the multi-scale modeling of the bone metabolic processes Multi-scale modeling of the musculoskeletal system plays an essential role in the deep understanding of complex mechanisms underlying the biological phenomena and processes such as bone metabolic processes.", "Malignant cells show a pronounced increase in metabolic processes where the 10- to 15-fold rise in glucose consumption is only the tip of the iceberg.", "Studies on mitochondrial metabolic processes in offspring of alcoholized rats--I. Evidence for altered activity and sensitivity to monoamine oxidase-dependent control by biogenic amines of some membrane-bound enzymes.", "In recent years, metabolomics based investigations have revealed the major deregulated metabolic processes involved in carcinogenesis.", ".2% ) , protein metabolism ( 24.2% ) , carbohydrate metabolism ( 19.4% ) , and amino acid metabolism ( 14.5% ) . Exogenous Put up - regulated most identified proteins involved in carbohydrate", "Due to the ability of several naturally occurring microorganisms to generate hydrogen using different metabolic processes, biohydrogen production is considered a feasible and sustainable technology.", "of the iceberg . Aerobic glycolysis ( Warburg effect ) is one of the hallmarks of cancer metabolism that implies excessive production of protons , which if stayed inside the cells would result in", "Network-based analysis identified coordinated metabolic processes during development and demonstrated the presence of five network communities.", "drought - responsive proteins as key regulators were significantly involved in carbon metabolism , lipid metabolism , and signal transduction . Comparable gene expression was used to identify the", "polyamines contents by regulating the transcription levels of key enzymes in polyamine metabolism . Taken together , these results suggest that Put may alleviate NaCl - induced growth inhibition", "However, the integrative analysis of the holistic metabolic processes with genomics is at an early stage."], "par_relations": ["Metabolism", "Phenomena and Processes (MeSH Category)", "Metabolism", "Metabolism"], "chd_relations": ["Metabolism", "Metabolism", "Absorption", "Acid-Base Equilibrium", "Acylation", "Aerobiosis", "Alkylation", "Amination", "Anaerobiosis", "Biological Transport", "Biotransformation", "Body Composition", "Brain Chemistry", "Cyclization", "Dealkylation", "Deamination", "Decarboxylation", "Energy Metabolism", "Enterohepatic Circulation", "Enzyme Activation", "Esterification", "Hydrogenation", "Hydroxylation", "Metabolic Clearance Rate", "Nitrosation", "Oxygen Consumption", "Pharmacokinetics", "Phosphorylation", "Protein Binding", "Renin-Angiotensin System", "RNA Processing, Post-Transcriptional", "Secretory Rate", "Prenylation", "Oxidative Stress", "Halogenation", "Toxicokinetics", "Cell Respiration", "Carbohydrate Metabolism", "Dimerization", "Biotinylation", "Proteolysis", "Lipid Metabolism", "Peptide Biosynthesis", "Osmoregulation", "Phototrophic Processes", "Autotrophic Processes", "Heterotrophic Processes", "Metabolic Networks and Pathways", "Biocatalysis", "Metabolome", "Catabolite Repression", "Metabolism"], "syn_relations": ["Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism", "Metabolism"], "sib_relations": ["Biological Phenomena", "Cell Physiological Phenomena", "Circulatory and Respiratory Physiological Phenomena", "Microbiological Phenomena", "Ocular Physiological Phenomena", "Reproductive and Urinary Physiological Phenomena", "Plant Physiological Phenomena", "Physical Phenomena", "Chemical Phenomena", "Genetic Phenomena", "Immune System Phenomena", "Mathematical Concepts", "Musculoskeletal and Neural Physiological Phenomena", "Digestive System and Oral Physiological Phenomena", "Integumentary System Physiological Phenomena", "Physiological Phenomena"]}}
{"label": 1, "source_ent": {"research_entity_id": "HPO:HP:0100245", "canonical_name": "Desmoid tumors", "aliases": ["desmoid tumors"], "definition": "Benign, slow-growing tumors without any metastatic potential. Despite their benign nature, they can damage nearby structures causing organ dysfunction. Histologically they resemble low-grade fibrosarcomas, but they are very locally aggressive and tend to recur even after complete resection. There is a tendency for recurrence in the setting of prior surgery and the most common localisation of these tumors is intraabdominal from smooth muscle cells of the instestine. [HPO:sdoelken]", "other_contexts": [], "par_relations": ["Fibroma", "Fibrosarcoma", "Neoplasm of the gastrointestinal tract"], "chd_relations": [], "syn_relations": [], "sib_relations": ["Biliary tract neoplasm", "Neoplasm of the large intestine", "Esophageal neoplasm", "Gingival fibromatosis", "Intestinal polyp", "Neoplasm of the liver", "Neoplasm of the stomach", "Zollinger-Ellison syndrome", "Ovarian fibroma", "Neurofibromas", "Fibroadenoma of the breast", "Ossifying fibroma", "Angiofibromas", "Gastrointestinal stroma tumor", "Subungual fibromas", "Neoplasm of the small intestine", "Ungual fibroma", "Benign gastrointestinal tract tumors", "Malignant gastrointestinal tract tumors", "Cardiac fibroma", "Lung fibroma", "Primary peritoneal carcinoma", "Intestinal carcinoid", "Multiple intestinal neurofibromatosis"]}, "target_ent": {"research_entity_id": "MSH:D018222", "canonical_name": "Fibromatosis, Aggressive", "aliases": ["fibromatoses, aggressive", "desmoids", "aggressive fibromatoses", "desmoid", "fibromatosis, aggressive", "aggressive fibromatosis"], "definition": "A childhood counterpart of abdominal or extra-abdominal desmoid tumors, characterized by firm subcutaneous nodules that grow rapidly in any part of the body but do not metastasize. The adult form of abdominal fibromatosis is FIBROMATOSIS, ABDOMINAL. (Stedman, 25th ed)", "other_contexts": ["surgeons and 23 oncologists ( 14 clinical , nine medical ) were analysed . Desmoid fibromatosis management is generally shared by surgeons and oncologists within sarcoma multidisciplinary teams", "current management of desmoid ( aggressive ) fibromatosis . AIMS The optimal management of desmoid fibromatosis remains unclear , leading to significant variability in patient management . To", "The authors report the case of an 18-month-old boy who underwent resection of a right temporal desmoid tumor (initially diagnosed as cranial fasciitis) and developed a bilateral frontoparietal calvarial desmoid tumor 2 years later.", "We report a case of postoperative retroperitoneal desmoid tumor that developed 29 mo after the first excision of a gastrointestinal stromal tumor.", "AIMS The optimal management of desmoid fibromatosis remains unclear , leading to significant variability in patient management .", "Desmoids are very rare tumors in the general population but occur frequently in FAP patients, being encountered in 23–38 %.", "It reinforces the need for timely and accurate diagnosis when a new mass develops in the region of a preexisting desmoid tumor, and more generally when a desmoid tumor modifies its clinical or radiological aspect.", "The authors believe, however, that some of the cases previously reported as cranial fasciitis are likely desmoid tumors pathobiologically and genetically.", "selective estrogen receptor modulators ( SERMs ) for sporadic and FAP - associated desmoid tumors . Desmoids are very rare tumors in the general population but occur frequently in FAP patients ,", "at 12 months of follow - up . DISCUSSION Conventional treatment of abdominal wall desmoid tumors consists in a wide and radical resection . However , complete resection is not always feasible", "with familial adenomatous polyposis requiring bifrontoparietal cranioplasty : case report . Desmoid tumors , also known as aggressive fibromatosis , are locally infiltrating musculoaponeurotic", "treatment is successful in most patients . The recurrence rate is negligible with no desmoid - related mortality in this large series . Therefore surgical resection , especially for", "proliferative and invasive benign lesions . They can be sporadic , but in most instances , desmoid tumors develop in the context of Gardner 's syndrome with principal localization in the abdominal", "We recently experienced a case of true intrathoracic desmoid tumor presenting as multiple lung nodules at 13 years after resection of a previous intraabdominal desmoid tumor.", "was investigated . MATERIALS AND METHODS A hypothetical case of intramuscular limb girdle desmoid fibromatosis in a fit 65-year - old patient was devised . Surgical and non - surgical oncology", "prospective screening of FAP . No new cases of FAP were found . The risk of FAP among desmoid tumor patients was 4.8% . In the FAP desmoid group , there were more males and patients were younger", ", especially in the retroperitoneum . We report a case of postoperative retroperitoneal desmoid tumor that developed 29 mo after the first excision of a gastrointestinal stromal tumor . Sporadic", "resection of a desmoid tumor in a patient with a Gardner 's syndrome . INTRODUCTION Desmoid tumors are rare proliferative and invasive benign lesions . They can be sporadic , but in most instances ,", "alone or rt alone might also be reasonable treatment options , regardless of whether the desmoid umours are deemed to be resectable . RECOMMENDATIONS FOLLOW - UP STRATEGIES Undergo evaluation for", "wall , or intra - abdominally . Our aim was to examine the outcome of radiotherapy of desmoid tumors in a single institution series . We evaluated 41 patients with desmoid tumors treated with 4", "We evaluated 41 patients with desmoid tumors treated with 49 radiotherapies between 1987 and 2012.", "and invasive benign lesions . They can be sporadic , but in most instances , desmoid tumors develop in the context of Gardner 's syndrome with principal localization in the abdominal cavity", "after resection of a desmoid tumor in a patient with a Gardner 's syndrome . INTRODUCTION Desmoid tumors are rare proliferative and invasive benign lesions . They can be sporadic , but in most", "excision of a gastrointestinal stromal tumor . Sporadic trauma - related intra - abdominal desmoid tumors reported in the English literature are also reviewed . Despite an extremely low incidence ,", "The recurrence rate is negligible with no desmoid-related mortality in this large series.", "Postoperative intra-abdominal desmoid tumor is rare, especially in the retroperitoneum.", "at least 1 year of treatment . Response was defined as stable size or regression of desmoid size between two CT or MRI scans . A total of 134 patients were included . 64 ( 47.8 % ) patients", "evidence ; a national consensus or a desmoid fibromatosis registry may help to standardise desmoid fibromatosis care .", "identified individuals with attenuated FAP by APC gene mutation test . We compared sporadic desmoid patients ' and FAP patients ' clinical characteristics . RESULTS Ten of 106 patients already had", ". Here we report on a 61-year - old patient who presented a locally advanced breast desmoid tumor diagnosed 20 years after post - operative radiotherapy for breast carcinoma . After 2 years", "INTRODUCTION Desmoid tumors are rare proliferative and invasive benign lesions.", "revision of his cranioplasty . This is the first report describing a recurrent cranial desmoid tumor in a pediatric patient with FAP . The authors believe , however , that some of the cases", "an elevated risk of familial adenomatous polyposis . BACKGROUND The prevalence of desmoid tumors among patients with familial adenomatous polyposis ( FAP ) is at least 10% , and the prevalence of", ", very few cases have extra - abdominal locations . The origin of intrathoracic desmoid tumors is predominantly the chest wall with occasional involvement of pleura . True intrathoracic primary", "survey . We propose a review of current evidence ; a national consensus or a desmoid fibromatosis registry may help to standardise desmoid fibromatosis care .", "RECOMMENDATIONS TREATMENTS Surgery with or without rt can be a reasonable treatment option for patients with desmoid tumours whose surgical morbidity is deemed to be low .", ", a high - grade undifferentiated pleomorphic soft tissue sarcoma arose within the desmoid tumor . Despite extensive surgery removing both tumors , the patient showed locoregional relapse by the", "or pleura are extremely rare . We recently experienced a case of true intrathoracic desmoid tumor presenting as multiple lung nodules at 13 years after resection of a previous intraabdominal", "UK , with function - sparing surgery possible ( observation 51% , resection 51% ) , primary desmoid fibromatosis with neurovascular involvement ( hormone therapy with non - steroidal anti -", "showed regressive or stable desmoid size . Patients with previous history of multiple desmoid - related surgeries showed less - favorable response . The mean time to reach at least stable size", ", it is a clinical challenge to distinguish recurrent malignant neoplasms from desmoid tumors , and surgical resection is the treatment option depending on the anatomic location .", "SERMs as an effective and safe treatment for both , sporadic and FAP - associated desmoid tumors . While invasive treatment frequently results in high recurrence rates , high morbidity and high", "True intrathoracic primary desmoid tumors with no involvement of the chest wall or pleura are extremely rare.", "Desmoid tumor is a locally invasive, myofibroblastic, nonmetastatic tumor.", "teams in the UK . Variation exists in the chosen initial management of primary desmoid fibromatosis in the UK , with function - sparing surgery possible ( observation 51% , resection 51% ) , primary", "BACKGROUND The prevalence of desmoid tumors among patients with familial adenomatous polyposis (FAP) is at least 10%, and the prevalence of FAP among desmoid patients varies between 7.5-16%. METHODS Data included 106 desmoid patients identified from the database of the Department of Pathology, Helsinki University Hospital, years 2000-2012.", ", complete resection is not always feasible because of difficulty to differentiate the desmoid tumor from adjacent tissues . The surgical approach may require different techniques to repair the", ").provide clinical - expert consensus opinions on follow - up strategies in patients with desmoid tumours after primary interventional management . METHODS This guideline was developed by Cancer", "literature are also reviewed . Despite an extremely low incidence , postoperative desmoid tumor should be considered in the differential diagnosis when a recurrent neoplasm is found at least one", ", a high - grade undifferentiated pleomorphic soft tissue sarcoma arose within the desmoid tumor . Despite extensive surgery removing both tumors , the patient showed locoregional relapse", "therapy ( rt ) , systemic therapy , or any combinations thereof - for patients with desmoid tumours once the decision to undergo active treatment has been made ( that is , monitoring and observation", "new mass develops in the region of a preexisting desmoid tumor , and more generally when a desmoid tumor modifies its clinical or radiological aspect .", "in case of infection . CONCLUSION We have encountered a case of a symptomatic growing desmoid tumor of the abdominal wall in a young patient with Gardner 's syndrome , successfully treated by", "Our aim was to examine the outcome of radiotherapy of desmoid tumors in a single institution series .", "High - grade soft tissue sarcoma arising in a desmoid tumor : case report and review of the literature Desmoid tumors are rare benign monoclonal fibroblastic tumors .", "The origin of intrathoracic desmoid tumors is predominantly the chest wall with occasional involvement of pleura.", "Desmoid tumor patients carry an elevated risk of familial adenomatous polyposis.", "Intra-abdominal desmoids were more common in the FAP group.", "Desmoid tumors, also known as aggressive fibromatosis, are locally infiltrating musculoaponeurotic neoplasms arising in connective tissues.", "Here we report on a 61-year-old patient who presented a locally advanced breast desmoid tumor diagnosed 20 years after post-operative radiotherapy for breast carcinoma.", ", sex hormones and traumatic injury , including surgery . Postoperative intra - abdominal desmoid tumor is rare , especially in the retroperitoneum . We report a case of postoperative", "preference of surgical resection of symptomatic disease progression in cases of primary desmoid fibromatosis without neurovascular involvement ( 60% ) . By contrast , radiotherapy was the", "report the case of an 18-month - old boy who underwent resection of a right temporal desmoid tumor ( initially diagnosed as cranial fasciitis ) and developed a bilateral frontoparietal", "of his cranioplasty . This is the first report describing a recurrent cranial desmoid tumor in a pediatric patient with FAP . The authors believe , however , that some of the cases", "mortality in this large series . Therefore surgical resection , especially for mesenteric desmoids , should be deferred favoring this convincingly effective , well tolerated regimen .", "Radiotherapy in desmoid tumors Desmoid tumors ( aggressive fibromatosis ) are rare soft tissue tumors which frequently recur after surgery .", ". However , it is a clinical challenge to distinguish recurrent malignant neoplasms from desmoid tumors , and surgical resection is the treatment option depending on the anatomic location .", "The arising of a soft tissue sarcoma in a desmoid tumor is an exceptional event since our case is the fourth one reported so far in literature.", "The results of this study fortify the role of sulindac and high - dose SERMs as an effective and safe treatment for both , sporadic and FAP - associated desmoid tumors .", "Despite an extremely low incidence, postoperative desmoid tumor should be considered in the differential diagnosis when a recurrent neoplasm is found at least one year after operation.", "We compared sporadic desmoid patients' and FAP patients' clinical characteristics.", "Eleven patients had had FAP screening already earlier due to desmoid and three of them were found to have FAP.", "teams in the UK . Variation exists in the chosen initial management of primary desmoid fibromatosis in the UK , with function - sparing surgery possible ( observation 51% , resection 51%", "DISCUSSION Conventional treatment of abdominal wall desmoid tumors consists in a wide and radical resection.", ". MATERIALS AND METHODS A hypothetical case of intramuscular limb girdle desmoid fibromatosis in a fit 65-year - old patient was devised . Surgical and non - surgical oncology members of the", "- dose selective estrogen receptor modulators ( SERMs ) for sporadic and FAP - associated desmoid tumors . Desmoids are very rare tumors in the general population but occur frequently in FAP", "Recurrent giant cranial desmoid tumor in a 3-year-old boy with familial adenomatous polyposis requiring bifrontoparietal cranioplasty: case report.", "occurred totally out - of - target . Radiotherapy is a valuable option for treating desmoid tumors . Radiotherapy dose appears to be significantly associated to local control . Desmoide (", "cranioplasty : case report . Desmoid tumors , also known as aggressive fibromatosis , are locally infiltrating musculoaponeurotic neoplasms arising in connective tissues . Desmoid", "Treatment and follow-up strategies in desmoid tumours: a practice guideline.", "of FAP were found . The risk of FAP among desmoid tumor patients was 4.8% . In the FAP desmoid group , there were more males and patients were younger than in the sporadic group . Intra -", "English literature are also reviewed . Despite an extremely low incidence , postoperative desmoid tumor should be considered in the differential diagnosis when a recurrent neoplasm is found at", "of a gastrointestinal stromal tumor . Sporadic trauma - related intra - abdominal desmoid tumors reported in the English literature are also reviewed . Despite an extremely low incidence ,", "wall or pleura are extremely rare . We recently experienced a case of true intrathoracic desmoid tumor presenting as multiple lung nodules at 13 years after resection of a previous intraabdominal", "develops in the region of a preexisting desmoid tumor , and more generally when a desmoid tumor modifies its clinical or radiological aspect .", "Desmoid tumors may be associated with familial adenomatous polyposis ( FAP ) , a genetic disorder that presents with hundreds to thousands of precancerous colorectal polyps .", "familial adenomatous polyposis ( FAP ) is at least 10% , and the prevalence of FAP among desmoid patients varies between 7.5 - 16% . METHODS Data included 106 desmoid patients identified from the", ", very few cases have extra - abdominal locations . The origin of intrathoracic desmoid tumors is predominantly the chest wall with occasional involvement of pleura . True intrathoracic", "therapy ( rt ) , systemic therapy , or any combinations thereof - for patients with desmoid tumours once the decision to undergo active treatment has been made ( that is , monitoring and", "Variation exists in the chosen initial management of primary desmoid fibromatosis in the UK , with function - sparing surgery possible ( observation 51% , resection 51% ) , primary desmoid fibromatosis with neurovascular involvement ( hormone therapy with non - steroidal anti - inflammatory drugs 51% , radiotherapy 27% , observation 22% ) and for cases of desmoid fibromatosis recurrence ( radiotherapy 41% , hormone therapy and non - steroidal anti - inflammatory drugs 27% , observation 24% ) .", "clinical - expert consensus opinions on follow - up strategies in patients with desmoid tumours after primary interventional management . METHODS This guideline was developed by Cancer Care", "Intrathoracic Desmoid Tumor Presenting as Multiple Lung Nodules 13 Years after Previous Resection of Abdominal Wall Desmoid Tumor Desmoid tumors are rare soft tissue tumors considered to have locally infiltrative features without distant metastasis until now.", "hormones and traumatic injury , including surgery . Postoperative intra - abdominal desmoid tumor is rare , especially in the retroperitoneum . We report a case of postoperative retroperitoneal", "In the FAP desmoid group, there were more males and patients were younger than in the sporadic group.", "Radiotherapy is a valuable option for treating desmoid tumors .", "Depending on individual patient preferences , systemic therapy alone or rt alone might also be reasonable treatment options , regardless of whether the desmoid umours are deemed to be resectable .", "fibromatosis ) are rare soft tissue tumors which frequently recur after surgery . Desmoid tumors arise from musculoaponeurotic tissue in the extremities , head and neck , abdominal wall , or", "of FAP among desmoid patients varies between 7.5 - 16% . METHODS Data included 106 desmoid patients identified from the database of the Department of Pathology , Helsinki University", ". Here we report on a 61-year - old patient who presented a locally advanced breast desmoid tumor diagnosed 20 years after post - operative radiotherapy for breast carcinoma . After 2 years of", "as Multiple Lung Nodules 13 Years after Previous Resection of Abdominal Wall Desmoid Tumor Desmoid tumors are rare soft tissue tumors considered to have locally infiltrative features", "Asymptomatic patients with desmoid situated in extra truncal region may not need to be screened .", "RESULTS Ten of 106 patients already had FAP diagnosis before the desmoid.", "inflammatory drugs 51% , radiotherapy 27% , observation 22% ) and for cases of desmoid fibromatosis recurrence ( radiotherapy 41% , hormone therapy and non - steroidal anti - inflammatory drugs 27% ,", "Sporadic trauma-related intra-abdominal desmoid tumors reported in the English literature are also reviewed.", "of desmoid tumors in a single institution series . We evaluated 41 patients with desmoid tumors treated with 49 radiotherapies between 1987 and 2012 . Radiologic images for response", "locally infiltrating musculoaponeurotic neoplasms arising in connective tissues . Desmoid tumors may be associated with familial adenomatous polyposis ( FAP ) , a genetic disorder that presents", "Response was defined as stable size or regression of desmoid size between two CT or MRI scans .", "Lung Nodules 13 Years after Previous Resection of Abdominal Wall Desmoid Tumor Desmoid tumors are rare soft tissue tumors considered to have locally infiltrative features without distant", "DISCUSSION Several groups have issued formal guidelines for clinicians managing desmoid fibromatosis, including the British Sarcoma Group, the National Comprehensive Cancer Network and the European Society for Medical Oncology.", "national consensus or a desmoid fibromatosis registry may help to standardise desmoid fibromatosis care .", "After 2 years of medical treatment, a high-grade undifferentiated pleomorphic soft tissue sarcoma arose within the desmoid tumor.", "Overall 114 (85.1 %) patients showed regressive or stable desmoid size.", "- sparing surgery possible ( observation 51% , resection 51% ) , primary desmoid fibromatosis with neurovascular involvement ( hormone therapy with non - steroidal anti - inflammatory drugs 51%", "for timely and accurate diagnosis when a new mass develops in the region of a preexisting desmoid tumor , and more generally when a desmoid tumor modifies its clinical or radiological aspect .", "of a 24-year - old female presenting Gardner 's syndrome with a symptomatic abdominal wall desmoid tumor . Lack of response to medical treatment led to surgical management consisting in a complete", "soft tissue sarcoma arising in a desmoid tumor : case report and review of the literature Desmoid tumors are rare benign monoclonal fibroblastic tumors . Their aggressiveness is local with no", "The risk of FAP among desmoid tumor patients was 4.8%.", "diagnosis before the desmoid . Eleven patients had had FAP screening already earlier due to desmoid and three of them were found to have FAP . Total of 52 patients participated into prospective", "patients . DISCUSSION Several groups have issued formal guidelines for clinicians managing desmoid fibromatosis , including the British Sarcoma Group , the National Comprehensive Cancer Network and", "anti - inflammatory drugs 51% , radiotherapy 27% , observation 22% ) and for cases of desmoid fibromatosis recurrence ( radiotherapy 41% , hormone therapy and non - steroidal anti -", "diagnosed as cranial fasciitis ) and developed a bilateral frontoparietal calvarial desmoid tumor 2 years later . The patient underwent gross - total resection of the tumor that required a large", "We propose a review of current evidence; a national consensus or a desmoid fibromatosis registry may help to standardise desmoid fibromatosis care.", "Nationwide trends in the current management of desmoid (aggressive) fibromatosis.", "Patients with previous history of multiple desmoid-related surgeries showed less-favorable response.", "CONCLUSION We have encountered a case of a symptomatic growing desmoid tumor of the abdominal wall in a young patient with Gardner's syndrome, successfully treated by complete resection and reconstruction with a biologic mesh to correct the parietal defect.", "CASE-REPORT We report the case of a 24-year-old female presenting Gardner's syndrome with a symptomatic abdominal wall desmoid tumor.", "Long - term outcome of sporadic and FAP - associated desmoid tumors treated with high - dose selective estrogen receptor modulators and sulindac : a single - center long - term observational study in 134 patients Aim of this study is to evaluate the outcome of long - term conservative treatment with sulindac and high - dose selective estrogen receptor modulators ( SERMs ) for sporadic and FAP - associated desmoid tumors .", "OBJECTIVES We set out to determine the optimal treatment options - surgery , radiation therapy ( rt ) , systemic therapy , or any combinations thereof - for patients with desmoid tumours once the decision to undergo active treatment has been made ( that is , monitoring and observation have been determined to be inadequate).provide clinical - expert consensus opinions on follow - up strategies in patients with desmoid tumours after primary interventional management . METHODS This guideline was developed by Cancer Care Ontario 's Program in Evidence - Based Care and the Sarcoma Disease Site Group .", "Reconstruction of an abdominal wall defect with biologic mesh after resection of a desmoid tumor in a patient with a Gardner's syndrome.", "at 12 months of follow - up . DISCUSSION Conventional treatment of abdominal wall desmoid tumors consists in a wide and radical resection . However , complete resection is not always", "There was a clear preference of surgical resection of symptomatic disease progression in cases of primary desmoid fibromatosis without neurovascular involvement (60%).", "Several groups have issued formal guidelines for clinicians managing desmoid fibromatosis , including the British Sarcoma Group , the National Comprehensive Cancer Network and the European", "clinical characteristics . RESULTS Ten of 106 patients already had FAP diagnosis before the desmoid . Eleven patients had had FAP screening already earlier due to desmoid and three of them were", "estrogen receptor modulators ( SERMs ) for sporadic and FAP - associated desmoid tumors . Desmoids are very rare tumors in the general population but occur frequently in FAP patients , being", "report the case of an 18-month - old boy who underwent resection of a right temporal desmoid tumor ( initially diagnosed as cranial fasciitis ) and developed a bilateral frontoparietal calvarial", "This is the first report describing a recurrent cranial desmoid tumor in a pediatric patient with FAP.", "shown by this survey . We propose a review of current evidence ; a national consensus or a desmoid fibromatosis registry may help to standardise desmoid fibromatosis care .", "This study included all desmoid patients that were treated and followed at our institution and had completed at least 1 year of treatment .", "Surgery with or without rt can be a reasonable treatment option for patients with desmoid tumours whose surgical morbidity is deemed to be low . The decision about whether rt should be", "recent publications , potentially explaining the significant variation in the management of desmoid fibromatosis in the UK shown by this survey . We propose a review of current evidence ; a national", "Therefore surgical resection, especially for mesenteric desmoids, should be deferred favoring this convincingly effective, well tolerated regimen.", "the chest wall with occasional involvement of pleura . True intrathoracic primary desmoid tumors with no involvement of the chest wall or pleura are extremely rare . We recently experienced a", "of surgical resection of symptomatic disease progression in cases of primary desmoid fibromatosis without neurovascular involvement ( 60% ) . By contrast , radiotherapy was the preferred treatment", "adenomatous polyposis requiring bifrontoparietal cranioplasty : case report . Desmoid tumors , also known as aggressive fibromatosis , are locally infiltrating musculoaponeurotic neoplasms", "However , these are in some ways contradictory and may not reflect recent publications , potentially explaining the significant variation in the management of desmoid fibromatosis in the UK shown by this survey .", "desmoid tumor mimics recurrent gastrointestinal stromal tumor : a case report . Desmoid tumor is a locally invasive , myofibroblastic , nonmetastatic tumor . Its pathogenesis remains unclear", ". Intra - abdominal desmoids were more common in the FAP group . CONCLUSIONS Patients with desmoid carry an elevated risk of FAP and therefore screening is indicated . Asymptomatic patients with", "of desmoid tumors in a single institution series . We evaluated 41 patients with desmoid tumors treated with 49 radiotherapies between 1987 and 2012 . Radiologic images for response evaluation", "tissue sarcoma arising in a desmoid tumor : case report and review of the literature Desmoid tumors are rare benign monoclonal fibroblastic tumors . Their aggressiveness is local with no potential", "from 14 sarcoma surgeons and 23 oncologists ( 14 clinical , nine medical ) were analysed . Desmoid fibromatosis management is generally shared by surgeons and oncologists within sarcoma", "the chest wall with occasional involvement of pleura . True intrathoracic primary desmoid tumors with no involvement of the chest wall or pleura are extremely rare . We recently", "were more males and patients were younger than in the sporadic group . Intra - abdominal desmoids were more common in the FAP group . CONCLUSIONS Patients with desmoid carry an elevated risk of", "1.5 % ) patients were sporadic . Overall 114 ( 85.1 % ) patients showed regressive or stable desmoid size . Patients with previous history of multiple desmoid - related surgeries showed less -", "carry an elevated risk of familial adenomatous polyposis . BACKGROUND The prevalence of desmoid tumors among patients with familial adenomatous polyposis ( FAP ) is at least 10% , and the", ", however , that some of the cases previously reported as cranial fasciitis are likely desmoid tumors pathobiologically and genetically .", "Desmoid tumors arise from musculoaponeurotic tissue in the extremities, head and neck, abdominal wall, or intra-abdominally.", "They can be sporadic , but in most instances , desmoid tumors develop in the context of Gardner 's syndrome with principal localization in the abdominal cavity and abdominal wall .", "However , it is a clinical challenge to distinguish recurrent malignant neoplasms from desmoid tumors , and surgical resection is the treatment option depending on the anatomic location .", "Treatment of desmoids is still most controversial since response can not be predicted and they are prone to develop recurrence .", "Surgery with or without rt can be a reasonable treatment option for patients with desmoid tumours whose surgical morbidity is deemed to be low . The decision about whether rt should be offered in", "as Multiple Lung Nodules 13 Years after Previous Resection of Abdominal Wall Desmoid Tumor Desmoid tumors are rare soft tissue tumors considered to have locally infiltrative features without", "24-year - old female presenting Gardner 's syndrome with a symptomatic abdominal wall desmoid tumor . Lack of response to medical treatment led to surgical management consisting in a complete", "of desmoid ( aggressive ) fibromatosis . AIMS The optimal management of desmoid fibromatosis remains unclear , leading to significant variability in patient management . To assess this", "diagnosed as cranial fasciitis ) and developed a bilateral frontoparietal calvarial desmoid tumor 2 years later . The patient underwent gross - total resection of the tumor that required a", "but occur frequently in FAP patients , being encountered in 23–38 % . Treatment of desmoids is still most controversial since response can not be predicted and they are prone to develop", "MATERIALS AND METHODS A hypothetical case of intramuscular limb girdle desmoid fibromatosis in a fit 65-year-old patient was devised.", "into prospective screening of FAP . No new cases of FAP were found . The risk of FAP among desmoid tumor patients was 4.8% . In the FAP desmoid group , there were more males and patients were", "Postoperative retroperitoneal desmoid tumor mimics recurrent gastrointestinal stromal tumor: a case report.", "CONCLUSIONS Patients with desmoid carry an elevated risk of FAP and therefore screening is indicated.", "as multiple lung nodules at 13 years after resection of a previous intraabdominal desmoid tumor .", ", or intra - abdominally . Our aim was to examine the outcome of radiotherapy of desmoid tumors in a single institution series . We evaluated 41 patients with desmoid tumors treated with 49", ", then death 25 months after the surgery . The arising of a soft tissue sarcoma in a desmoid tumor is an exceptional event since our case is the fourth one reported so far in literature . It", "can not be predicted and they are prone to develop recurrence . This study included all desmoid patients that were treated and followed at our institution and had completed at least 1 year of", "desmoid tumor mimics recurrent gastrointestinal stromal tumor : a case report . Desmoid tumor is a locally invasive , myofibroblastic , nonmetastatic tumor . Its pathogenesis remains", "However, complete resection is not always feasible because of difficulty to differentiate the desmoid tumor from adjacent tissues.", ", are locally infiltrating musculoaponeurotic neoplasms arising in connective tissues . Desmoid tumors may be associated with familial adenomatous polyposis ( FAP ) , a genetic disorder that", ", potentially explaining the significant variation in the management of desmoid fibromatosis in the UK shown by this survey . We propose a review of current evidence ; a national consensus or", "especially in the retroperitoneum . We report a case of postoperative retroperitoneal desmoid tumor that developed 29 mo after the first excision of a gastrointestinal stromal tumor . Sporadic", "- dose SERMs as an effective and safe treatment for both , sporadic and FAP - associated desmoid tumors . While invasive treatment frequently results in high recurrence rates , high morbidity and", "timely and accurate diagnosis when a new mass develops in the region of a preexisting desmoid tumor , and more generally when a desmoid tumor modifies its clinical or radiological aspect .", "fibromatosis ) are rare soft tissue tumors which frequently recur after surgery . Desmoid tumors arise from musculoaponeurotic tissue in the extremities , head and neck , abdominal wall ,", "Presenting as Multiple Lung Nodules 13 Years after Previous Resection of Abdominal Wall Desmoid Tumor Desmoid tumors are rare soft tissue tumors considered to have locally infiltrative features", "an elevated risk of FAP and therefore screening is indicated . Asymptomatic patients with desmoid situated in extra truncal region may not need to be screened .", "however , that some of the cases previously reported as cranial fasciitis are likely desmoid tumors pathobiologically and genetically ."], "par_relations": ["Fibroma"], "chd_relations": ["Desmoid disease, hereditary"], "syn_relations": ["Fibromatosis, Aggressive", "Fibromatosis, Aggressive", "Fibromatosis, Aggressive", "Fibromatosis, Aggressive", "Fibromatosis, Aggressive", "Fibromatosis, Aggressive", "Fibromatosis, Aggressive", "Fibromatosis, Aggressive"], "sib_relations": ["Dupuytren Contracture", "Fibromatosis, Plantar", "Fibroma, Ossifying", "Fibroma, Desmoplastic", "Fibromatosis, Abdominal"]}}
{"label": 1, "source_ent": {"research_entity_id": "HPO:HP:0006744", "canonical_name": "Adrenocortical carcinoma", "aliases": ["adrenal carcinoma", "adrenocortical carcinoma", "adrenal gland carinoma"], "definition": "A malignant neoplasm of the adrenal cortex that may produce hormones such as cortisol, aldosterone, estrogen, or testosterone. [HPO:probinson]", "other_contexts": ["CONCLUSIONS When diagnosed in children , adrenal carcinoma is associated with virilism and a less aggressive natural history ; however , when it occurs in adults , the disease presents more commonly as a mixed Cushing - virilizing syndrome and has a virulent course .", "Validation of the prognostic role of the \" Helsinki Score \" in 225 cases of adrenocortical carcinoma .", "Figitumumab was administered on day 1 of each 21-day cycle at the maximal feasible dose ( 20 mg / kg ) to a cohort of patients with metastatic , refractory adrenocortical carcinoma .", "of the prognostic role of the \" Helsinki Score \" in 225 cases of adrenocortical carcinoma . Adrenocortical carcinoma patient prognosis is extremely variable and poorly predictable . The", "Although myelolipomas of the adrenal glands are detected with increasing frequency with advances in imaging , the occurrence of myelolipoma with adrenal cortical carcinoma remains very rare .", "\"Dominant\" myelolipoma encasing adrenal cortical carcinoma: an unusual variation of myelolipoma occurring as a synchronous and predominant neoplasm.", "RESULTS There is a bimodal age incidence of adrenal carcinoma , with the disease peaking in the first and fourth decades of life .", ". RESULTS Vasculogenic mimicry was observed in 19 of the 46 ( 41.30% ) adrenocortical carcinoma samples . Both vasculogenic mimicry and vascular endothelial growth factor receptor 2 expressions", "OBJECTIVES To determine the prognostic role of vasculogenic mimicry in adrenocortical carcinoma, and to explore its relationship with vascular endothelial growth factor receptor 2 expression.", "RECENT FINDINGS A retrospective analysis showing that adjuvant mitotane may prolong recurrence - free survival in a large cohort of patients with radically resected adrenocortical carcinoma has recently been published .", "factor receptor 2 seem to correlate with poor prognostic outcomes in adrenocortical carcinoma . Anti - angiogenesis treatments targeting vascular endothelial growth factor receptor 2 should be", "METHODS In this international , double - blind , placebo - controlled phase 3 study , adult patients with histologically confirmed locally advanced or metastatic adrenocortical carcinoma were recruited at clinical sites in nine countries .", "Three-dimensional culture method was applied to test the ability of vasculogenic mimicry formation by adrenocortical carcinoma cell lines SW-13 and H295R. Quantitative polymerase chain reaction and western blotting were used to monitor the expression of vascular endothelial growth factor receptor 2 in SW-13 and H295R. After being treated with specific inhibitor or small interfering ribonucleic acid to downregulate expression of vascular endothelial growth factor receptor 2, vasculogenic mimicry formation and cell prolifration of SW-13 cells were evaluated by 3-D culture and Cell Counting Kit-8 methods.", "Childhood adrenal carcinoma is characterized by a high rate of incidence of virilization , marked overproduction of androgens , and a less aggressive clinical course , and appears to be more amenable to surgical and other therapeutic modalities .", "Anti - angiogenesis treatments targeting vascular endothelial growth factor receptor 2 should be combined with therapies targeting vasculogenic mimicry in adrenocortical carcinoma .", "Fourteen patients with adrenocortical carcinoma received 50 cycles of figitumumab at the 20 mg / kg .", "Further studies of IGF-1R and insulin receptor inhibitors, together with genetic profiling of responders, might pave the way toward individualised and improved therapeutic options in adrenocortical carcinoma.", "Extended survival in a patient with recurrent and metastatic adrenal cortical carcinoma by aggressive transarterial embolization--a case report.", "Linsitinib ( OSI-906 ) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma : a double - blind , randomised , phase 3 study .", "Patients were randomly assigned (2:1) twice-daily 150 mg oral linsitinib or placebo via a web-based, centralised randomisation system and stratified according to previous systemic cytotoxic chemotherapy for adrenocortical carcinoma, Eastern Cooperative Oncology Group performance status, and use of one or more oral antihyperglycaemic therapy at randomisation.", "We report a case of recurrent and metastatic adrenal cortical carcinoma in which prolonged survival of 58 months was achieved with aggressive three sequential transarterial embolization.", "A 60-year-old man received operation for left adrenal cortical carcinoma.", "Mitotane , an analogue of the insecticide dichlorodiphenyltrichloroethane , has been used for treatment of advanced adrenocortical carcinoma since the 1960s , but its use as an adjunctive postoperative measure has remained controversial .", "RESULTS Vasculogenic mimicry was observed in 19 of the 46 (41.30%) adrenocortical carcinoma samples.", "remains very rare . We present a case of combined myelolipoma with adrenal cortical carcinoma in a 47-year - old man . In previously reported cases of adrenal cortical carcinoma and", "METHODS A total of 46 samples of adrenocortical carcinoma were collected and reviewed .", "Modern day imaging methods have improved the diagnosis and staging of adrenal carcinoma greatly .", "Safety , tolerability , and pharmacokinetics of the anti - IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma Insulin - like growth factor 1 receptor signaling through upregulation of the stimulatory ligand IGF - II has been implicated in the pathogenesis of adrenocortical carcinoma .", "Adrenocortical carcinoma: clinical and laboratory observations.", "Pharmacokinetics of figitumumab was comparable to patients with solid tumors other than adrenocortical carcinoma .", "In conclusion , the Helsinki Score is a valuable system to predict prognosis in adrenocortical carcinoma , outperforming the currently established prognostic parameters .", "Adrenocortical carcinoma is a rare cancer with a poor but heterogeneous prognosis .", "Previous studies have identified overexpression of insulin - like growth factor 2 ( IGF-2 ) and constitutive activation of β-catenin as key factors involved in the development of adrenocortical carcinoma .", "No general consensus on the diagnostic and therapeutic measures for adrenocortical carcinoma exists, but collaborative efforts, such as international conferences and networks, including the European Network for the Study of Adrenal Tumors (ENSAT), have substantially advanced the field.", "Vasculogenic mimicry plays an important role in adrenocortical carcinoma .", "We will first consider the situation of a pregnant woman with a clinical suspicion of adrenocortical carcinoma: which diagnostic procedures will be useful and safe for the foetus?", "As there is a paucity of effective therapies, this dose expansion cohort of a phase 1 study was undertaken to determine the safety, tolerability, pharmacokinetics, and effects on endocrine markers of figitumumab in patients with adrenocortical carcinoma.", "was applied to test the ability of vasculogenic mimicry formation by adrenocortical carcinoma cell lines SW-13 and H295R. Quantitative polymerase chain reaction and western blotting were used", "The side effect profile and pharmacokinetics of figitumumab were similar in patients with adrenocortical carcinoma in comparison to patients with other solid tumors.", "role of the \" Helsinki Score \" in 225 cases of adrenocortical carcinoma . Adrenocortical carcinoma patient prognosis is extremely variable and poorly predictable . The newly introduced Helsinki", "Aggressive transarterial embolization seems to be a safe and effective procedure for symptoms relief , and may prolong survival in the management of inoperable adrenal cortical carcinoma .", "Most patients present with steroid hormone excess , for example Cushing syndrome or virilization , or abdominal mass effects , but a growing proportion of patients with adrenocortical carcinoma ( currently > 15% ) is initially diagnosed incidentally .", "the European Network for the Study of Adrenal Tumor ( ENS@T ) database of adrenocortical carcinoma .", "In previously reported cases of adrenal cortical carcinoma and myelolipoma, the latter occurred as incidental foci within or peripheral to the carcinoma, perhaps representing \"myelolipomatous metaplasia\" rather than true neoplasia.", "Adrenocortical carcinoma: a clinician's update.", "Results of a large phase III trial in advanced adrenocortical carcinoma are anticipated for 2011 and will hopefully establish a benchmark therapy .", "The data shown here were obtained from studies carried out in a tertiary reference medical centre in Paris ( Hôpital Cochin ) and from the European Network for the Study of Adrenal Tumor ( ENS@T ) database of adrenocortical carcinoma .", "We assessed linsitinib against placebo to investigate efficacy in patients with advanced adrenocortical carcinoma .", "We present a case of combined myelolipoma with adrenal cortical carcinoma in a 47-year - old man .", "The prognosis of inoperable recurrent or metastatic adrenal cortical carcinoma is poor due to lack of effective treatment modalities.", "Over the past 17 years , the authors have evaluated and treated 47 patients with adrenocortical carcinoma referred to the University of Sao Paulo , 22 of whom were children .", "Adrenocortical carcinoma patient prognosis is extremely variable and poorly predictable .", "growth factor receptor 2 expression . METHODS A total of 46 samples of adrenocortical carcinoma were collected and reviewed . Vasculogenic mimicry and vascular endothelial growth factor receptor", "The incidence rate and natural history of childhood adrenal carcinoma generally has been under emphasized .", "SUMMARY Radical surgical resection of adrenocortical carcinoma offers the best chance for prolonged recurrence-free survival; however, a significant number of patients without objective and biochemical evidence of residual tumor after surgery are destined to relapse.", "In patients with suspected adrenocortical carcinoma , a thorough endocrine and imaging work - up is recommended to guide the surgical approach aimed at complete resection of the tumor .", "2 should be combined with therapies targeting vasculogenic mimicry in adrenocortical carcinoma .", "PURPOSE OF REVIEW Description of the adjunctive treatment strategies in patients with adrenocortical carcinoma after complete surgical resection.", "BACKGROUND The clinical features and natural history of adrenocortical carcinoma are highly dependent on the type of center reporting their experience.", "frequency with advances in imaging , the occurrence of myelolipoma with adrenal cortical carcinoma remains very rare . We present a case of combined myelolipoma with adrenal cortical carcinoma in a", "CONCLUSIONS Vasculogenic mimicry and overexpression of vascular endothelial growth factor receptor 2 seem to correlate with poor prognostic outcomes in adrenocortical carcinoma .", "The aim of the study was to validate the prognostic role of the Helsinki Score for adrenocortical carcinoma characterization.", "carcinoma in a 47-year - old man . In previously reported cases of adrenal cortical carcinoma and myelolipoma , the latter occurred as incidental foci within or peripheral to the carcinoma ,", "It can be considered in any patient with inoperable adrenal cortical carcinoma if not contraindicated.", "By contrast , adrenocortical carcinoma occurring in adults presents more commonly as a mixed Cushing and virilizing syndrome , with overproduction of corticoids and androgens and a far more aggressive clinical course , leading to rapid death within months or years . Nonfunctioning adrenocortical carcinoma is less common ; it generally occurs in older adults and exhibits a rapid downhill course .", "BACKGROUND Adrenocortical carcinoma is a rare , aggressive cancer for which few treatment options are available .", "of the study was to validate the prognostic role of the Helsinki Score for adrenocortical carcinoma characterization . Thus , 225 adrenocortical carcinomas were reclassified using the Weiss Score", "consider the situation of a pregnant woman with a clinical suspicion of adrenocortical carcinoma : which diagnostic procedures will be useful and safe for the foetus ? What are the therapeutic", "Adrenocortical carcinoma is a rare heterogeneous neoplasm with an incompletely understood pathogenesis and a poor prognosis .", "The recent demonstration that mitotane treatment following macroscopically complete removal of adrenocortical carcinoma was associated with beneficial effects on outcome in a well designed , multicenter , international study should renew interest in adjuvant mitotane therapy .", ", the Helsinki Score is a valuable system to predict prognosis in adrenocortical carcinoma , outperforming the currently established prognostic parameters .", "Helsinki Score for adrenocortical carcinoma characterization . Thus , 225 adrenocortical carcinomas were reclassified using the Weiss Score and the Helsinki Score ( 3× mitotic count + 5 × necrosis +", ". OBJECTIVES To determine the prognostic role of vasculogenic mimicry in adrenocortical carcinoma , and to explore its relationship with vascular endothelial growth factor receptor 2 expression .", "Adjunctive treatment of adrenocortical carcinoma.", "[Adrenocortical carcinoma and pregnancy]."], "par_relations": ["Neoplasm of the adrenal cortex"], "chd_relations": [], "syn_relations": ["Adrenocortical carcinoma", "Adrenocortical carcinoma", "Adrenocortical carcinoma", "Adrenocortical carcinoma"], "sib_relations": ["Adrenocortical adenoma"]}, "target_ent": {"research_entity_id": "MSH:D018268", "canonical_name": "Adrenocortical Carcinoma", "aliases": ["carcinomas, adrenocortical", "adrenal cortical carcinomas", "adrenocortical carcinoma", "adrenal cortical carcinoma", "carcinomas, adrenal cortical", "carcinoma, adrenal cortical", "adrenocortical carcinomas", "carcinoma, adrenocortical"], "definition": "A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.", "other_contexts": [], "par_relations": ["Adenocarcinoma", "Adrenal Cortex Neoplasms"], "chd_relations": ["Adrenocortical Carcinoma, Hereditary", "Adrenocortical Carcinoma, Pediatric"], "syn_relations": ["Adrenocortical Carcinoma", "Adrenocortical Carcinoma", "Adrenocortical Carcinoma", "Adrenocortical Carcinoma", "Adrenocortical Carcinoma", "Adrenocortical Carcinoma", "Adrenocortical Carcinoma", "Adrenocortical Carcinoma", "Adrenocortical Carcinoma", "Adrenocortical Carcinoma"], "sib_relations": ["Adenocarcinoma, Papillary", "Carcinoid Tumor", "Adenocarcinoma, Bronchiolo-Alveolar", "Carcinoma, Intraductal, Noninfiltrating", "Adenocarcinoma, Mucinous", "Carcinoma, Renal Cell", "Adenocarcinoma, Scirrhous", "Choriocarcinoma", "Carcinoma, Adenoid Cystic", "Cystadenocarcinoma", "Paget Disease, Extramammary", "Pulmonary Adenomatosis, Ovine", "Adrenocortical Adenoma", "Adenocarcinoma, Clear Cell", "Adenocarcinoma, Follicular", "Adenocarcinoma, Sebaceous", "Carcinoma, Acinar Cell", "Carcinoma, Endometrioid", "Carcinoma, Lobular", "Carcinoma, Mucoepidermoid", "Carcinoma, Neuroendocrine", "Carcinoma, Signet Ring Cell", "Carcinoma, Skin Appendage", "Cholangiocarcinoma", "Adenocarcinoma in Situ", "Carcinoma, Ductal", "Eccrine Porocarcinoma", "Carcinoma, Islet Cell", "Carcinoma, Hepatocellular"]}}
{"label": 1, "source_ent": {"research_entity_id": "HPO:HP:0000831", "canonical_name": "Insulin-resistant diabetes mellitus", "aliases": ["insulin resistant diabetes", "insulin-resistant diabetes", "insulin-resistant diabetes mellitus", "insulin resistant diabetes mellitus"], "definition": "A type of diabetes mellitus related not to lack of insulin but rather to lack of response to insulin on the part of the target tissues of insulin such as muscle, fat, and liver cells. This type of diabetes is typically associated with increases both in blood glucose concentrations as will as in fasting and postprandial serum insulin levels. [HPO:probinson, pmid:7706500]", "other_contexts": ["Insulin receptor studies ruled out insulin resistant diabetes type A and B. At this point, we diagnosed this patient as having lipoatrophic diabetes, which is a syndrome characterized by insulin resistant diabetes, acanthosis nigricans, generalized lipoatrophy, and other metabolic disturbances.", "Lipoatrophic diabetes A female patient with acanthosis nigricans, insulin resistant diabetes, and generalized lipoatrophy is reported.", "The results suggested that the treatment with a high dose of rhIGF-1 by both SI and CSI is effective for preventing the postnatal growth retardation and normalizing glucose metabolism in patients with genetic form of extremely severe insulin resistant diabetes and that IGF-1 deficient state and partial GH resistance such as the impairment of the production of IGF-1 and IGFBP-3 may contribute to the growth retardation.", "A family is presented in which at least five members in three generations suffered a characteristic syndrome of generalised lipoatrophy, sparing the head and neck, and muscle hypertrophy variably associated with high plasma insulin and lipid levels and insulin resistant diabetes.", "Leprechaunism is the most severe form of insulin resistant diabetes and accompanied with growth retardation.", "Dermatomyositis, systemic sclerosis, and internal malignancy were ruled out, and the diagnosis of acanthosis nigricans and insulin resistant diabetes was made.", "Although rare, they are of considerable interest as they, like obesity, typically lead to ectopic lipid accumulation, dyslipidaemia and insulin resistant diabetes.", "Insulin-resistant diabetes mellitus.", "Remission of insulin resistant diabetes in two patients with anti-insulin receptor antibodies.", "Insulin-resistant diabetes precipitated by cortisone and reversed by nitrogen mustard.", "Insulin-resistant diabetes mellitus associated with hemochromatosis.", "Partial lipoatrophy with insulin resistant diabetes and hyperlipidaemia (Dunnigan syndrome).", "[Biological and clinical analyses of the mechanism of growth retardation and the effect of recombinant human insulin-like growth factor-1 (rhIGF-1) treatment on glucose metabolism and growth in leprechaunism with severe insulin resistant diabetes].", "Remission occurred 15 months after the onset of insulin resistant diabetes.", "Since Kahn et al. reported in 1976 insulin resistant diabetes due to anti-insulin receptor antibodies, an unusual form of diabetes mellitus (type B) has been found in many countries.", "It is important to note that spontaneous remission may occur more than half a year after the onset of insulin resistant diabetes.", "Insulin-resistant diabetes mellitus in a black woman with ataxia-telangiectasia.", "Insulin resistant diabetes mellitus.", "Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC Lipodystrophic syndromes are characterized by adipose tissue deficiency."], "par_relations": ["Diabetes mellitus", "Insulin resistance"], "chd_relations": ["Insulin-resistant diabetes mellitus at puberty", "Neonatal insulin-dependent diabetes mellitus"], "syn_relations": ["Insulin-resistant diabetes mellitus", "Insulin-resistant diabetes mellitus", "Insulin-resistant diabetes mellitus", "Insulin-resistant diabetes mellitus", "Insulin-resistant diabetes mellitus", "Insulin-resistant diabetes mellitus"], "sib_relations": ["Type I diabetes mellitus", "Type II diabetes mellitus", "Diabetic ketoacidosis", "Maternal diabetes", "Maturity-onset diabetes of the young"]}, "target_ent": {"research_entity_id": "OMIM:MTHU034767", "canonical_name": "Diabetes mellitus, insulin-resistant", "aliases": ["diabetes mellitus, insulin-resistant"], "definition": "", "other_contexts": [], "par_relations": ["ENDOCRINE FEATURES"], "chd_relations": [], "syn_relations": [], "sib_relations": ["LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4", "LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5"]}}
{"label": 1, "source_ent": {"research_entity_id": "HGNC:HGNC:17931", "canonical_name": "SERTA domain containing 3", "aliases": ["rbt1", "serta domain containing 3", "rpa-binding trans-activator", "sertad3", "sertad3 gene"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["SERTA domain containing 3", "SERTA domain containing 3", "SERTA domain containing 3", "SERTA domain containing 3"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:612125", "canonical_name": "SERTA DOMAIN-CONTAINING 3", "aliases": ["serta domain-containing 3", "rbt1", "rpa-binding transactivator 1", "sertad3"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["SERTA DOMAIN-CONTAINING 3", "SERTA DOMAIN-CONTAINING 3", "SERTA DOMAIN-CONTAINING 3", "SERTA DOMAIN-CONTAINING 3", "SERTA DOMAIN-CONTAINING 3", "SERTA DOMAIN-CONTAINING 3"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:D014646", "canonical_name": "Varicocele", "aliases": ["varicoceles", "varicocele"], "definition": "A condition characterized by the dilated tortuous veins of the SPERMATIC CORD with a marked left-sided predominance. Adverse effect on male fertility occurs when varicocele leads to an increased scrotal (and testicular) temperature and reduced testicular volume.", "other_contexts": ["Before varicocele treatment, a significantly higher number of DPVP+ patients (25/30 = 83.3 %) had seminal fluid hyperviscosity compared to DPVP- patient (2/20 = 10.0 %).", "In addition , the potential impact of varicocele on serum total antioxidant capacity ( TAOC ) and total thiol molecules ( TTM ) were examined .", "CONCLUSION Our data suggested that experimentally induced varicocele negatively impacted sperm maturation and chromatin integrity in a time - dependent manner .", "Germ cell apoptosis has been proposed as one of the mechanisms by which varicocele can influence fertility.", "patients ( aged 20 - 38 years ) who underwent surgical treatment for grade III bilateral varicocele . RESULTS Thirty patients with varicocele had also DPVP ( DPVP+ ) ( 60 % ) . Sperm concentration", "left varicocoele who underwent DDUS , the incidence of right clinical and subclinical varicocoele s as well as the influence of Tanner stage , varicocoele grade , laterality , peak retrograde flow", "between varicocoele and body mass index after adjusting for possible confounders . Varicocoele was diagnosed in 1911 of 39,559 participants with an overall prevalence of 4.83% . The prevalence", "Urologists should consider examining young , tall men to detect various grades of varicocele as a part of their physical examination .", "study was designed to assess the occupational and lifestyle factors of development of varicocele among male infertile , for a better prevention and management of the varicocele . MATERIALS AND", "MATERIALS AND METHODS Sperm parameters were evaluated using the conventional WHO criteria, and seminal fluid viscosity was further evaluated by quantitative viscometry, in 50 patients (aged 20-38 years) who underwent surgical treatment for grade III bilateral varicocele.", "Clinics in Zahedan , Iran . Expert urologists examined the patients for the existence of varicocele and determined its grade as I to III . The age , grade of varicocele , and the side of varicocele", "Levels of IGFBP7 protein are increased in varicocele.", ": In patients with lower BMI , the testicular vein may have a higher grade of varicocele . Urologists should consider examining young , tall men to detect various grades of varicocele as", "No significant differences were seen between varicocele and occupation or alcohol drinking for the prevalence of varicocele .", "RESULTS Thirty patients with varicocele had also DPVP (DPVP+) (60 %).", "with Occupation , Smoking and Drinking Alcohol BACKGROUND Existing data suggests that varicocele plays a central role in progressive infertility . AIMS This study was designed to assess the", "varicocele ( C ) , 22 with varicocele and normal semen analysis ( VNS ) and 19 with varicocele and altered semen analysis ( VAS ) . Seminal plasma from each patient was used for Western", "Prevalence of Varicocele among Primary and Secondary Infertile Men : Association with Occupation , Smoking and Drinking Alcohol BACKGROUND Existing data suggests that varicocele plays a central role in progressive infertility .", "RESULTS The ROS levels measured in the ISV of men with varicocele were higher than in the control group regardless of the varicocele grade except for subclinical grade; however, in the BV, a difference was noted only for grade III.", "Rate in Varicocele - positive Rats BACKGROUND We designed this study to clarify how varicocele can time - dependently affect sperm morphological parameters and DNA integrity . In this study ,", "The prevalence also decreased as body mass index increased in all three varicocoele grades.", "- inducing ligand and its relationship to infertility in Egyptian patients with varicocele . Germ cell apoptosis has been proposed as one of the mechanisms by which varicocele can influence", "We aimed to determine the relationship between body mass index (BMI) and the frequency and grade of varicocele among a sample of Iranian men in southeast Iran.", "ISV and the BV were compared . RESULTS The ROS levels measured in the ISV of men with varicocele were higher than in the control group regardless of the varicocele grade except for subclinical", "Body Mass Index and frequency and grade of varicocele in southeast Iran Background : Varicocele is associated with impaired spermatogenesis . It may also be associated with the patients ' weight", "venous plexus : effects on semen viscosity sperm parameters . INTRODUCTION Since varicocele is often associated with other venous abnormalities , this study was undertaken to evaluate the", ". DNA damage was severely and time - dependently substantiated in all test groups . Varicocele significantly reduced the ability of sperm derived from varicocele rats to undergo IVF . Serum", "the contribution of right varicocoele s to fertility is controversial , these right varicocoele s can influence clinically relevant parameters , particularly testicular asymmetry , and thus", "Future efforts should be made to validate the risk factors for varicocoele and strengthen the prevention and treatment of varicocoele , especially in underweight men .", "plasma levels of IGFBP7 , responsible for proliferative activity , are increased in varicocele grades II and III , and DNASE1 , responsible for apoptosis regulation , are lower in varicocele ,", "Association between Body Mass Index and frequency and grade of varicocele in southeast Iran Background: Varicocele is associated with impaired spermatogenesis.", "consumption , body mass index was still inversely and independently associated with varicocoele ( p < 0.001 ) . Compared with normal weight men , underweight men ( OR = 1.34 ; 95% CI , 1.10 - 1.6", "from those with left varicocele ( P=0.34 ) . The BMI of patients with bilateral varicocele was not different with those having right ( P=0.94 ) and left ( P=0.17 ) varicocele . 17.9% , 56.5%", "associated with left varicocoele s in adolescents . Although the contribution of right varicocoele s to fertility is controversial , these right varicocoele s can influence clinically relevant", "protein ( PARK7—protein deglycase DJ-1 ) . Levels of IGFBP7 protein are increased in varicocele . Levels of DNASE1 are progressively decreased in varicocele ( lower in varicocele and normal", "A significant negative correlation was also detected between seminal TRAIL levels and normal sperm morphology in the fertile varicocele (P = 0.007) and infertile varicocele patients (P = 0.047).", "17.9%, 56.5%, and 25.6% of the patients had varicocele grade I, II, and III, respectively.", "Percentage of varicocele was significantly higher in smokers compared with non-smokers (P = 0.035).", "Moreover, DNASE1 is capable of discriminating a varicocele that causes alterations to semen quality from one that does not.", "in patients with varicocele . This study included 112 males : 30 fertile males with varicocele , 44 infertile males with varicocele and 38 healthy fertile control subjects without varicocele .", "examined . Their occupations , smoking , and drinking alcohol , presence or absence of varicocele were evaluated . The lifestyle factors associated with varicocele were analyzed . RESULTS The data", "IVF . Serum TAOC and TTM levels reduced in a time - dependent manner . Right testes varicocele - induced rats showed remarkably less damaged profile for all investigated parameters compared to", "Paternity Rates and Time to Conception in Adolescents with Varicocele Undergoing Microsurgical Varicocele Repair vs Observation Only : A Single Institution Experience with 408 Patients .", "Mean ± SD time to conception was significantly shorter in the microsurgical varicocele repair group ( 11.18 ± 6.5 months ) than in the control group ( 16.85 ± 6.9 months , p < 0.005 ) . Respective percentages of patients with significant increase in sperm concentration and motility were significantly higher ( 53.8% and 62.2% ) in the microsurgical varicocele repair group compared to the control group ( 43.4% and 46.7% , p < 0.05 for both ) .", "linear regression . Right retrograde flow was detected in 204 of 506 ( 40.3% ) boys . Varicocoele grades were subclinical in 89 ( 18% ) , grade I in 51 ( 10% ) , grade II in 63 ( 12% ) and grade", "Right testes varicocele - induced rats showed remarkably less damaged profile for all investigated parameters compared to the left testes varicocele .", ", and DNASE1 , responsible for apoptosis regulation , are lower in varicocele , lowest in varicocele and low semen quality . These proteins demonstrate molecular alterations brought upon by", "In this study , we intend to estimate the effect of various periods of varicocele on the in vitro fertilization ( IVF ) rate in rats .", ", 44 infertile males with varicocele and 38 healthy fertile control subjects without varicocele . Semen analysis was performed , and serum levels of reproductive hormones were measured . Seminal", "consequently caused a remarkable reduction in IVF ability . The detrimental effect of varicocele may be attributed to the significant reduction of antioxidant capacity of the serum .", "The prevalence of varicocoele was highest in underweight (6.29%) and lowest in obese patients (3.71%, p < 0.05).", "Of the patients 286 underwent microsurgical subinguinal or inguinal varicocele repair and 122 did not undergo varicocele surgery and were followed conservatively.", "men . RESULTS The paternity rate was 77.3% ( 221 of 286 patients ) in the microsurgical varicocele repair group and 48.4% ( 59 of 122 ) in the control group , revealing a highly significant", "Mean PRF and MVD values were lower in right as compared to left varicocoele s. Contrary to common perception, both subclinical and palpable right varicocoele s are frequently associated with left varicocoele s in adolescents.", "( OR = 2.420 ; 95% CI = 1.04 , 5.61 ) . No significant differences were seen between varicocele and occupation or alcohol drinking for the prevalence of varicocele . CONCLUSIONS The findings of", "in varicocele . Levels of DNASE1 are progressively decreased in varicocele ( lower in varicocele and normal semen analysis , lowest in varicocele and altered semen analysis ) when compared to", ". PURPOSE We compared paternity rates and time to conception between adolescents with varicocele undergoing microsurgical varicocele repair and patients who did not undergo surgery and were", "men with a varicocele than in controls . They were correlated with varicocele grade , varicocele duration , the degree of testicular hypotrophy , and sperm viability . In addition , ROS levels", "were included in this study , of which 20 controls without varicocele ( C ) , 22 with varicocele and normal semen analysis ( VNS ) and 19 with varicocele and altered semen analysis ( VAS ) .", "MATERIALS AND METHODS The study included 408 males 12 to 19 years old at presentation with clinical palpable varicocele .", "was more frequent in the age group of 20 - 30 years . Most patients had grade II varicocele without a significant difference between the age groups ( P=0.11 ) . The mean BMI of patients with", "Compared with normal weight men , underweight men ( OR = 1.34 ; 95% CI , 1.10 - 1.63 ) were more likely to have varicocoele , whereas overweight men ( OR = 0.88 ; 95% CI , 0.79 - 0.99 ) and obese men ( OR = 0.75 ; 95% CI , 0.58 - 0.97 ) were less likely to have varicocoele .", "less damaged profile for all investigated parameters compared to the left testes varicocele . CONCLUSION Our data suggested that experimentally induced varicocele negatively impacted sperm", "left varicocoele s. Contrary to common perception , both subclinical and palpable right varicocoele s are frequently associated with left varicocoele s in adolescents . Although the contribution of", "( IVF ) rate in rats . MATERIALS AND METHODS In this experimental study , left varicocele were induced as the test group ( n=18 ) which was further sub - divided into three groups based on", "in 1911 of 39,559 participants with an overall prevalence of 4.83% . The prevalence of varicocoele was highest in underweight ( 6.29% ) and lowest in obese patients ( 3.71% , p < 0.05 ) . The", "< 0.005 ) . Mean ± SD time to conception was significantly shorter in the microsurgical varicocele repair group ( 11.18 ± 6.5 months ) than in the control group ( 16.85 ± 6.9 months , p < 0.005 ) .", "CONCLUSIONS Microsurgical varicocele repair in adolescents with varicocele significantly increases paternity rates and decreases time to conception postoperatively.", "to conception postoperatively . Patients with varicocele who underwent microsurgical varicocele repair had increased sperm parameters and 3.63 times greater odds of paternity than controls who", "China ; body mass index was inversely and independently associated with the presence of varicocoele . Future efforts should be made to validate the risk factors for varicocoele and strengthen the", "grades II and III , and DNASE1 , responsible for apoptosis regulation , are lower in varicocele , lowest in varicocele and low semen quality . These proteins demonstrate molecular alterations", "The lifestyle factors associated with varicocele were analyzed.", "This study included 112 males: 30 fertile males with varicocele, 44 infertile males with varicocele and 38 healthy fertile control subjects without varicocele.", "ROS levels were determined by spectrophotometry , and comparisons between the varicocele and control groups were performed .", "Seminal Tumour necrosis factor-related apoptosis-inducing ligand and its relationship to infertility in Egyptian patients with varicocele.", "A total of 61 male adolescents were included in this study , of which 20 controls without varicocele ( C ) , 22 with varicocele and normal semen analysis ( VNS ) and 19 with varicocele and altered semen analysis ( VAS ) .", "PURPOSE We compared paternity rates and time to conception between adolescents with varicocele undergoing microsurgical varicocele repair and patients who did not undergo surgery and were followed conservatively .", "Alterations in the proliferative/apoptotic equilibrium in semen of adolescents with varicocele To verify if the presence of varicocele (grades II and III) with and without seminal alterations, using the 5th centile cutoff values in table A1.1 of the World Health Organization (WHO, 2010) manual, alters the seminal plasma levels of proteins DNASE1 (deoxyribonuclease-1) and IGFBP7 (Insulin-like growth factor-binding protein 7), which are related to apoptosis regulation and cell proliferation, respectively, demonstrating that these proteins are important for correct spermatogenesis.", "and ( iii ) the difference in duplex doppler ultrasound ( DDUS ) findings between left varicocoele s and contralateral right varicocoele s. Among 506 boys with a known left varicocoele who", "The age , grade of varicocele , and the side of varicocele as well as the weight and height of the patients were measured and recorded .", "( i ) the presence of subclinical and palpable right varicocoele s in boys with a left varicocoele , ( ii ) the effect , if any , of right varicocoele on asymmetry measurements and ( iii ) the", "decreased in varicocele ( lower in varicocele and normal semen analysis , lowest in varicocele and altered semen analysis ) when compared to adolescents without varicocele . DNASE1 levels are", ") . The mean BMI of patients with right varicocele was not different from those with left varicocele ( P=0.34 ) . The BMI of patients with bilateral varicocele was not different with those having", "levels and normal sperm morphology in the fertile varicocele ( P = 0.007 ) and infertile varicocele patients ( P = 0.047 ) . Seminal TRAIL was significantly correlated with varicocele grade whether", ": The patients ' mean age was 27.9 ± 7.6 years and their mean BMI was 23.5 ± 4.7 kg/ m2 . Varicocele was more frequent in the age group of 20 - 30 years . Most patients had grade II varicocele", "II in 63 ( 12% ) and grade III in 1 ( 0.2% ) . In patients with bilaterally palpable varicocoele s , increasing left grade was associated with greater testicular asymmetry ( p = 0.02 ) and", "( 32% ) with varicocele and 555 ( 68% ) without varicocele were found . Percentage of varicocele was significantly higher in smokers compared with non - smokers ( P = 0.035 ) . The adjusted OR", "the levels of reactive oxygen species ( ROS ) and the clinical characteristics of varicoceles among patients with varicocele - induced infertility . MATERIALS AND METHODS Ninety - eight", "In this experimental study, left varicocele were induced as the test group (n=18) which was further sub-divided into three groups based on the study termination time (4, 6 and 8 months after varicocele induction).", "Reactive Oxygen Species in the Internal Spermatic and Brachial Veins of Patients with Varicocele-Induced Infertility PURPOSE The aim of this study was to evaluate the relationship between the levels of reactive oxygen species (ROS) and the clinical characteristics of varicoceles among patients with varicocele-induced infertility.", "P = 0.001 ) or infertile ( P = 0.035 ) . Seminal TRAIL may thus have a potential role in varicocele - associated male infertility through its negative effect on sperm motility and morphology .", "the ISV of men with varicocele were higher than in the control group regardless of the varicocele grade except for subclinical grade ; however , in the BV , a difference was noted only for grade", "We investigated our adolescent varicocoele database to determine (i) the presence of subclinical and palpable right varicocoele s in boys with a left varicocoele, (ii) the effect, if any, of right varicocoele on asymmetry measurements and (iii) the difference in duplex doppler ultrasound (DDUS) findings between left varicocoele s and contralateral right varicocoele s. Among 506 boys with a known left varicocoele who underwent DDUS, the incidence of right clinical and subclinical varicocoele s as well as the influence of Tanner stage, varicocoele grade, laterality, peak retrograde flow (PRF) and maximum vein diameter (MVD) on testicular volume and asymmetry was examined using univariate and multivariate linear regression.", "Varicocele significantly reduced the ability of sperm derived from varicocele rats to undergo IVF .", ". These latter showed a statistically significant reduction of sperm viscosity after varicocele surgical repair compared to pretreatment values . Finally , periprostatic venous plexus diameter", ".79 - 0.99 ) and obese men ( OR = 0.75 ; 95% CI , 0.58 - 0.97 ) were less likely to have varicocoele . This study revealed that the prevalence of varicocoele was 4.83% among rural men in eastern", "Although the contribution of right varicocoele s to fertility is controversial, these right varicocoele s can influence clinically relevant parameters, particularly testicular asymmetry, and thus influence which left varicocoele s undergo surgery.", ", lowest in varicocele and altered semen analysis ) when compared to adolescents without varicocele . DNASE1 levels are positively correlated with sperm concentration and morphology ( correlation", "This study revealed that the prevalence of varicocoele was 4.83% among rural men in eastern China; body mass index was inversely and independently associated with the presence of varicocoele.", "to the control group ( 43.4% and 46.7% , p < 0.05 for both ) . CONCLUSIONS Microsurgical varicocele repair in adolescents with varicocele significantly increases paternity rates and decreases time", ". CONCLUSIONS The findings of the present study indicated that a high frequency of varicocele was indentified among male infertile . Therefore , it is necessary for those male cigarette -", "relevant parameters , particularly testicular asymmetry , and thus influence which left varicocoele s undergo surgery .", "and low semen quality . These proteins demonstrate molecular alterations brought upon by varicocele . Moreover , DNASE1 is capable of discriminating a varicocele that causes alterations to semen", "Two hundred and sixty-one men (32%) with varicocele and 555 (68%) without varicocele were found.", "higher in infertile men with a varicocele than in controls . They were correlated with varicocele grade , varicocele duration , the degree of testicular hypotrophy , and sperm viability . In", "The study included 408 males 12 to 19 years old at presentation with clinical palpable varicocele . Of the patients 286 underwent microsurgical subinguinal or inguinal varicocele repair and 122", "Univariate and multivariate logistic regression models were constructed to assess the association between varicocoele and body mass index after adjusting for possible confounders.", "Conclusions: In patients with lower BMI, the testicular vein may have a higher grade of varicocele.", "In addition, the ROS levels were analyzed according to the characteristics of the varicocele, and ROS levels in the ISV and the BV were compared.", "Affects DNA Integrity of Sperm Cells : Evidence for Lower In vitro Fertilization Rate in Varicocele - positive Rats BACKGROUND We designed this study to clarify how varicocele can time - dependently", "Rates and Time to Conception in Adolescents with Varicocele Undergoing Microsurgical Varicocele Repair vs Observation Only : A Single Institution Experience with 408 Patients . PURPOSE We", "21 - 71 years , were included in the study . Two hundred and sixty - one men ( 32% ) with varicocele and 555 ( 68% ) without varicocele were found . Percentage of varicocele was significantly higher", "% , p < 0.05 ) . The prevalence also decreased as body mass index increased in all three varicocoele grades . In multivariate logistic regression analysis after adjusting for region , age , height ,", "higher in smokers compared with non - smokers ( P = 0.035 ) . The adjusted OR for varicocele in smokerswas significantly higher than that in non - smoker ( OR = 2.420 ; 95% CI = 1.04 , 5.61 )", "paternity rates and decreases time to conception postoperatively . Patients with varicocele who underwent microsurgical varicocele repair had increased sperm parameters and 3.63 times", "to semen quality from one that does not . We propose that the initial response of varicocele is to increase proliferative activity which , if followed by regulation of apoptosis , may lead to", "equilibrium in semen of adolescents with varicocele To verify if the presence of varicocele ( grades II and III ) with and without seminal alterations , using the 5th centile cutoff values", "Varicocele and concomitant dilation of the periprostatic venous plexus: effects on semen viscosity sperm parameters.", "the risk factors for varicocoele and strengthen the prevention and treatment of varicocoele , especially in underweight men .", "varicocoele s and contralateral right varicocoele s. Among 506 boys with a known left varicocoele who underwent DDUS , the incidence of right clinical and subclinical varicocoele s as well as the", "These latter showed a statistically significant reduction of sperm viscosity after varicocele surgical repair compared to pretreatment values.", "The presence and severity of varicocoele were measured by physical examinations .", "Prevalence of varicocoele and its association with body mass index among 39,559 rural men in eastern China: a population-based cross-sectional study.", ". In addition , the ROS levels were analyzed according to the characteristics of the varicocele , and ROS levels in the ISV and the BV were compared . RESULTS The ROS levels measured in the ISV", "CONCLUSIONS The findings of the present study indicated that a high frequency of varicocele was indentified among male infertile.", "brought upon by varicocele . Moreover , DNASE1 is capable of discriminating a varicocele that causes alterations to semen quality from one that does not . We propose that the initial", "These proteins demonstrate molecular alterations brought upon by varicocele.", "A significant negative correlation was found between seminal TRAIL and progressive (P < 0.001) and total motility scores (P < 0.001) in the infertile varicocele group.", "the existence of varicocele and determined its grade as I to III . The age , grade of varicocele , and the side of varicocele as well as the weight and height of the patients were measured and", "presence or absence of varicocele were evaluated . The lifestyle factors associated with varicocele were analyzed . RESULTS The data of 816 men , aged 21 - 71 years , were included in the study .", ", sperm progressive motility was low in all patients and increased significantly after varicocele repair , but only in DPVP- patients . Before varicocele treatment , a significantly higher number", "and motility were significantly higher ( 53.8% and 62.2% ) in the microsurgical varicocele repair group compared to the control group ( 43.4% and 46.7% , p < 0.05 for both ) . CONCLUSIONS", "When the difference in testis volume between sides was greater than 3 ml , and the varicocele had been present for more than 3 years , ROS levels were higher in the ISV than in the BV .", "The mean BMI of patients with right varicocele was not different from those with left varicocele ( P=0.34 ) .", ", both subclinical and palpable right varicocoele s are frequently associated with left varicocoele s in adolescents . Although the contribution of right varicocoele s to fertility is controversial ,", "varicocele was not different with those having right ( P=0.94 ) and left ( P=0.17 ) varicocele . 17.9% , 56.5% , and 25.6% of the patients had varicocele grade I , II , and III , respectively .", "men , underweight men ( OR = 1.34 ; 95% CI , 1.10 - 1.63 ) were more likely to have varicocoele , whereas overweight men ( OR = 0.88 ; 95% CI , 0.79 - 0.99 ) and obese men ( OR = 0.75 ; 95% CI ,", "% , p < 0.05 for both ) . CONCLUSIONS Microsurgical varicocele repair in adolescents with varicocele significantly increases paternity rates and decreases time to conception postoperatively .", "We propose that the initial response of varicocele is to increase proliferative activity which , if followed by regulation of apoptosis , may lead to the ejaculation of a population of sperm that are in accordance with WHO cutoff values but , in the presence of dysregulated apoptosis , leads to lower sperm concentration and morphology .", "Patients with varicocele who underwent microsurgical varicocele repair had increased sperm parameters and 3.63 times greater odds of paternity than controls who did not undergo varicocele surgery .", "This subset of patients did not take advantage from varicocele surgical repair since only DPVP- varicocele patients showed a significant improvement of sperm progressive motility and seminal fluid viscosity.", "species ( ROS ) and the clinical characteristics of varicoceles among patients with varicocele - induced infertility . MATERIALS AND METHODS Ninety - eight patients with infertile varicocele", "levels of reproductive hormones were measured . Seminal TRAIL levels in the infertile varicocele group were significantly higher than in the fertile varicocele and the control groups ( P = 0.014 )", "These findings suggest the evaluation of the periprostatic venous plexus and seminal fluid viscosity before patients with varicocele undergo surgical repair for asthenozoospemia .", "varicocele had a concomitant DPVP . This subset of patients did not take advantage from varicocele surgical repair since only DPVP- varicocele patients showed a significant improvement of sperm", "The aim of this study was to investigate the relationship between seminal tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) levels and male infertility in patients with varicocele.", "The adjusted OR for varicocele in smokerswas significantly higher than that in non-smoker (OR = 2.420; 95% CI = 1.04, 5.61).", "CONCLUSIONS Serum ROS levels were higher in infertile men with a varicocele than in controls .", "Blood samples were drawn from the brachial vein (BV) and the dilated internal spermatic vein (ISV) on the side of the varicocele during surgery.", "varicocoele database to determine ( i ) the presence of subclinical and palpable right varicocoele s in boys with a left varicocoele , ( ii ) the effect , if any , of right varicocoele on asymmetry", "Viscosity quantitative measurement was significantly higher in DPVP+ patients both before and after varicocele repair compared to DPVP- patients.", "were seen between varicocele and occupation or alcohol drinking for the prevalence of varicocele . CONCLUSIONS The findings of the present study indicated that a high frequency of varicocele was", "for those male cigarette - smokers to evaluate their possibilities of infertility and varicocele .", "( p = 0.01 ) . Mean PRF and MVD values were lower in right as compared to left varicocoele s. Contrary to common perception , both subclinical and palpable right varicocoele s are", "of varicocoele . Future efforts should be made to validate the risk factors for varicocoele and strengthen the prevention and treatment of varicocoele , especially in underweight men .", "levels in the infertile varicocele group were significantly higher than in the fertile varicocele and the control groups ( P = 0.014 ) . A significant negative correlation was found between", "right clinical and subclinical varicocoele s as well as the influence of Tanner stage , varicocoele grade , laterality , peak retrograde flow ( PRF ) and maximum vein diameter ( MVD ) on testicular", "in all test groups . Varicocele significantly reduced the ability of sperm derived from varicocele rats to undergo IVF . Serum TAOC and TTM levels reduced in a time - dependent manner . Right", "Seminal TRAIL may thus have a potential role in varicocele-associated male infertility through its negative effect on sperm motility and morphology.", "Levels of DNASE1 are progressively decreased in varicocele ( lower in varicocele and normal semen analysis , lowest in varicocele and altered semen analysis ) when compared to adolescents without varicocele .", "0.97 ) were less likely to have varicocoele . This study revealed that the prevalence of varicocoele was 4.83% among rural men in eastern China ; body mass index was inversely and independently", "of patients did not take advantage from varicocele surgical repair since only DPVP- varicocele patients showed a significant improvement of sperm progressive motility and seminal fluid", "RESULTS Histological results showed that varicocele negatively influenced TDI and RI .", "parameters and 3.63 times greater odds of paternity than controls who did not undergo varicocele surgery .", "RESULTS The paternity rate was 77.3% ( 221 of 286 patients ) in the microsurgical varicocele repair group and 48.4% ( 59 of 122 ) in the control group , revealing a highly significant difference ( OR 3.63 , p < 0.005 ) .", "the left testes varicocele . CONCLUSION Our data suggested that experimentally induced varicocele negatively impacted sperm maturation and chromatin integrity in a time - dependent manner . This", "Ninety - eight patients with infertile varicocele and 22 control subjects without varicocele were enrolled . Blood samples were drawn from the brachial vein ( BV ) and the dilated internal", "varicocoele s in boys with a left varicocoele , ( ii ) the effect , if any , of right varicocoele on asymmetry measurements and ( iii ) the difference in duplex doppler ultrasound ( DDUS )", "logistic regression models were constructed to assess the association between varicocoele and body mass index after adjusting for possible confounders . Varicocoele was diagnosed in 1911", ". Urologists should consider examining young , tall men to detect various grades of varicocele as a part of their physical examination .", "In conclusion , in adolescents , seminal plasma levels of IGFBP7 , responsible for proliferative activity , are increased in varicocele grades II and III , and DNASE1 , responsible for apoptosis regulation , are lower in varicocele , lowest in varicocele and low semen quality .", "increased significantly after varicocele repair , but only in DPVP- patients . Before varicocele treatment , a significantly higher number of DPVP+ patients ( 25/30 = 83.3 % ) had seminal fluid", "difference between the age groups ( P=0.11 ) . The mean BMI of patients with right varicocele was not different from those with left varicocele ( P=0.34 ) . The BMI of patients with bilateral", "brachial vein ( BV ) and the dilated internal spermatic vein ( ISV ) on the side of the varicocele during surgery . ROS levels were determined by spectrophotometry , and comparisons between the", "In multivariate logistic regression analysis after adjusting for region, age, height, occupation, cigarette smoking and alcohol consumption, body mass index was still inversely and independently associated with varicocoele (p < 0.001).", "doppler ultrasound ( DDUS ) findings between left varicocoele s and contralateral right varicocoele s. Among 506 boys with a known left varicocoele who underwent DDUS , the incidence of right", "INTRODUCTION Since varicocele is often associated with other venous abnormalities, this study was undertaken to evaluate the frequency of dilation of the periprostatic venous plexus (DPVP) in these patients and the effects of this association on sperm parameters before and after varicocelectomy.", "study . Two hundred and sixty - one men ( 32% ) with varicocele and 555 ( 68% ) without varicocele were found . Percentage of varicocele was significantly higher in smokers compared with non -", "Seminal TRAIL levels in the infertile varicocele group were significantly higher than in the fertile varicocele and the control groups ( P = 0.014 ) .", "Varicocele Time - dependently Affects DNA Integrity of Sperm Cells : Evidence for Lower In vitro Fertilization Rate in Varicocele - positive Rats BACKGROUND We designed this study to clarify how varicocele can time - dependently affect sperm morphological parameters and DNA integrity .", "and determined its grade as I to III . The age , grade of varicocele , and the side of varicocele as well as the weight and height of the patients were measured and recorded . The patients were", "39,559 rural men in eastern China : a population - based cross - sectional study . Varicocoele is a common cause of male infertility . We undertook a population - based cross - sectional study", "apoptosis - inducing ligand ( TRAIL ) levels and male infertility in patients with varicocele . This study included 112 males : 30 fertile males with varicocele , 44 infertile males with", "On the other hand , sperm progressive motility was low in all patients and increased significantly after varicocele repair , but only in DPVP- patients .", ". CONCLUSIONS In conclusion , these results showed that a large number of patients with varicocele had a concomitant DPVP . This subset of patients did not take advantage from varicocele surgical", "We undertook a population - based cross - sectional study to evaluate the prevalence of varicocoele among rural men in eastern China and its association with body mass index . A total of 39,559", "total thiol molecules ( TTM ) were examined . RESULTS Histological results showed that varicocele negatively influenced TDI and RI . All sperm morphological parameters were lower than those in the", "measurement was significantly higher in DPVP+ patients both before and after varicocele repair compared to DPVP- patients . These latter showed a statistically significant reduction of", "They were correlated with varicocele grade, varicocele duration, the degree of testicular hypotrophy, and sperm viability.", "with ROS levels . CONCLUSIONS Serum ROS levels were higher in infertile men with a varicocele than in controls . They were correlated with varicocele grade , varicocele duration , the degree", "also detected between seminal TRAIL levels and normal sperm morphology in the fertile varicocele ( P = 0.007 ) and infertile varicocele patients ( P = 0.047 ) . Seminal TRAIL was significantly", "In patients with bilaterally palpable varicocoele s, increasing left grade was associated with greater testicular asymmetry (p = 0.02) and increasing right grade was associated with less testicular asymmetry (p = 0.01).", "varicocele patients ( P = 0.047 ) . Seminal TRAIL was significantly correlated with varicocele grade whether the patients were fertile ( P = 0.001 ) or infertile ( P = 0.035 ) . Seminal TRAIL", "Most patients had grade II varicocele without a significant difference between the age groups (P=0.11).", "Therefore , it is necessary for those male cigarette - smokers to evaluate their possibilities of infertility and varicocele .", "varicocele . Germ cell apoptosis has been proposed as one of the mechanisms by which varicocele can influence fertility . The aim of this study was to investigate the relationship between", "DNA integrity . In this study , we intend to estimate the effect of various periods of varicocele on the in vitro fertilization ( IVF ) rate in rats . MATERIALS AND METHODS In this experimental", "7 protein are increased in varicocele . Levels of DNASE1 are progressively decreased in varicocele ( lower in varicocele and normal semen analysis , lowest in varicocele and altered semen analysis )", "surgical treatment for grade III bilateral varicocele . RESULTS Thirty patients with varicocele had also DPVP ( DPVP+ ) ( 60 % ) . Sperm concentration and the percentage of spermatozoa with", "and progressive ( P < 0.001 ) and total motility scores ( P < 0.001 ) in the infertile varicocele group . A significant negative correlation was also detected between seminal TRAIL levels and", "and time to conception between adolescents with varicocele undergoing microsurgical varicocele repair and patients who did not undergo surgery and were followed conservatively . MATERIALS AND", "The detrimental effect of varicocele may be attributed to the significant reduction of antioxidant capacity of the serum.", "of varicocele among male infertile , for a better prevention and management of the varicocele . MATERIALS AND METHODS All males with infertility , who presented at Fatemezahra Infertility and", "surgery . ROS levels were determined by spectrophotometry , and comparisons between the varicocele and control groups were performed . In addition , the ROS levels were analyzed according to the", "Seminal TRAIL was significantly correlated with varicocele grade whether the patients were fertile (P = 0.001) or infertile (P = 0.035).", "of the periprostatic venous plexus and seminal fluid viscosity before patients with varicocele undergo surgical repair for asthenozoospemia .", "Varicocele was more frequent in the age group of 20-30 years.", "III . When the difference in testis volume between sides was greater than 3 ml , and the varicocele had been present for more than 3 years , ROS levels were higher in the ISV than in the BV . Sperm", "in adults is much higher than among adolescents . We investigated our adolescent varicocoele database to determine ( i ) the presence of subclinical and palpable right varicocoele s in boys", "divided into three groups based on the study termination time ( 4 , 6 and 8 months after varicocele induction ) . The control - sham group ( n=6 ) consisted of rats who received no treatment .", "and ability to undergo IVF were assessed . In addition , the potential impact of varicocele on serum total antioxidant capacity ( TAOC ) and total thiol molecules ( TTM ) were examined .", "MATERIALS AND METHODS Ninety-eight patients with infertile varicocele and 22 control subjects without varicocele were enrolled.", "and Shandong provinces were recruited from 2011 to 2012 . The presence and severity of varicocoele were measured by physical examinations . Univariate and multivariate logistic regression models", "total of 61 male adolescents were included in this study , of which 20 controls without varicocele ( C ) , 22 with varicocele and normal semen analysis ( VNS ) and 19 with varicocele and altered", "varicocele . Of the patients 286 underwent microsurgical subinguinal or inguinal varicocele repair and 122 did not undergo varicocele surgery and were followed conservatively . Only men who", "AIMS This study was designed to assess the occupational and lifestyle factors of development of varicocele among male infertile, for a better prevention and management of the varicocele.", "CONCLUSIONS In conclusion, these results showed that a large number of patients with varicocele had a concomitant DPVP.", "- induced infertility . MATERIALS AND METHODS Ninety - eight patients with infertile varicocele and 22 control subjects without varicocele were enrolled . Blood samples were drawn from the", "Their occupations, smoking, and drinking alcohol, presence or absence of varicocele were evaluated.", "Expert urologists examined the patients for the existence of varicocele and determined its grade as I to III.", "The BMI of patients with bilateral varicocele was not different with those having right ( P=0.94 ) and left ( P=0.17 ) varicocele .", "study included 112 males : 30 fertile males with varicocele , 44 infertile males with varicocele and 38 healthy fertile control subjects without varicocele . Semen analysis was performed , and", "microsurgical subinguinal or inguinal varicocele repair and 122 did not undergo varicocele surgery and were followed conservatively . Only men who desired conception were included in the", "We undertook a population - based cross - sectional study to evaluate the prevalence of varicocoele among rural men in eastern China and its association with body mass index .", "the relationship between body mass index ( BMI ) and the frequency and grade of varicocele among a sample of Iranian men in southeast Iran . Methods : This cross - sectional study was", "( P=0.94 ) and left ( P=0.17 ) varicocele . 17.9% , 56.5% , and 25.6% of the patients had varicocele grade I , II , and III , respectively . Conclusions : In patients with lower BMI , the testicular"], "par_relations": ["Genital Diseases, Male", "Vascular Diseases"], "chd_relations": [], "syn_relations": ["Varicocele", "Varicocele"], "sib_relations": ["Aneurysm", "Angiomatosis", "Angioedema", "Aortic Diseases", "Arterial Occlusive Diseases", "Arteriovenous Malformations", "Cerebrovascular Disorders", "Compartment Syndromes", "Diabetic Angiopathies", "Epididymitis", "Genital Neoplasms, Male", "Hematocele", "Hemorrhoids", "Hepatic Veno-Occlusive Disease", "Herpes Genitalis", "Hyperemia", "Hypertension", "Hypotension", "Infertility", "Penile Diseases", "Prostatic Diseases", "Pulmonary Veno-Occlusive Disease", "Reperfusion Injury", "Retinal Vein Occlusion", "Scimitar Syndrome", "Sexually Transmitted Diseases", "Spermatic Cord Torsion", "Spermatocele", "Splenic Infarction", "Superior Vena Cava Syndrome", "Telangiectasis", "Testicular Diseases", "Thoracic Outlet Syndrome", "Tuberculosis, Male Genital", "Varicose Veins", "Vasculitis", "Venous Insufficiency", "Vascular Fistula", "Peripheral Vascular Diseases", "Embolism and Thrombosis", "Angiodysplasia", "Hemospermia", "Myocardial Ischemia", "Optic Neuropathy, Ischemic", "Colitis, Ischemic", "Vascular System Injuries", "Sexual Dysfunction, Physiological", "Fournier Gangrene", "Vascular Neoplasms", "Stenosis, Pulmonary Vein", "Capillary Leak Syndrome", "Hemostatic Disorders", "Spinal Cord Vascular Diseases", "Hand-Arm Vibration Syndrome", "Mesenteric Ischemia", "Prehypertension", "Testicular Hydrocele", "Reproductive Tract Infections", "Vasoplegia"]}, "target_ent": {"research_entity_id": "OMIM:125647", "canonical_name": "DESMOPLAKIN", "aliases": ["desmoplakin", "cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis", "skin fragility-woolly hair syndrome", "reclassified - variant of unknown significance", "keratosis palmoplantaris striata ii (1 family)", "variant of unknown significance", "desmoplakin ii", "epidermolysis bullosa, lethal acantholytic", "cardiomyopathy, dilated, with woolly hair and keratoderma", "arrhythmogenic right ventricular dysplasia, familial, 8", "dspi", "desmoplakin i", "dsp", "dspii"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["DESMOPLAKIN", "DESMOPLAKIN", "DESMOPLAKIN", "DESMOPLAKIN", "DESMOPLAKIN", "DSP, GLN331TER", "DSP, 1-BP DEL, 7901G", "DSP, SER299ARG", "DSP, ASN287LYS", "DSP, CYS809TER", "DSP, ARG2366CYS", "DSP, GLN664TER", "DSP, ARG1934TER", "DSP, ARG1267TER", "DSP, ARG2834HIS", "DSP, ARG2366HIS", "DSP, 1-BP DEL, 7780T", "DSP, 2-BP DEL, 6370TT", "DSP, 30-BP INS, NT1823", "DSP, SER597LEU", "DSP, THR564ILE", "DSP, 5-BP DEL, NT2874", "DSP, 1-BP DEL, 7248T", "DSP, VAL30MET (dbSNP rs121912998)", "DSP, LEU622PRO", "DSP, HIS618PRO", "DSP, GLN616PRO", "DSP, HIS586PRO", "DESMOPLAKIN"], "sib_relations": ["DSP, ASN287LYS", "DSP, CYS809TER", "DSP, ARG2366CYS", "DSP, GLN664TER", "DSP, ARG2366HIS", "DSP, SER299ARG", "DSP, ARG2834HIS", "DSP, 1-BP DEL, 7901G", "DSP, ARG1267TER", "DSP, 1-BP DEL, 7780T", "DSP, ARG1934TER", "DSP, 2-BP DEL, 6370TT", "DSP, 5-BP DEL, NT2874", "DSP, 1-BP DEL, 7248T", "DSP, HIS586PRO", "DSP, 30-BP INS, NT1823", "DSP, SER597LEU", "DSP, THR564ILE", "DSP, LEU622PRO", "DSP, HIS618PRO", "DSP, GLN616PRO", "DSP, VAL30MET (dbSNP rs121912998)", "DSP, GLN331TER"]}}
{"label": 1, "source_ent": {"research_entity_id": "HGNC:HGNC:19123", "canonical_name": "DnaJ heat shock protein family (Hsp40) member C9", "aliases": ["jdd1", "sb73", "dnajc9 gene", "dnaj heat shock protein family (hsp40) member c9", "dnajc9"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["DnaJ heat shock protein family (Hsp40) member C9", "DnaJ heat shock protein family (Hsp40) member C9", "DnaJ heat shock protein family (Hsp40) member C9", "DnaJ heat shock protein family (Hsp40) member C9", "DnaJ heat shock protein family (Hsp40) member C9", "DnaJ heat shock protein family (Hsp40) member C9"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:611206", "canonical_name": "DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 9", "aliases": ["j domain of dnaj-like protein 1", "dnaj/hsp40 homolog, subfamily c, member 9", "jdd1", "kiaa0974", "dnajc9"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 9", "DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 9", "DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 9", "DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 9", "DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 9", "DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 9", "DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 9", "DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 9"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:1659", "canonical_name": "CD33 molecule", "aliases": ["p67", "sialic acid binding ig-like lectin 3", "siglec-3", "cd33 molecule", "cd33", "cd33 gene", "siglec3", "flj00391"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["CD33 molecule", "CD33 molecule", "CD33 molecule", "CD33 molecule", "CD33 molecule", "CD33 molecule", "CD33 molecule", "CD33 molecule", "CD33 molecule", "CD33 molecule"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:159460", "canonical_name": "MYELIN-ASSOCIATED GLYCOPROTEIN", "aliases": ["spastic paraplegia 75, autosomal recessive", "sialic acid-binding immunoglobulin-like lectin 4a", "myelin-associated glycoprotein", "mag", "siglec4a"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["MYELIN-ASSOCIATED GLYCOPROTEIN", "MYELIN-ASSOCIATED GLYCOPROTEIN", "MYELIN-ASSOCIATED GLYCOPROTEIN", "MAG, CYS430GLY", "MAG, SER133ARG", "MYELIN-ASSOCIATED GLYCOPROTEIN", "MYELIN-ASSOCIATED GLYCOPROTEIN", "MYELIN-ASSOCIATED GLYCOPROTEIN"], "sib_relations": ["MAG, CYS430GLY", "MAG, SER133ARG"]}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0002154", "canonical_name": "Hyperglycinemia", "aliases": ["elevated blood glycine levels", "hyperglycinemia", "hyperglycinaemia"], "definition": "An elevated concentration of glycine in the blood. [HPO:gcarletti, pmid:16902722, pmid:4696900]", "other_contexts": ["In the case of transient neonatal hyperglycinemia, the elevated plasma and cerebrospinal fluid glycine levels are normalized within 2 to 8 weeks.", "Almost all patients with the classic form of nonketotic hyperglycinemia survive with severe neurologic sequela , whereas most of the patients with the transient form exhibit normal development .", "PURPOSE Neonatal nonketotic hyperglycinemia is an autosomal recessive inborn disorder of glycine metabolism in which large quantities of glycine accumulate in all body tissues .", "The Authors report their clinical and laboratory experience in the diagnosis of different forms of hyperglycinemia .", "Patients with attenuated nonketotic hyperglycinemia make variable developmental progress .", "To elucidate the pathogenesis of transient neonatal hyperglycinemia , we studied three patients by screening mutations in the genes that encode three components of the glycine cleavage system .", "Transient neonatal hyperglycinemia is clinically or biochemically indistinguishable from nonketotic hyperglycinemia at onset.", "Measurement of liver glycine cleavage system activity is indicated when nonketotic hyperglycinemia is suggested by clinical features and peripheral glycine levels but cerebrospinal fluid glycine is normal.", "Therefore , distinguishing the transient form of nonketotic hyperglycinemia from classic nonketotic hyperglycinemia is important to predict outcome of the patients .", "[ Hyperglycinemia in clinical - laboratory practice ] .", "Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5.", "Heterozygous mutations were identified in all of the three patients, suggesting that transient neonatal hyperglycinemia develops in some heterozygous carriers for nonketotic hyperglycinemia.", "Patients with GLRX5-associated variant nonketotic hyperglycinemia had normal development with childhood-onset spastic paraplegia, spinal lesion, and optic atrophy.", "Patients with lipoate synthase - deficient variant nonketotic hyperglycinemia varied in severity from mild static encephalopathy to Leigh disease and cortical involvement .", "The recognition of variant nonketotic hyperglycinemia is important for physicians evaluating patients with abnormalities in glycine as this will affect the genetic causation and genetic counselling , and provide prognostic information on the expected phenotypic course .", "Of 11 individuals identified with variant nonketotic hyperglycinemia , we were able to determine the genetic aetiology in eight patients and delineate the clinical and biochemical phenotypes .", "We studied two siblings who have the neurologic and peripheral biochemical features of the atypical variant of nonketotic hyperglycinemia but have normal cerebrospinal fluid glycine and cerebrospinal fluid to plasma glycine ratios.", "Hyperglycinemia was induced by dipropylacetate ( DPA ) ( dose 14 - 41 mg / kg per day ) in 10 Finnish epileptic patients with neurologically disabling diseases of various kinds .", "In comparison with corresponding values in nonketotic hyperglycinemia and ketotic hyperglycinemia, this condition probably arises in a manner similar to secondary hyperglycinemia in organic aciduria.", "The purpose of this study is to evaluate the musculoskeletal findings of neonatal nonketotic hyperglycinemia .", "Transient nonketotic hyperglycinemia has been reported in only seven neonates .", "RESULTS Patients with severe nonketotic hyperglycinemia required multiple anticonvulsants, whereas patients with developmental quotient (DQ) > 30 did not require anticonvulsants.", "There are no reports about the orthopaedic manifestations of neonatal nonketotic hyperglycinemia .", "Three patients with nonketotic hyperglycinemia (1 patient with transient neonatal form, 1 with the classic neonatal form, and 1 with late onset form), 6 patients with ketotic hyperglycinemia (1 propionic acidemia, 5 methylmalonic acidurias), and 8 patients with hyperglycinemia during sodium valproate treatment are described.", "Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia OBJECTIVE Nonketotic hyperglycinemia is a neurometabolic disorder characterized by intellectual disability, seizures, and spasticity.", "From the above data as well as from clinical and biochemical observations in three patients , it was concluded that there exists a true nonketotic hyperglycinemia which is not related etiologically to the different disorders of the ketotic hyperglycinemia syndrome .", "The diagnosis of nonketotic hyperglycinemia is considered to depend upon the presence of increased cerebrospinal fluid glycine and an increased cerebrospinal fluid to plasma glycine ratio .", "Glycine concentrations were measured in plasma and cerebrospinal fluid of five patients in different types of hyperglycinemia to determine why severe neurologic deterioration is confined to the so - called nonketotic form of hyperglycinemia .", "Nonketotic hyperglycinemia .", "Glycine content was two to four times above normal in several brain regions, and brain glycine cleavage enzyme activity was absent in two patients dying of nonketotic hyperglycinemia.", "METHODS This is a retrospective IRB-approved study of all patients in our Orthopaedic and Genetics Clinics with the diagnosis of neonatal nonketotic hyperglycinemia during a 10-year period.", "By contrast, glycine content was normal and glycine cleavage activity present in the brain of an infant who died of hyperglycinemia of unknown cause.", "Brain malformations occurred mainly in patients with severe nonketotic hyperglycinemia ( 71% ) but rarely in patients with attenuated nonketotic hyperglycinemia ( 7.5% ) .", "Hyperglycinemia is a non rarely observed biochemical finding which can be caused by a primary defect of the glycine cleavage system ( nonketotic hyperglycinemia ) or by an enzymatic block due to toxic metabolites ( ketotic hyperglycinemia in organic acidurias ) or to specific drugs ( such as sodium valproate ) .", "It must be distinguished by exclusion from mild forms of the ketotic hyperglycinemia syndrome which may present clinically as hyperglycinemia without ketosis.", "True nonketotic hyperglycinemia is not associated with ketoacidosis even after loading with propionate- and MMA precursors .", "Patients with nonketotic hyperglycinemia and deficient glycine cleavage enzyme activity , but without mutations in AMT , GLDC or GCSH , the genes encoding its constituent proteins , constitute a clinical group which we call ' variant nonketotic hyperglycinemia ' .", "In this study the diagnostic iter and the importance of a precise diagnosis of the hyperglycinemia for the appropriate treatment are discussed .", "CONCLUSION Neonatal nonketotic hyperglycinemia is a rare metabolic disorder presented in the past as a lethal condition.", "Heterozygous GLDC and GCSH gene mutations in transient neonatal hyperglycinemia .", "Neonatal presentation did not correlate with outcome, but age at onset ≥ 4 months was associated with attenuated nonketotic hyperglycinemia.", "Spinal - fluid glycine concentrations were 15 to 30 times above normal in patients with nonketotic hyperglycinemia , but were normal in those with hyperglycinemias of undetermined type who had comparable elevations of plasma glycine .", "Transient nonketotic hyperglycinemia: two case reports and literature review.", "Nonketotic hyperglycinemia can be present in the absence of increased cerebrospinal fluid glycine .", "Musculoskeletal manifestations of neonatal nonketotic hyperglycinemia.", "Atypical nonketotic hyperglycinemia with normal cerebrospinal fluid to plasma glycine ratio.", "Acute neonatal nonketotic hyperglycinemia: normal propionate and methylmalonate metabolism.", "This article adds two cases to the transient nonketotic hyperglycinemia and reviews the relevant literature .", "Transient nonketotic hyperglycinemia is characterized by clinical and biochemical findings similar to those seen in classic nonketotic hyperglycinemia.", "Dipropylacetate and hyperglycinemia.", "Clinical features of BOLA3-associated variant nonketotic hyperglycinemia include severe neurodegeneration after a period of normal development .", "RESULTS Twelve patients with neonatal nonketotic hyperglycinemia were evaluated, with a mean age of 7 years and 2 months (range: 5 months to 21 years)."], "par_relations": ["Abnormality of glycine metabolism", "Abnormality of serum amino acid levels"], "chd_relations": ["Nonketotic hyperglycinemia"], "syn_relations": ["Hyperglycinemia", "Hyperglycinemia", "Hyperglycinemia", "Hyperglycinemia"], "sib_relations": ["Hyperlysinemia", "Hyperalaninemia", "Hyperglycinuria", "Hyperglutaminemia", "Hypomethioninemia", "Hyperthreoninemia", "Hypoglycinemia", "Abnormality of sarcosine metabolism"]}, "target_ent": {"research_entity_id": "OMIM:MTHU048681", "canonical_name": "Giant plaque of porokeratosis ptychotropica", "aliases": ["giant plaque of porokeratosis ptychotropica"], "definition": "", "other_contexts": [], "par_relations": ["Skin"], "chd_relations": [], "syn_relations": [], "sib_relations": ["POROKERATOSIS 3, MULTIPLE TYPES"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:D019080", "canonical_name": "Cafe-au-Lait Spots", "aliases": ["spot, cafe-au-lait", "cafe-au-lait spot", "cafe au lait spots", "spots, cafe-au-lait", "cafe-au-lait spots"], "definition": "Light brown pigmented macules associated with NEUROFIBROMATOSIS and Albright's syndrome (see FIBROUS DYSPLASIA, POLYOSTOTIC).", "other_contexts": [], "par_relations": ["Skin Manifestations", "Pigmentation Disorders"], "chd_relations": ["Gastrocutaneous syndrome", "Cafe au lait spots, multiple", "Legius syndrome"], "syn_relations": ["Cafe-au-Lait Spots", "Cafe-au-Lait Spots", "Cafe-au-Lait Spots", "Cafe-au-Lait Spots", "Cafe-au-Lait Spots", "Cafe-au-Lait Spots", "Cafe-au-Lait Spots", "Cafe-au-Lait Spots"], "sib_relations": ["Argyria", "Ecchymosis", "Incontinentia Pigmenti", "Jaundice", "Pallor", "Pruritus", "Purpura", "Urticaria Pigmentosa", "Xeroderma Pigmentosum", "Livedo Reticularis", "Striae Distensae", "Hyperpigmentation", "Hypopigmentation", "Necrolytic Migratory Erythema", "Yellow Nail Syndrome", "Cellulite"]}, "target_ent": {"research_entity_id": "OMIM:133230", "canonical_name": "ESTERASE A-5", "aliases": ["esa7", "acetylesterase, adult brain", "acetylesterase, fetal brain", "esterase a-5", "esa5"], "definition": "", "other_contexts": ["Furthermore there was suggestive evidence that ESA7 and ESA5 may be interconvertible .", "( 3 ) A variant esterase isozyme pattern , which shows unusual features of both ESA7 and ESA5 , was found in a survey of 120 foetal brains .", "( 2 ) Detailed biochemical investigation of partially purified human adult brain ESA5 and the foetal esterase ESA7 has revealed a close resemblance in the biochemical properties of these two isozymes .", "Earlier studies had pointed to the foetal brain esterase ESA7 as a probable example .", "The genetic relationship between the human foetal acetylesterase ESA7 and the adult acetylesterase ESA5 ."], "par_relations": [], "chd_relations": [], "syn_relations": ["ESTERASE A-5", "ESTERASE A-5", "ESTERASE A-5", "ESTERASE A-5"], "sib_relations": []}}
{"label": 1, "source_ent": {"research_entity_id": "HPO:HP:0003038", "canonical_name": "Fibular hypoplasia", "aliases": ["short calf bone", "hypoplastic fibula", "short fibula", "short fibulae", "fibular hypoplasia"], "definition": "Underdevelopment of the fibula. [HPO:probinson]", "other_contexts": [], "par_relations": ["Short long bone", "Aplasia/Hypoplasia of the fibula", "Abnormal morphology of bones of the lower limbs"], "chd_relations": ["Rudimentary fibula", "Hypoplasia of proximal fibula"], "syn_relations": ["Fibular hypoplasia", "Fibular hypoplasia", "Fibular hypoplasia", "Fibular hypoplasia", "Fibular hypoplasia", "Fibular hypoplasia", "Fibular hypoplasia", "Fibular hypoplasia"], "sib_relations": ["Short femur", "Short humerus", "Fibular aplasia", "Tibial bowing", "Hypoplasia of the lesser trochanter", "Long fibula", "Short metatarsal", "Short tibia", "Forearm undergrowth", "Hypoplasia of the femoral head", "Femoral bowing", "Fibular overgrowth", "Hyperplasia of the femoral trochanters", "Increased fibular diameter", "Increased length of the tibia", "Fibular bowing", "Bifid femur", "Broad phalanx of the toes", "Synostosis involving the tibia", "Synostosis involving the fibula"]}, "target_ent": {"research_entity_id": "OMIM:MTHU021004", "canonical_name": "Hypoplastic fibulae", "aliases": ["hypoplastic fibulae"], "definition": "", "other_contexts": [], "par_relations": ["Limbs"], "chd_relations": [], "syn_relations": [], "sib_relations": ["PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA"]}}
{"label": 1, "source_ent": {"research_entity_id": "HPO:HP:0000589", "canonical_name": "Coloboma", "aliases": ["ocular colobomas", "ocular coloboma", "coloboma"], "definition": "A developmental defect characterized by a cleft of some portion of the eye or ocular adnexa. [HPO:probinson]", "other_contexts": [], "par_relations": ["Abnormality of the orbital region"], "chd_relations": ["Optic nerve coloboma", "Iris coloboma", "Retinal coloboma", "Chorioretinal coloboma", "Lens coloboma", "Ciliary body coloboma"], "syn_relations": ["Coloboma", "Coloboma", "Coloboma", "Coloboma"], "sib_relations": ["Abnormality of globe size", "Abnormality of globe location", "Abnormal morphology of the ocular adnexa", "Hamartoma of the orbital region", "Abnormality of bony orbit of skull"]}, "target_ent": {"research_entity_id": "MSH:D003103", "canonical_name": "Coloboma", "aliases": ["coloboma", "coloboma, uveoretinal", "colobomas", "uveoretinal coloboma", "coloboma, ocular", "coloboma of iris, choroid, and retina", "ocular coloboma"], "definition": "Congenital anomaly in which some of the structures of the eye are absent due to incomplete fusion of the fetal intraocular fissure during gestation.", "other_contexts": [], "par_relations": ["Eye Abnormalities"], "chd_relations": ["Coloboma of optic nerve", "Coloboma, cleft lip-palate and mental retardation syndrome", "Yim Ebbin syndrome", "Otodental Dysplasia", "Macrosomia obesity macrocephaly ocular abnormalities", "Median cleft lip, corpus callosum, lipoma, and skin polyps", "Corpus Callosum, Agenesis of, with Mental Retardation, Ocular Coloboma, and Micrognathia", "Microphthalmia, Isolated, with Coloboma 1", "Zunich neuroectodermal syndrome", "Thumb, Hypoplastic, with Choroid Coloboma, Poorly Developed Antihelix, and Deafness", "Coloboma, Uveal, with Cleft Lip and Palate and Mental Retardation", "Coloboma of macula type B brachydactyly", "Papillorenal syndrome", "Hereditary macular coloboma", "Microphthalmia, Isolated, with Coloboma 2", "Microphthalmia, Isolated, with Coloboma 4", "Marles Greenberg Persaud syndrome", "Arima syndrome", "Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation", "Temtamy syndrome", "Coloboma of Macula and Skeletal Anomalies", "COACH syndrome", "Biemond syndrome II", "Coloboma of Alar-nasal cartilages with telecanthus", "Aortic Arch Interruption, Facial Palsy, and Retinal Coloboma", "Hypospadias, Hypertelorism, Upper Lid Coloboma, and Mixed-Type Hearing Loss", "Microphthalmia, Isolated, with Coloboma 3", "Microphthalmia, Cataracts, and Iris Abnormalities", "Brachydactyly, Coloboma, And Anterior Segment Dysgenesis", "Coloboma-Obesity-Hypogenitalism-Mental Retardation Syndrome", "Nasopalpebral lipoma coloboma syndrome", "Microphthalmia, Isolated, with Coloboma 5", "Kahrizi Syndrome", "Microtia With Nasolacrimal Duct Imperforation And Eye Coloboma", "Alsing syndrome", "Microphthalmia and mental deficiency", "Microphthalmia associated with colobomatous cyst", "Pfeiffer Mayer syndrome", "Baraitser Rodeck Garner syndrome", "Calloso-genital dysplasia", "Hittner Hirsch Kreh syndrome"], "syn_relations": ["Coloboma", "Coloboma"], "sib_relations": ["Aniridia", "Anophthalmos", "Blepharophimosis", "Ectopia Lentis", "Hydrophthalmos", "Microphthalmos", "Retinal Dysplasia", "Fraser Syndrome", "Persistent Hyperplastic Primary Vitreous"]}}
{"label": 1, "source_ent": {"research_entity_id": "HGNC:HGNC:22998", "canonical_name": "transmembrane channel like 4", "aliases": ["transmembrane channel like 4", "tmc4 gene", "tmc4"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["transmembrane channel like 4", "transmembrane channel like 4"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:617181", "canonical_name": "TRANSMEMBRANE CHANNEL-LIKE PROTEIN 4", "aliases": ["transmembrane channel-like protein 4", "tmc4"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["TRANSMEMBRANE CHANNEL-LIKE PROTEIN 4", "TRANSMEMBRANE CHANNEL-LIKE PROTEIN 4"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C537195", "canonical_name": "Spinocerebellar ataxia 13", "aliases": ["spinocerebellar ataxia 13", "autosomal dominant cerebellar ataxia with mental retardation", "cerebellar ataxia, autosomal dominant with mental retardation"], "definition": "", "other_contexts": ["We detail the clinical phenotype of four SCA13 kindreds that confirm causation of the KCNC3R423H allele .", "Therefore , our data strongly suggest that changes in Kv3.3 gating contribute significantly to an early age of onset in SCA13 .", "This phenotype might be directly relevant to infant - onset SCA13 because interaction with inappropriate synaptic partners might trigger cell death during brain development .", "In an effort to identify the molecular basis of this allelic form of SCA13 , we first determined that human KCNC3(WT ) and KCNC3(R420H ) display disparate post - translational modifications , and the mutant protein has reduced complex glycan adducts .", "3(R420H ) allele and provide new insight into the molecular basis of disease manifestation in SCA13 .", "An autosomal dominant mutation in the gene encoding Kv3.3 has been demonstrated in a large Filipino kindred manifesting as spinocerebellar ataxia type 13 ( SCA13 ) .", "In the rodent brain , Kv3.3 mRNAs are expressed most strongly in PCs , suggesting that the mutations severely affect PCs in SCA13 patients .", "Spinocerebellar ataxia type 13 ( SCA13 ) is an autosomal dominant disease , and SCA13 patients exhibit cerebellar atrophy and cerebellar symptoms .", "The KCNC3(R420H ) mutation was first identified as causative for SCA13 in a four - generation Filipino kindred with over 20 affected individuals .", "negative phenotype . In an effort to identify the molecular basis of this allelic form of SCA13 , we first determined that human KCNC3(WT ) and KCNC3(R420H ) display disparate post -", "From these results , we speculate that infant - onset SCA13 is associated with marked changes in the development of Kv3.3-expressing cerebellar neurons , reducing their health and viability early in life and resulting in the withered cerebellum seen in affected children .", "Recently , studies have shown that mutations in the voltage - gated potassium channel KCNC3 are causative for SCA13 .", "To address these questions , we used lentiviral vectors to express mutant mouse Kv3.3 ( mKv3.3 ) channels harbouring an R424H missense mutation , which corresponds to the R423H mutation in the Kv3.3 channels of SCA13 patients , in mouse cerebellar cultures .", "Sca13 Spinocerebellar ataxia 13 ( SCA13 ) , initially described in a four - generation French family , has now also been characterized in a large Filipino pedigree .", "The F448L mutation alters channel gating and causes early - onset SCA13 .", "- gated potassium channel . The KCNC3(R420H ) mutation was first identified as causative for SCA13 in a four - generation Filipino kindred with over 20 affected individuals . Electrophysiological", "However , R420H results in the adult form of the disease whereas R423H produces the early - onset , neurodevelopmental form with significant clinical overlap with F448L. Since individuals with SCA13 have one wild type and one mutant allele of the Kv3.3 gene , we analysed the properties of tetrameric channels formed by mixtures of wild type and mutant subunits .", "A KCNC3 mutation causes a neurodevelopmental , non - progressive SCA13 subtype associated with dominant negative effects and aberrant EGFR trafficking The autosomal dominant spinocerebellar ataxias ( SCAs ) are a diverse group of neurological disorders anchored by the phenotypes of motor incoordination and cerebellar atrophy .", "spinocerebellar ataxia 13 displays aberrant intracellular trafficking . Spinocerebellar ataxia 13 ( SCA13 ) is an autosomal dominant disease resulting from mutations in KCNC3 ( Kv3.3 ) , a voltage", "Different mutations produce either early onset SCA13 , associated with delayed motor and impaired cognitive skill acquisition , or late onset SCA13 , which typically produces cerebellar degeneration in middle age .", "Depending on the causative mutation , SCA13 is either a neurodevelopmental disorder that is evident in infancy or a progressive neurodegenerative disease that emerges during adulthood .", "Spinocerebellar ataxia 13 ( SCA13 ) is an autosomal dominant disease resulting from mutations in KCNC3 ( Kv3.3 ) , a voltage - gated potassium channel .", "Recent studies have shown that missense mutations in the voltage - gated K(+ ) channel Kv3.3 are responsible for SCA13 .", "ataxia 13 displays aberrant intracellular trafficking . Spinocerebellar ataxia 13 ( SCA13 ) is an autosomal dominant disease resulting from mutations in KCNC3 ( Kv3.3 ) , a voltage - gated", "The high degree of homology between human and zebrafish Kv3.3 channels suggests that the zebrafish will be a useful model system for studying pathogenic mechanisms in SCA13 .", "These results suggest that PCs in SCA13 patients also exhibit similar defects in PC excitability and induced cell death , which may explain the pathology of SCA13 .", "Surprisingly , several individuals exhibited the auditory deficits even though they were pre - symptomatic for SCA13 .", "To assess the potential usefulness of the zebrafish as a model system for SCA13 , we have characterized the functional properties of zebrafish Kv3.3 channels with and without mutations analogous to those that cause SCA13 .", "Spinocerebellar ataxia with mental retardation ( SCA13 ) Spinocerebellar ataxia 13 is a slowly progressive and relatively pure autosomal dominant cerebellar ataxia with childhood onset and mental deficiency .", "Our results therefore confirm the KCNC3R423H allele as causative for SCA13 , through a dominant negative effect on KCNC3WT and links with EGFR that account for dominant inheritance , congenital onset , and disease pathology .", "Spinocerebellar ataxia type 13 mutation that is associated with disease onset in infancy disrupts axonal pathfinding during neuronal development Spinocerebellar ataxia type 13 ( SCA13 ) is an autosomal dominant disease caused by mutations in the Kv3.3 voltage - gated potassium ( K(+ ) ) channel ."], "par_relations": ["Spinocerebellar Ataxias"], "chd_relations": [], "syn_relations": [], "sib_relations": ["congenital"]}, "target_ent": {"research_entity_id": "OMIM:610978", "canonical_name": "CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION", "aliases": ["brain-lung-thyroid syndrome", "choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction", "cahtp"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION", "CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION", "CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION", "CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION"], "sib_relations": ["Ataxia", "Hypothyroidism, congenital", "Dysarthria", "Hypotonia", "Choreoathetosis", "Dystonia", "Autosomal dominant", "Global developmental delay", "Onset at birth", "Increased serum thyroid-stimulating hormone (TSH)", "Delayed motor development", "Hypoplasia of the thyroid gland in some patients", "Difficulty walking in childhood", "Serum thyroxine may be decreased or normal", "'Compensated hypothyroidism' with increased TSH and normal T4", "Caused by mutation in the thyroid transcription factor 1 gene (TITF1, 600635.0005)", "Allelic disorder to benign hereditary chorea (118700), which is less severe", "Asthma (in some patients)", "Recurrent respiratory infections", "Symptoms of hypothalamic disturbances (in some patients)", "Sleep disturbances (in some patients)", "Hunger and thirst disturbances (in some patients)", "Congenital septal defects (in some patients)", "Unexplained fever (in some patients)", "Respiratory distress, neonatal"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:D005277", "canonical_name": "Fenfluramine", "aliases": ["hydrochloride, fenfluramine", "fenfluramine hydrochloride, r-isomer", "fenfluramine hydrochloride", "fenfluramine hydrochloride, r isomer", "fenfluramine, r-isomer", "pondimin", "fenfluramine, r isomer", "fenfluramine, (+-)-isomer", "isomeride", "benzeneethanamine, n-ethyl-alpha-methyl-3-(trifluoromethyl)-", "fenfluramine hydrochloride, (+-)-isomer", "fenfluramine"], "definition": "A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release.", "other_contexts": ["A pharmacological blockade of K(V ) channels by 4-aminopyridine ( 3 x 10(-3 ) mol / l ) markedly potentiated the pulmonary vasoconstrictor response to fenfluramine but was without effect on the reactivity to 5-HT .", "Fenfluramine suppressess the body weight of experimental animals during chronic treatment by a mechanism that is not yet clear.", "Fenfluramine ( 2.5 - 10 mg / kg ) suppressed tumor necrosis factor - alpha production , but only fenfluramine ( 5 and 10 mg / kg ) suppressed interleukin-1beta production . Fenfluramine ( 10 mg / kg)-induced suppression of interleukin-1beta and", "Using in vitro analyses, we demonstrated that the immunosuppressive effect of fenfluramine was not due to a direct effect on immune cells.", "Tolerance to the anorectic effects of fenfluramine was not complete however -- food intake of fenfluramine - treated rats fell below control levels on 7 of the remaining 20 days of treatment .", "Both 5-HT (10(-5) mol/l) and fenfluramine (5 x 10(-4) mol/l) caused significant increases in perfusion pressure.", "A higher ritanserin dose ( 10(-5 ) mol / l ) completely abolished the responses to 5-HT but had no more inhibitory effect on the responses to fenfluramine .", "It has been postulated that fenfluramine affects brain serotonin ( 5HT ) neurons resulting in decreased food intake and altered autonomic outflow which , in turn , increases metabolism .", "These changes in hypothalamic CRF and plasma corticosterone correlated with brain fenfluramine levels.", "By contrast , on the second day of fenfluramine withdrawal the TEF of fenfluramine treated rats was suppressed to 17% of control levels .", "This finding suggests that preexisting K(V)-channel insufficiency may predispose some patients to the development of pulmonary hypertension during fenfluramine treatment .", "Levels of 5-HT and 5-HIAA in somatosensory cortex , hypothalamus , striatum and hippocampus were depleted significantly 2 weeks after the last daily fenfluramine injection .", "Fenfluramine is an amphetamine derivative which is used as a weight - reducing agent in the treatment of obesity .", "In addition, we sought to determine whether pharmacological reduction of voltage-gated potassium (K(V)) channel activity would potentiate the pulmonary vascular reactivity to fenfluramine.", "As a follow - up study to an earlier report that racemic fenfluramine can acutely potentiate the analgesic effects of morphine in humans , we investigated the effects of fenfluramine on the development of tolerance to morphine analgesia in rats .", "The effect of fenfluramine coinfusion occurred in the absence of a significant increase in plasma or brain morphine concentration , or a decrease in the accumulation of morphine 's putative antagonistic metabolite , morphine-3-glucuronide .", "injection of 5 mg/kg of dl-fenfluramine hydrochloride.", "The sleep suppressant action of fenfluramine may therefore result from a direct action of the drug on postsynaptic 5-HT receptors.", "Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels.", "In human studies , the plasma level of fenfluramine has been the only direct measure of effective concentrations of drug .", "Because 5HT is a potent CRF secretagogue , we tested the hypothesis that the weight - reducing effects of fenfluramine administration may be mediated , in part , through altered CRF secretion .", "In humans, the concentrations of fenfluramine always exceed those of norfenfluramine despite the slightly longer half-life of the latter.", "In keeping with the well known development of tolerance to the weight - reducing effects of fenfluramine , chronic fenfluramine treatment resulted in lesser increases in corticosterone secretion than after acute treatment .", "Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine.", "Whole-genome gene expression profiles in fenfluramine-treated human pulmonary artery smooth muscle (PASMC) and endothelial (PAEC) cells (isolated from normal subjects) were compared with baseline expression in untreated cells.", "Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: importance of dose, species and drug.", "Pathways and biological processes such as those related to cell cycle, however, were enriched among the dysregulated genes in PAEC, indicating that fenfluramine could affect unique pathways (or differentially) in different types of pulmonary artery cells.", "REE was unaffected by fenfluramine treatment.", "Acute administration of fenfluramine produced a dose - dependent decrease in milk intake and 5-HT and 5-hydroxyindoleacetic acid ( 5-HIAA ) levels in cortex , hypothalamus and hippocampus .", "Chronic fenfluramine treatment (1-24 mg/kg sc, twice daily, 4 days) resulted in a dose-dependent decrease in hypothalamic CRF concentration at 30 min after the final drug injection and was accompanied by a significant reciprocal increase in plasma corticosterone concentration.", "However, mifepristone (10 mg/kg) failed to attenuate the suppressive effect of fenfluramine on interleukin-1beta and tumor necrosis factor-alpha production, indicating that glucocorticoids do not mediate fenfluramine-induced immunosuppression.", "Whereas weight loss observed after chronic fenfluramine treatment was associated with stimulation of hypothalamic-pituitary-adrenocortical hormone secretion, the weight-recovery phase after cessation of drug treatment was associated with decreased levels of plasma corticosterone.", "Chronic fenfluramine treatment: effects on body weight, food intake and energy expenditure.", "On the 15th day of drug administration and the first day of fenfluramine withdrawal , however , the TEF of control and treated animals no longer differed .", "The transcriptional and posttranscriptional changes in these genes may, therefore, contribute to the pathogenesis of fenfluramine-associated IPAH.", "Finally , our results demonstrate that anorexia in animals receiving the fenfluramine / fluoxetine combination is not secondary to nonspecific behavioral suppression , because water intake is increased although food intake is decreased in the same animals .", "In rats , a plasma half - life of only about 2 h for fenfluramine , while norfenfluramine has a half - life of at least 12 h.", "However , the ability of fenfluramine to suppress tumor necrosis factor - alpha production can not be accounted for by increased interleukin-10 production , as pretreatment with the beta - adrenoceptor antagonist nadolol completely blocked the increase in interleukin-10 without altering the suppression of tumor necrosis factor - alpha induced by fenfluramine .", "The underlying mechanism of fenfluramine - associated pulmonary hypertension is still largely unknown .", "Fenfluramine (10 mg/kg) increased interleukin-10 production following an in vivo lipopolysaccharide challenge.", "The pathway for elimination of fenfluramine involves conversion to norfenfluramine , principally in the liver .", "Particularly, idiopathic pulmonary arterial hypertension (IPAH), previously referred to as primary pulmonary hypertension (PPH), was found to be associated with the use of Fen-Phen, fenfluramine, and fenfluramine derivatives.", "Fenfluramine is an anorectic agent in clinical use that is believed to act by enhancing 5-hydroxytryptamine (5-HT) neurotransmission.", "Fenfluramine Absorption and Metabolism (+)-(S)-N-ethyl-α-methyl-m-(trifluoromethyl) phenethylamine (HCl) dexfenfluramine / D-fenfluramine ....... the (+)-enantiomer of fenfluramine A serotonin releasing/uptake-inhibiting agent Fenfluramine, an amphetamine derivative, devoid of the psychomotor stimulant and abuse potential of d-amphetamine, interacts with 5-hydroxytryptamine (serotonin, 5-HT) transporters to release 5-HT from neurons.", "The acute 5-HT depleting effect of fenfluramine was markedly attenuated in these regions 2 weeks after the 4-day regimen of fenfluramine.(ABSTRACT TRUNCATED AT 250 WORDS )", "Fenfluramine, a clinically prescribed appetite suppressant, has been found to damage brain serotonin (5-HT) neurons in every animal species tested to date.", "Fenfluramine treatment caused dysregulation in a substantial number of genes involved in a variety of pathways and biological processes.", "In contrast, high dose fenfluramine treatment significantly increased hippocampus, midbrain, and spinal cord CRF concentrations whereas levels in cerebral cortex, caudate putamen, thalamus, pons/medulla, and cerebellum were unaffected.", "It is possible that tolerance to fenfluramine may be related to the 5-HT depletions.", "Twenty - four hours after initiation of treatment the TEF of fenfluramine treated animals was higher than that of controls .", "The present study investigated the involvement of presynaptic serotonergic mechanisms in the sleep suppressant action of fenfluramine , an indirect serotonin ( 5-HT ) receptor agonist .", "Recent findings indicate that fluoxetine , a selective 5-HT reuptake inhibitor ( SSRI ) , can prevent fenfluramine - induced 5-HT neurotoxicity without blocking fenfluramine - induced appetite suppression .", "We tested the hypothesis that the pulmonary vasoconstrictive action of fenfluramine is at least in part mediated by 5-HT receptor activation.", "Discerning the neurobiology underlying the anorexic action of fenfluramine may facilitate the development of new drugs to prevent and treat obesity .", "Together, these data suggest that the anorectic and 5-HT neurotoxic effects of fenfluramine may involve different mechanisms, and that by combining fenfluramine with SSRIs, it may be possible to exploit fenfluramine's clinically useful properties (e.g., anorexia) without risking brain 5-HT neural injury.", "injection of fenfluramine ( 2.4 mg / kg ) .", "These findings suggest that the effect of fenfluramine on body weight involves modulation of both food intake and energy expenditure.", "Results from our studies indicate that fluoxetine's effects are, indeed, dose-related, because higher doses of fluoxetine are required to protect against the 5-HT neurotoxic effects of higher doses of fenfluramine.", "The present research investigated the contributions of fenfluramine-induced alterations in food intake and two components of energy expenditure, resting energy expenditure (REE) and the thermic effect of food (TEF), to maintenance of a lowered body weight in male Long Evans rats.", "Furthermore , neither pretreatment with fluoxetine nor PCPA antagonized the head - shaking induced by fenfluramine , a behavior associated with activation of central 5-HT receptors .", "Tolerance to the anorectic properties of fenfluramine develops rapidly and long - lasting depletions of brain 5-HT have been reported to occur after repeated administration .", "These data indicate that the pulmonary vasoconstrictor response to fenfluramine is partly mediated by 5-HT receptors .", "Coinjection of fenfluramine acutely potentiated the antinociceptive potency of morphine .", "Fenfluramine coinfusion attenuated the development of tolerance to morphine ; > 70% maximal possible effect was still present on day 4 .", "Thus, fenfluramine is …", "In addition, whilst fenfluramine increases production of the anti-inflammatory cytokine interleukin-10, this cannot account for the suppression of the pro-inflammatory cytokine tumor necrosis factor-alpha induced by fenfluramine.", "infusion of 1) 22 mg/kg/day of morphine, 2) 20 mg/kg/day fenfluramine, 3) morphine plus fenfluramine or 4) saline.", "These results demonstrate that fenfluramine significantly attenuates tolerance development to morphine by modulating the pharmacological process responsible for tolerance development to morphine .", "However, anorectic treatment with fenfluramine is associated with the development of cardiac valvulopathy and pulmonary hypertension, including a condition known as cardiac fibrosis which led to the withdrawal of this compound from the U.S. market in 1997.", "80% of the response to 5-HT reduced the response to fenfluramine by approximately 50%.", "DI-Fenfluramine (20 mg/kg) produced an initial severe anorexia and weight loss.", "The body weight of fenfluramine treated rats remained significantly below control levels throughout the entire treatment period , but rose rapidly to control levels following fenfluramine withdrawal .", "After the US withdrawal of fenfluramine , it was also withdrawn from most other markets around the world .", "Coinfusion of fenfluramine increased ED50 to only 3.7 mg / kg .", "We examined the immunomodulatory potential of acute fenfluramine administration , by measuring production of the pro - inflammatory cytokines interleukin ( IL)-1beta and tumor necrosis factor ( TNF)-alpha in response to an in vivo challenge with bacterial lipopolysaccharide in rats .", "As fenfluramine activates the hypothalamic pituitary adrenal axis, we examined the ability of the glucocorticoid receptor antagonist mifepristone to block fenfluramine-induced immunosuppression.", "infusion of 1) 22 mg/kg/day of morphine, 2) 20 mg/kg/day of fenfluramine, 3) both drugs concomitantly or 4) saline.", "We also assessed the effect of fenfluramine on production of the anti - inflammatory cytokine interleukin-10 , as interleukin-10 can suppresses pro - inflammatory cytokine production .", "Pretreatment with fluoxetine failed to antagonize the fenfluramine-induced suppression of slow-wave sleep and rapid-eye-movement sleep.", "Sleep suppressant action of fenfluramine in rats.", "Following reports in the late 1970s of the profound influence of fenfluramine on appetite and subsequent reviews of the clinical effects of both fenfluramine and the metabolite norfenfluramine, the long term efficacy of fenfluramine in the treatment of obesity was established.", "Norfenfluramine has anorectic and other properties broadly similar to those of fenfluramine and has a plasma half - life about 2 x that of fenfluramine .", "Fenfluramine-induced gene dysregulation in human pulmonary artery smooth muscle and endothelial cells Fenfluramine is prescribed either alone or in combination with phentermine as part of Fen-Phen, an anti-obesity medication.", "However, chemical analyses showed that fluoxetine pretreatment completely prevented the depletion of brain 5-HT produced by fenfluramine, suggesting that fenfluramine did not gain entry into serotonergic neurons.", "Fenfluramine was withdrawn from the US market in 1997 due to reports of heart valvular disease, pulmonary arterial hypertension, and cardiac fibrosis.", "By contrast , fenfluramine treatment significantly altered the TEF .", "While awaiting validation in a larger cohort , these results strongly suggested that fenfluramine could induce significant dysregulation of genes in multiple biological processes and pathways critical for normal pulmonary vascular functions and structure .", "The anorexic agent fenfluramine considerably increases the risk of primary pulmonary hypertension .", "These data, demonstrating fenfluramine-induced alterations in brain CRF and plasma corticosterone, suggest that CRF may represent an important endogenous transmitter which mediates the weight-reducing effects of the drug.", "Because administration of fenfluramine to PCPA-pretreated rats produced no additional depletion of 5-HT, it appears that 5-HT was no longer available for release by fenfluramine in these animals.", "Fenfluramine - induced immunosuppression : an in vivo analysis .", "The purpose of our studies was several-fold: 1) To determine whether the ability for fluoxetine to dissociate fenfluramine-induced anorexia and neurotoxicity is dose-related; 2) to ascertain whether other SSRIs also prevent fenfluramine-induced neurotoxicity without altering its anorectic effect; 3) to determine whether similar fluoxetine/fenfluramine interactions are seen in another animal species (i.e., mice) and 4) to determine whether decreases in food intake seen after the fluoxetine/fenfluramine combination can be attributed to nonspecific behavioral suppression.", "These data indicate that the suppression of sleep produced by fenfluramine is not mediated through release of 5-HT as brain 5-HT concentrations were not related to the behavioral effects of the drug .", "The absorption half - life of fenfluramine after oral administration to humans is about 1 h , much less than its plasma half - life of 24 h.", "We reasoned that investigating drug-induced gene dysregulation would enhance our understanding of the fenfluramine-associated pathogenic mechanism of IPAH.", "Role for brain corticotropin - releasing factor in the weight - reducing effects of chronic fenfluramine treatment in rats .", "Two or 8 weeks later rats were administered fenfluramine acutely (0, 1.25, 6.25 or 12.5 mg/kg; n = 6/group), tested for milk intake and sacrificed 2 hr later. Brains were removed and regions assayed for dopamine, 5-HT and metabolites.", "Rats ( n = 96 ) , previously allowed to drink sweetened condensed milk during daily 15-min sessions , were treated with fenfluramine ( 6.25 mg / kg/12 hr x 4 days ) or saline .", "Cotreatment with racemic fenfluramine inhibits the development of tolerance to morphine analgesia in rats.", "Depletion of brain 5-HT by PCPA also failed to antagonize the sleep suppression caused by fenfluramine as well as that observed after administration of quipazine, a direct 5-HT receptor stimulant.", "Brain levels of fenfluramine and norfenfluramine are substantial and remain high longer than corresponding plasma levels .", "Tolerance to the effects of acute fenfluramine on milk intake was observed in rats at 2 weeks (ED50 = 3.24 vs. 6.37 mg/kg; saline vs. fenfluramine pretreatment, respectively) and, to a lesser extent, at 8 weeks (ED50 = 2.99 vs. 4.04 mg/kg; saline vs. fenfluramine pretreatment) after the 4-day regimen of fenfluramine.", "Furthermore, the pulmonary vasoconstrictor potency of fenfluramine is elevated when the K(V)-channel activity is low.", "The appetite-reducing action of fenfluramine is mediated by its interaction with the metabolism of serotonin [5-hydroxytryptamine (5-HT)] in the brain.", "Taken together, these data demonstrate that fenfluramine promotes an immunosuppressive cytokine phenotype in vivo.", "Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.", "Much of the efficacy of fenfluramine as an anorectic is thought to be derived from activation of the 5-HT 2C receptor, whereas interaction with the 5-HT 2B receptor is associated with heart valve hypertrophy.", "Fenfluramine treatment alone had no effect.", "There was no effect of this fenfluramine treatment protocol on regional brain TRH or neurotensin concentrations."], "par_relations": ["Phenethylamines", "Serotonin Uptake Inhibitors", "Serotonin Agents", "Fenfluramine", "Fenfluramine", "Fenfluramine", "Fenfluramine", "Fenfluramine", "Fenfluramine", "Fenfluramine"], "chd_relations": ["Fenfluramine", "Fenfluramine", "Fenfluramine", "Fenfluramine", "Fenfluramine", "Fenfluramine", "Fenfluramine", "Norfenfluramine", "1-(3-trifluoromethylphenyl)-2-propanol", "benfluorex", "flutiorex", "1-(3-trifluoromethylphenyl)-2-(N-(2-hydroxyethyl)amino)propane", "1-(3-trifluoromethylphenyl)-2-(2-carboxymethyl)aminopropane", "1204 SE", "nortiflorex", "ITA 213", "1-(3-trifluoromethylphenyl)-1,2-propanediol", "N-methyl fenfluramine", "sennomotokounou", "nitrosofenfluramine", "1-(3-(pentafluorosulfanyl)phenyl)propan-2-amine", "N-ethyl-1-(3-(pentafluorosulfanyl)phenyl)propan-2-amine"], "syn_relations": ["Fenfluramine", "Fenfluramine", "Fenfluramine", "Fenfluramine", "Fenfluramine", "Fenfluramine"], "sib_relations": ["2-Hydroxyphenethylamine", "Albuterol", "Amphetamines", "Butoxamine", "Dexfenfluramine", "Dimethoxyphenylethylamine", "Dobutamine", "Ephedrine", "Fendiline", "Hexoprenaline", "Isoxsuprine", "Mescaline", "Methoxamine", "Octopamine", "Nylidrin", "Oxyfedrine", "Prenylamine", "Pseudoephedrine", "Ritodrine", "Selegiline", "Suloctidil", "Verapamil", "Venlafaxine Hydrochloride", "p-Methoxy-N-methylphenethylamine", "Tiapamil Hydrochloride"]}, "target_ent": {"research_entity_id": "RXNORM:377361", "canonical_name": "dichlorodifluoromethane / trichlorotrifluoroethane Topical Spray", "aliases": ["dichlorodifluoromethane / trichlorotrifluoroethane topical spray"], "definition": "", "other_contexts": [], "par_relations": ["dichlorodifluoromethane / trichlorotrifluoroethane Topical Product"], "chd_relations": ["dichlorodifluoromethane 8.5 % / trichlorotrifluoroethane 1.5 % Topical Spray"], "syn_relations": [], "sib_relations": ["trichlorotrifluoroethane", "dichlorodifluoromethane", "Topical Spray"]}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:20041", "canonical_name": "zinc finger protein 408", "aliases": ["znf408", "znf408 gene", "zinc finger protein 408", "flj12827"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["zinc finger protein 408", "zinc finger protein 408", "zinc finger protein 408", "zinc finger protein 408"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:MTHU049068", "canonical_name": "Atrophy of type I fibers", "aliases": ["atrophy of type i fibers"], "definition": "", "other_contexts": [], "par_relations": ["MUSCLE SOFT, TISSUE"], "chd_relations": [], "syn_relations": [], "sib_relations": ["MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPIC HYPOGONADISM"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C567263", "canonical_name": "Retinitis Pigmentosa 7, Digenic", "aliases": ["retinitis pigmentosa 7, digenic"], "definition": "", "other_contexts": [], "par_relations": ["Retinitis Pigmentosa"], "chd_relations": [], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:613756", "canonical_name": "RETINITIS PIGMENTOSA 49", "aliases": ["retinitis pigmentosa 49", "rp49"], "definition": "", "other_contexts": ["Three loci that exhibited constant expression in the presence and absence of JH III ( RP49 [ FBgn0002626 ] , FBgn0023529 , and FBgn0034354 ) were evaluated and found to be reliable invariant reference transcripts for real - time RT - qPCR analysis using BestKeeper and geNorm software .", "In this study , twelve candidate genes ( Ach , Act , Cht2 , EF1α , RPL32 , Hsp70 , Tub , RP49 , SDH , GAPDH , 18S , and His ) were analyzed with four statistical methods : the delta Ct approach , geNorm , Bestkeeper and NormFinder .", "The best - ranked reference genes across different tissues are RPL32 , Hsp70 and RP49 .", "The hybridization and washing conditions for control single stranded DNA probes ( for RP49 ) were done as suggested by ZACHAR , CHOU and BINGHAM ( 1 987 ) .", "In some experiments we have also used RP49 ( O'CONNELL and ROSBASH 1984 ) to control for loading ( see for example Table 3 ) .", "The result demonstrated that for different developmental stages , EF1α , Hsp70 and RPL32 exhibited the most stable expression status for all samples ; EF1α and RPL32 were selected as the best reference genes for studies involving embryo and larvae stages , while SDH and RP49 were identified for adult stage .", "The selected genes were the orthologs of actin , EF1a , GAPDH , RP49 , TubA1 , Ubi , and CG13220 ."], "par_relations": [], "chd_relations": [], "syn_relations": ["RETINITIS PIGMENTOSA 49", "RETINITIS PIGMENTOSA 49"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:935", "canonical_name": "BTB domain and CNC homolog 1", "aliases": ["btb domain and cnc homolog 1", "btbd24", "bach1", "bach1 gene", "bach-1"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["BTB domain and CNC homolog 1", "BTB domain and CNC homolog 1", "BTB domain and CNC homolog 1", "BTB domain and CNC homolog 1", "BTB domain and CNC homolog 1", "BTB domain and CNC homolog 1"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:MTHU016789", "canonical_name": "Short stature (in some cases)", "aliases": ["short stature (in some cases)"], "definition": "", "other_contexts": [], "par_relations": ["Height"], "chd_relations": [], "syn_relations": [], "sib_relations": ["AMYOTROPHY, HEREDITARY NEURALGIC"]}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:39081", "canonical_name": "FMR1 antisense RNA 1", "aliases": ["antisense fragile x mental retardation protein", "fmr1-as1", "fmr1 antisense rna 1", "asfmr1", "fmr1-as1 gene", "fmr4"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["FMR1 antisense RNA 1", "FMR1 antisense RNA 1", "FMR1 antisense RNA 1", "FMR1 antisense RNA 1", "FMR1 antisense RNA 1", "FMR1 antisense RNA 1"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:615245", "canonical_name": "MICRO RNA 671", "aliases": ["micro rna 671", "mirna671", "mir671"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["MICRO RNA 671", "MICRO RNA 671", "MICRO RNA 671", "MICRO RNA 671"], "sib_relations": []}}
{"label": 1, "source_ent": {"research_entity_id": "HGNC:HGNC:26558", "canonical_name": "hydrolethalus syndrome 1", "aliases": ["flj32915", "hyls1", "hyls1 gene", "hydrolethalus syndrome 1"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["hydrolethalus syndrome 1", "hydrolethalus syndrome 1", "hydrolethalus syndrome 1", "hydrolethalus syndrome 1"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:610693", "canonical_name": "HYLS1 GENE", "aliases": ["flj32915", "hyls1", "hyls1 gene", "hydrolethalus syndrome"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["HYLS1 GENE", "HYLS1, ASP211GLY", "HYLS1 GENE", "HYLS1 GENE", "HYLS1 GENE"], "sib_relations": ["HYLS1, ASP211GLY"]}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:23682", "canonical_name": "phospholipid phosphatase 6", "aliases": ["phospholipid phosphatase 6", "pdp1", "flj46512", "flj90191", "polyisoprenoid diphosphate phosphatase type 1", "presqualene diphosphate phosphatase", "plpp6", "plpp6 gene"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["phospholipid phosphatase 6", "phospholipid phosphatase 6", "phospholipid phosphatase 6", "phospholipid phosphatase 6", "phospholipid phosphatase 6", "phospholipid phosphatase 6", "phospholipid phosphatase 6", "phospholipid phosphatase 6"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:603092", "canonical_name": "DUAL-SPECIFICITY PHOSPHATASE 11", "aliases": ["rna/rnp complex-interacting phosphatase", "pir1", "dual-specificity phosphatase 11", "dusp11", "phosphatase that interacts with rna/rnp complex 1"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["DUAL-SPECIFICITY PHOSPHATASE 11", "DUAL-SPECIFICITY PHOSPHATASE 11", "DUAL-SPECIFICITY PHOSPHATASE 11", "DUAL-SPECIFICITY PHOSPHATASE 11", "DUAL-SPECIFICITY PHOSPHATASE 11", "DUAL-SPECIFICITY PHOSPHATASE 11", "DUAL-SPECIFICITY PHOSPHATASE 11", "DUAL-SPECIFICITY PHOSPHATASE 11"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C537932", "canonical_name": "Filaminopathy, autosomal dominant", "aliases": ["myopathy, myofibrillar, filamin c-related", "mfm, filamin c-related", "myofibrillar myopathy, filamin c-related", "filaminopathy, autosomal dominant", "filamin c-related myofibrillar myopathy"], "definition": "", "other_contexts": [], "par_relations": ["Muscular Dystrophies"], "chd_relations": [], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:141800.0079", "canonical_name": "HBA1, LYS127ASN", "aliases": ["hba1, lys127asn"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["HEMOGLOBIN--ALPHA LOCUS 1"], "sib_relations": ["HEMOGLOBIN--ALPHA LOCUS 1"]}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0008220", "canonical_name": "Hypocortisolemia", "aliases": ["hypocortisolism", "decreased cortisol production", "glucocorticoid insufficiency", "hypocortisolemia"], "definition": "A reduced concentration of cortisol in the blood. [HPO:probinson]", "other_contexts": [], "par_relations": ["Primary adrenal insufficiency"], "chd_relations": [], "syn_relations": ["Hypocortisolemia", "Hypocortisolemia", "Hypocortisolemia", "Hypocortisolemia"], "sib_relations": ["Hypocortisolemia", "Hypocortisolemia", "Hypoaldosteronism"]}, "target_ent": {"research_entity_id": "OMIM:202355", "canonical_name": "ADRENOCORTICAL UNRESPONSIVENESS TO ACTH WITH POSTRECEPTOR DEFECT", "aliases": ["adrenocortical unresponsiveness to acth with postreceptor defect", "familial glucocorticoid deficiency due to defect distal to acth receptor"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["ADRENOCORTICAL UNRESPONSIVENESS TO ACTH WITH POSTRECEPTOR DEFECT", "ADRENOCORTICAL UNRESPONSIVENESS TO ACTH WITH POSTRECEPTOR DEFECT"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "ICD10CM:B20", "canonical_name": "Human immunodeficiency virus [HIV] disease", "aliases": ["aids-related complex [arc]", "hiv infection, symptomatic", "human immunodeficiency virus [hiv] disease", "acquired immune deficiency syndrome [aids]"], "definition": "", "other_contexts": [], "par_relations": ["Human immunodeficiency virus [HIV] disease (B20)"], "chd_relations": [], "syn_relations": ["Human immunodeficiency virus [HIV] disease", "Human immunodeficiency virus [HIV] disease", "Human immunodeficiency virus [HIV] disease", "Human immunodeficiency virus [HIV] disease", "Human immunodeficiency virus [HIV] disease", "Human immunodeficiency virus [HIV] disease", "Human immunodeficiency virus [HIV] disease", "Human immunodeficiency virus [HIV] disease"], "sib_relations": []}, "target_ent": {"research_entity_id": "LNC:47029-4", "canonical_name": "HIV 2 Ab:PrThr:Pt:CSF:Ord:IB", "aliases": ["hiv 2 ab csf ql ib", "hiv 2 ab:prthr:pt:csf:ord:ib", "human immunodeficiency virus 2 antibody:presence or threshold:point in time:cerebral spinal fluid:ordinal:immune blot", "hiv 2 ab [presence] in cerebral spinal fluid by immunoblot"], "definition": "", "other_contexts": [], "par_relations": ["HIV 2 Ab &#x7C; cerebral spinal fluid", "Microbiology", "HIV 1 & 2 tests - Meaningful Use set:-:Pt:^Patient:-"], "chd_relations": [], "syn_relations": ["HIV 2 Ab:PrThr:Pt:CSF:Ord:IB", "HIV 2 Ab:PrThr:Pt:CSF:Ord:IB", "HIV 2 Ab:PrThr:Pt:CSF:Ord:IB", "HIV 2 Ab:PrThr:Pt:CSF:Ord:IB", "HIV 2 Ab:PrThr:Pt:CSF:Ord:IB", "HIV 2 Ab:PrThr:Pt:CSF:Ord:IB"], "sib_relations": ["Ab", "CSF", "CSF", "Cerebral spinal fluid", "HIV", "HIV 2", "IB", "MICRO", "2", "HIV 2 Ab", "human immunodeficiency virus 2 Antibody", "Ord", "Pt", "PrThr"]}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:26043", "canonical_name": "odontogenic, ameloblast asssociated", "aliases": ["odam gene", "odam", "flj20513", "apin", "odontogenic, ameloblast asssociated"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["odontogenic, ameloblast asssociated", "odontogenic, ameloblast asssociated", "odontogenic, ameloblast asssociated", "odontogenic, ameloblast asssociated", "odontogenic, ameloblast asssociated", "odontogenic, ameloblast asssociated"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:MTHU056727", "canonical_name": "Dystonia, focal, upper limbs", "aliases": ["dystonia, focal, upper limbs"], "definition": "", "other_contexts": [], "par_relations": ["Central nervous system"], "chd_relations": [], "syn_relations": [], "sib_relations": ["DYSTONIA 28, CHILDHOOD-ONSET"]}}
{"label": 0, "source_ent": {"research_entity_id": "HGNC:HGNC:28441", "canonical_name": "GA binding protein transcription factor beta subunit 2", "aliases": ["ga binding protein transcription factor beta subunit 2", "gabpb2 gene", "mgc29891", "gabpb2"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["GA binding protein transcription factor beta subunit 2", "GA binding protein transcription factor beta subunit 2", "GA binding protein transcription factor beta subunit 2", "GA binding protein transcription factor beta subunit 2"], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:605409", "canonical_name": "TRANSCRIPTION ELONGATION REGULATOR 1", "aliases": ["tcerg1", "tbp-associated factor, rna polymerase ii, 150-kd", "transcription elongation regulator 1", "ca150", "transcription factor ca150", "taf2s", "tata box-binding protein-associated factor 2s"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["TRANSCRIPTION ELONGATION REGULATOR 1", "TRANSCRIPTION ELONGATION REGULATOR 1", "TRANSCRIPTION ELONGATION REGULATOR 1", "TRANSCRIPTION ELONGATION REGULATOR 1", "TRANSCRIPTION ELONGATION REGULATOR 1", "TRANSCRIPTION ELONGATION REGULATOR 1", "TRANSCRIPTION ELONGATION REGULATOR 1", "TRANSCRIPTION ELONGATION REGULATOR 1", "TRANSCRIPTION ELONGATION REGULATOR 1", "TRANSCRIPTION ELONGATION REGULATOR 1", "TRANSCRIPTION ELONGATION REGULATOR 1", "TRANSCRIPTION ELONGATION REGULATOR 1"], "sib_relations": []}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:D003520", "canonical_name": "Cyclophosphamide", "aliases": ["cyclophosphamide monohydrate", "(+,-)-2-(bis(2-chloroethyl)amino)tetrahydro-2h-1,3,2-oxazaphosphorine 2-oxide monohydrate", "b-518", "b518", "procytox", "cyclophosphamide anhydrous", "monohydrate, cyclophosphamide", "cytoxan", "sendoxan", "neosar", "anhydrous, cyclophosphamide", "cytophosphan", "nsc 26271", "cyclophosphamide, (r)-isomer", "cyclophosphamide, (s)-isomer", "cytophosphane", "endoxan", "cyclophosphane", "nsc26271", "b 518", "nsc-26271", "cyclophosphamide"], "definition": "Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.", "other_contexts": ["The side effects of cyclophosphamide such as bone marrow suppression,2 11 gonadal toxicity,'2 and possibly oncogenicity4 seem to be dose related.", "Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group.", "• Gastroenterology • Toxicology . OBJECTIVE Unexpected drug reaction . BACKGROUND Cyclophosphamide is commonly used to treat cancers , systemic vasculitides , and kidney diseases ( e.g. , lupus", "Whole blood concentrations of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide vs. time data and urinary excretion of cyclophosphamide data from the first course were co-modeled using a one-compartment model with Michaelis-Menten saturable elimination in parallel with first-order renal elimination (N = 7) or first-order metabolic and renal elimination (N = 5) for cyclophosphamide and one-compartment model with first-order elimination for 4-hydroxycyclophosphamide/aldophosphamide.", "Cyclophosphamide - thalidomide - dexamethasone was non - inferior to cyclophosphamide - vincristine - doxorubicin - dexamethasone for progression - free and overall survival , and there was a trend toward a late survival benefit with cyclophosphamide - thalidomide - dexamethasone in responders .", "- induced acute hepatotoxicity PATIENT Male , 48 FINAL DIAGNOSIS : Low dose cyclophosphamide - induced acute hepatotoxicity Symptoms : Epigastric pain Medication : Withdrawal of", "BACKGROUND High doses ( > or=500 mg / m ) of cyclophosphamide are known to cause venoocclusive disease ( VOD ) .", "Whole blood cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide concentrations were measured by a GC-EIMS method using deuterium labeled compounds as internal standards.", "developing within 24 hours of administration of low - dose intravenous cyclophosphamide ( 200 mg ) . Physicians should be aware of this serious adverse reaction and should not repeat the", "Dogs with previous or preexisting immune - mediated disease were significantly more likely to develop cyclophosphamide - associated SHC .", "administration of furosemide concurrently with cyclophosphamide and decreased incidence of cyclophosphamide - associated SHC .", "A trend toward an overall survival advantage for cyclophosphamide-thalidomide-dexamethasone over cyclophosphamide-vincristine-doxorubicin-dexamethasone was also observed in a subgroup of patients with favorable interphase fluorescence in situ hybridization.", "The number of cells mobilized with granulocyte - colony stimulating factor plus cyclophosphamide was higher . However , in both groups , the median number of CD34 + cells was sufficient to", "Incidences of infections were similar in the randomized groups, whereas cladribine and cyclophosphamide combination, but not cladribine alone, induced more frequent neutropenia, anemia, and thrombocytopenia compared with cyclophosphamide, vincristine, and prednisone combination (P < .05 for each).", "Low dose pretreatment with cyclophosphamide did not prevent the lung injury or fibrosis from a subsequent higher dose.", "Incidence of cyclophosphamide - associated SHC was similar in treated dogs that did not receive concurrent furosemide to that observed for other studies in which cyclophosphamide was administered orally .", "with a cyclophosphamide , thalidomide and dexamethasone regimen ? BACKGROUND Cyclophosphamide plus thalidomide as induction for multiple myeloma patients eligible for autologous stem cell", "CONCLUSIONS Hepatotoxicity may occur even after low-dose intravenous cyclophosphamide treatment.", "In addition, plasma and urine cyclophosphamide concentrations were determined by a GC assay.", "10.2 for the combination with cyclophosphamide 500 micromol / L ; P < or= 0.005 for all tested combinations vs. control ) .", "The involvement of other metabolic pathways , such as cooxidation via prostaglandin H synthase , in the toxicity of cyclophosphamide has not been studied .", "34 + cells mobilized using granulocyte - colony stimulating factor with and without cyclophosphamide after induction with cyclophosphamide , thalidomide and dexamethasone . METHODS A retrospective", ". CONCLUSIONS Hepatotoxicity may occur even after low - dose intravenous cyclophosphamide treatment . To the best of our knowledge , this is the first report of severe , non - viral ,", "Low-dose cyclophosphamide-induced acute hepatotoxicity PATIENT Male, 48 FINAL DIAGNOSIS: Low dose cyclophosphamide-induced acute hepatotoxicity Symptoms: Epigastric pain Medication: Withdrawal of cyclophosphamide Clinical Procedure: - Specialty: Nephrology • Hepatology • Gastroenterology • Toxicology.", "Thirty two patients were treated with cyclophosphamide for eight weeks, and 41 for 12 weeks.", "induced acute hepatotoxicity Symptoms : Epigastric pain Medication : Withdrawal of cyclophosphamide Clinical Procedure : - Specialty : Nephrology • Hepatology • Gastroenterology • Toxicology .", "The only difference was much higher frequency of renal biopsy in \"high dose\" cyclophosphamide pulse (85% versus 32%), confirming the presence of proliferative lupus nephritis.", "[Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].", "Although cyclophosphamide is activated by the cytochrome P-450 mixed function oxidase (MFO) system, a role for this system in the development of lung injury has not been established.", "OBJECTIVES To determine incidence and identify predisposing factors for sterile hemorrhagic cystitis ( SHC ) in dogs with lymphoma that were treated with cyclophosphamide and to evaluate whether furosemide administered i.v .", "The complete response rates were 13.0% with cyclophosphamide - thalidomide - dexamethasone and 8.1% with cyclophos - phamide - vincristine - doxorubicin - dexamethasone ( P=0.0083 ) , with this differential response being maintained in patients who received autologous stem - cell transplantation ( post - transplant complete response 50.0% versus 37.2% , respectively ; P=0.00052 ) .", "METHODS The effect of roxithromycin on the metabolism and toxicity of cyclophosphamide was studied using human hepatic microsomes and a human endothelial cell line.", "The median age was 58 years old ( range : 51 - 62 ) for the granulocyte - colony stimulating factor group and 56.5 years old ( range : 54 - 60 ) for granulocyte - colony stimulating factor plus cyclophosphamide group .", "The oral cyclophosphamide and thalidomide induction doses used were 1500mg/month and 100-200mg/day, respectively.", "DISCUSSION Similar efficacy of two different cyclophosphamide regimens in our patients with lupus nephritis was not surprising considering that cummulative cyclophosphamide doses and treatment duration were similar obtaining similar control of disease.", "The mean renal clearance ( Clr ) of cyclophosphamide was 29 ml / min and 24 ml / min for the first course and the second course , respectively .", "Physicians should be aware of this serious adverse reaction and should not repeat the cyclophosphamide dose when there is hepatotoxicity caused by the first dose .", "During the course of cyclophosphamide the white cell count was estimated weekly , and the drug was discontinued if the total count was 1147 group.bmj.com on June 26 , 2017 Published by http://adc.bmj.com/ Downloaded from", "RESULTS The post - induction overall response rate ( ≥ partial response ) for the intent - to - treat population was significantly higher with cyclophosphamide - thalidomide - dexamethasone ( n=555 ) versus cyclophosphamide - vincristine - doxorubicin - dexamethasone ( n=556 ) ; 82.5% versus 71.2% ; odds ratio 1.91 ; 95% confidence interval 1.44 - 2.55 ; P<0.0001 .", "Treatment with indomethacin, nordihydroguiaretic acid, or aspirin prior to cyclophosphamide greatly reduced levels of pulmonary thymidine incorporation and/or hydroxyproline content, compared to cyclophosphamide alone.", "sufficient . RESULTS Eighty - eight patients were analyzed ; only 18 received cyclophosphamide . The median age was 58 years old ( range : 51 - 62 ) for the granulocyte - colony stimulating", "The mean Vmax and Km for cyclophosphamide were 0.78 microM / min and 247 microM , respectively .", "Data for the 2 groups were analyzed to determine the incidence and predisposing factors ( age , breed , sex , weight , previous or preexisting disease , previous or preexisting urinary tract infection , neutropenia , azotemia , dose , and number of cyclophosphamide treatments ) for cyclophosphamide - associated SHC .", "The correlations between cyclophosphamide AUCs and 4-hydroxycyclophosphamide/aldophosphamide AUCs were sought for both drug courses.", "cystitis , nausea , vomiting , and hair loss . Hepatotoxicity with high dose cyclophosphamide is well recognized but hepatitis due to low dose cyclophosphamide has rarely been described . CASE", "at two Brazilian centers between May 2009 and July 2013 . The oral cyclophosphamide and thalidomide induction doses used were 1500mg / month and 100 - 200mg / day , respectively .", "alone to mobilize progenitor cells in multiple myeloma patients induced with a cyclophosphamide , thalidomide and dexamethasone regimen ? BACKGROUND Cyclophosphamide plus thalidomide as", "with high dose cyclophosphamide is well recognized but hepatitis due to low dose cyclophosphamide has rarely been described . CASE REPORT We report the case of a 48-year - old Chinese man with a", "were 10 - 15mcg / kg granulocyte - colony stimulating factor with 2 - 4g / m2 cyclophosphamide , or 15 - 20mcg / kg granulocyte - colony stimulating factor alone for 5 days . Collection of > 2.0", "The present prospective study was designed to determine whether eight week or 12 week courses of cyclophosphamide at a dose of 2 mg/ kg/day were more effective in a large number of children with steroid dependent minimal change nephrotic syndrome who had severe steroid toxicity.", "BACKGROUND The objective of this study was to compare the efficacy of 3 regimens, cladribine alone, cladribine and cyclophosphamide combination, or cyclophosphamide, vincristine, and prednisone combination in previously untreated patients with low-grade B-cell non-Hodgkin lymphoma (LGNHL).", "Aggressive immunosuppressive treatment with cyclophosphamide has significantly ameliorated the outcome of lupus nephritis .", "To the best of our knowledge , this is the first report of severe , non - viral , liver inflammation developing within 24 hours of administration of low - dose intravenous cyclophosphamide ( 200 mg ) .", "10.4% apoptotic cells [in % of total cells] for the combination of cyclophosphamide and roxithromycin, 0.7 +/-", "Cyclophosphamide was a moderately active reducing cosubstrate for 5-phenyl-4-pentenyl hydroperoxide in both lung and liver microsomes.", "RESULTS Compared with cyclophosphamide , vincristine , and prednisone combination regimen , cladribine alone or cladribine and cyclophosphamide combination induced higher probability of overall response ( odds ratio [ OR ] = 4.0 ; 95% confidence interval [ CI ] , 1.7 - 9,3 ; P = .002 , and OR = 8.5 ; 95% CI , 3.2 - 22.7 ; P < .0001 , respectively ) , complete remission ( OR = 5.8 ; 95% CI , 1.8 - 18.5 ; P = .003 ; and OR = 14 ; 95% CI , 4.4 - 44 ; P < .0001 , respectively ) , progression - free survival ( log - rank test P < .0001 ) , but not overall survival .", "The parallelism between cyclophosphamide and 4-hydroxycyclophosphamide / aldophosphamide disposition curves implies that the pharmacokinetics of 4-hydroxycyclophosphamide / aldophosphamide is formation limited ; only the fractional 4-hydroxycyclophosphamide/ aldophosphamide clearance rate ( Clmet / Fmet ) can be estimated .", "The relapse free rate of patients treated for eight weeks ( 25% ) was similar to that of those treated for 12 weeks ( 24% ) five years after stopping the treatment , and the mean relapse free interval and the sparing effect of cyclophosphamide ( if any ) on subsequent treatment with steroids did not differ between the groups .", "Each patient received an initial dose of 4 g / m2 of cyclophosphamide over 90 min to prime peripheral blood progenitor cells ( the first course ) , and 3 weeks later , 6 g / m2 of cyclophosphamide with 800 mg / m2 of thiotepa by 96-hr infusion before marrow stem cell infusion ( the second course ) .", "Cyclophosphamide - associated SHC appeared to develop early during the course of chemotherapy when furosemide was not administered concurrently with cyclophosphamide .", "None of the patients had received any relevant drugs other than prednisolone before the course of cyclophosphamide.", "The authors recently observed a patient treated with immunosuppressive cyclophosphamide doses ( 100 mg / day ) and roxithromycin who developed VOD .", "Significant proportion (42%) of patients who achieved partial remission, as well as complete remission, developed flare of renal disease several months after the end of the treatment, necessitating restarting of pulse cyclophosphamide therapy.", "Because of steroid dependence and severe steroid toxicity, each patient was randomly allocated to one of the following two treatment regimens of cyclophosphamide after remission had been induced: 2 mg/kg/day of cyclophosphamide for eight weeks (total dosage, 112 mg/kg), or the same daily dose for 12 weeks (total dosage, 168 mg/kg).", "METHODS For this 3-arm , phase 3 study , 197 patients were randomly allocated to receive 6 monthly courses of cladribine alone , cladribine and cyclophosphamide combination , or cyclophosphamide , vincristine , and prednisone combination .", "week courses of cyclophosphamide in nephrotic syndrome Seventy three children with steroid dependent minimal change nephrotic syndrome were randomly allocated to receive treatment with cyclophosphamide (2 mg/kg/day) for either eight or 12 weeks, in combination with prednisolone.", "However , the combination of roxithromycin ( 500 micromol / L ) and cyclophosphamide was toxic for all the tested cyclophosphamide concentrations ( 0.05 to 500 micromol / L ) without clear concentration dependence ( LDH ratio 38.3 + /-", "Although roxithromycin inhibited P-glycoprotein, this was not the mechanism by which cyclophosphamide toxicity was increased because cyclophosphamide in combination with other P-glycoprotein inhibitors was not toxic to endothelial cells.", "Accepted 14 May 1990 Cyclophosphamide has been widely used in combination with corticosteroids ( steroids ) to treat children with frequently relapsing nephrotic syndrome and produces a long remission .", "We conclude that cyclophosphamide should be used for no longer than eight weeks at a dose of 2 mg/kg/day in children with steroid dependent minimal change nephrotic syndrome.", ", plasmapheresis , intermittent hemodialysis , and low - dose intravenous cyclophosphamide . CONCLUSIONS Hepatotoxicity may occur even after low - dose intravenous cyclophosphamide", "Mobilization doses were 10-15mcg/kg granulocyte-colony stimulating factor with 2-4g/m2 cyclophosphamide, or 15-20mcg/kg granulocyte-colony stimulating factor alone for 5 days.", "Dogs receiving cyclophosphamide and furosemide concurrently were significantly less likely to develop SHC than dogs that did not receive furosemide .", "Risk factors for sterile hemorrhagic cystitis in dogs with lymphoma receiving cyclophosphamide with or without concurrent administration of furosemide: 216 cases (1990-1996).", "CONCLUSION Treatment response did not differ between two different cyclophosphamide regimens ( small pulses and standard high doses protocol ) , but standard protocol seemed to be more comfortable for patients .", "Patients and methods From February 1975 to August 1988, 73 children (54 boys) with steroid dependent minimal change nephrotic syndrome confirmed by the classic clinical and laboratory features and histological examination of a renal biopsy specimen were treated with a combination of prednisolone and cyclophosphamide.3 All patients had relapsed while the dose of prednisolone was being reduced, or within 14 days of discontinuing prednisolone, in the six months before cyclophosphamide treatment (steroid dependent).", "and follow - up liver function tests should be monitored in all patients receiving cyclophosphamide treatment .", "severe acute hepatic failure within 24 hours of receiving low - dose intravenous cyclophosphamide . The diagnosis of granulomatosis with polyangiitis was supported with a positive c - ANCA", "Treatment with SKF 525A, piperonyl butoxide, or 1-benzylimidazole, followed by a single 200 mg/kg dose of cyclophosphamide, did not diminish pulmonary thymidine incorporation (an index of cell division after injury) or hydroxyproline content (an indicator of fibrosis), compared to mice treated with cyclophosphamide alone.", "METHODS We analyzed the results of two follow-up studies comprising patients with lupus nephritis, treated with cyclophosphamide: 1) 41 females treated with \"small pulses\", consisting of 400 mg of cyclophosphamide weekly at treatment onset, followed by the same dose fortnightly for the next three months, and finally on monthly basis for several months or years; 2) 33 patients (29 females and 4 males) treated with standard protocol consisting of \"induction phase\" with 6 monthly pulses of high doses (0.5-0.75 g/m2 body surface), followed by \"maintenance phase\" with quarterly pulses for additional 1-2 years.", "concurrently with cyclophosphamide decreased the incidence of SHC .", "The patient was treated with high dose methylprednisolone, plasmapheresis, intermittent hemodialysis, and low-dose intravenous cyclophosphamide.", "The group that received cyclophosphamide collected a higher median number of progenitor cells [ 3.8 ( range : 3.1 - 4.4 ) vs. 3.2 ( range : 2.3 - 3.8 ) ] ( p - value=0.008 ) .", "Is it feasible to use granulocyte-colony stimulating factor alone to mobilize progenitor cells in multiple myeloma patients induced with a cyclophosphamide, thalidomide and dexamethasone regimen?", "INTRODUCTION Immunosuppressive drugs , particularly cyclophosphamide , are widely accepted as the treatment of choice for severe , proliferative lupus nephritis .", "56.5 years old ( range : 54 - 60 ) for granulocyte - colony stimulating factor plus cyclophosphamide group . Fifty - two patients were male . Eighty cases ( 90.9% ) were Durie - Salmon Staging System", "The pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide / aldophosphamide has been evaluated in 12 patients with metastatic breast cancer undergoing high - dose chemotherapy followed by bone marrow transplantation .", "Based on its oral administration and the reduced incidence of infection and cytopenia , cyclophosphamide - thalidomide - dexa - methasone may be considered an effective induction therapy option for patients with newly diagnosed multiple myeloma .", "Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.", "In addition, the ability of a low dose of cyclophosphamide to prevent the lung injury from a later higher dose was determined.", "BACKGROUND Cyclophosphamide plus thalidomide as induction for multiple myeloma patients eligible for autologous stem cell transplantation may be a limiting factor for cell mobilization.", "CONCLUSION The number of cells mobilized with granulocyte-colony stimulating factor plus cyclophosphamide was higher.", "Mechanisms of venoocclusive disease resulting from the combination of cyclophosphamide and roxithromycin.", "0.25% for cyclophosphamide alone, 0% for roxithromycin alone; P < 0.0001) most probably by mitochondrial membrane permeability transition and release of cytochrome c. CONCLUSIONS The combination cyclophosphamide and roxithromycin, but not the individual compounds, is toxic to endothelial cells by inducing apoptosis.", "During induction phase of treatment, patients on small pulses have received even higher cummulative dose of cyclophosphamide.", "Although roxithromycin did not favor the generation of toxic metabolites from cyclophosphamide, it led to cyclophosphamide accumulation due to inhibition of both CYP3A4 and CYP2B6.", "This resulted in a higher frequency of prolongation of intervals between cladribine and cyclophosphamide combination and cyclophosphamide , vincristine , and prednisone combination cycles ( P < .05 ) , but dose reductions due to hematological or other toxicity did not differ significantly in cladribine alone , cladribine and cyclophosphamide combination , and cyclophosphamide , vincristine , and prednisone combination groups .", "Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results.", "Initial and follow-up liver function tests should be monitored in all patients receiving cyclophosphamide treatment.", "CONCLUSIONS For patients with LGNHL, first-line cladribine alone or cladribine and cyclophosphamide combination regimens both provided similar treatment responses, acceptable toxicity, and better response rates than cyclophosphamide, vincristine, and prednisone combination.", "A single i.p . dose of cyclophosphamide produces lung cell injury and fibrosis in mice .", "The objectives of the current study were to assess the effects of various inhibitors of MFO and prostaglandin H synthase activity on the development of cyclophosphamide - induced lung damage and fibrosis in mice , to determine whether arachidonic acid as well as NADPH could support the activation of cyclophosphamide to an alkylating metabolite , and to assess the capacity of cyclophosphamide to serve as a reducing cosubstrate .", "Combining other treatments to granulocyte-colony stimulating factor, such as cyclophosphamide, could overcome the mobilization limitation.", "PROCEDURE Medical records of dogs with lymphoma that received cyclophosphamide chemotherapy in accordance with 1 of 2 protocols, with or without concurrent i.v.", "The first has comprised the so called \" small pulses \" that have been used since 1985 , and the second has been standard protocol with high doses of cyclophosphamide , accepted in 1990 .", ". Combining other treatments to granulocyte - colony stimulating factor , such as cyclophosphamide , could overcome the mobilization limitation . The objective of this study was to assess the", "In the presence of roxithromycin ( 500 micromol / L ) , cyclophosphamide ( 500 micromol / L ) induced apoptosis in endothelial cells ( 34.3 + /-", "However , there is no consensus with regard to : 1 ) the dose required for achieving control of disease activity ; 2 ) duration of cyclophosphamide therapy after the achievement of treatment response ; 3 ) treatment of lupus nephritis relapses [ 1 - 5 ] .", "Cummulative dose of cyclophosphamide and treatment duration were not significantly different between treatment groups.", "Cooxidation of cyclophosphamide as an alternative pathway for its bioactivation and lung toxicity .", "These results demonstrate that pathways in lung tissue unrelated to MFOs can metabolize cyclophosphamide to an alkylating compound and that MFO-mediated activation of cyclophosphamide may not be essential for the development of the pulmonary toxicity associated with this drug.", "In the Institute of Rheumatology, Belgrade, two regimens of intravenous cyclophosphamide have been introduced in the treatment of lupus nephritis patients years ago.", "10.2 for the combination with cyclophosphamide 500 micromol/L; P", "Because roxithromycin inhibits cytochrome P450 ( CYP ) 3A4 and P - glycoprotein , the patient may have been exposed to higher cyclophosphamide and/or cyclophosphamide metabolite concentrations .", "SEM] for the combination with cyclophosphamide 0.05 micromol/L and 50.2 +/-", "should be aware of this serious adverse reaction and should not repeat the cyclophosphamide dose when there is hepatotoxicity caused by the first dose . Initial and follow - up liver", "All patients had previously relapsed while the dosage was being reduced or within 14 days of discontinuing prednisolone in the six months before receiving cyclophosphamide treatment (steroid dependent), and had severe steroid toxicity.", "Hepatotoxicity with high dose cyclophosphamide is well recognized but hepatitis due to low dose cyclophosphamide has rarely been described. CASE REPORT We report the case of a 48-year-old Chinese man with a rapidly progressive glomerulonephritis secondary to granulomatosis with polyangiitis who developed severe acute hepatic failure within 24 hours of receiving low-dose intravenous cyclophosphamide.", "RESULTS Cyclophosphamide or roxithromycin at concentrations from 0.05 to 500 micromol / L were not toxic to endothelial cells as assessed by lactate dehydrogenase ( LDH ) leakage assay .", "CONCLUSIONS The cyclophosphamide-thalidomide-dexamethasone regimen showed improved response rates and was not inferior in terms of survival outcomes to the standard infusional regimen of cyclophosphamide-vincristine-doxorubicin-dexamethasone.", "RESULTS Eighty-eight patients were analyzed; only 18 received cyclophosphamide.", "cyclophosphamide and roxithromycin .", "DESIGN AND METHODS Oral cyclophosphamide , thalidomide , and dexamethasone was compared with infusional cyclophosphamide , vincristine , doxorubicin , and dexamethasone in patients with newly diagnosed multiple myeloma .", "- colony stimulating factor with and without cyclophosphamide after induction with cyclophosphamide , thalidomide and dexamethasone . METHODS A retrospective study was performed of a cohort of", "Blood and plasma cyclophosphamide concentrations were remarkably similar, indicating that cyclophosphamide partitions equally in the red cell and plasma volume.", "Previous studies suggested that children with frequently relapsing nephrotic syndrome without steroid dependence could be more successfully treated with cyclophosphamide than those with steroid dependence.8 9 Other authors have compared eight week and 12 week courses of cyclophosphamide, and reported that a 12 week course of treatment is more likely to result in sustained remission in steroid dependent nephrotic patients.1 0 Despite the results of this relatively small study, it is still uncertain whether cyclophosphamide is more effective when given for 12 weeks than for eight weeks to treat steroid dependent nephrotic patients with minimal change.", "The mean nonrenal clearance ( Clnr ) of cyclophosphamide for five patients with apparent first - order elimination of cyclophosphamide was 67 ml / min .", "BACKGROUND Cyclophosphamide is commonly used to treat cancers, systemic vasculitides, and kidney diseases (e.g., lupus nephritis and focal segmental glomerulosclerosis).", "AIM The aim of this study was to compare the efficacy of two regimens of intravenous pulse cyclophosphamide in the treatment of patients with severe lupus nephritis.", "The objective of this study was to assess the number of CD34 + cells mobilized using granulocyte - colony stimulating factor with and without cyclophosphamide after induction with cyclophosphamide , thalidomide and dexamethasone .", "were International Staging System 2 and 3 , respectively . The group that received cyclophosphamide collected a higher median number of progenitor cells [ 3.8 ( range : 3.1 - 4.4 ) vs. 3.2 ( range :", "Compared with cyclophosphamide-vincristine-doxorubicin-dexamethasone, cyclophosphamide-thalidomide-dexamethasone was associated with more constipation and somnolence, but a lower incidence of cytopenias.", "RESULTS Cyclophosphamide - associated SHC developed in 12 of 133 ( 9% ) dogs that had not received concurrent administration of furosemide and cyclophosphamide treatments ; of the 83 dogs that had received furosemide , only 1 ( 1.2% ) developed SHC ."], "par_relations": ["Phosphoramide Mustards", "Antirheumatic Agents", "Immunosuppressive Agents", "Mutagens", "Antineoplastic Agents, Alkylating", "Myeloablative Agonists", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide"], "chd_relations": ["Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Ifosfamide", "4-hydroxycyclophosphamide", "4-ketocyclophosphamide", "4-methylcyclophosphamide", "4-peroxycyclophosphamide", "4-phenylcyclophosphamide", "4-S-(hexane-6-ol)sulfidocyclophosphamide", "4-S-(propionic acid)sulfidocyclophosphamide", "5-chlorocyclophosphamide", "AC protocol", "ACE protocol 1", "ACF protocol", "ACFM protocol", "ACFT protocol", "AcFuCy protocol", "ACOMLA protocol", "ACOP-E protocol", "ACP protocol", "ANAVACYM protocol", "Asta Z 7557", "BACT protocol", "BCD protocol", "BCP protocol", "BCPP protocol", "BCVP protocol", "BFM 78 protocol", "BV-CAP protocol", "BVCPP protocol", "CAC protocol", "CAE-P protocol", "CAF protocol", "CAFVP protocol", "CAM combination", "CAMEO protocol", "CAMF protocol", "CAMFTP protocol", "CAMP protocol", "CAMP-L protocol", "CAPF protocol", "CAV protocol", "CBV protocol", "CBVPM protocol", "CCE protocol", "CCOM protocol", "CCV protocol", "CCV-AV protocol", "CCVPP protocol", "CEOP protocol 1", "CEP combination", "CEV protocol", "CF protocol", "CFP protocol", "CHAMOCA regimen", "CHAMOMA protocol", "CHF protocol", "CHOP protocol", "CHOP-B protocol", "CHOP-VP16 protocol", "CHVP protocol", "CISCA protocol", "CISCA(II)-VB(IV) protocol", "CMB protocol", "CMF-B protocol", "CMFDV protocol", "CMFP protocol", "CMFPT protocol", "CMFVP protocol", "CMOPP protocol", "COAP protocol", "COF protocol", "COMF protocol", "COMLA protocol", "COMP protocol", "COMP-1 protocol", "COP-B protocol", "COP-BLAM protocol", "COPAC protocol", "COPAD protocol", "COPP protocol", "COPU protocol", "CP protocol", "CV protocol", "CVD protocol", "COP protocol 2", "CVPP I protocol", "CYVADIC protocol", "DECAV protocol", "ECHO protocol", "EVAC protocol", "F-MACHOP protocol", "FACP protocol", "FEC protocol", "HCOMLA protocol", "HEAVD protocol", "hexa CAF protocol", "iminophosphamide", "JAC protocol", "LNH 84 protocol", "LSA2-L2 protocol", "M-2 protocol", "M-BACOD protocol", "M-BACOP protocol", "MAC combination", "MAC III protocol", "MACC combination", "MACOP-B protocol", "MACOP-B regimen", "mafosfamide", "mafosfamide-lysine", "MCC protocol", "MCOP protocol", "MCPD protocol", "MECY protocol", "MEV protocol", "MEVAP protocol", "MOCCA protocol", "MPCCV protocol", "MTX-CHOP protocol", "Murphy-Bowmann protocol", "MVP-CAB protocol", "N,N-diethylcyclophosphamide", "OPEC protocol 1", "OPPA protocol", "PAB-CAP protocol", "PM-FAC protocol", "POCC protocol", "POMB-ACE protocol", "PROMACE protocol", "PROMACE-CytaBOM protocol", "Rosen's T-10 protocol", "sufosfamide", "TACC protocol", "trofosfamide", "VAB-6 regimen", "VAB-III protocol", "VAB-IV protocol", "VAC protocol", "VAC-MAP protocol", "VACA protocol", "VAP-cyclo protocol", "VAPAC protocol", "VEMP protocol 1", "VEP-THP protocol", "VEPA-M protocol", "VMCP protocol", "VPCBAE protocol", "4-hydroperoxydechlorocyclophosphamide", "ACVB protocol", "ADOC protocol", "CVAD protocol", "CVPP regimen", "dechloroethylcyclophosphamide", "HiC-COM protocol", "LSA(2)L(2) protocol", "M-BNCOD protocol", "m-M-BACOD protocol", "MACHO protocol", "MI-MIV maintenance protocol", "ProMACE-MOPP protocol", "AVCF protocol", "BAEC protocol", "BECALM protocol", "CHOEP protocol", "CHOP protocol, modified", "COP-PAF protocol", "CTCb regimen", "CVACE protocol", "FMC protocol", "GIMEMA LAL 0288 protocol", "MADDOC protocol", "N4SE protocol", "St Jude's regimen", "VACOP-B protocol", "VCPC protocol", "VCRP protocol", "VCSP protocol", "perfosfamide", "ABCM protocol", "MiNa protocol", "VAPEC-B protocol", "VCAD regimen", "CyADIC regimen", "BACOD protocol", "D-CECaT regimen", "AIEOP acute lymphoblastic leukemia protocol", "T7 protocol", "New York protocol", "COMVP protocol", "RACOP protocol", "LNH-80 regimen", "CEMP protocol", "BEACOPP protocol", "P-VEBEC protocol", "CEFT protocol", "BFM-ALL 81 protocol", "V-CAM protocol", "alcophosphamide", "PCMF protocol", "CAV-HEM protocol", "COMPA protocol", "PCV regimen", "CAP-1 protocol", "CEF regimen", "LNH87-2 protocol", "EVDAC regimen", "CMxMF regimen", "CAMBO-VIP protocol", "VETOPEC protocol", "CAPE-PALE protocol", "VNCOP-B protocol", "CHVmP-VB protocol", "maphosphamide", "ML-Y1 protocol", "TSOP protocol", "COCE protocol", "CEO-PE protocol", "CEE protocol", "MECHOP-BM protocol", "COPE regimen", "DAC protocol", "CAP protocol 2", "MAPECO protocol", "CALF protocol", "CMCp protocol", "VEBEP regimen", "ECBC protocol", "PECC protocol", "CAV-T protocol", "m-BECOD protocol", "cyclone protocol", "N(3)-methyl-4-(propylthio)cyclophosphamide", "N(3)-methyl-4-(diethyldithiocarbamoyl)cyclophosphamide", "COMET-A protocol", "CEOP-B protocol", "M-BACOS protocol", "PACE-BOM protocol", "BCHE protocol", "4-hydroxyperoxycyclophosphamide", "VECABOP protocol", "CVPPABO protocol", "BUCY-2 protocol", "CEOP-IMVP-Dexa regimen", "IVAD protocol", "CE-CAP protocol", "POMB-ACE regimen", "COPADEM protocol", "COP protocol 1", "CNV protocol", "HD-CNV protocol", "LNH 87 protocol", "BMF phase II protocol", "ProMECE-CytaBOM protocol", "P-COMM-B protocol", "CVAD-V protocol", "EC regimen", "MCHOD protocol", "BFM-86 protocol", "FEMP protocol", "MSK-NY-II protocol, modified", "TCCSG B-8801 protocol", "CAOP protocol", "MAC conditioning regimen", "DAT-COAP regimen", "CODBLAM IV protocol", "NCVB protocol", "CTVP protocol", "CEOP protocol 2", "NCI PB 93-C-207 protocol", "CEC protocol", "3-methoxy-1,3,5(10)-estratriene-17(R)-spiro-6'-(2'-(bis-(2-chloroethyl)amino)-2'-oxo-1'-oxa-3'-aza-2'-phosphorane)", "5-fluorocyclophosphamide", "3-hydroxycyclophosphamide", "BCOMM protocol", "CDOP protocol", "VbCFM protocol", "ACMFVP protocol", "4-ureidooxycyclophosphamide", "AVCT protocol", "3-(1-oxy-2,2,6,6-tetramethyl-4-piperidinyl)cyclophosphamide", "L-6 protocol", "CYOMAD protocol", "CARA protocol", "VCDP protocol", "DCCM protocol", "ABC protocol", "COATA protocol", "CAVB protocol", "CVAP-B protocol", "TRAMPCO protocol", "CMCF protocol", "5,5-dimethylcyclophosphamide", "VCCP protocol", "AAABC protocol", "MCHC protocol", "CAPE protocol", "(COMPADRI)-III protocol", "OPEC-D protocol", "TRAMPCOL protocol", "COFP protocol 1", "CFMPV protocol", "AVLF protocol", "R-14 regimen", "VAC-M protocol", "DAEP protocol", "VPC protocol", "CHAMP-5 protocol", "4-S-ethanolsulfido-cyclophosphamide", "VBCMF protocol", "VEMFAH protocol", "COMB protocol", "UCH I protocol", "VinMCP protocol", "CHAC-1 protocol", "COFB protocol", "CCP protocol", "OC-HDP protocol", "COFP protocol 2", "BCPE protocol", "protocol 8001", "VCAA protocol", "VCMA protocol", "CADOM protocol", "CEP regimen", "CAPT protocol", "PATCO protocol", "CMU protocol", "MEV-AD protocol", "phenylketophosphamide", "COMP-VAN protocol", "MCPP protocol", "ARA-COP protocol", "CAEVM protocol", "ECAPP protocol", "ACT regimen", "Mallinson protocol", "CEPP protocol", "MOPLACE protocol", "CAP-M protocol", "CMED protocol", "CAF-PH protocol", "CECA protocol", "PCAV protocol", "T-6 protocol", "MNCOP-B protocol", "m-ACOD protocol", "POMACE protocol", "MCP 842 regimen", "Pro-MACE-C-MOPP protocol", "TCAP protocol", "ALL-1 protocol", "CEOP-MB protocol", "MDACC protocol", "CMVP regimen", "FAC-MV protocol", "COBDP regimen", "CWAP regimen", "ACOB regimen", "POMB-ACE-PAV regimen", "BACOD-VP16 protocol", "ECP regimen", "VDBCP protocol", "MATCOP regimen", "7+3 protocol", "CMFPTH regimen", "CDPTH regimen", "VACO-B protocol", "CEVP protocol", "Stanford University protocol", "LALA 87 protocol", "B-8801 protocol", "MiCaT protocol", "CCAVP16 protocol", "MOPLEC protocol", "T10 A protocol", "DD1 protocol", "CIOP protocol", "ACM protocol", "EACB protocol", "POG 8493 protocol", "P-DOCE protocol", "ACOP protocol 2", "FCC protocol", "NEO-MACOP-B protocol", "CVP protocol 2", "VICOP-B protocol", "TNCF regimen", "THP-COPBLM regimen", "MLL-93 protocol", "PMitCEBO protocol", "VEMP protocol 3", "VQEP protocol", "COPEP protocol", "CIOP-Bleo protocol", "VACAD protocol", "ACOPA II protocol", "VHCP protocol", "DVP-M-CHOP protocol", "CAPABLE protocol", "C-VAMP protocol", "PACEBO protocol", "VCAV protocol", "VICED protocol", "HM 89 protocol", "HM 91 protocol", "STAMP V regimen", "TAC protocol", "CHASE protocol", "LSG15 regimen", "DAC protocol 2", "VEPA-L protocol", "VACIME protocol", "HCVAD protocol", "CEVBP protocol", "Cis-VACD protocol", "CEVAD protocol", "TEC protocol", "MMC protocol", "CYVEDIC protocol", "VCD protocol", "CTEC protocol", "CCA protocol", "HD-CEP regimen", "STAMP-I protocol", "CMF regimen", "CCC protocol", "CHEP protocol", "CN3OP regimen", "CAF protocol 2", "CAT combination", "BuCEt protocol", "malmo protocol", "CAD protocol 3", "OPEC OJEC protocol", "CMC protocol 2", "LMB89 protocol", "TMC regimen", "2-dechloroethylcyclophosphamide", "Stanford-NCOG protocol", "OXAC protocol", "VEPA-B protocol", "CHOP-V-MMV protocol", "VEPEMB protocol", "CHVP regimen", "BOP-CISCA-POMB-ACE regimen", "Berlin-Frankfurt-Muenster protocol II", "DCEP protocol", "DT-PACE protocol", "PETHEMA ALL-96 protocol", "ABCDV protocol", "CAT-G protocol", "CPDD protocol", "BEMOP-CA protocol", "hyperCDT protocol", "PETHEMA ALL-3-97 protocol", "4-glutathionylcyclophosphamide", "CIOD protocol", "ICBV regimen", "TCID protocol", "4-hydroperoxydidechlorocloclophosphamide", "ALL-BFM-95 protocol", "diiodocyclophosphamide", "iodocyclophosphamide", "CE protocol II", "d4-cyclophosphamide", "R-FCM protocol", "BOVAPEC protocol", "COPP-ABVD protocol", "EMA-CO protocol", "3-methyl-9-(2-oxa-2lambda(5)-2H-1,3,2-oxazaphosphorine-2-cyclohexyl)-3,6,9-triazaspiro(5.5)undecane", "TL-118", "R-CHOP protocol", "VCP protocol 2", "EPOCH protocol", "4,6-diphenylcyclophosphamide"], "syn_relations": ["Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide", "Cyclophosphamide"], "sib_relations": ["Cyclophosphamide", "Cyclophosphamide"]}, "target_ent": {"research_entity_id": "RXNORM:1366736", "canonical_name": "Prevantics (chlorhexidine gluconate 31.5 MG/ML / isopropyl alcohol 0.7 ML/ML) Medicated Pad", "aliases": ["prevantics (chlorhexidine gluconate 31.5 mg/ml / isopropyl alcohol 0.7 ml/ml) medicated pad", "chlorhexidine gluconate 31.5 mg/ml / isopropyl alcohol 0.7 ml/ml medicated pad [prevantics]", "prevantics (chlorhexidine gluconate 3.15 % / isopropyl alcohol 70 % ) medicated pad"], "definition": "", "other_contexts": [], "par_relations": ["chlorhexidine gluconate 31.5 MG/ML / Isopropyl Alcohol 0.7 ML/ML Medicated Pad", "Chlorhexidine / Isopropyl Alcohol Medicated Pad [Prevantics]", "Prevantics Topical Product", "Prevantics Medicated Pad or Tape"], "chd_relations": [], "syn_relations": ["Prevantics (chlorhexidine gluconate 31.5 MG/ML / isopropyl alcohol 0.7 ML/ML) Medicated Pad", "Prevantics (chlorhexidine gluconate 31.5 MG/ML / isopropyl alcohol 0.7 ML/ML) Medicated Pad", "Prevantics (chlorhexidine gluconate 31.5 MG/ML / isopropyl alcohol 0.7 ML/ML) Medicated Pad", "Prevantics (chlorhexidine gluconate 31.5 MG/ML / isopropyl alcohol 0.7 ML/ML) Medicated Pad"], "sib_relations": ["Medicated Pad", "Isopropyl Alcohol 0.7 ML/ML", "chlorhexidine gluconate 31.5 MG/ML", "Prevantics", "chlorhexidine gluconate 31.5 MG/ML / Isopropyl Alcohol 0.7 ML/ML [Prevantics]"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C537577", "canonical_name": "Microcephalic osteodysplastic primordial dwarfism, type 1", "aliases": ["microcephalic osteodysplastic primordial dwarfism, type i", "osteodysplastic primordial dwarfism, type 1", "mopd i", "mopd1", "taybi-linder syndrome", "mopdi", "cephaloskeletal dysplasia", "osteodysplastic primordial dwarfism, type i", "taybi linder syndrome", "microcephalic osteodysplastic primordial dwarfism, type 1", "brachymelic primordial dwarfism", "low-birth-weight dwarfism with skeletal dysplasia", "mopd 1", "mopd"], "definition": "", "other_contexts": [], "par_relations": ["Dwarfism", "Fetal Growth Retardation", "Microcephaly", "Osteochondrodysplasias"], "chd_relations": [], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:134637.0015", "canonical_name": "FAS, ASN102SER", "aliases": ["fas, asn102ser"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["FAS CELL SURFACE DEATH RECEPTOR"], "sib_relations": ["FAS CELL SURFACE DEATH RECEPTOR"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C563443", "canonical_name": "Neuronopathy, Distal Hereditary Motor, Type V", "aliases": ["spinal muscular atrophy, distal type v", "spinal muscular atrophy, distal, with upper limb predominance", "hmn5", "dhmn-v", "neuropathy, distal hereditary motor, type v", "distal hereditary motor neuropathy, type v", "dsmav", "distal spinal muscular atrophy, type v", "hmn v", "spinal muscular atrophy, distal, type v", "distal hereditary motor neuronopathy, type v", "dhmn5", "neuronopathy, distal hereditary motor, type v", "dhmn v"], "definition": "", "other_contexts": [], "par_relations": ["Muscular Atrophy, Spinal"], "chd_relations": [], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:615548", "canonical_name": "NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII", "aliases": ["hsan vii", "hsan7", "neuropathy, hereditary sensory and autonomic, type vii", "insensitivity to pain, congenital, with gastrointestinal dysfunction and hyperhidrosis"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII", "NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII", "NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII", "NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII", "NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII", "NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII"], "sib_relations": ["Constipation", "Diarrhea", "Hyperhidrosis", "Pruritis", "Insensitivity to pain", "Self injury", "Autosomal dominant", "Gastrointestinal dysfunction", "Autonomic dysfunction", "Delayed motor development, mild", "Muscle weakness, mild", "De novo mutation", "Painless fractures", "Inability to feel pain", "Slow-healing wounds due to painless injuries", "Caused by mutation in the voltage-gated sodium channel, type XI, alpha subunit gene (SCN11A, 604385.0001)", "Three unrelated patients with the same de novo mutation have been reported (last curated December 2015)", "Dystonic posturing (in some patients)"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:D007052", "canonical_name": "Ibuprofen", "aliases": ["ibuprofen", "trauma-dolgit gel", "calcium salt ibuprofen", "ibuprofen, copper (2+) salt", "ibuprofen, sodium salt", "ibuprofen, (+-)-isomer", "alpha-methyl-4-(2-methylpropyl)benzeneacetic acid", "aluminum salt ibuprofen", "ibuprofen, calcium salt", "ibuprofen-zinc", "sodium salt ibuprofen", "rufen", "ibuprofen, aluminum salt", "ibuprofen zinc", "ibuprofen, zinc salt", "traumadolgit gel", "ibuprofen, magnesium salt", "trauma dolgit gel", "salt ibuprofen, sodium", "magnesium salt ibuprofen", "salprofen", "benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-", "ibumetin", "i.v. solution, ibuprofen", "ibuprofen, potassium salt", "ip 82", "brufen", "ip-82", "motrin", "ibuprofen, (s)-isomer", "salt ibuprofen, magnesium", "salt ibuprofen, zinc", "ip82", "ibuprofen i.v. solution", "ibuprofen, (r)-isomer", "zinc salt ibuprofen", "potassium salt ibuprofen", "nuprin"], "definition": "A nonsteroidal anti-inflammatory agent with analgesic properties used in the therapy of rheumatism and arthritis.", "other_contexts": [". A significant difference was observed between fast - acting formulations and standard ibuprofen tablets for both maximum concentration and time taken to reach it . Individual formulations had an", "Changes in PGE2 could be used to quantify the COX2 inhibition after ibuprofen administration .", "One study (64 infants) compared oral ibuprofen with placebo and noted a significant reduction in failure to close a PDA (RR 0.26, 95% CI 0.11 to 0.62; RD -0.44, 95% CI -0.65 to -0.23; NNTB 2, 95% CI 2 to 4).Twenty-one studies (1102 infants) reported failure rates for PDA closure with ibuprofen (oral or iv) compared with indomethacin (oral or iv).", "Enrolled subjects received the following three 200 mg ibuprofen formulations: ibuprofen arginine, solubilized ibuprofen capsule, and standard ibuprofen.", "Fewer participants needed rescue medication with ibuprofen + oxycodone combination than with placebo or ibuprofen alone .", "CONCLUSION Rapid absorption and higher peak concentration were observed in ibuprofen arginine and the solubilized ibuprofen capsule.", "The median time to use of rescue medication was 7.6 hours for ibuprofen 200 mg + paracetamol 500 mg, 8.3 hours with ibuprofen 400 mg + paracetamol 1000 mg, and 1.7 hours with placebo.", "estimated before and after treatment . The treatment of sPDA infants with ibuprofen ( ibuprofen group ) or acetaminophen ( acetaminophen group ) caused a significant decrease in the plasma and", "The rates of treatment - related AEs between the first and second doses of study medication were significantly lower for FDC ibuprofen 400 mg / paracetamol 1000 mg ( 8/149 patients [ 5.4% ] ) than for placebo ( 14/73 [ 19.2% ] ; P < 0.01 ) and paracetamol 1000 mg ( 10/74 [ 13.5% ] ; P < 0.05 ) ; and also lower for FDC ibuprofen 200 mg / paracetamol 500 mg ( 9/143 [ 6.3% ] ) compared with ibuprofen 200 mg ( 12/75 [ 16.0% ] ; P < 0.05 ) and paracetamol 500 mg ( 17/76 [ 22.4% ] ; P < 0.001 ) .", "A multicenter , randomized , double - blind , placebo - controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain .", "Median remedication times with both doses of ibuprofen arginate were similar to those with both doses of ibuprofen, ranging from 4.0 to 5.2 hours.", "A significant difference was observed between fast - acting formulations and standard ibuprofen tablets for both maximum concentration and time taken to reach it .", "2 ( 0.427 ) was less than that of plasma PGE2 ( 0.539 ) . The clinical efficacy of oral ibuprofen and acetaminophen in the treatment of preterm infants with sPDA was similar with low adverse", "Compared with placebo, a greater number of patients achieved meaningful pain relief with ibuprofen 400 mg from 45 minutes through 6 hours; with ibuprofen 200 mg.", "OBJECTIVE This study assessed the analgesic efficacy, speed of onset, and tolerability of ibuprofen arginate compared with a commercially available form of ibuprofen in patients with postoperative dental pain.", "All patients received morphine administered by patient-controlled analgesia pump, or by hospital staff at the request of the patient, after surgery and were randomly assigned in a 1:1:1 ratio to receive ibuprofen 400 mg IV, ibuprofen 800 mg IV, or inactive vehicle (placebo).", "SELECTION CRITERIA Randomised , double - blind clinical trials of single dose , oral ibuprofen plus paracetamol compared with placebo or the same dose of ibuprofen alone for acute postoperative pain in adults . DATA COLLECTION AND ANALYSIS Two review authors independently considered trials for inclusion in the review , assessed quality , and extracted data .", ", serum creatinine and alanine transaminase showed no significant changes between the ibuprofen and acetaminophen groups ( P>0.05 ) . Following treatment with ibuprofen or acetaminophen , the", "To assess the analgesic efficacy and adverse effects of a single oral dose of ibuprofen plus oxycodone for moderate to severe postoperative pain .", "No statistically significant difference was observed between the ibuprofen formulations in terms of adverse events and specifically with respect to hemorrhagic scores ; 41 ( 46.0% ) adverse events ( AEs ) occurred after administration of ibuprofen sodium dihydrate , and 46 ( 52.9% ) after ibuprofen arginate .", ", the median times to maximum concentration were 0.42 , 0.5 , and 1.25 hours in ibuprofen arginine , solubilized ibuprofen capsule , and ibuprofen , respectively . The maximum observed", "A randomized, double-blind, placebo-controlled comparison of the analgesic efficacy, onset of action, and tolerability of ibuprofen arginate and ibuprofen in postoperative dental pain.", "Pharmacokinetics of ibuprofen sodium dihydrate and gastrointestinal tolerability of short - term treatment with a novel , rapidly absorbed formulation .", "Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial The aim of the present study was to analyze the changes of plasma and urinary prostaglandin E2 (PGE2) levels in preterm infants with symptomatic patent ductus arteriosus (sPDA) treated with oral ibuprofen and acetaminophen.", "CONCLUSIONS In these patients undergoing postoperative pain management , ibuprofen 800 mg IV q6h was associated with significant reductions in morphine use and pain at rest and with movement compared with placebo .", "OBJECTIVE This study was conducted to assess the effects of intravenously administered ibuprofen 400 and 800 mg q6h in postoperative pain management.", "We calculated relative risk (RR) and number needed to treat to benefit (NNT) for ibuprofen plus paracetamol, ibuprofen alone, or placebo.", "and pharmacodynamic relationships for COX2 inhibition according to three formulations of ibuprofen in healthy male subjects . MATERIALS AND METHODS A randomized , open - label , single - dose ,", "After the first hour, pain reduction was similar for the similar doses of the 2 ibuprofen preparations.", "Ibuprofen reduces the risk of NEC and transient renal insufficiency.", "With respect to the number of patients who experienced serious AEs , the differences in the 400-mg IV ibuprofen group ( 118/134 [ 88% ] ) and the 800-mg IV ibuprofen group ( 124/138 [ 90% ] ) compared with the placebo group ( 126/134 [ 94% ] ) were not statistically significant .", "Single dose oral ibuprofen plus oxycodone for acute postoperative pain in adults.", "Pharmacokinetic and pharmacodynamic evaluation according to absorption differences in three formulations of ibuprofen OBJECTIVE Prostaglandin E2 (PGE2) synthesis is modulated by COX2.", "University from October , 2012 to June , 2015 were selected and randomly divided into the ibuprofen group ( n=43 , 10 mg / kg ibuprofen administered orally as initial dose , followed by 5 mg / kg", ", and ibuprofen , respectively . The maximum observed plasma concentration was lower in ibuprofen , and the area under the plasma concentration - time curve was comparable among the three", "To evaluate the safety of the fixed combination of ibuprofen and famotidine compared with ibuprofen alone from two 24-week , multicenter , double - blind trials designed to evaluate the comparative", "Two studies compared intravenous (iv) ibuprofen versus placebo (270 infants).", "High dose versus standard dose of iv ibuprofen , early versus expectant administration of iv ibuprofen , echocardiographically guided iv ibuprofen treatment vs. standard iv ibuprofen treatment and continuous infusion of ibuprofen vs. intermittent boluses of ibuprofen and long - term follow - up were studied in too few trials to draw any conclusions .", "CONCLUSIONS The new formulation of ibuprofen sodium dihydrate dissolves quickly in vitro , has the same extent of absorption as other fast - acting ibuprofen formulations , and is absorbed into plasma more rapidly than conventional ibuprofen .", "The incidence of oliguria was less among sPDA infants of the acetaminophen group [ 1 ( 2.3% ) ] than observed among the sPDA infants of the ibuprofen group [ 6 ( 14.0% ) ] ; however , this difference was not statistically significant ( P=0.108 ) .", "Dizziness occurred in a significantly greater proportion of patients in the ibuprofen 800-mg q6h group compared with the placebo group (P = 0.011).", "patients in the combination group . Of these , 80% were reports of hypertension ( 8% ibuprofen / famotidine vs. 2% ibuprofen ) . Three cases of hypertension in the ibuprofen / famotidine group", "OBJECTIVES To assess the efficacy and adverse effects of single dose oral ibuprofen plus paracetamol for acute postoperative pain using methods that permit comparison with other analgesics evaluated in standardised trials using almost identical methods and outcomes .", "The proportion of participants using rescue medication with ibuprofen 400 mg was 48% , giving an NNT to prevent use for ibuprofen 400 mg + paracetamol 1000 mg compared with ibuprofen alone of 4.3 ( 3.0 to 7.7).The proportion of participants experiencing one or more adverse events was 30% with ibuprofen 200 mg + paracetamol 500 mg , 29% with ibuprofen 400 mg + paracetamol 1000 mg , and 48% with placebo , giving NNT values in favour of the combination treatment of 5.4 ( 3.6 to 10.5 ) and 5.1 ( 3.5 to 9.5 ) for the lower and higher doses respectively .", "The proportion of participants experiencing one or more adverse events was 25% with ibuprofen 400 mg + oxycodone 5 mg, 25% with placebo, 26% with ibuprofen alone, and 35% with oxycodone alone; they were not significantly different.", "ibuprofen : ibuprofen arginine 18.4% , solubilized ibuprofen capsule 18.4% , and standard ibuprofen 11.6% . CONCLUSION Rapid absorption and higher peak concentration were observed in ibuprofen", "A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: a multicenter, two-stage, randomized, double-blind, parallel-group, placebo-controlled, factorial study.", "concentration were 0.42 , 0.5 , and 1.25 hours in ibuprofen arginine , solubilized ibuprofen capsule , and ibuprofen , respectively . The maximum observed plasma concentration was lower in", "South Korean male volunteers . Enrolled subjects received the following three 200 mg ibuprofen formulations : ibuprofen arginine , solubilized ibuprofen capsule , and standard ibuprofen .", "OBJECTIVE To evaluate the safety of the fixed combination of ibuprofen and famotidine compared with ibuprofen alone from two 24-week , multicenter , double - blind trials designed to evaluate the comparative incidence of endoscopically documented upper gastrointestinal ulcers and a 28-week double - blind extension study .", "These data offer additional evidence supporting a new therapeutic option to improve gastrointestinal safety and adherence for patients who require long-term ibuprofen.", "Serious adverse events were reported only after abdominal surgery 6/169 with the combination, 1/175 with ibuprofen alone, 3/52 with oxycodone alone, and 1/60 with placebo.", "Additionally , the incidences of fecal occult blood positive rate , intraventricular hemorrhage , neonatal necrotizing enterocolitis and bronchopulmonary dysplasia were distributed similarly in the ibuprofen and acetaminophen groups ( P>0.05 ) .", "Events judged to be treatment related were significantly lower with the ibuprofen / famotidine combination ( 20.6% vs. 25% ) .", "The duration of ventilatory support was reduced with ibuprofen ( oral or iv ) compared with iv or oral indomethacin ( six studies , 471 infants ; mean difference ( MD ) -2.4 days , 95% CI -3.7 to -1.0 ; I(2 ) = 19%).Eight studies ( 272 infants ) reported on failure rates for PDA closure in a subgroup of the above studies comparing oral ibuprofen with indomethacin ( oral or iv ) .", "pharmacodynamic evaluation according to absorption differences in three formulations of ibuprofen OBJECTIVE Prostaglandin E2 ( PGE2 ) synthesis is modulated by COX2 . Changes in PGE2 could be used", "RESULTS A total of 406 patients were enrolled ( 319 women , 87 men ; mean [ SD ] age , 45 [ 12 ] years ; weight , 83.8 [ 19.1 ] kg ; ibuprofen 400 mg IV , 134 patients ; ibuprofen 800 mg IV , 138 ; and placebo , 134 ) .", "Significantly greater numbers of patients achieved meaningful pain relief with ibuprofen arginate 400 mg compared with placebo from 20 minutes through 6 hours and with ibuprofen arginate 200 mg from 30 minutes through 6 hours ( P < 0.05 ) .", "in significantly lower WAI in standard ibuprofen : ibuprofen arginine 18.4% , solubilized ibuprofen capsule 18.4% , and standard ibuprofen 11.6% . CONCLUSION Rapid absorption and higher peak", "SELECTION CRITERIA Randomised, double-blind clinical trials of single dose, oral ibuprofen plus oxycodone compared with placebo or the same dose of ibuprofen alone for acute postoperative pain in adults. DATA COLLECTION AND ANALYSIS Two review authors independently considered trials for inclusion in the review, assessed quality, and extracted data.", "Fixed - dose combinations of ibuprofen and oxycodone are available , and the drugs may be separately used in combination in some acute pain situations .", "In one study (136 infants), ibuprofen reduced the composite outcome of infant mortality, infants who dropped out, or infants who required rescue treatment (RR 0.58, 95% CI 0.38 to 0.89; RD -0.22, 95% CI -0.38 to -0.06; NNTB 5, 95% CI 3 to 17).", "To make further recommendations , studies are needed to assess the effectiveness of high - dose versus standard - dose ibuprofen , early versus expectant administration of ibuprofen , echocardiographically guided versus standard iv ibuprofen , and continuous infusion versus intermittent boluses of ibuprofen .", "2 was applied to the pharmacodynamic evaluation . RESULTS After a single oral dose of the ibuprofen formulations , the median times to maximum concentration were 0.42 , 0.5 , and 1.25 hours in", "For ibuprofen 400 mg alone the proportion was 52% , giving an NNT for ibuprofen 400 mg + paracetamol 1000 mg compared with ibuprofen alone of 5.4 ( 3.5 to 12).Ibuprofen + paracetamol at the 200/500 mg and 400/1000 mg doses resulted in longer times to remedication than placebo .", "The differences between ibuprofen arginate and ibuprofen were statistically significant (both doses, P < 0.05).", "A total of 87 preterm infants with sPDA admitted to the Neonatal Ward of the Affiliated Xuzhou Hospital of Medical College of Southeast University from October, 2012 to June, 2015 were selected and randomly divided into the ibuprofen group (n=43, 10 mg/kg ibuprofen administered orally as initial dose, followed by 5 mg/kg during the first 24 and 48 h later) and acetaminophen group (n=44, 15 mg/kg acetaminophen administered orally once every 6 h for three days).", "Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight ( or both ) infants .", "For ibuprofen 400 mg alone the proportion was 50%, producing no significant difference between ibuprofen 400 mg + oxycodone 5 mg and ibuprofen 400 mg alone.", "We used the area under the pain relief versus time curve to derive the proportion of participants prescribed ibuprofen plus oxycodone, ibuprofen alone, oxycodone alone, or placebo with at least 50% pain relief over six hours, using validated equations.", "Following treatment with ibuprofen or acetaminophen, the extent of decrease of plasma and urinary PGE2 was significantly higher among sPDA infants with oliguria (135.0±38.0", ", 2015 were selected and randomly divided into the ibuprofen group ( n=43 , 10 mg / kg ibuprofen administered orally as initial dose , followed by 5 mg / kg during the first 24 and 48 h later )", "The levels of platelet, serum creatinine and alanine transaminase showed no significant changes between the ibuprofen and acetaminophen groups (P>0.05).", "a follow - on extension . OBJECTIVE To evaluate the safety of the fixed combination of ibuprofen and famotidine compared with ibuprofen alone from two 24-week , multicenter , double - blind", "CONCLUSION FDC ibuprofen 200 mg/paracetamol 500 mg and ibuprofen 400 mg/paracetamol 1000 mg were significantly more effective in this population than were comparable doses of ibuprofen or paracetamol alone in moderate to severe acute dental pain and were significantly more effective than placebo in providing sustained pain relief.", "Ibuprofen 400 mg IV q6h was associated with significant reductions in pain at rest and with movement during the 6- to 24-hour and 12- to 24-hour time periods compared with placebo .", "OBJECTIVES To determine the effectiveness and safety of ibuprofen compared with indomethacin, other cyclo-oxygenase inhibitor, placebo or no intervention for closing a patent ductus arteriosus in preterm, low birth weight, or preterm and low birth weight infants.", "11.6% . CONCLUSION Rapid absorption and higher peak concentration were observed in ibuprofen arginine and the solubilized ibuprofen capsule . Additionally , fast - acting formulations had", "AUTHORS ' CONCLUSIONS Ibuprofen is as effective as indomethacin in closing a PDA and currently appears to be the drug of choice .", "Some combinations of ibuprofen and paracetamol are available for use without prescription in some acute pain situations.", "The median time to use of rescue medication was more than 5 hours for ibuprofen 400 mg + oxycodone 5 mg, and 2.3 hours or less with placebo.", "In stage 1 , patients were randomly assigned to ibuprofen 200 mg , ibuprofen 400 mg , paracetamol 500 mg , paracetamol 1000 mg , FDC ibuprofen 100 mg / paracetamol 250 mg , FDC ibuprofen 200 mg / paracetamol 500 mg , FDC ibuprofen 400 mg / paracetamol 1000 mg , or placebo .", "Meaningful pain relief was reached after a median of 29 and 28 minutes with ibuprofen arginate 200 and 400 mg, respectively, and after 52 and 44 minutes with ibuprofen 200 and 400 mg, respectively (all, P < 0.05).", "0.42 , 0.5 , and 1.25 hours in ibuprofen arginine , solubilized ibuprofen capsule , and ibuprofen , respectively . The maximum observed plasma concentration was lower in ibuprofen , and the area", "ng/l) were significantly lower than those in the ibuprofen group (73.5±44.8 ng/l, P=0.002).", "Fewer participants needed rescue medication with ibuprofen + paracetamol combination than with placebo or ibuprofen alone .", "There were significant reductions in the numbers of patients experiencing pyrexia in the 400- and 800-mg IV ibuprofen groups compared with the placebo group ( 9/134 [ 7% ] and 10/138 [ 7% ] vs 23/134 [ 17% ] ; P = 0.013 and P = 0.015 ) .", "In the FDC treatment groups , the need for rescue medication included 27 of 71 ( 38.0% ) , 40 of 143 ( 28.0% ) , and 32 of 149 ( 21.5% ) patients in the ibuprofen 100-mg / paracetamol 250-mg , ibuprofen 200-mg / paracetamol 500-mg , and ibuprofen 400-mg / paracetamol 1000-mg groups , respectively .", "CONCLUSIONS Ibuprofen arginate was effective in this population of patients experiencing moderate to severe pain after surgical extraction of > or = 1 impacted third molar, with 16 to 24 minutes' faster time to meaningful pain relief than with ibuprofen.", "safety data from two pivotal trials and a long - term extension study indicate that the ibuprofen / famotidine combination demonstrates a favorable gastrointestinal safety profile and more", "Included studies provided data from 508 participants for the comparison of ibuprofen 200 mg + paracetamol 500 mg with placebo , 543 participants for the comparison of ibuprofen 400 mg + paracetamol 1000 mg with placebo , and 359 participants for the comparison of ibuprofen 400 mg + paracetamol 1000 mg with ibuprofen 400 mg alone .", "Because of its enhanced pharmacokinetic characteristics , ibuprofen arginate might be expected to provide faster pain relief than standard ibuprofen formulations in patients experiencing acute pain .", ", discontinuation rates due to any cause and dyspepsia were significantly lower for the ibuprofen / famotidine combination versus ibuprofen alone . Other than dyspepsia , gastrointestinal and", "MATERIAL AND METHOD Four separate studies investigated : the in vitro dissolution rates of ibuprofen sodium dihydrate ( at pH 1.2 , 3.5 and 7.2 ) ; the bioavailability of ibuprofen sodium dihydrate ( in two pharmacokinetic studies ; combined n = 38 ) compared with conventional ibuprofen , ibuprofen lysinate , ibuprofen arginate and ibuprofen liquagels ( all 2 x 200 mg ibuprofen ) ; and the gastroduodenal tolerance of ibuprofen sodium dihydrate and ibuprofen arginate ( both 2 x 200 mg ibuprofen t.i.d . ) in an endoscopy safety study , where endoscopy was performed at baseline and at the end of each treatment period using a five - point scale to assess the integrity of the gastric and duodenal mucosa .", "formulations : ibuprofen arginine , solubilized ibuprofen capsule , and standard ibuprofen . Pharmacokinetic and pharmacodynamic blood samples were collected for 16 hours following", "SELECTION CRITERIA Randomised or quasi-randomised controlled trials of ibuprofen for the treatment of a PDA in newborn infants.", "The proportion was 34% with ibuprofen 200 mg + paracetamol 500 mg, 25% with ibuprofen 400 mg + paracetamol 1000 mg, and 79% with placebo, giving NNTs to prevent use of rescue medication of 2.2 (1.8 to 2.9) and 1.8 (1.6 to 2.2) respectively compared with placebo.", "Ibuprofen, another cyclo-oxygenase inhibitor, may be as effective as indomethacin with fewer adverse effects.", "enterocolitis and bronchopulmonary dysplasia were distributed similarly in the ibuprofen and acetaminophen groups ( P>0.05 ) . The levels of platelet , serum creatinine and alanine", "The prevalences of AEs and abnormalities in laboratory measurements were not significantly different between patients who received IV ibuprofen and those who received placebo .", "during the 8 hours following treatment , resulting in significantly lower WAI in standard ibuprofen : ibuprofen arginine 18.4% , solubilized ibuprofen capsule 18.4% , and standard ibuprofen 11.6% .", "Single dose oral ibuprofen plus paracetamol ( acetaminophen ) for acute postoperative pain .", "Oro - gastric administration of ibuprofen appears as effective as iv administration .", "The proportion was 40% with ibuprofen 400 mg + oxycodone 5 mg , 83% with placebo , 53% with ibuprofen alone , and 83% with oxycodone alone , giving NNT to prevent one patient needing rescue medication of 2.4 ( 2.0 to 2.9 ) , 11 ( 6.1 to 56 ) , and 2.6 ( 2.1 to 3.4 ) for comparisons of ibuprofen 400 mg + oxycodone 5 mg with placebo , ibuprofen alone , and oxycodone alone , respectively .", "In one study ( 134 infants ) ibuprofen reduced the incidence of failure to close a PDA ( risk ratio ( RR ) 0.71 , 95% confidence interval ( CI ) 0.51 to 0.99 ; risk difference ( RD ) -0.18 , 95% CI -0.35 to -0.01 ; number needed to treat for an additional beneficial outcome ( NNTB ) 6 , 95% CI 3 to 100 ) .", "the following three 200 mg ibuprofen formulations : ibuprofen arginine , solubilized ibuprofen capsule , and standard ibuprofen . Pharmacokinetic and pharmacodynamic blood samples were", ", whereas acetaminophen - induced PGE2 levels were less than the levels observed in the ibuprofen - treated group . The incidence of oliguria was also lower in the acetaminophen group compared to", "and higher peak concentration were observed in ibuprofen arginine and the solubilized ibuprofen capsule . Additionally , fast - acting formulations had more predominant inhibitory activity on", "METHODS Patients were randomized to receive ibuprofen arginate 200 or 400 mg , ibuprofen 200 or 400 mg , or placebo in this multicenter , double - blind , double - dummy , parallel - group trial .", "The FDC ibuprofen 200 mg / paracetamol 500 mg was also significantly more effective than paracetamol 1000 mg ( P < 0.001 ) , but failed to reach statistical significance in comparison with ibuprofen 400 mg .", "The treatment of sPDA infants with ibuprofen ( ibuprofen group ) or acetaminophen ( acetaminophen group ) caused a significant decrease in the plasma and urinary PGE2 levels in comparison with plasma and urinary PGE2 levels before treatment ( P<0.05 ) .", "In addition, the present studies suggest that the tolerability and safety profile of ibuprofen sodium dihydrate is comparable to existing ibuprofen formulations.", "Three cases of hypertension in the ibuprofen / famotidine group were considered treatment related .", "CONCLUSIONS One-year safety data from two pivotal trials and a long-term extension study indicate that the ibuprofen/famotidine combination demonstrates a favorable gastrointestinal safety profile and more patients continued on therapy compared to ibuprofen alone.", "The arterial duct closure rate was similar between the acetaminophen [ 31 ( 70.5% ) ] and ibuprofen groups [ 33 ( 76.7% ) , P=0.506 ] . The incidence of oliguria was less among sPDA infants of the", "modulated by COX2 . Changes in PGE2 could be used to quantify the COX2 inhibition after ibuprofen administration . This study investigated the pharmacokinetic and pharmacodynamic relationships for", "RESULTS After a single oral dose of the ibuprofen formulations , the median times to maximum concentration were 0.42 , 0.5 , and 1.25 hours in ibuprofen arginine , solubilized ibuprofen capsule , and ibuprofen , respectively .", "Incidence of cardiovascular - related AEs of special interest were 11% ( ibuprofen / famotidine ) and 2% ( ibuprofen ) ( p=0.06 ) , possibly due to a higher number of rheumatoid arthritis patients in the combination group .", "AUTHORS' CONCLUSIONS The combination of ibuprofen 400mg + oxycodone 5mg provided analgesia for longer than oxycodone alone, but not ibuprofen alone (at the same dose).", "The NSAID ibuprofen has antiinflammatory and analgesic properties, and a multimodal approach may reduce opioid requirements.", "Transient renal insufficiency was less common in infants who received ibuprofen compared with indomethacin.", "Studies are lacking evaluating the effect of ibuprofen on longer-term outcomes in infants with PDA.", "the groups . Incidence of cardiovascular - related AEs of special interest were 11% ( ibuprofen / famotidine ) and 2% ( ibuprofen ) ( p=0.06 ) , possibly due to a higher number of rheumatoid", "8 hours following treatment , resulting in significantly lower WAI in standard ibuprofen : ibuprofen arginine 18.4% , solubilized ibuprofen capsule 18.4% , and standard ibuprofen 11.6% . CONCLUSION", "This study compared the efficacy and tolerability of 3 doses of a single - tablet fixed - dose combination ( FDC ) of ibuprofen and paracetamol ( ibuprofen / paracetamol doses of 100 mg/250 mg , 200 mg/500 mg , and 400 mg/1000 mg ) with comparable doses of ibuprofen ( 200 or 400 mg ) monotherapy , paracetamol ( 500 or 1000 mg ) monotherapy , and placebo in the 8 hours after surgical removal of 3 to 4 impacted third molars ( stage 1 ) and with placebo over the next 72 hours ( stage 2 ) .", "The mean plasma concentration for ibuprofen sodium dihydrate was significantly higher than for conventional ibuprofen (p = 0.028) 10 minutes post-dose and the t(max) for ibuprofen sodium dihydrate was reached significantly earlier than for conventional ibuprofen (p = 0.018).", "Ibuprofen sodium dihydrate had similar C(max) to ibuprofen lysinate and ibuprofen liquagels and significantly higher Cmax than conventional ibuprofen (p = 0.002).", "The clinical efficacy of oral ibuprofen and acetaminophen in the treatment of preterm infants with sPDA was similar with low adverse events, whereas acetaminophen-induced PGE2 levels were less than the levels observed in the ibuprofen-treated group.", "One occurrence of an invasive ulcer was observed after administration of ibuprofen arginate.", "( 8% ibuprofen / famotidine vs. 2% ibuprofen ) . Three cases of hypertension in the ibuprofen / famotidine group were considered treatment related . The probability of a cardiovascular event", "- related AEs of special interest were 11% ( ibuprofen / famotidine ) and 2% ( ibuprofen ) ( p=0.06 ) , possibly due to a higher number of rheumatoid arthritis patients in the combination", "The proportion of participants achieving at least 50% maximum pain relief over 6 hours was 69% with ibuprofen 200 mg + paracetamol 500 mg, 73% with ibuprofen 400 mg + paracetamol 1000 mg, and 7% with placebo, giving NNTs of 1.6 (1.5 to 1.8) and 1.5 (1.4 to 1.7) for the lower and higher doses respectively compared with placebo.", "gastrointestinal safety profile and more patients continued on therapy compared to ibuprofen alone . No new safety signals have been identified . These data offer additional evidence", ". The incidence of oliguria was also lower in the acetaminophen group compared to the ibuprofen group . In addition , monitoring urinary PGE2 levels was more suitable because of its non -", "The proportion of participants achieving at least 50% pain relief over 6 hours was 60% with ibuprofen 400 mg + oxycodone 5 mg and 17% with placebo , giving an NNT of 2.3 ( 2.0 to 2.8 ) .", "The ibuprofen and placebo were administered while patients had access to morphine throughout the duration of the study.", "BACKGROUND The combination of ibuprofen and paracetamol may confer analgesic benefits over monotherapy with either agent .", "Included studies provided data from 603 participants for the comparison of ibuprofen 400 mg + oxycodone 5 mg with placebo , 717 participants for the comparison of ibuprofen 400 mg + oxycodone 5 mg with ibuprofen 400 mg alone , and 471 participants for the comparison of ibuprofen 400 mg + oxycodone 5 mg with oxycodone 5 mg alone .", "and dyspepsia were significantly lower for the ibuprofen / famotidine combination versus ibuprofen alone . Other than dyspepsia , gastrointestinal and cardiovascular AEs of special interest were", "For oxycodone 5 mg alone the proportion was 23% , giving an NNT for ibuprofen 400 mg + oxycodone 5 mg compared with oxycodone alone of 2.9 ( 2.3 to 4.0).Ibuprofen + oxycodone resulted in longer times to remedication than with placebo .", "This study investigated the pharmacokinetic and pharmacodynamic relationships for COX2 inhibition according to three formulations of ibuprofen in healthy male subjects .", "OBJECTIVE This paper describes four studies investigating the dissolution, plasma pharmacokinetics and safety of a novel, fast-acting ibuprofen formulation, ibuprofen sodium dihydrate.", "AUTHORS' CONCLUSIONS Ibuprofen plus paracetamol combinations provided better analgesia than either drug alone (at the same dose), with a smaller chance of needing additional analgesia over about eight hours, and with a smaller chance of experiencing an adverse event.", "of the acetaminophen group [ 1 ( 2.3% ) ] than observed among the sPDA infants of the ibuprofen group [ 6 ( 14.0% ) ] ; however , this difference was not statistically significant ( P=0.108 ) .", "Of these , 80% were reports of hypertension ( 8% ibuprofen / famotidine vs. 2% ibuprofen ) .", "The percentages of patients who achieved meaningful pain relief within the first hour after treatment were 77.6% and 83.7% for ibuprofen arginate 200 and 400 mg, respectively, 61.0% and 63.0% for ibuprofen 200 and 400 mg, respectively, and 39.8% for placebo.", "One - year safety of ibuprofen / famotidine fixed combination versus ibuprofen alone : pooled analyses of two 24-week randomized , double - blind trials and a follow - on extension .", "The maximum observed plasma concentration was lower in ibuprofen, and the area under the plasma concentration-time curve was comparable among the three formulations.", "the acetaminophen group ( 45.0±36.9 ng / l ) were significantly lower than those in the ibuprofen group ( 73.5±44.8 ng / l , P=0.002 ) . The arterial duct closure rate was similar between the", "The incidence of oliguria was also lower in the acetaminophen group compared to the ibuprofen group.", "The risk of NEC was reduced with oral ibuprofen compared with indomethacin ( oral or iv ) ( seven studies , 249 infants ; typical RR 0.41 , 95% CI 0.23 to 0.73 ; typical RD -0.13 , 95% CI -0.22 to -0.05 ; NNTB 8 , 95% CI 5 to 20 ; I(2 ) = 0% for both RR and RD ) .", "The risk of developing necrotising enterocolitis (NEC) was reduced for ibuprofen (16 studies, 948 infants; typical RR 0.64, 95% CI 0.45 to 0.93; typical RD -0.05, 95% CI -0.08 to -0.01; NNTB 20, 95% CI 13 to 100; I(2) = 0% for both RR and RD).", "There were significant reductions in the proportions of patients who experienced gastrointestinal disorders in the 400- and 800-mg IV ibuprofen groups compared with the placebo group (99/134 [74%] and 98/138 [71%], respectively, vs 113/134 [84%]; P = 0.05 and P = 0.009).", "RESULTS Ibuprofen sodium dihydrate dissolved significantly more rapidly at pH 1.2, 3.5 and 7.2 than conventional ibuprofen, ibuprofen lysinate and ibuprofen liquagels.", "There was a decreased risk of failure to close a PDA with oral ibuprofen compared with iv ibuprofen ( four studies , 304 infants ; typical RR 0.41 , 95% CI 0.27 to 0.64 ; typical RD -0.21 , 95% CI -0.31 to -0.12 ; NNTB 5 , 95% CI 3 to 8) .", "two groups were estimated before and after treatment . The treatment of sPDA infants with ibuprofen ( ibuprofen group ) or acetaminophen ( acetaminophen group ) caused a significant decrease in the", "For the primary efficacy end point ( SPRID8 ) , FDC ibuprofen 400 mg / paracetamol 1000 mg was significantly more effective than ibuprofen 400 mg ( P = 0.02 ) and paracetamol 1000 mg ( P < 0.001 ) in the immediate postoperative period ( stage 1 ) , and FDC ibuprofen 200 mg / paracetamol 500 mg was significantly more effective than ibuprofen 200 mg ( P < 0.001 ) and paracetamol 500 mg ( P < 0.001 ) .", "In the intent-to-treat population, median morphine use was significantly reduced during the first 24 hours after administration of the study drug in patients who received ibuprofen 800 mg IV q6h (by 22% vs placebo; P = 0.030).", "group . Of these , 80% were reports of hypertension ( 8% ibuprofen / famotidine vs. 2% ibuprofen ) . Three cases of hypertension in the ibuprofen / famotidine group were considered treatment", "These findings suggest that ibuprofen 800 mg IV q6h was effective for postoperative pain management and was generally well tolerated .", "Individual formulations had an effect on PGE2 WAI during the 8 hours following treatment , resulting in significantly lower WAI in standard ibuprofen : ibuprofen arginine 18.4% , solubilized ibuprofen capsule 18.4% , and standard ibuprofen 11.6% .", "to improve gastrointestinal safety and adherence for patients who require long - term ibuprofen .", "In the pivotal efficacy and safety trials, discontinuation rates due to any cause and dyspepsia were significantly lower for the ibuprofen/famotidine combination versus ibuprofen alone.", "between the ibuprofen and acetaminophen groups ( P>0.05 ) . Following treatment with ibuprofen or acetaminophen , the extent of decrease of plasma and urinary PGE2 was significantly higher", "The use of ibuprofen 800 mg IV q6h was associated with significant reductions in pain at rest and with movement across 3 time periods ( 1 - 24 , 6 - 24 , 12- 24 hours ) compared with placebo .", ". Enrolled subjects received the following three 200 mg ibuprofen formulations : ibuprofen arginine , solubilized ibuprofen capsule , and standard ibuprofen . Pharmacokinetic and", "During stage 1 , rescue medication was required by 53 of 73 ( 72.6% ) , 29 of 75 ( 38.7% ) , 21 of 74 ( 28.4% ) , 56 of 76 ( 73.7% ) , and 51 of 74 ( 68.9% ) patients in the placebo group and the ibuprofen 200-mg , ibuprofen 400-mg , paracetamol 500-mg , and paracetamol 1000-mg treatment groups , respectively .", "In a previous study, an ibuprofen/paracetamol combination provided significantly better analgesic efficacy than comparable doses of ibuprofen or paracetamol alone in patients experiencing moderate to severe acute postoperative pain after extraction of impacted third molars. OBJECTIVE", "in preterm infants with symptomatic patent ductus arteriosus ( sPDA ) treated with oral ibuprofen and acetaminophen . A total of 87 preterm infants with sPDA admitted to the Neonatal Ward of the", "were similar . Events judged to be treatment related were significantly lower with the ibuprofen / famotidine combination ( 20.6% vs. 25% ) . In the safety extension population , there were no", "After the initial 8 doses , the protocol allowed for continued administration of IV ibuprofen or placebo every 6 hours , at the discretion of the investigator , for control of postoperative pain for a total of up to 120 hours ( 5 days ) .", "Ibuprofen IV was not associated with significant increases in AEs compared with placebo , with the exception of dizziness with the 800-mg dose .", "The arterial duct closure rate was similar between the acetaminophen [ 31 ( 70.5% ) ] and ibuprofen groups [ 33 ( 76.7% ) , P=0.506 ] ."], "par_relations": ["Phenylpropionates", "Anti-Inflammatory Agents, Non-Steroidal", "Cyclooxygenase Inhibitors", "Analgesics, Non-Narcotic", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen"], "chd_relations": ["Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "ibuprofen diethylaminoethyl ester", "metoxibutropate", "ibuprofen piconol", "solufenum", "2-(4-dimethylvinylphenyl)propionic acid", "ibuprofen acyl glucuronide", "cholesteryl ibuprofen", "ibuprofen dimethyl aminoethanol octyl", "L 5409709", "ibuprofen arginine", "6-isobutyl alpha-methyl-3-pyridineacetic acid", "Poly-5", "2-(4'-isobutylphenyl)propionitrile", "2-(4-hydroxyethoxyphenyl)propionic acid", "carboxyibuprofen", "hydroxyibuprofen", "Myprodol", "2-mercaptoethylibuprofenate", "2-(acetyloxy)benzoic acid 6-(nitrooxymethyl)-2-phenylmethyl ester", "ibuprofen-N-octyl-pyridostigmine", "ibuprofen-N-decyl-pyridostigmine", "ibuprofen-S-acyl-glutathione", "dexibuprofen", "oxycodone hydrochloride, ibuprofen drug combination", "dextran ibuprofen ester", "imidazolium ibuprofenate", "hydrocodone tartrate, ibuprofen drug combination", "2-(4-isobutylphenyl)propionic acid 4-(diethoxyphosphoryloxy)butyl ester", "4-(nitrooxy)butyl 2-(4-isobutylphenyl)propanoate", "4-(5-thioxo-5H-1,2-dithiol-3-yl)-phenyl 2-(4-isobutyphenyl)propanoate", "ibuprofen hydrazide", "phospho-ibuprofen amide", "3,3,3-trifluoro-2-(4-isobutylphenyl)propanoic acid", "ibuprofen 2-amino-3-methylpyridine amide"], "syn_relations": ["Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen"], "sib_relations": ["Ibuprofen", "Ibuprofen", "Ibuprofen", "Fenoprofen", "Indoprofen", "Ketoprofen", "Suprofen", "Ibuprofen", "Ibuprofen", "Ibuprofen"]}, "target_ent": {"research_entity_id": "RXNORM:1154153", "canonical_name": "Calcium Chloride / Lactate / Magnesium Chloride / Potassium Chloride / Sodium Acetate / Sodium Chloride Injectable Product", "aliases": ["calcium chloride / lactate / magnesium chloride / potassium chloride / sodium acetate / sodium chloride injectable product"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": ["Calcium Chloride 0.005 MEQ/ML / Magnesium Chloride 0.0015 MEQ/ML / K+ Chloride 0.01 MEQ/ML / Sodium Acetate 0.0471 MEQ/ML / NaCl 0.0848 MEQ/ML / Sodium Lactate 0.008 MEQ/ML Injectable Solution", "Calcium Chloride / Lactate / Magnesium Chloride / Potassium Chloride / Sodium Acetate / Sodium Chloride Injectable Solution", "Plasma-Lyte R Injectable Product"], "syn_relations": [], "sib_relations": ["Calcium Chloride", "Magnesium Chloride", "Potassium Chloride", "Sodium Chloride", "Injectable Product", "Sodium Acetate", "Lactate"]}}
{"label": 0, "source_ent": {"research_entity_id": "HPO:HP:0009743", "canonical_name": "Distichiasis", "aliases": ["distichiasis of eyelid eyelashes", "distichiasis"], "definition": "Double rows of eyelashes. [HPO:probinson]", "other_contexts": ["Distichiasis without lymphedema is not commonly seen .", "Distichiasis is a rare congenital eyelid anomaly in which accessory eyelashes are present in the meibomian gland orifices.", "CLINICAL REPORT Microcephaly, Intellectual Impairment, Bilateral Vesicoureteral Reflux, Distichiasis, and Glomuvenous Malformations AssociatedWith a 16q24.3 Contiguous Gene Deletion and a Glomulin Mutation Two hereditary syndromes, lymphedema-distichiasis (LD) syndrome and blepharo-chelio-dontic (BCD) syndrome include the aberrant growth of eyelashes from the meibomian glands, known as distichiasis.", "condition indicates that selective breeding could be used to reduce the incidence of distichiasis .", "females are more likely to get distichiasis than males . The correlation between the distichiasis status of the parents and their offspring revealed a significant association between the breeding", "Distichiasis : management with cryotherapy to the posterior lamella .", "REASONS FOR PERFORMING STUDY Distichiasis is very uncommon in horses and treatment options and outcome remain unknown .", "Distichiasis was present in three generations of the proband 's maternal side of the family .", "of hairs and recurrence ( P<0.002 ) . CONCLUSIONS There is a breed predisposition of distichiasis in the Friesian horse . In Friesian horses that present with uni- or bilateral corneal irritation", "processes . We previously described six unrelated families with primary lymphedema - distichiasis in which patients showed different FOXC2 mutations located outside of the forkhead domain . Of", "Novel FOXC2 Mutation in Hereditary Distichiasis Impairs DNA - Binding Activity and Transcriptional Activation Distichiasis presents as double rows of eyelashes arising from aberrant differentiation of the meibomian glands of the eyelids , and it may be sporadic or hereditary . FOXC2", "Distichiasis-lymphedema syndrome: tetralogy of Fallot, chylothorax, and neonatal death.", "remain unknown . OBJECTIVES To describe treatment and long - term follow - up of distichiasis in the horse . STUDY DESIGN Retrospective clinical study . METHODS Case records of horses admitted", "estimated at 49.31 % with a gender predisposition that females are more likely to get distichiasis than males . The correlation between the distichiasis status of the parents and their offspring", "Distichiasis is the congenital condition of partial or complete accessory rows of eyelashes which exit from the posterior lid margin at or near the meibomian gland orifices .", "was estimated to be moderate to high , i.e. , 0.22 to 0.51 . The prevalence of distichiasis in English Cocker spaniels from Denmark , examined in 2004–2013 was shown to be extremely high .", "[ Distichiasis : an anomaly of eyelashes ] .", "association between the breeding combination of the parents and the occurrence of distichiasis in the offspring ( p < 0.0001 ) . A relative risk ( RR ) ranging from 1.3 to 1.8 demonstrates that", "Case records of horses admitted for diagnosis and treatment of uni- or bilateral distichiasis between 2003 and 2012 were reviewed . Long - term ( > 6 months after last treatment ) follow - up", "develops at or after puberty . In 90 - 95% of patients , lymphedema is accompanied by distichiasis . FOXC2 is a member of the forkhead / winged - helix family of transcription factors and plays", "irritation and excessive lacrimation ( secretion of tears ) in the dog . The term distichiasis originates from the Greek words di and stichos meaning two and rows , respectively , and as the", "Distichiasis was noted at age 6 weeks .", "study . The number of dogs examined during this period was 799 , and the prevalence of distichiasis within this cohort was estimated at 49.31 % with a gender predisposition that females are more", "ulceration , careful examination of the eyelid margins should be performed to diagnose distichiasis . Electrocautery is a valid and successful therapeutic modality which is minimally invasive ,", "special reference to the Friesian horse : a case series . REASONS FOR PERFORMING STUDY Distichiasis is very uncommon in horses and treatment options and outcome remain unknown . OBJECTIVES To", "Distichiasis and cleft palate .", "or ulceration concurrent with distichiasis . In total , 29 eyes were affected with distichiasis of which 23 had clinical signs . All corneas were stained with fluorescein and 13 had fluorescein", "BACKGROUND Distichiasis, ie, a second row of eyelashes arising from the meibomian glands of the eyelids, can be inherited either alone (Online Mendelian Inheritance in Man [OMIM] no.", "Friesians . All horses had signs of corneal irritation or ulceration concurrent with distichiasis . In total , 29 eyes were affected with distichiasis of which 23 had clinical signs . All corneas"], "par_relations": ["Multiple rows of eyelashes"], "chd_relations": [], "syn_relations": ["Distichiasis", "Distichiasis"], "sib_relations": ["Three rows of eyelashes"]}, "target_ent": {"research_entity_id": "OMIM:MTHU010798", "canonical_name": "Long eyelashes in irregular rows", "aliases": ["long eyelashes in irregular rows"], "definition": "", "other_contexts": [], "par_relations": ["Eyes"], "chd_relations": [], "syn_relations": [], "sib_relations": ["SCHWARTZ-JAMPEL SYNDROME, TYPE 1"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C008729", "canonical_name": "oxaprozin", "aliases": ["rhoxal-oxaprozin", "dayrun", "oxaprozin", "danoprox", "wy-21,743", "apo-oxaprozin", "daypro", "4,5-diphenyl-2-oxazolepropionic acid"], "definition": "", "other_contexts": ["Oxaprozin is as effective as other NSAIDs and offers once - daily dosing ; however , it does not offer any therapeutic advantage over other currently available NSAIDs .", "Investigator - assessed shoulder function improved in both groups but more so in the oxaprozin group ( p = 0.028 at day 15 ) .", "Hepatic disease and rheumatoid arthritis do not significantly alter the disposition of oxaprozin .", "RESULTS At day 15 , the mean changes in shoulder pain score from baseline in the oxaprozin and diclofenac groups were -5.85 + /-", "This indicates that serotonergic activation could also contributed to the analgesic properties of oxaprozin like that of other NSAIDs.", "[ Anti - inflammatory activity of a non - steroidal anti - inflammatory agent , oxaprozin , in experimental models ] .", "By inhibiting cyclo-oxygenase, oxaprozin decreases the formation of prostaglandin (PG) precursors from arachidonic acid, resulting in decreased PG biosynthesis and reduced pain and inflammatory responses.", "MTT and LDH assays revealed that the formulations only presented cytotoxicity in Caco-2 cells for oxaprozin concentrations superior to 100 μM. Permeability studies in Caco-2 cells shown that oxaprozin encapsulation did not interfered with oxaprozin permeability ( around 0.8 × 10−5 cm / s in simulated intestinal fluid and about 1.45 × 10−5 cm / s in PBS ) .", "Oxaprozin : a once - daily nonsteroidal anti - inflammatory drug .", "The pharmacology , pharmacokinetics , clinical efficacy , adverse effects , and dosage of oxaprozin are reviewed .", "the basis for passive and active targeting strategies . Two formulations containing oxaprozin were developed : NLCs with and without folate functionalization . In order to target the", "Two formulations containing oxaprozin were developed : NLCs with and without folate functionalization .", "Oxaprozin was shown to be superior to diclofenac in improving shoulder function and was considered by investigators and patients to have greater overall efficacy than diclofenac.", "After administration of multiple doses, the apparent oral clearance (CL/F) and Vd of total oxaprozin increased while those of the unbound drug decreased significantly.", "For treatment of osteoarthritis , oxaprozin was as effective as naproxen and more effective than aspirin or piroxicam .", "studies in Caco-2 cells shown that oxaprozin encapsulation did not interfered with oxaprozin permeability ( around 0.8 × 10−5 cm / s in simulated intestinal fluid and about 1.45 × 10−5 cm / s", "Tryptophan release from albumin , which has a role in central analgesic actions of anti - rheumatic drugs by enhancing CNS turnover of 5-hydroxytryptamine ( serotonin ) , was increased by 50 - 100 μM oxaprozin , as well as other NSAIDs .", "In collagen - induced rat platelet aggregation ex vivo , oxaprozin showed a weak but significant inhibitory effect with oral dose of 300 mg / kg .", "The inhibitory effects of oxaprozin , a new non - steroidal anti - inflammatory drug , on platelet aggregation and prostaglandin ( PG ) synthetase activity were studied .", "In clinical studies, oxaprozin was equally or more effective than aspirin and as effective as naproxen in the treatment of rheumatoid arthritis.", "The urinary elimination profiles of each horse were significantly different from each other with more than one peak in oxaprozin concentration before the 29 - 31-h collection time .", "At week 2, the oxaprozin group showed significantly greater improvement than the placebo group in role physical, vitality, and mental component summary (MCS) scores (P < 0.05), and in physical functioning, bodily pain, social functioning, and physical component summary (PCS) scores (P < 0.01).", "However , oxaprozin did not inhibit rat hind paw edemas induced by dextran , formalin and serotonin .", "These results suggest that oxaprozin, like many other acidic non-steroidal anti-inflammatory drugs, suppresses platelet aggregation by mainly inhibiting PG synthetase activity.", "Two major urinary metabolites were isolated and identified as hydroxylated oxaprozin .", "The formulations retained the oxaprozin release in simulated gastric fluid (only around 10%) promoting its release on simulated intestinal fluid.", "Oxaprozin oral clearance was significantly lower ( by 20% ) during both the cimetidine and ranitidine trials versus control ( 0.047 vs 0.047 vs 0.059 ml / min / kg ) , but clearance during acetaminophen was not significantly different from control .", "This study compared the health - related quality of life ( HRQOL ) of patients receiving oxaprozin 1200 mg QD with that of patients receiving nabumetone 1000 mg QD or nabumetone 1500 mg QD for the treatment of signs and symptoms of OA of the knee .", "The peak average urinary concentrations of oxaprozin were 25.1 and 17.0 microg/mL at collection times of 8-10 and 18-22 h, respectively.", "The latest detection of oxaprozin in urine was at the last collection time of 119-121 h postadministration at a concentration close to the detection limit of approximately 0.1 microg/mL. The serum elimination profiles do not vary between horses as much as the urinary elimination profiles.", "OBJECTIVE To evaluate the efficacy and safety of oxaprozin in comparison with diclofenac in patients with periarthritis pain of the shoulder previously unsuccessfully treated with nonsteroidal anti-inflammatory drugs other than diclofenac and oxaprozin.", "Although phenylbutazone also exhibited an inhibitory effect with 300 mg / kg , the effect was more potent than that of oxaprozin . ADP - induced platelet aggregation both in rabbit in vitro and rat ex vivo was not affected by oxaprozin .", "At week 2, the oxaprozin group showed a greater change than the nabumetone 1000-mg group in PCS score (P < 0.05).", "Nabumetone 1000 mg to 1500 mg once a day ( QD ) and oxaprozin 1200 mg QD are commonly recommended doses .", "Moreover, oxaprozin administered orally inhibited dose-dependently AA-induced pulmonary thrombotic mortality in mice, and its median effective dose was 56.4 mg/kg.", "In adrenalectomized rats , the anti - edema activity of oxaprozin in the carrageenin hind paw edema test was the same as that in intact rats .", "Daypro, a formulation of oxaprozin, was administered orally at a dose of 4.8 g to four standardbred mares.", "Radiolabelled oxaprozin accumulated in cartilage to a much greater extent than observed with other NSAIDs.", "Quality of life as measured by SF-36 total score was also improved in both treatment groups , with a trend toward greater improvement in the oxaprozin group .", "Confirmation of oxaprozin in postadministration extracts was accomplished by gas chromatographic- mass spectrometric analysis of methylated extracts or liquid chromatography with tandem mass spectrometry daughter ion mass spectra of underivatized extracts .", "Oxaprozin did not exacerbate the IL-1β and/or TNFα-induced proteoglycan destruction in pig or bovine cartilage in organ culture as observed with indomethacin and aspirin .", "Base hydrolysis of equine urine before extraction resulted in an increase in the amount of oxaprozin measured, an indication of conjugation by ester formation.", "Results of this study suggest that oxaprozin 1200 mg QD has a significant positive impact on the HRQOL of patients with OA of the knee compared with nabumetone 1000 mg QD and placebo .", "In contrast, the binding of oxaprozin to free-fatty acid depleted albumin was only appreciably affected by captopril and caffeine.", "oxaprozin during concurrent acetaminophen , 500 mg 4 times daily;c .", "Oxaprozin, like other NSAIDs, can cause gastrointestinal adverse effects.", "A trend towards better tolerability results for oxaprozin compared with diclofenac was also noted.", "a caveolae uptake mechanism . The developed nanoparticles enclose a great potential for oxaprozin oral administration with significant less gastric side - effects .", "Therefore, in rats, oxaprozin exhibited a weak anti-inflammatory effect.", "Oxaprozin inhibited erythema formation induced by ultra-violet rays in guinea pigs.", "oxaprozin with cimetidine , 300 mg 4 times daily;d .", "The elimination profiles of oxaprozin in equine urine and serum after a 4.8-g dose.", "A significant drug interaction has been demonstrated between oxaprozin and aspirin ( acetylsalicylic acid ) .", "concentrations superior to 100 μM. Permeability studies in Caco-2 cells shown that oxaprozin encapsulation did not interfered with oxaprozin permeability ( around 0.8 × 10−5 cm / s in", "Interaction of oxaprozin with acetaminophen, cimetidine, and ranitidine Twelve healthy male volunteers participated in a single-dose four-way crossover study to evaluate potential drug interactions with oxaprozin, a nonsteroidal antiinflammatory agent of the propionic class.", "CONCLUSIONS As expected, once-daily oxaprozin proved to be as effective as diclofenac three times daily in reducing the primary efficacy variable of patient-assessed shoulder pain score in patients with periarthritis of the shoulder refractory to previous treatments with other NSAIDs.", "It was suggested from these findings that oxaprozin is a potent and long acting anti-inflammatory drug in clinical use.", "oxaprozin , 1200 mg alone;b .", "These studies indicate that the potentially-significant pharmacodynamic actions of oxaprozin in arthritic joints may involve inhibition of the release of pro-inflammatory cytokines from inflamed synovium and relatively high rate of drug uptake into inflamed joints.", "The inhibitory effect of oxaprozin was less potent than that of indomethacin and piroxicam , almost equipotent as that of ibuprofen , and more potent than that of phenylbutazone and aspirin .", "oxaprozin with ranitidine , 150 mg every 12 hours .", "The latest detection was at the last collection time of 120 h. Oxaprozin is metabolized in the horse by hydroxylation .", "Oxaprozin is primarily eliminated by urinary excretion of the unchanged drug .", "The inhibitory potency of oxaprozin against prostaglandin E2 biosynthesis in vitro was equal to that of ibuprofen .", "On the other hand , in mice , oxaprozin was more potent than aspirin , ibuprofen and phenylbutazone , and it was as potent as sulindac and fenbufen in acetic acid vascular permeability and carrageenin hind paw edema tests .", "Anti - inflammatory activity and mode of action of oxaprozin , a new non - steroidal anti - inflammatory agent , were investigated in experimental animal models and in vitro tests .", "The oxaprozin group had significantly better scores than the nabumetone 1500-mg group in the PCS ( P < 0.05 ) , and it showed significantly greater improvement than the nabumetone 1000 mg group in role physical and PCS score ( P < 0.01 ) and in role emotional ( P < 0.05 ) .", "A method for the extraction of oxaprozin from equine urine and serum and its quantitation by high - performance liquid chromatography - ultraviolet detection is presented .", "The area under the plasma concentration - time curve ( AUC ) of oxaprozin is linearly proportional to the dose for oral doses up to 1200 mg .", "Oxaprozin is only slightly affected pharmacokinetically by some co-prescribed drugs or patho-physiologic metal ions but these effects may be of limited clinical consequence principally as oxaprozin has a relatively long plasma elimination half-life (50-60 h) and any small increase in free concentrations of the drug in circulating plasma increases elimination of the drug.", "Oxaprozin versus diclofenac in NSAID - refractory periarthritis pain of the shoulder .", "towards Overcoming NSAIDs Side - Effects Nanostructured Lipid Carriers ( NLCs ) loading oxaprozin were developed to address an effective drug packaging and targeted delivery , improving the drug", "The elimination half - life of oxaprozin is extended , 49 to 69 hr , in humans .", "Oxaprozin is well absorbed after oral administration, and peak plasma concentration is reached in three to six hours.", "Clinical pharmacokinetics of oxaprozin .", "In addition, oxaprozin showed a trend toward superior results in improving patients' quality of life compared with diclofenac.", "At doses greater than 1200 mg there is an increase in the unbound fraction of drug , leading to an increased clearance and volume of distribution ( Vd ) of total oxaprozin .", "No significant differences existed among the four treatment conditions in peak plasma oxaprozin concentration (86 µg/ml), volume of distribution (0.23 l/kg), time of peak concentration (3.7 h after dosage), or elimination half-life (54 h).", "In children , oxaprozin 10 - 20 mg / kg / day has been used to treat juvenile rheumatoid arthritis .", "The free oxaprozin was slightly increased by zinc and copper ions ( which are increased in rheumatic conditions ) in normal as well as fatty acid - free albumin .", "Anti-inflammatory potency of oxaprozin was almost equal to that of aspirin in acetic acid vascular permeability, carrageenin hind paw edema, cotton pellet granuloma and adjuvant arthritis tests in rats.", "Oxaprozin is a nonsteroidal anti - inflammatory drug which reaches peak plasma concentrations 2 to 6 hours after oral administration .", "Ulcerogenicity of oxaprozin was weaker than those of phenylbutazone and aspirin in rats.", "Nabumetone and oxaprozin are 2 of the newer NSAIDs and have been shown to have similar safety and efficacy profiles.", "Oxaprozin , a nonsteroidal anti - inflammatory drug ( NSAID ) under consideration for approval by the Food and Drug Administration , is characterized as a propionic acid .", "Oxaprozin is eliminated following biotransformation to glucuroconjugated metabolites which are excreted in urine and bile , with little drug being eliminated unchanged .", "In arachidonic acid (AA)-induced rabbit platelet aggregation in vitro, oxaprozin exhibited a dose-dependent inhibitory effect, and its median inhibitory concentration was 124.2 microM. The effect of oxaprozin was less potent than that of indomethacin and piroxicam, equipotent as that of aspirin and phenylbutazone, and 2 times as potent as that of ibuprofen.", "The reduction in oxaprozin clearance due to cimetidine or ranitidine is statistically significant but small in magnitude.", "At week 6, oxaprozin treatment resulted in significantly greater improvement than placebo in physical functioning, role physical, and bodily pain (P < 0.05); social functioning, role emotional, and mental health (P < 0.01); and vitality and MCS score (P < 0.001).", "The effect of oxaprozin was less potent than of sulindac , piroxicam and ibuprofen , equipotent as that of aspirin , and 5 times as potent as that of phenylbutazone .", "Oxaprozin binds extensively, in a concentration-dependent manner, to plasma albumin.", "to 95% and the loading capacity was of 9% , approximately . The formulations retained the oxaprozin release in simulated gastric fluid ( only around 10% ) promoting its release on simulated", "Recent pharmacodynamic and pharmacokinetic findings on oxaprozin Oxaprozin has proven a safe and effective treatment for arthritic conditions.", "Oxaprozin showed a concentration-dependent inhibition of heat-induced denaturation of bovine serum albumin and lysis of rabbit erythrocytes in vitro.", "Furthermore , a significantly more favourable effect on the SF-36 ' mental health ' item was observed in oxaprozin compared with diclofenac - treated patients at day 15 ( p = 0.0202 ) .", "On the other hand, oxaprozin inhibited dose-dependently PG synthetase activity.", "Oxaprozin - Loaded Lipid Nanoparticles towards Overcoming NSAIDs Side - Effects Nanostructured Lipid Carriers ( NLCs ) loading oxaprozin were developed to address an effective drug packaging and targeted delivery , improving the drug pharmacokinetics and pharmacodynamics properties and avoiding the local gastric side - effects .", "Acetaminophen, cimetidine, or ranitidine were begun 24 hours prior to oxaprozin dosage and continued for the 10-day duration of each trial.", "The blood concentration of oxaprozin in rats is extremely low because the metabolic rate of oxaprozin is rapid in rats.", "Thus acetaminophen, cimetidine or ranitidine has only a small influence on the pharmacokinetics of a single oral dose of oxaprozin.", "As assessed by investigators , the overall efficacy of oxaprozin was superior to that for diclofenac at visit 3 ( 8 + /-", "Patients with renal impairment demonstrate an increase in unbound plasma concentrations of oxaprozin .", "Patients also assessed the overall efficacy of oxaprozin as superior to that of diclofenac at visits 3 ( 8 + /-", "The difference between the two groups was not statistically significant, confirming the hypothesis of the study that oxaprozin is as effective as diclofenac.", "Studies have also shown oxaprozin to be effective therapy for juvenile rheumatoid arthritis and ankylosing spondylitis.", "Among the major effects of oxaprozin ( 10 - 100 μM ) observed on components of joint destruction was ( a ) the inhibition of the production of interleukin-1β ( IL-1β ) from pig synovial tissues in organ culture and IL-1β , IL-6 and IL-8 , as well as tumour necrosis factor-α ( TNFα ) from THP-1 mononuclear cells at 50 - 100 μM. Oxaprozin ( 1.0 - 100 μM ) did not affect NO production from porcine synovial tissue , whereas indomethacin and nimesulide reduced production of NO .", "Species differences in the metabolic rate of oxaprozin were shown .", "However, in mice, oxaprozin had a low metabolic rate, and the effect of oxaprozin was as potent as sulindac and fenbufen.", "We have investigated the pharmacology of oxaprozin on (a) the biochemical components of joint destruction in vitro, and (b) the pharmacokinetic interactions of this drug with albumin in vitro in which drug interactions are modelled by competitive binding of the drug with endogenous ligands or drugs that are commonly prescribed with NSAIDs.", "After this collection time , the differences between the oxaprozin urinary concentrations of each horse follow each other more closely .", "The developed nanoparticles enclose a great potential for oxaprozin oral administration with significant less gastric side - effects .", "In trial 1, patients were randomized to receive oxaprozin 1200 mg QD (n = 109), nabumetone 1000 mg QD (n = 110), or placebo (n = 109); in trial 2, patients received oxaprozin 1200 mg QD (n = 116), nabumetone 1500 mg QD (n = 115), or placebo (n = 116).", "The free concentrations of oxaprozin were , however , increased slightly by the same concentrations of warfarin , prednisolone , diazepam and captopril .", "Substantial concentrations of oxaprozin are attained in synovial fluid, which is a proposed site of action for nonsteroidal anti-inflammatory drugs.", "[The inhibitory effect of oxaprozin, a new non-steroidal anti-inflammatory drug, on platelet aggregation].", "Health - related quality - of - life effects of oxaprozin and nabumetone in patients with osteoarthritis of the knee .", "It was suggested from these results that the mode of action of oxaprozin is similar to those of other acidic non - steroidal anti - inflammatory drugs .", "METHODS In this open , multicentre , randomised , controlled study , eligible patients with periarthritis of the shoulder were randomised to receive either oxaprozin 1200 mg once daily ( n = 49 ) or diclofenac 50 mg three times daily ( n = 47 ) .", "LDH assays revealed that the formulations only presented cytotoxicity in Caco-2 cells for oxaprozin concentrations superior to 100 μM. Permeability studies in Caco-2 cells shown that oxaprozin"], "par_relations": ["Anti-Inflammatory Agents, Non-Steroidal", "Propionates", "oxaprozin", "oxaprozin", "oxaprozin", "oxaprozin", "oxaprozin", "oxaprozin"], "chd_relations": ["oxaprozin", "oxaprozin", "oxaprozin", "oxaprozin", "oxaprozin", "oxaprozin"], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "RXNORM:261137", "canonical_name": "Cholestin 600 MG Oral Capsule", "aliases": ["monascus purpureus west 600 mg oral capsule [cholestin]", "cholestin 600 mg oral capsule"], "definition": "", "other_contexts": [], "par_relations": ["Monascus purpureus West Oral Capsule [Cholestin]", "Monascus purpureus West 600 MG Oral Capsule", "Cholestin Oral Product", "Cholestin Pill"], "chd_relations": [], "syn_relations": ["Cholestin 600 MG Oral Capsule", "Cholestin 600 MG Oral Capsule"], "sib_relations": ["Oral Capsule", "Monascus purpureus West 600 MG", "Cholestin", "Monascus purpureus West 600 MG [Cholestin]"]}}
{"label": 1, "source_ent": {"research_entity_id": "HPO:HP:0011521", "canonical_name": "Deuteranopia", "aliases": ["green-blind", "deuteranopia"], "definition": "Complete lack of the M photopigment, which is replaced with the L photopigment. Affected individuals tend to confuse red and green. [DDD:gblack]", "other_contexts": [], "par_relations": ["Red-green dyschromatopsia", "Dichromacy"], "chd_relations": [], "syn_relations": ["Deuteranopia", "Deuteranopia"], "sib_relations": ["Protanomaly", "Protanopia", "Deuteranomaly"]}, "target_ent": {"research_entity_id": "OMIM:MTHU016525", "canonical_name": "Red-green dyschromatopsia", "aliases": ["red-green dyschromatopsia"], "definition": "", "other_contexts": [], "par_relations": ["Eyes"], "chd_relations": [], "syn_relations": [], "sib_relations": ["OPTIC ATROPHY 1", "OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY", "OPTIC ATROPHY 9"]}}
{"label": 0, "source_ent": {"research_entity_id": "MSH:C564151", "canonical_name": "Hypocalciuric Hypercalcemia, Acquired", "aliases": ["hypocalciuric hypercalcemia, acquired"], "definition": "", "other_contexts": [], "par_relations": ["Hypercalcemia"], "chd_relations": [], "syn_relations": [], "sib_relations": []}, "target_ent": {"research_entity_id": "OMIM:603313", "canonical_name": "ALG10, S. CEREVISIAE, HOMOLOG OF", "aliases": ["alg10", "potassium channel regulator 1", "kcr1", "alg10, s. cerevisiae, homolog of", "long qt syndrome 2, acquired, reduced susceptibility to"], "definition": "", "other_contexts": [], "par_relations": [], "chd_relations": [], "syn_relations": ["ALG10, S. CEREVISIAE, HOMOLOG OF", "ALG10, S. CEREVISIAE, HOMOLOG OF", "ALG10, ILE447VAL", "ALG10, S. CEREVISIAE, HOMOLOG OF", "ALG10, S. CEREVISIAE, HOMOLOG OF", "ALG10, S. CEREVISIAE, HOMOLOG OF", "ALG10, S. CEREVISIAE, HOMOLOG OF"], "sib_relations": ["ALG10, ILE447VAL"]}}
